العلاجات المحظورة وامبراطورية الطب الحديدية - 39474

‫ﺍﻟﻌﻼﺟﺎﺕ ﺍﶈﻈﻮﺭﺓ ﻭﺇﻣﱪﺍﻃﻮﺭﻳﺔ ﺍﻟﻄﺐ ﺍﳊﺪﻳﺪﻳﺔ‬
‫

‬
‫ﺍﻟﻔﻬﺮﺱ‬
‫‬
‫
‬
‫‪ ! "#‬‬
‫ ‪$ ! % $‬‬
‫ )(‪& ' $ $‬‬
‫‪, & ' $"+ *$‬‬

‫

‬
‫
‬
‫‪-% ." & $/%‬‬

‫
‬
‫
‬ ‫ & ! ‬
‫‪
" # $%‬‬
‫('
&
&‪$‬‬
‫
‪ #‬‬
‫‪$ $ % 0 1 2$34‬‬
‫ ‪5 6‬‬

‫
)‪)*
+(
, -.‬‬
‫‪"#/01 #.‬‬
‫

‪"
2
&/‬‬
‫
*‪#
– 0
3‬‬
‫
‪5
366
"
# 7 5 0‬‬
‫‪#
) "
8
0/0
-#‬‬
9
0
:6;
#.)

5
-.)

& &7 $(1 '
) 8
9 #$#
: "#
; .
$ = : *$ #( <#
, $ '93
9$"( )$ $$ 9 ; ..$>:" $ $
& 34

A$ 7 @ )
$" (
$1 B$ .$

8 .. = %
" 6$ ,+ C)
)( = % 1 $" .."$4 $
3 "
)! 7 9 #
=$ ," 2
% $ ) % ..:$!
DDD"+ DD% #D
, $
$$ #
$/ -$ $ ) A
DF ! % E$ & ) A
$ $ G $>:" -$$7) '
")
6 C , % H I
1
"<
*
=

# 9 # (0

>
?
&

?
&

&
&

&
<#
@%. %*
5&
0
*/ 9/#
?
&
; A
5)

A "% "5<" 30/

)# ..; % "
0
)#
.3:#)
B) "&
G
%1 " 0( 1 A H =% I, & =*/ G"
& !. A& ..E) F

.; 0
J %% 30
#
" 0 " =*/ & , 0
"N A&
? .; 7/F 50( E:* ..E:* 5? E, K < ", K
6 9L G+(1 H6< 50 M& =*/
5 O&J 9</ . &
)* # " : "
/ G

0
=:
00 O$
7 # ? I6
G0
P M* 9
? 5#, " * G<
L <
)*
%*
"
.3 $ @ , Q/ @
&
@/( G (1

G"*/
. 9, 00

9P
50 "J :1 @#
0)
/
? , ..9/ 50 = E* >0, ' !*
GE / S1 ". E & G>0, >0,
9
< 0
&

. /#, .. &
&
> E)* >0 , "&T
/
=
I&

" # 9 ", 0
G
% 0
" ?./ P </
Q/ E:( 5)
)/ ) A "& E (, -$ &$#
&%
)
//F .06U Q6V 3 T , 8>V ", "
= ."0& "6
9< +01 9 G9
)
1 / %
! G
A ) ? ?# "F(
.. +6&? 3# E.> ) E+/ &% -6
>0, . 7 )
", 0 G)
)
91 + @0 6<
P , " @( , $&
M/
%? @/ = ' , I6
GI(
#
5)
, )
K < "V0
. . L #
I, G"..> , T

.." :")
"
" O&
5. %
5>
@ " B) "&
. &
O&1 " . M* I, ./ "0 ? &
G@& 300
9
$# >0, '

N , G
:
91 +
A
J P

V* K < 5< . # "0 "0 , &
&
:
W:
H6< 0 "J 5& 5F/
S* E ' ,
(0? =% 5)# I6
0
Q/
A 9 +/ , ..E.> # V* ..X / #
I<#
" # 5% " */
9 O& GE// @ 0 & # ? 3/
", , XE& E, ):
?
& < 50 A
9&
8; "6
..."#
..S
"

)
6
)

X=#, 9
)
K
60 9 5 ,
6< ' A& G$0 50( $ ) 8 "$) =% + *( 50 A 5) / L 0 P& K <
0
5:
%
! G: 50( (
Y#
, =#
@ E E* ? =%

7 "V 9/ , % ") !
", .&
L
" E <) (5
M*
) Q1
9P \5P 9
* 6 9:( 3/ "0
.300
6 / * 58> ? :$/

=(
A $
51
0 '6 9, " ")0 & , G& @$# 6 # P "
9)# "3)
:0
"
S1 A */
..9)
9P
'

0? "0 9
6J 6< G9<0 % # 0 , 0 50

" @ 5
3#
T% 6< G5 I, K < !
G8 < 50 <
& " H I6
"V
5% .3%

.+( ; =*/ ? ..$6
GM/
9
@( @ V Q

9
S "0( "0 ", I, G:& =8%
Q/ A B) ,
G)* L < K
6 L +( I, G)*
< 6< "V / , = "& .@/ I6
5> !: #
9
6< "0
A&
>0, & ' , O& @ @ V( I6
"
A ? G:& =8%
< 6< ..5, "0
A&
Q&J * "%
(
)#
(
.5, "0
A& .. & * A 3;
#
+(
"
GE): E E; "0 G@ I6
!F
7
+( 50 "V 9#
" A V( GP
)

)U
$
0
9<:P&
/
&
# #
" !".."*(
5, ".." @ V )U
G )# 5
( 0 .@6 < <#
"0
G'*/
A >0
$;
X9
$; E:( "V ) 5< .
*/
I, K
60 G =#
I, ."
' 0
"*&
= 0
@(
A P&
3#

. /F " & %
#
0
!
$9 I6
< (H^ A
J ..# //) 0&

" !
G50(
6 1 "0 ",
" !
G$# L _* 6< 50 ", 9) "0 "0
"/ S @ V 9) "0 . ) > 300

K E)# ", A
J < 0 5&1 $/ ",

50 ; =*/ G@/ " )
* & ' U
@ , #
GE# 5( E# I% < GY`
"0 K <
.50

/ ; G+(
# P
") ">0
5)# G
:*
P
H6< ; A 5) 7/ 30
6< ", ,
& :0 (0 ! 1 G 0 , <# "0 ? /& >0 M:& .@
V I6
=%
1
"/& ,
M.1 " 0 # 5)
3*
/ "
5 , 5 7/ .1 A & )*
..5
/ @ " HL, " %? "6)(
@% I6
5#
6< .(<
A
J )

6< .&/1 ) 9
)
% > 78 O& G
)
M/1 %.)
%? &, ) ' V
F 0, 5> G)(
//
*/
A
J /
01 //F
= K(
I %? 9P

.!
%/ L I(
":0
A
@# I6
:6;
9P
A
J G1 7 *
-.)
;
01 3
/1 A 0
?
a&
& I )
"/ ' , .< "0 ? /:
& A
J Q, G)
//F
!
:6;
0(

5#, :( 9 % .//
)
//F
5# 5
5# " :
F
H6< # !F 8(<
:5 0 5& >0
$*
#
" $&
(
+/ 3#"
"</ !
/

=%
", "0
.HL !
@& < 3/
-.)
..@
& Q, < ..@/ 3* @ , "/ /
( A 50
? # (" ,) " ) ".
5. ."*(
" '%, < I6
=%
6< .E 7
."/ & E//, 9 ? 6
# @#, I6
*
9P
6< .I )
01 3*

@/ 9 .1 @# A "/ J 50 & * A

J 5/ I6
G
)
*
9P
6< //F A 7$)
"0
G"0, A& , "&# , +*, " "F/ 908 V "N ")% % .Q, -. 5:/ " HL "
!3* I, 9 " !
", < $
&

$() ., .
)
. $*
@*J
0, @P & , G"()

"
5:, 6 0 */ & /:

)
1 0( 9P) =
9)
/
5
6< " 7
.;
9
)
)
//F
*
9)
5

A +`
/
:)
" # 3.*
"<6, !;
E 9$ / W 9/ 5#, " < 5#1
.0
1 % A S1 M8 /
0 .I ."#

>,
" 0
1 9/ 0 $/ 98)
)#
0
* /
0 P M;
1 0( ! G%
! .#
&
A P&
&
/
0 " &
A < )
)
"$(
"//
A */
A
J G(E//,
E0 "0 %
) 9. 5:/ A E0 E>V 0

5:/
"#
) "6
+*1 , ./
//
3
& A& 9 9 5. " "
9) "

&
9 9 G&
%
G0(
H6< @$# " 7 )* 3
/,
.
&.
") G(//
=$: #$#
#
) G9
9
)
+& , =# :/
$*
* H6< !/F ", < ) 3#
&

@> K
60 .# & E) / bc " >0, B G0. "# < G

&
5# &
/

I, ? 9
<.0 ", <
&
H6< $/ .E, &
&
) / cd B I6
G;
. "#
" 5F/
I(/? 3*
G0
1 3 # A
J G )8 0
(
, 6L1 "
.9
)
3)( " @/ A I6
*
9P
%. I, @
!
homeopathic E>< E#
) "0 &
4$) A

/,
9P
, /
M/
# I, K < ) 9
G9ecbf 9)
)
&
?

."+>

5# J" " )
ee "
F // (01 I %? B&
) ; 0 , 30 G9ecbf 9)

& , 0 < "1 G&
?
"0
) 9

/,
9P
/
M/ "V 06
/ "
.K
6 &/ 6J ?J &/ /
", !0&
K
6 G+( 50 "0
S ."@
$/ P "0(/ =
6 ") 5*1 0 7/ G
"0
" :; 0 7
5. " $
9P
6< !0 9 G/
M/ @ E * EP ", (@,) +>1 A ; 0
50 "V ? / A 5)
.9P 60< = 5)
A
5#1 3$
!
9)
A */

Q/ 5)
' ? 0&
5)# .
@& E&# "0 7/ (
5 9)
9 "
!
$*/" G.
I %? 9P
A 50
*/
"0 G*
H6 .)
(
H6< A ?
"#? "/
" ; # I, 5*1 5 = /
H6< ", A
J G9) 98)
."3L 3/& @# @)# +( 0 =#

% 9 0 "6

F .'.8
$)$! . A

* 5% " G$&
I,
)( & G&/
01 &
A 50
*/
9 G9ebeg 9)
6
3 9. 0 0
:#, ; 0 0 O G@*J 8 @ ) "0
."L.3.-
< %? #? //
7%
%
&
+N ) " 9
@ <( 50 "J .0
.I Y "
$ J
G"$& G380 9 " _( "

7/ .9 5# , G"> , /. 9<?, , !
+?F< " 5)# "
7/ ..."
G"// G"P G+*, G"& G"/ G"/
G"
" ") "< " O& "
7/ .+, , G+)(
+?F< 3 < G# , 0 */ < , 3 ) 3#
$
...9 >0

O& G
5#
* 51 "/ 70 98)
*, 9P 9 7/ K
6
.0, # "0
"N < 0 9& B)
!

"...5&
G"80
G5
9, 9:^ @ 9 E E?0 >0,
MNOP $ J 0 "J$F L$$" J# & " A
G

0 * J " 5$1 5F/
< Frederick Gates "!L K" 8%
)
$!

.0 //F
9)
. (/
G(Q(
)

= !
ebeg .0 )# Q&J G9)

)
!#
+,
L
3/& 01 >
@#
; 0 , 0.I."# 5% " 9)
)
!#
5 !/V 9
9 )
!#
6< 9% .

9# M/ < //1 7
O& 0./ > A
J &
, .(0
1 -.)
* !0 <,) )
#< 90&
*( ?
". 0
)#

.> ?
M&/
< < "0 G
$
Q(

)
//F

&7 "")" $#
;
3*
/ /&
5$&
*
" "N "6)(

, Y(
" "
")0/
<h+*J "0 ? *
!

? "J ..."

H6< A
J "
% <, Q M%
< @ !& , 3 ") 3# GE "N " ...5L1
"...(

E) G@ !/, A % H , I6

G9ebef 9 !; 0
A
J 9
" /0" " * H6<
0
1 9/ ? #. 9P I, ' ," :^ A ) .#
)
3<6
" #
#.)
9/& $&
."> !/, I, A / ? 1 Ga
) " P, G % L * 6)( ) A
#
)
!Q") ) 9
@ , 0 .$*
9)
5& "; 0" //F 9/ @ 9 I6
(

3& < /0 9<, "/ 0

./
*
9)
0
#.)
"*
O&2
0 //F" W
9 5$, !$/F "0
!L K H$/ /0

/
A (9)

) " /0" G"*
O&2
0 //F" + !# 5$,
G#
3*
5# ""/
"
" A& ? G& ) 9
Q, & A 7$) "N
:
9& 5. ) 9
*/ 50 9 1
! <$ $&

!!! 9ebie 9)

V "7 5" 0
G&
?
+*1 , " 3* ll 9$0 G9ebie / > "( / jf
:1 "*/
A +

) / #J " 7 0
"0
."1 50
"
& +(
.1 A
J 0
1
:5F/
S* 0n @ , G/
H6< A 9 mg ) "0
!!Q $ $ -$ $" 9 $A
) A 7$) "N .K

6 > &
A H 9 O& 5$) "^ < @
I6
+
",
"

:""/
"
" ) ?
G &
" M:&

29 C)S 6 $ 0

$ ! 1
Q$ $
$" 9 9
9, $"V 9+ 9

/ .$:

@ /

#& " &
A 3#
" 5# )
$:
0(
%,
:
0&
" A & ? K < .I(
9/.
/ / ^ <
$)
? 50 #, :< N "&
" 9/
$
$) >01 Y
"0 G0 & E, $/

E * &
/#

5< "0
.@ K0(
+
./ " 80V
5#, " &
A *

:3#
5& %

M:&
.X (

", **
3.0
"0 "0
GE / J 5 ($/ $% @( $) scopolamine "?0/
" 9Lj 0 "J ...."
=*/ .!3 2
& 9)* ) @8 0
0 : A ", 9/ *
"0 .!$
: A, # 5$&
G"/, "

0
5) ", 0 3) " 9 ", (
" K:( "&) 9(

$0 = ", 9 L1 =*/ ...B#
" 50 - 9/ =*/ K/
& J 0 E/ @)
>/ 3/ G"/ oU po I6
"
.(
9/
% 0 5)/

H6< G
"
G+;$
*
9/ )
=:(
!
!3)>
5 ",
&
"0 Q, & " .":
**
Q
$ #
"...guineapig I

<
5$ ^ "& 5 G:1 " ( I6
"/

E$ 9 ) 2"$ = +" ')
W / 7/ G&/1 ) 9

)
0, > ) +
% ", & A ) ", )
+/ < H# 3/ GH# 3/ A P& ", " +
=*/ ? M.)
I %? B&
6< "V (
9</ 9: A P& 0
// 3
/V 3&
M.
>n &/1 ) 5) 0 .$&

/:
3/
.#/ ! ") /
$*
9P
/, +
) ", Q G&/1 = 5. "
:

< E >01 &
"0
.1 0(
) % E6J )
1 :1 ( ?
)" $ =T $ !

6)7
$ +#J *( "* (0 : E ) :6;

1 0( A ":
=#
", " 9, )
#? H6< .eugenics @ /& 5/
& 7 )
/
F
<$
( 50 980& "0
G3&
+#
" 0/

" &

$) 5:/ #J < <, Q&J .E?

"V 9)
= .E, *
)
H6< * 6L1 0( ", 806 !!3# >0
) *
0( */
% gf = !$/ #
) %. 0( ! 0 :6;

# " %bf
/
1 +?F< 5% " E 90&
9
)
6< B)

5? 5< .<& Nestle @/ Unilever
.X"

/ 6

!
5) G5)
" +*1 3, )
9 .* +

#
>V
3/ (/
( 7 " 5 &
?
ebmc 9
H% .+*1 5% " 1 7 (
+/ 3/ &
?
( mj,fff 5% Gebbe
* ) 6
.E >.> M / &/1 " *, +*1 5)# G$ &/, & jl,fmi
Q/
A $&

5# 5:1
") &
?
.9
)
5 % A $< >V
."
" ) 9
)
5 % E 68 &
?
$&

9
5 & G
)

?) G9ebmi 9)
50 (
.
50
+*1 3J ) G&
"*/
9s
GJerusalem Burial Society A
"
"9/#" )# %, + &J M ./ A , A
J
gj
K < +*1 3, O& G9ebmd 9)

0 L & ( 7P .7
A
J
:" K
>0" & (, 0 GE
*
" &
&J 5% " K
6 " M&
9 % ".%ig A
J
Q/ G3 5."
5. K
60 G
0 / )
H6< 0 % .National Morticians Association of Columbia.
0
.9ebmc 9 &
0
+*1 3J
"0 ? =:% 0
G(

H6< ")
G'#
, < 7 < M:&
H6< 06 9 #,
5:/
" >0
@ ":
GI
*
@#
6< +(
+*1 " >0
G 0
:>1 ) 90
J GQ# " "0
G

$ A 6&7
>0, 6< 50 – +

"N L =
5< G1 I#
Y
G/
$

(

. -
"
M 5#/ ,/, K 1 *J " 5)#
$ !
># ; $ B/ 1 2$ 6$ /
John Braithwaite 6$ $ )
* EF
0&? >0, /
< GAMA 01 *
&? / /
G*
0&? * $"J"

#.)
5:/
$"J . )
" I, &1 " 3)( "F( ", "0 E* E#) <>0, 5
"6
AMA 01 *
& ";

5% " 7 ) 9#T 7/ )* */ ^ 3
/, 9/
@ 0 98U 7/ *
& = 7
& ? 3* 50 $"J .9s A
J 5
5&? Y
7
A
J "F#
G E ( ", I6
$&
9 50 $"J .!
& 6< +*, 5% " $U * 5$#
+*1 +?F< 5% " E @# $9 7/ GS
A& , 5 , $/
1 A
J +#
" )* 5:/ E/
">
= O& E % @&. A
J 3*
)/ 9/ "<( G" S# 50( @ O& " )

".E
L
L $ $ – F$ ' H ) 2J. W. Hodge 8 9 $ . .8
E# ? G3:$
) 5% "

G+
//F /
*
&.
.& "J"
0&
# M/
" @#J 50
H 9/ (E) E*/ E* , E>& "0 6J .50
&
."@ 3
"&
3),
$9 $ 7 ($ ." 2 $ .,A .J$
+/ .& " "6

"0&
7<, 3/ 0 6J ?J G1 9/ ? I6
-.)
5& &
=% $9
"
, " "#
)
, 9P)
9 M* " "#
)
, ")*
"#
)
5% " ! #.)
M*
H6< 0
E, , "
9
K8 n G9
"/ "6
+0&
+*1 5% " , 3(1 "#
)
, " &

."Q0
7&

$9 $ 7 ($ ." 2 $ .,A .J$
& $$ #$#
$ G(
&
" 9& +# <
$", 0 ( G9
)
+& , 9P) G1 0( &#
Q " $&

5$) 9/& 50( $*
9P
9% G@>

)
(
5. " .1 )

."<#
0
%)
" :& & 9# 9 G!
" $)
0
$&

-.)

$&
A P&
)* 50( $# G& '
$ .)* $& "
(
" 01 9/

A )* % @
G5)
K
60 G9/#
"1 G , 5& 58 I, & 38* E .)
Q #

@& 3.
9 9
I6
G)
H6< '*/ A & I( ":0 # 5< :< 5F/
"0
.
+(

3)

#
)8
:6;

5 G9)*
'
5. " G
", 6 @& *
*/ B)
* G3(
H A
J

"
00/
;
(
G6;
"

!!X @ # H0 (
/ A *; I)/ I 0./ 9P
! ) 8 9 #$#
!
M:&
/
6< ... &
5
5/ //, 1 < 30
")/
M:&

*
W
6< / 5. " ... V*
"0 &

& J G#
" # A 9$#
, < 7
@)# I6
3/
*
9P
6< 6# A 7$)
5& 7/ .@/0 @ @//V " "
F/
A
J (
A P&
E ) 9
+
", 7) 7/ <) .-.)
*
H6< p
H6< ;
H6
", 7) 7/ G*
9P
6< +% ) .:*
&#
)
, O&
5 & 5& ?J G&

&
&
* 9$ 5 5 9P
6< 5 /
< ()
5*) 1 5$) Y (
&
9

.
"
(
A ,*
P

" !/, I,

!
Q0 60, " < O&
3*
)
5* " *
:/
0
"J :;
GO&
*
W
6< " =/ 9

:
M*
B)
:
5:
" >0
K < 5. .&

9P A
J +?F< & * < < /
. / egf eff " "() (, <, " E):( 5?
.:6;

F
A +
</
< "

" I#
- P
&

8)
H

</ 0
G<L
/
% "/
5> G1 A %
1 #, 9 , '& .E.>
0

& " .E//, E "0 G &

5) 0 /#, >0 A +
%
!
< /:
@, 3/ ", EF " I6
."/ & A ./ E , >0, , #. )% GQ,
" ) 0( .H^ A
J .. E E/ E: E:6L @ 3.
.0
9
)
/, 5% " @

&
*
.H)/ H
E ) 5 " <L #
:

? *?
)
;
0(
7
<
%.)

)
K./? 0 ; K/ A
J 5$& %
..E# 0
GI/ 9) .9/& 9/& $
*
9%1 9:% " " ; 9% ./ #

8)
0(
H6< " &
&
/
.(

H6< A 9$# , $# " 0,
.
< E: )
...$&
9> &
A 7$)
.&
) < *$
/
+# 6 <) "0 G- /? "/& 9> " G)
30
6< )
9</ ", #,
.5$1 9
< < 6< .K&

$ ! % $
//F 5>
*
O&
5# A E. $:0

98P "()
"
" 5$1 7

5 */ 0
*(
# 6< Rockefellers 0 : & .$*
)#
(/
&

)
!/, A E O&
"0 O& G&
?
$*
$0
)#
$
< ' O&

K $, .

9)
!# M* "
)
$*
//F
5(
//
H6< )o/U 9> ($
I0
+
)
#
# O& "
= (. G "0 $
I0
)
!/, A $
L O&

.I0
!/1 6 E& >01 :
=(
&
I. G. Farben " .- .I, *J 01 0 *J " ": I0& &8" +( J 9 Gebib 9
&?" M =# 0( 50( A ) P 8 0
G" 0( K0 9
)
3&
) .
1
0( GBorden " 0( GICI
$:0

0( :0(
H6< "$ G":
I0&?
Pet K GNestle @/ GM. W. Kellogg t0 5 9, 0( GGeneral Mills 5 # GCarnation "( 0
5L 0 GWhitehall 5< GBristol Meyers 5/ GSquib and Sons H?, 30/ GMilk
#
8P "$: "0( ) GHoechst and Beyer (< GRoche B GProcter and Gamble
0( K .(J !# +/F0 Fritz ter Meer Fredrich Jaehne"# B "0&
3&

&
?
$:
9/1 7 " Chase Manhattan Bank " ( 7 = ")
"N 0
'
G+
) +# "
E&, +
/0 3&
6 .9
)
+
=
=$# 0, <
.&/1 ) 9
)
9, >
>

)
3&
5%
, ".#.I, 0( 0
"
: $ %. 5# I(
":0
$&
)
M8) G"()
&
"
G9
,
= (I0
+
9/ A
J
& 9
)
"0/ =#) 9
)
50 =/ ( 6 < G& , A ?

.+
)8 IV

S1 " " *
5% " M J
5
50 3*
/ ) $&
< $&

//F $L, A "N 0(
H6< */

9< & & & , 98 0
GE%> E , >01 #.)
u$
E&, +*1 ) 9
.$*

<)
" +*1 -$ ) .(Q( 50( A 51 V E
L) 9>&1

+
0( A 9

#
%)
1 " 5:
90
3)/ ) "# G1 0( 5% "

*
0

90
"J .@#. / 9> / 3*
A 3#
GM/1 0(
&*
$

", O&
&
=
A
J Q, 6< G1 ): " E//, V 9)
3*
5 &
)
" 5:

" -$
) //, 50( )
")# G9<
<*)
$:0

" ) +*1 +?F< >
. G&
&
" =
6< W: , .1 K ):
8P 80, Gebcf 9 .&/ jff,fff " M/1
$*
&/
' ,
9 .O
>
9
)
$# $& 5#, " $ < 1 " Y jlf a", $
)
$&

A ;/ ? " ) Y 1 H6< " jd $# a"V &
92
)

*
8P &$ ebce
."
+( 9< $: 0( I, Q

# ? .&, &
"0/
" (
&
+/ A $:
0(
)

$:0

= # , M &
+/ A P&
=/ / 9< 0(
Q
.A

5 .
&
3/
< "0 E "
, #
)" Y % & &
+/ ( =$#( 7/
5# :
P
#
@& 5. G$#
$)
#
John Braithwaite O "# 0

:1
>0, 6< 50 – +

"N L =
5< G1 I#
Y
G/
$

(

. -
"
M 5#/ ,/, K 1 *J " 5)#
9 .* +

#
>V
3/ (/
( 7 " 5 &
?
ebmc 9
H% .+*1 5% " 1 7 (
+/ 3/ &
?
( mj,fff 5% Gebbe
* ) 6
.E >.> M / &/1 " *, +*1 5)# .$ &/, & jl,fmi

5# 5:1
") &
?
+*, a"1 * Q, 5 A $< >V
" ) * E 68 &
?
$&

9
5 & G
)
Q/
A $&

."

$ G&
" 9& +# <
$", 0 ( G9
)
+& , 9P) G1 0( &#
Q " $&

G5$) 9/& 50( G$*
9P
9% G@>

)
(
5. " .1 )

."<#
0
%)
" :& & 9# 9 G!
" $)
0
$&

-.)

5:/
u
",
"$ G/
*
02
I &
, 5
)
W
9
980&
5. "
.Q1 #.)
u
" <L 0 )
O&
& " $# E <# a9 % -.)
$)*

#
)
:6;
3*
5>
=

$) u "/& O&
$&
3/1 PT
#.)
,
3 " E 8 , A $:
8P
5% " v U G9. 5:/ w/ 50( # $ $)*

$&
5&? a &
0 G1 0( 5% "
P .& A &/
" <& 60 9 G6)(

.Healthwatch $&
%
P "N A/ & ,
Campaign Against Health Fraud
" < "

" "% 5* w'# w50( /
)*
#.)
# +(
a", 0 E, %$/ %
A
J <(
9. #, */) L.J 9 E
L ."0 6& wK( 5)T ", 3# "5:"
K0( +*, 5% " 3(1 -.)
M* +/ 3/ " ( , ( 5T% , $x 70 (/ )
.+*1 5% " Q&
0 YaT
$
1 $ "6
7?N " %
! 9) 9
8 0
G9<V
.)
H6< 5)
)
< I)
+
9
"@$#
9."
#.)
a", "+0&
" 9:/F A 3(
")
+*1 9) 9 G;
@#
6 o*
5&
A
J 9: )
&
#.)
" yI, 9 5
# ? @8 V 9<$) .6)(
( < I
;
o3*

) .Y
E/
(J 0& 5#
6< " O&
8
L GE.> &
%*
-.)
0 G

9> G1 0( '

E
)
O&1 /
" :
0
K 3.*
, K
6
$&
P
# @0 6< 5. " "/ O& G1 O># A *
" / J.
" )
!

.$
+*1 9)
%
6 G<
)
98)
& 5. )
M1
& " -
% I, 3(
3*
!
:)
P
9P) ) t
5/L *
H6< .X)
#.)
3
/, " O&
@
&
%
& A P&
:< /:
00
.5 @
!
& I 9P A
J , 5
% A 5)

9 G! G50V (
' # A
J #
9
)
" 5) ? G9
)

" 5
9

&? >0 9%
&
H6< G5(
" 7

& 58> / 5 A
J .9
)
A
.9)
& 5
&

_( 9P
6< .P
"2
E @( $ I: 9P " ' , ;
*
9P
", E&
9 $# 0V @
/
<# " *
&
0
Y 9 O& & $# A @
J "

/ G5
G@, "5(
" 7
" !L A 5) P 1 " Y
6 .+
A H/
9P
'

9< % A = I6
", Q G%
! .9<<# 0
" "N /
5"
)*
5
"
5#, " # /
<
G/ #
)
1 0( 5 G"#
) , +*, !
&
9P
6<
*/
$/
5&
#
P
= G/
+ G9 .*/
5
5#, " 5 /
.9
)
A
50 (9
% "6
) @ ":
@ ! I6
%
/
E 3)(
" *
9P
)
& 9</ 5. <
&
" 90 9 ? G6
*/
5
5#, " )
0
6)(
3
/,
.9<, M&
/ O& G

&
@)// < 1 0( @/ I6
0
Y
A '
'
5>

9/%, =# A
J :. 3$/ 0(
H6< M Q " 7(0
GAIDS & A % P
) M& 5#, " K
6 50 G"U 9 G*
!
) < //1 9< G$&

9P Y
./
*
P >
G / J #0 V( ,
$1 8P
G(
/
>
0
1
& ' $ $()
I )
$*
W
"
=*
)
$ !
% 30 "
"5 .I, .!" 78
F
"* ( &

M/ & <) Morris.A.Bealle "5 .I, .!" "0 G
"
" >.>

.J &/ I( $&
+0
0( 0
G)*
Q&J 8& & (
<
M% E: 0 O& Bealle "5" A &/

" 0 / *; / "0 1 6< .Y/, 50
:/ "
"6
:$% ) " = E? &
( GBealle "5"
E) G91 Q&J "0
.0
0( /& I6
I(/? 50
5% " @& <J 0 "5 !" A G+0
0( 5% "
#
0(
>/ )
( +;
J A
J IF/ "&
**
#" I, "V H, .&
Q
+0

.#
! . 7
;
0( " 50 +;
J K
60 )

5& @ 0n "0 .&

5)
K ", <) $% G" $&
" &$
A/ + 0
&
"5" K, <
? "N 7&
I& "n G(
7/2
"0
G . 1 0
*/1 *
A
J @8 1 K
6
./
&
" P&
6< "0
".> " <) - "$&

&
" 5# A/ 5& E$) E: / E>& I#
$
@ "5" ")/
9
E# 7) "0 @ , " 9L
A .Rockefeller 0 5 G1 % :" ) < G" "&
) ?J
K ( , * " "0 9
@ , ?J G ( >
@. A
J G"&
&

6< "0 .eblb 9 "* ( )
GThe Columbia Publishing House (

0 G
@0( V( ,
@ 7 6< !
, G"")#(
"* &1 ." */
%$
M*

& A E$/: E?>
9 G&
?
//
&$
5& 30
9<, &, < " 1 % " 30 $", " 9L$
A .X 0,
GK
6 = .
E$ & Y "0 G& I, 5% " @ O&
9 9
0
0
5% " @ 7? 9
GBiworld Publishers
( z ( +/V ">.8>
>
>
@)* "0 )/
H ,%
.Utah H GOrem 9,
u
/ 0( .5
E$# E ) >/
5
!, " %d *) I6
5)
"n GBealle 5 (, 0
G"/
>
G:
0 *J */ 0( Q%, 0, < GSterling Drug, Inc 2
; 5 , " G3:

Y*% ) E? ji,ldi,meb ; % ebde 9)
#
<: 0
& G0 */ Q, 0( < Squibb "30/" , .%gl / : I, GE? li,efc,efd
.0
)

" %gmd 8 J %d * !
) 9
&
=
&#
1 30 B#
"&#
*
30 "0 G
3&
/ 5. ,
$&
5# #
+ E.) 9/
H6< "& % 5 G1 K >
$) I6
. =
M$/

J 9<F. G0 0( K( 6
5+/ 5? " K < 5< .# " jff "& 9 A& G"01
B#
)
$*
M

5)
30

#
#
01 )
&
30

1 6L1
50(, =# & =% 7 G.
+& , 7 "&
"
F/
" 7?N G&
=
1 30
) 0 //F " I / ^ ":Beale 5 5 !!!X 1 9/ 9 A =#(
-.)

% G
E ll
5. 0&
//F
?0
)#
!
0
//F
%

)
=# .* "& )
//F
H6< "n =*
.!? 7 A # ;

0
)#
) = 5)
5 & 6< GQ, < K < "0 " ?J G+
5& ) 0
.E
=* G3601 9) " ) 0 A $

W
" GE? c mdl lii u 8 G
):6 *
0 = GHarvard < )# ,
Johns Hopkins 0< "# )# GE? m bjm cff A & Yale 5 )# .2
0 0( )
u Washington University in St. Louis !
/ "* ( )# 8 GE? ef lec gie A &
Cornell 5 0 )# GE? g ljl ime u 8 K Columbia
0 )# GE? j clj emj
...H^ A
J ...H^ A
J .....E? e mfb fmj u 8
0( & @# < 0 G, W " "6

:.)
u

H6< Y$ 0 //F 0
/$/, % 0 0( $", & - /? 0 Bealle 5
O&1 /
/ ">.>
0 . I, M

!/1 < *
"5, /" 0( 0 =*
.I( 5 / ", "0 $ *J 0, a*

0, @)#
John. D Rockefeller 0 I ."# % .$
0 *J @ I6

!/, "0 .E/% <# A& , / "N 9 "0
G=#
Q
) GE/( 9<>0, G
; "6
"

"" !(" K 9/ "N 7)
GChase NationaI Bank " *
!(" K < :

@*J
.Chase Manhattan Bank
9/ 9
)
1 =
0( # 0, 0 K 5 G* 1 # A 0 9/, 7% ?
GM/1 E E ejfff " >0, K < $", & , .1 H6< )

@
/, @ 0J 50
.0 0( ) ? , 6 Ga
%)
" )
P //V ebef 9 9> .9)

9)
) M 9/ Gebfl 9 0 //F !/V 9
51 " >0
Y

M*
5. " G9)
9)
) M & , #& G0 //F 9/
.ebei G, Gel K )(8
:
" & A 5 &
" "0 0 )

.?
=# "(
&$
V "
+.)
" )

0 # ", _#
" !
GK
6
, G)

1 A E0 ) 3)( A
J 9& 7 G01 9)
I,
" 7>
" &
H6< 9
I6
>V
M* " GE^ !
E, G@#
". M* " $9> /
5<1 M* " 80 "/ K
6
. .J (
%.)
9. 5:/ A //F
@0
9 6 , &

?
Q0
0(
", Advertising Age "". " A/ # O& P, %
H6< " .)
?
"0 K
6 GE? e efl jjl iml A
J 5 ". A :* u
eblc
("L ) 0 A
J )# <6
) 0(
'

6 G"L 0 0( G:
u

9
' , I6
3.
6< G1 &
5:/ 9)
I,$
3.8
P 0 Gu

H6< " :
" >
.M
5#
#
HP 9L M/ % I, " (& >0,
*(
0(
K
)
) + 1 ?0 A )
./ 7&
>0, A&":", & A
J Bealle "5" (
(/1 "
1 H6< "V K8(
" "&
3/ K < !
G<, A 5 &
(Q0

* 7&
%$
) % International Press Service , GUnited Press !
, Associated Press !
E& /
W8
.& + &, "0 G&
."/ O& 6< "0
G&
V 9 ,
New K # ( Arthur Hays Sulzberger L/ <>^ "0 Associated Pres ! (/1
.! (/1 I& Q%, 9<, &, "0 GYork Times
M) ) I, P '/ ? // ! (/1 )

&
Y %J 0 0(
5$/
" "0
W I, 5& ( &/ "
9< +
+?F< .0
")
: 5% " > 0 6J ?J 1
/
? )
1 &
" :$

/ 6< .)
9, ) 5%) ", "0

7&
=# &% 50 > 9
3601 " <L )
3 8
I0/
"*/
A
.# &
?

@<J I)

+
W /
, 5( I6
GEmanuel M .Josephon "/# .9, .5 J 0
(, %
"&
30
*
)#
+, Y %J " 0 +
0( ", A
J (, G ?& ) @J
9 A "% L ")
"&
":

)(
"V G "
5)
%., A + G")

(0? * " 9 G6
. (
)
(0? 1 )
<8P
% >J , &
. * :< 9, 9
K , $*
*/
5% "

" E/
/n E& {V* – 0, (
0, Q&J GBantam Books (
"9 " 0 6
/ 6<
", 5 G:% A "# # & 30 igff A
J Slaughter of the innocent"+1 '6" " ) 30
J #
0 G(0 */
") L) /
$*
%
") L 30 "& A
J @/
."/
3<L A
J 3<6 M/
" E.) 30
A, % ! 30
( 9/
K < "0 G(FDA) 6L1 1 J 3/& G@8 , = G

<, 1 "
Q86; 7&

K
6 G<& &
?
2
$ #
>V
3/ ebmc 9 (
"% 7 " H
G : ? M/1 Y
:
7 1 9P) $"V ")#(
">
3*
5#
/
&
9L
6J ?J G1 9/ ? I6
-.)
5& &
=% $9
" .5*
Q
A $6F , , K
6 " >0,
")*
"#
)
5% " ! #.)
M*
H6< 0 +/ .& " "6
"0&
7<, 3/ 0
+0&
+*1 5% " , 3(1 "#
)
, " &
, " "#
)
, 9P)
9 M* " "#
)
,
."Q0
7&
E, , "
9
K8 n G9
"/ "6

5) 6 9) "0 9

91 )8*
"V 98) ", I$
" G1
0 //F #
, 9) 9 0
", P,

"1
0
=
5*
30 " #
+ & "0
.I(
9/#
)
0 50( )# G
)

*/
" &
2
W
.& # ", 6 G01 1 &
< E )
&
%
", = 1 50
S
" "#" "N 5*1 *) .5*1 " E
>0, < G0 L )* 5:/ I, .&
+6;

+
M* " /0 "0
"$# $ = "
.+
//F @)
&, & (0 A :, " I, ") 3*
) FDA 6L1 1 J 9 0
" ( V "0 9
1 H6< .0 " 1 6 A & 5) 0 G5)
" @) "8/
+*1
Moriss 5 ! ( 0 G1 0 G(0 & ) 9
*
"5, /" 0( , 1 0(
)
G+

0 //F
/
#
<
AMA 2
01 )#
" V GBealle
) , <) 9 GK
6 L 9, ) 0 "J Q1 -.)
5:/ "
$# +*, +^ A
+*1 "1
" & %
-.)
5:/ 9P) ", 9)
= .0 //F '
= A( 3/&
K 9
J , 9) 9 9L G#. % , K ? 5:/
H6< ", % 2
01 )#
"

. E. , 5:/

: #$ Bealle $ ')
E# ? G3:$
) 5% "

G+
//F /
*
&.
.& "J"
0&
# M/
" @#J 50
H 9/ (E) E*/ E* , E>& "0 6J .50
&
."@ 3
"&
3),
"V S @ 1 G
. " 0/ " Adolphus Hohensee / << !
, 3*
0& $ G
Q&J
% AMA 2
01 )#
0 .)*
"
" @# A " =$( $$ 6$$(
."I(
9/#
/

" ", &$ )
*
P
% "
$# +*, (
$ % (
H6< ", 9
K
6 " ()
+*1 3$ GH !0 5 0& ( 9#
."
& , "

)
&
5#
5)

:
:% Bealle 5 , .FDA 6L1 1 J A
J J
B#
=
&#
9)
30
G01 +
"&
J G01 )
&
30 :0 0( A
*
01 G *
O&
)# G&
=
&#
1 30 G

#
#
G01
....9)
G=#
" =/ Q^ A +( 50 M& G0& >01 )
"* ( 9)
*
01 )
&, +
//F K .$*
5#
1 0
7
#
*) G&
5#
K 0( "</
0, +
&, Alfred.N.Richards ( .", .
, < .01 H6< /: ,
.1 M/ +$# " : M& 0
GMerck & Company H0(
G@6 0 //F !: @ 0 0 " G@

/ Richards ( 9% G&
H6< Bealle 5 '
" J.W.Hodge -< . .# 3 E.> *
1 & 8
% .Detlev.W.Bronk K . .7 <
)#
zE zA/ I6
G
W
1 0& "J ":$

0
@$, GK L ?.(
!
E/ * EL P
>0, J GE 9P
0&? Y , >0, * !
G2
01
3#( E/( E#< A G)* ^ 5:/ A
#
)
* I, $"J . )
=# 8 J * )
6<
.+< # 0 ) ? $ 60 8 , $#& )#
H6< % 5% "
W
+*, 5% " 5# " * 6)( " @ V 9 W
.& = 7
& ", " -.)
" " " 50
&
G$/
1 )/? " )* 5:/ /

&
A
J < J 5& & 50 ."/

) 9# O& 2
" )
;*
+?F< " ? 9 G
5 1 G:1 (

." 0 # A %, A
J
&&
-.)

) G$/ $ & llbd &&
-.)
"
0
0 /
M;/
/ ! /
)*
-.)

)# G/ $ & lfff 5%1 A #
&&
-.)
*
$0
G(
A 5 &
E.<F 3
*
' A& / 50
/ & 7
, A /

( 9 1 0& //F "n K
6 = .-8
/ & lijd & 3* L0(
" L 9 , A& , G0
3
<1 "0 ? )
//F
H6< "
+?F< ", 9

.1 9/ " 9< -.) " 9 1 * K
6 GE%.*J
I
L ) . !?0 3*
< G
8 "
")*
+*1 +?F< &, 9% Gebgc 9
*
!#
+ .
//1 "&? G&&
-.)
"
0
0 " - I6
Nicholas.P.Gremaldi
"& 5 &
9 # A, < (beGd) # A 5 & E)* E#
) E* di = 00 0 ?
.00 0 ?
*
:

:
!/V ebjm 9 9 O& .E# & V &
?
)
5#
0 *( >,
A M 0

G: 5 !,0 E? je fff fff u 9 G //F G9)
*

" " A :
H6< 6, .&
+ 3 #1 "//
A A& #1 )#
//F

9
A Q % : ) 0 A
J J GI(
! #
9<1
5 , A 0 0(
#

.0 :
)/ G' 0 G0 @ ! 50 ", ")
9) 9
.51 #

."
"/0
"
&
o
) 0
*
0( "0 G"$
9< 0
E: "0
@: , A )
Y
+# I6
" &
31 E6^ G&
*
"0 0 + G
*
:
!/V 9
."
5 1 3*
/ // ? " lg u 0 0( >/ % .+*/

", "* " gff Y %J " 0 6J 0 < " // , !/, A 0
H6< !/V $9
"& "6
G+0&
")(
9:*,
3(1 A /

N #.)
M*
=#

/
1 H6< .&
?

*/
1 %)
K ) M
"$
" "%
.3)
H6< A 8/
" #) ", )
#
1 P # Q, # V
/ 9

90 A 3#
M* "
0 1 9#.
) >J " +0&
"
+*1 +?F< "0 9
6J
+?F
/
<, 6 # #: ) "
G$ % 6 /
, )/ G
&
" 5:<
0 ) 9
GE 0 E, #
) 9
"
1 9 (
/ .";
"6)(
&$/

. .
0, 5
"
5> Q, 5 A
J <
3)(
&
G5
3& G7*)
=(1 & "0 @ , < & # A
J ?J
@&
% / , ", "0 ? .."
A
J #
5& % .... @>
$ $/ ** 5
!
6< "0 .;
< 5
) O&
A
J /
@<6 A
J (, G$
P
9/ P)
@P A M*, .... /
/
@
/V <$ 3&
/ ", "0 & 0 Q/ K < !
."$
E/ ?J !
6< G@/ A 5
0
%
/ 0

"....D( ..6< 50 A
J
"0( " 0 Joh.D.Rockefeller 0 .I ."# A Ida Tarbell 5 , @*, I6
7
< 6<
" 5% 6< "0 Gebfg 9 & 50( A Mc,Clure "0" # @( I6
'History of the Standard Oil Company'

)
3&
) "0
.<) @& I6
$(
% A
J ) 5 9
< 0 "0 O& G / ) "

&6
"? 0 " , 0 " / 9.0 I, , E G# , 0, +/ G&, , ", 3)
" "0 >

/
I& ? ."/$/F
9./, /
& "6
)1 0 &, " ? GH
A* A / I6

X6< 5 & 70 "0
G/1 H6
'
Q/ ;
9
)
0 (

9
# A
J G@& E#J E; 5 & / %
0 & / >01 ">&
"0 ", /
"
:< .@/ < <
/
(L0( A
J /0, )# "
, ) @
E0 ) & , /
H6<) *
/
E)
L @/ 3/ 01 0&
" @ J Gebee / < ")
" 5)
" 0

*J @& 0(
v\5&
6< .0( lf " 0
*
0( # 5& E, , (

" Q, A 5) 0(
# 0 G%
K
6 A& .O&

5>
M/ 9
#
GP)

G* H6< YV %.
*% ")
+(
5% " 9
A / 0 K
6
=#

5&
H6< A 1 G9#
"0 ", " =/
/ +
5) & , G
6< )
.

* =/, 9P, & , ", A
J
E :/ %

K
6 A& 0
G@ "/& A 0 #, ebel 9 O& >
/
O&

%

0 0( ")
5$)
#, = United Mine Workers 9#
5$ & 3
* .9)
I,
P
" "# 9P) 9#
5$ "0 .9() 7P "/& G0 0( Q&J G3
&
0(
e,dc) u
9<#, 0 .= #, 5 0(
<J 9*, |0, " 9< ,
"

0(
) !: 0 A
J "<6 0(
)
"
8?J 7 ? / 50( A = (9
E?
0(
0 0 G0(
*/ ! 9<?, "8) G0(
"P " 9< //

0 .Darwin "
Y 1 5 , :5> $ >^ 6 0 <)
5# %
30
)/
580
* " E) 9
A P&
9 0 "6
!/#
9#
!$& "&
" )
K 0(

.$
&? 9P
!L . .K 8%

G0(
E & "0 I6
"? 0 3*? 9#
5$ 9%
" 7
, #V/ O& G0(
" 9<* % G5$)
+?F< =
G0 //F
E "0 I6

*
!&
+/ Ammons , 90&
) %, G&
Baldwin – Felts
0 " 3? /0 $%
.3*?
9<* 6 $ 9 0
9.: % "6
9#
5$ !&
" 0) A
J K
6 Q$, %
A +
" E, 0

$ H "/ !:
K
90&
5 GP
)* $(&
.7 ? (& 3?

< G0 '
(%. A)
# & "0 9

G K & %
:ebel G"/ Gje
" 5)
" "
9&
9# 5$ "

# / el $
/ 0) 9
# .."
9 G"
"
:% GLouis Tikas !0 !
5 W
G
0 *
!&

"..

:&
06

9

< GA&#
" 0 A
J J "
" )
! K < G(5*1 +/
" 9 ij) E ( lg 5 .."
, "

# 9&
9# 5$ ?
$% " (
/ el /
0)
&
&
&
O>#
" 0 A
J

$& .0 0(
")
G&
0( %

0 0(

&
":
0 "*/ 5*1 +/
"0 .
E.> $
3&
( 9
$ % 8 J . 1
6< TP ( a9
&
H6< Q&J (0 % .9%& "
9
J O& M
" " 9&
<&
"..", 5*, ( O># " 9

I6
Ivy Lee
, < G.
< ". &, #:/ 0 9% A
J >&
H6 =/

Q$,
% }E>& P
0 //F a", Lee
9 .+
*
9
)
$
A

\5 ?) u
0(
Y ", S%, G 5)/ & 9
8 0
: L1 ? " : u
G8*
H6< A
60< .) $)# !: 0 (/G )# G80 A
J (? " "
.7&
$/:
" )
5& ".
= , ,
" )
(
"#)
>V
6" %)
5& +06 L
60
$*

H6< 0
&
&6
L % @8 , , G3
9)
I,
/ % .6< A& :%
?
7&
/:

– $
&
MV )/? – 0 0( $% "6
"<
7*)
90
3/ 3 #1 "#
vM&
. //F ?* "6

M* " , 5

M* " +/ 7&
=# +( A
J J G&
5# +( a9 G&.
/

$9 % ebji 9 Henry Luce /
I < //,
Time # a"n G60< .0 5V 7&
H6< !/V
@*J "L ) .
50( # J. P. Morgan ."L . .# 5% " */

A
J J GTime # >
>
. ;
H6< A +./? %
0 =$ 9
G

0 7&
H6
E "0 O& E* el " E
F E0 A
Life # Fortune # (
.Time & Life A 9/ @ *, Rockefeller Center 0
9, 5:, //V $9

Newsweek < Time #
/
#
0 }E, E0( 0 "0
:)
+% , "^ +, GHarriman "< : GVincent Astor /, / G0 " #
0(

9/ , " " +( "0

/
" 0 B< G@0 ' , 50 A
J .0
.

@>/ o9<, &, &

$& G=%
.! ""0
" ""01" ""8)
" "">
"
8 J * //

0&
A */
0 M& 9
G# .
5 ")
@:<" 9 !/V
"
0 W
P
H6< GMedical Power "*

" E+ G"01 +)
">
A */

.9
O&
o3*
5# , " ") "6
#

, , 5 :# " :# I, A )

0 9P 9 " I, 5 & 9
:E# ) 3# & K <
.J A E
& )
GTime #
&
/
!/F
Henry Luce /
I < .
:# " <L
5, 9P) E)* E0(

&6 " E?F/ 0 ", "0 % .@ 3/ M 0 P& G0
" ) Time
# 7.L A "? 0 /
I < = Gebgd 9 G5& , A .:
H

:5> M8 % G"'$ "
M& * I, 5> E G& 0, 5*0 7v U +8

#? *(
9)U "? 0 & "1 .."
."../
5#
E M& // I, , 01 B#
E
G/
M8
K
60 "? 0 5& ) A& #
;

K "0 9
#
& :< a", G'
"
.0 .J A ) 8 1
&, "0 I6
ebmb 9 Nilson. A. Rockefeller 0 .I, ."/ < "? 0 + , &, ) G60<
"#/ # " E ( E?F/ "0 I6
– 0,
Q1 3&
9 3&
"P

,
:/ " G@
) Time
@ 0 % – 0,
".. V( " =
H. @# IF "0
.."
Y( < 0 //F a",

*J
, 6< \50 7) Peter Singer ; / /
"0
.
51 A
J 7 / J
'( ", S$ O& G"&
" ")
o9<, &, < I6
Singer ; / /
5 9 0 9
, 9o <, &,
@
+*1 9P) a"V 7) ", E "( $
% G*
9$
I ? %J &

.E I,

$<, >01 5 G$ $ E?, E: ) ? 8 J .9 "0
">
+ &
3/ "N & ,
$ A :* 5 $ ", 0 $) > !0 < :
.. * 5#, 9 1 * <: <
.5#1
A M
"
+ :( 9% 0 $"1 L0( A
J /0, " *
/
$ 6
"&
" ")
$9<, – Peter Singer ; / . )
@*J ,
G$*
/ L0( )#
". A 5 & G'
*
5&? !0

"&
A $*
? '(
E& 3
K I6
–
7%
")*/ ? "6
9. 5:/ ) G0 0(
=/

)
( ? A 0(0 ?

.) ( #
= % ; / a", 5

0 O& * 0 Singer ; /
$", E, 7) Time
#

"
.@$, 3& = "&
'( " 0 (9) =#
, & ' $"+ *$

" >0
>0
= ... /,
6< "0 E: .
# G"
< V( *J 50

:/

<& A P % * H6< < Q ) .Y
9
&(
A
J ...
(

)
)
/
//
.
<J >
) H6< .5/
6<
Q&J K+% 5. .
# 5$, "
< &
< 5 G*J = 0 ? GH,
A
J ...
#
/? 9P
)
0
5> 5)
" >0
# ", 3# G*
" $ . .// < E,
", 06 .$ < H, I6

", ) 6< G5)
H6< # 9
"J .H,
G# 6
J & , % )
"
& "1 G#
) >N & +
'/
./ G// G// * (
3s
A
J 5$
5)
A */
9> 3
7*)
90& 0
G%
3<6 G<#
#J :< //, 5 =# 9
"J *J ) ", "0 ? *
9#
/ 5# " 0
*/
< & & 5& 9<& E 9J 7 K
6 G
@ 9 I0
5
"F Q% % G(@/ A 5) I0
3<6
6
8P 0 * # 98& 6< ) L
3/&

M* 0) %* 5# " (M/, )/) 6 M* G: A P&
9.

GK
:E: 7
V
>.>
" 7
V
0&
*/
E, V 9> G(* 9< !, )$#
%*

)# % (>0,) )# 5)
H6< .*J M ", " ? G)# 6J 5)
H6< =# .8.#
G

5# "0 ? "0
G&/1 )
O& " >
)
% *J 0, 580(
5. " I )
"/ A */
/
#
3*
+
*J J .(*J S./

A 7)
E# 9
" G
*J 50 "V E
/ 06 % .H# 0 H @&
M%
.
O&1 I# 9
"J
/ ) "0 ? M:& A 7$) 0
G
/
I
5#
6<
.- /? 9> " 5V
7%
38*
5
)
* >0 ; &

6< ) .9eilm
" ~+ G / &
/
(
L &
0 L # 9/#V @ & A
J GI(
:6;
9P
# 5n0 G"/ &
*
H6< .1 A
J &
"/
& ; </ " <L Q, #. , G#

G&
7?^ +% 8
5

5. @
6 I6
#
" >0
#
/ ?

6
5$*
I)
/
5. P&. "0 ? < * P&. A / %
!
9
@# I6
/
*
9P
"1 G9 50( ;
9
)
&
/ A 0
, .5*

.9
)
+& , % A
J ( ", 5% E?, 0, , " M> 9> 580( !/V % (9
)
. =# A
J ) .
# 6A -$)
@ <
", A
J E# 580( P #.)
3<6
6< !/, , O& G
" , 7/
$/# ", "0 ? #.)
3<6
6 G
3/
06 % G 91 K :/

&
7 "J .9

# 0
$) 7P M
"* I6
G9
E:% ) 9
I6

6< .# @
"0 ", "
.H/ @: A P&

H#
9
9
"& G90 " ) "0 %
K , :/
&
7 5. " <$/#V/

PJ E: 5&
G(# "J) $#
=#
) 9.1 A ? Q/ "$0
? "/& " <P, 7/ "N , .7*
"/&
5)
) = "0

K
&

.&
) " ) % 6< "1 G7*
G 1 G &

GI#
G"*
:, " #
$) , 0 A
J ) 7/
ef " <% " & 9
A , '/0 Q, % , " <L GF
A& G!
GM

& I,) "
"0/ " cf,fff " >0, G( =/
"
7 A& .#< 50 5. 0/ " :
jf A
J
G+
6< "0 .XA*/
)
K
.* % ( 5. "*
+ #< " (/ 50 " "
.E, "0/
"0/
" =* 9
H6< 0
@ ... V V V GQ1 :1 " @% E&*

=#
0 % 0 G
0 G / if , jg 50 ", Y
"
"F
&, 5
K &

0 G"
" "%
.50
+
$) 0 +
" &/0 #
$) G

?
5
&
$/ "0
"
"0/ ", O& E# % G" A/
G6
(
%1
#
H6< A =#(
"V "F
&, 5 .&
(
:/
" $) 0
7
" $/
#

@
% .
V 0 E, #
.E& E, "0 ( ? 5
" ) ) "
A P&
"1 GE:% "0
A
J 5#, 5#1 $ G, +& , % E:/ "0 ( !/
"
/, " J. H. Elliott
,.<.-
" 9< 9% ):#
")
7?^ G"&* A& "0V "0V + L1 "0" :
, 5% .)

E# "6 */ 50 0 G"0/
% , .)
3
6 0
>/ ? $)
6< .
/
9#
."">
A "() "6

" 7?N ( V# G+6;
)/, 7* ; 5 & "& .)
%1 6< "0
6
#
...9
A 366 )/1 0 ( !/
( !
"
@ , 9)
= .I1 Y#
&
#
5 &" :5 9elcj 9 ! '/0 I6
+
A <( / |F E# G!:
=

9 7) 3/
+
8B A
J H Q, 6< G/ " E>&
A
J +
3< A
J Q, 7

." 50 "0 50 # G71 E G 0 #
"V 9)
=".96; +/ " #

&
H6< ", 06 .=/ M* A
9
3# " &
+/" ) 3 0 >0 M*
A
: &J 780 9
G, "
V 0 G
#
G"/:

/ ",
* ."% "

" "6
"0/
" M
) "# " )
"F
A& ."/
.0 " M
9/ ,
.Y#
" "6

A
J ."% 5* "
"0/
H 0 9/ 0 G6% 5:/ + G%*
3 # & M
, GY(
$/ /

&
K 5> G 50( ! 0 &
6F Q, >0
."+
&" G"
@ 5. G"/ !
|F
</
K
G3 # A
J E # <8 0 .+
" A
O># +&? 0 & & " 0
O>#
&: 0 90 .O>#
E <+. ) Q/ 3
<*; ? G * 580(
G87 M 87
P &: A
J .*
5*< ) $;
7
9, G+
&
K "
8)

!
9P) .6
9&: E, +&1 "0/
P /#
K " A
J :
9 % G(0
O>#
90,
G@# , H/# A 1 &, 06 . @
E ( 50 .9& $
A& &/ 9
" "0 .'/0 , G5

> @# , GA, 7 J #
0 , " HL , E.> I#
0
7)
"0 .)
:
*? , )
" /1 # 0 9 &: 5#
+/
"0 ", )*

<L G# #$ 3 G0, G'$
G)
&
5> =# " / Q, ?& A
."0/
" E#
V 0 $ # , "
Q&J .% I, G&/ 50 G"0 50 GY( 50 )% K 0 O& G"
=/ 50( :/ 0 #

B 9> G
S*/ Q&J "
& !, A 5> L I, , #& */J < (
%/
3
/,
G; < "<# I

|F
0 G 0 ."> +( I, , 5
" E>& 1 A
&

*
.Y
W
+L;
Y , =# B1 # # G71 "
" 50 /
3*? "
" 3 L , %/ , 5% # 7% " ? "6
G+01 L (*(
) "
5# 5% " "0 01
, G"1 )(
9 O& G
;
9 !
? "
& Q6L 6< 50 .K < , < Q1 "&

. 0 0
" 0 G#

) *( Q% " G* & '0 9
J P , " E

1 "

' G#
.M*
Y*%
= 0 0 *% G* ( 90,
9)
)

"+
3&" / )
3;(
5, 0, .3;(
5,
,
"

. ( eff,fff & S
9egjl
#? 7P
O& .
K 1 Q
% A M* #6 0 J % " "/ !
@
%
5)
.H0
G ;
\5;
&
H/ "0 " 0 G:/
#? 9
A
J G:0
$;

5&
0 ."&/
" 5 <

<1 L, =#
#
/

& "0 9<$& I6
&

"0 !"0/
O> 5)
6)(
&/
9? @# 9 , " Q, +& , Q% K < G0 J
.!E /
H6< 3/ " eff 5 , " ef
") 9
QV ? "6
G"(
+
"0": E.:% 5
* |F
30 G(
*J ) " #"
9
&
"PP& 0
.""
9)*
&
QV
5#, " +(
5* "$# O& "/
)0 +( 50 9/ ,
" " */ 50 ")
"0 GE& +(
5 G, "
(
M*
.P)

H6< A
+ L1 5)# I6
3/
< 6< !!+
.../
9:
9<: = =#
+
"0 7
5 .$#

+
" G"
" <L 0 ":5 |F
5 0 .7
+
"
"0
.":
5

1 "0 .9, ()

"/ 9L 5% " 0
"6
5*1 7
& G, +& , =#
< G5*1
^ /: 3/ K < G6;
+/ G
G)
+/ A
J .)
*
" E+/
90, A "
"0 */ 50 0 9 9<? " 9, "# "6
5*1 " 7?N 7?N ."#
"
... )0 " 0 "N .%*
3 # &
, G5
O

"V 5
G9
P
)
M:&
H % 6J .
K E:/ "0 I6
=%
< 6<
" 9
E
V ' , ", ) .9/#
Q/ < /: 3/ # $/# G@#. , @/ , @ "0
" G/? 9 G6;
+/ G )
G7
5> /
?&
", G+*1 * !
G(
=#
.9/#
A 9/& ( >V
) / ?& " <L ...GK(

G&
" &

3
9:
Y#
9P
)/? "
\56
# A %, # % A*/
)
3)( " H <( "J
:1 H6< P + 3/
" "N M& )# ?& " <L .... "1 9) 6

$K(

+?F< (

&
& # < 1 :1 H6< 0 6J : &, 5+/ % "0
.1
5 " <L G+6;
G ^ G& GP & B) I6
I )
"/
5 ? 6
G3)(

.!X< +
&
+% 5. " (@# / ,) H# 7/ "0
." , H "0 ? 5F/
6< A 3#

.

=1 6# *$

)1 "
"/ J " eff & +
6< .9eigf 9)
A& , (
+ 9eilm
.

P A
J , ., 0&

% " "/ S & G
9eigf
/1 5% " 0&
H6< A */
, "0
G3)(
A 0
0
*/
+ J A &
.)
0

G)
$&
5# O&1 5
@ # dfff u "
)# ' George Grote L -# 9elff
.)
$&

)
0&
& 6 ,

..J 0
" V #
9
)
A
J 80/
3 % @) 3&* !
0 /0 9elbi
.0 J
, " 50 A
J 80/
"&( +
G0# Antwerp G"3 " 80/
0 5) 5, +( J 9egff
.
H6< ( 30
*
=/ $* 9egfe
.* 9
8
"#
)
A $3*
/ ?
& 5$, 9egfb
.80/
0
E) ( " 50
(3<6
)
% " /, " " 5# 9egeg
.")
A
+&? $* L 0 !/V 9egii
.=/ M* A , ( 1 + 9eggm
.K/0
" $ 5$1 , A
J 5 u
9eggc
.80/
# A

5V %. % G!

( G /, K 9egdf
!

( /, K
.<& "
jf,fff 5 G, 3 "*
9egdi
.
A& ( # " "/ J " j G0, 3 # 9egdm
.lf,fff 5 ( 5;

) (
5# : 9egdc
.t/L, G

, 80/
0
= 5$, 9egmi
Guillame Baillou " 9?L" /

3*
5% " Pertussis M<(
+ A $ 5$1 7$)
9egmc
.! H( 5.
."
"/ J eg,fff 5 "*
9egbj
. /, "*

( 9egbb
. *
"1 <, 6
V/ & , , #
E# & < 80/
# ", "(0 " *
9eddf
- V I, A
J 01 )/
" - I, , u
, 80/
"&( = eddf 9)
& " %
.
1 , *
5&/

.0 J =/ 50( "*

( 9edfi
.0, Q, )/ # u

Y 9edej
."
A 5$, S 9edij
. 8 3* 5% " * *

A / u
= 9edig
."
@?0(
3( P 9edgm
.E / 80/
" 5* " ed / & , 0 J 9eddj

9& A
J 80/
9
"6
"0/
"V # ' 50( P&
% .0 J '/0
+ 9eddg
.+
6< # dc,fff .06 I6, IV 9
*
G &
" /
9
5 "/ 9 " W
*
& 3*
, P 9eddm
) ."/ J A
J 7 9 5
& ) K
6 .Q, " "& " /
9
5 "& 9 " W

.( 9ebdm The Hazards of Immunization "" &

*" " ) 30 G"/
9<L / :=#

.dysentary 5/ p GI#

+ 9eddm
.
, G/
5$, ' K 9eddc
.
0
A& 5& 5& O>
A& &
9edmf
.I#

P = "0
5/ ( " $&
9edmj
(9emmc 9)
P ,) .K
I#
S
P 9edmi
.3*
0
0
)
G! ! A (I80/
5
) I80/
+
06 5$, 9edml
#(1 " Y +&

" /
quinine "" 0
" 7(0 0 J .
+ P 9edmg
.

.! (90 !,)

( 9edmm
. &
I#
5& 0, * O& 5$, 9edmc
.M<(
+
7 !( ( "( ! 9edbg
.+
A&
9/ <) 7 . ( # + 9edbb
.E / 5* " jf 0 J 80/

/ 5$) ' , 9emff

0/
Q1 5
0 J " 50 \5/
( # 7 50(
9emff
.= H39 '
"$ ) ; 6$4 "+ " &7 O& 80/

./ 9<, " $0
80/
' , 9emff
P G9ecff 9emfj " $ ig P % .&

?
+
A&

P 5$, 9emfj
.9ecmb 9ecff " / 50
.9emef 9 A&

, G 0/ G/ G0 " 50 '/0 "*
9emfb
./ I#
S8
)
M> 5$, 9emej
"0 O& G0 " ) t I /

A G0 J I#
9)*
S8
//F 5$, 9emem
.? & 5? 5#
6<
.9emjf A& / G/ "*

( 9emeb
S
" # -6 9 > "0 A "<0 5& G&
?
G!/(/ G"*/ 9emje
jjf #
) *
H6 $9 .A)
(
# S# A I#
'% " ) "< M* " K
6 GI#

)
$) > "0
.-.)
6< = # 9
(1 +?F< " / * .( / 9 5. (
. A H6< -.)
* 3/ /(
D D WD D$% D" &S , / X# $

A
J 0
(, G0 J G 9emjj
", G@
* 6 S
/ 7 @ V 80, I6
( / bb H) " " *
&, 5%V (/ .$$
.!&$# $ $ , 6$A , GE, & 5. E
V "0 S
"V 06 @

9 >.> . ( jg ' " 3* 9% G

, I#
$ &
)
M> 5$, 9emji
.E /
H6< +;
J 9 K
6
#
D D$) $ F $F " 6A % G
, I#
$ &
)
M> 5$, 9emjl
.$ $# 6 " $9 &$# =
C) $) ) .6$
.5

9emjm
.
, G"
( I#
+ 9emlf
.. +
A&
+ 9emle
.Q, $ . +
A&
+ 9emlm
./ lg,fff &

G / eg 9 0/ '/0 M<(
+ 9emgf
.D& 6$ $) # *, /

H6< "0
. "0/ A
J I#
S
9 9emgl
." 7 = H39 < .$
&$# $
A # ) "0
.. +
A&
+ 9emdj
/ = 9 G6# A

J 3/
3/ % ."0/
" 0 &( & / '/0 I#
+ 9emdi
. / ! $
0&
5% " 9)*
S

./ I#
9)*
S
/ S/
J '# /
$*
=#
9emdc
.K
" V K
9)*
S
/
//F "& K
+*1 " # 9emmc
.9
<, " 9 "
5*1 ' 9 G
*J 9emmc
.9embf A& 9 G0, G .; J 1 + P 9emcb
.&
?
Y? +
" % 5, 9embf
.
/J @ # eg 5 , / )# " $* ( I( (S8
/ ") # 9embf
#
9 9embc 9)

.
I# GH " ( ec # 9
I6
G@ 9)* 9 # 9embe
.\5/
E je "/ @ .
I# @)*
$V .$9D 0D

= H3& " $:S 0
W A C)" =/ $ 7 9embj
., +& , =# *
80/
)* A
J *(
@ A &
# ,
.0, G .; J + 9embi

//
#? 0
) .&
?
G
. +
A&
+
=/ ( 9embi
.9embd A& Q1 ?
A
J <) ( % ..
# 9% .X# $ &( J$) # 7? 9 G0 J G(//L 9embd
"()
"/ A
' , ", ) .$ jf '
@)* 9% .I#
' H " >
9)*
.\5/
@ J #
.&
?

I# )/ W 9% 9embc
.!/(/ A
J S8
/ 5 G< )# " G!< "# 9ecff
. /
5* " edf 0 J 80/
K./ 5) 5 9ecff
.=/ 50( '

A ? , 9ecfe
5*2
I# '

0 " 8

9 .I#
S
A @? 50 @ # ef,ff # *
0&
' 9ecfj
.= :)! Y$# =) C 5
$9 G")
Q &" S

.
I# '

<1 / A
"
=$#( !/(/ ? 9ecfb
.(5>
#
)
) homeopathy >
-.)
7(0 " << 0
9ecef
) I#
3 gig " $)
) ( ( ecef d ) $*
", 50 "
" # 9ecef
# * S#
& egf .( '
) I#
J
& bm " (0 .'
A
Y
.+*, 0 "
" ( G'

5*2
I# '

c 80/
- J 5$) ' , .80/
0 = gff S G/ =/ M* A 80/
( 9ecej
.E / 5* "
. ( eff,fff 50 " mff :{5/

+ # K
5$) ' , 9ecej
(9eclj 9)
* , "0
) .0 J 5
+;
J 9eceg
80/
n "(; ")8
"0 O& G!
, 80/
9/ "
) 9$& E % 0 J 9eced
.
A
J
(1$ # "0 GI#
S
A @ 9
J @ # jf,fff # ' *
0&
9ecjj
D "D =D 6 $)
'"$ ) Y$# $ B &( A #$#
-7) $# <#$ A
.(7 6
./ :
;
(&
Y .9 $/
9ecjd
.

0
+ ( 9ecjd
. = )A $! = 6A ."

A
J "1 " M ec,bgd 5 0 J 9ecif
., */ A
J /
0
+ ( 9ecie
.+
// '
)
) "6
" bbg O& G
, Gt I#
+ ( 9ecie
., &$# $3 ZOOO '$A G/ G/ 9ecie
." *
*
*
" =( 9 9ecij
.>
-.)
/ _( " << "/0 9ecij
.
H6< 9/ A +*1 $ A
J Q, GK 9 :
;
(&
9ecii
.
(#
) 30/0
#, P 9ecig
5
$
=
# 3
/V0 / % G/ !
9 9/ A
J ( 8> ?& 5$, 9ecid
.)
.0 I#
( 9ecic
.* :0 # A
J
3/ G3*
8 5$1 9ecib
.:
;
(&
9/ 9) "/ " /1 3*
0 " "#
9eclf
.9<. A
J "2
* / A "
-#& O& G$ 0 ! $! ' 9eclf
&# +#n / !

9% G" ' !/F

) G"$" $.8" 0
9eclg
0 .$
" Y I, 9/ 9
K
6 9L &#
)
0 .1 +/
" )
A @
+/
H6< Q&J .9)
9 " #
1 K
60 S
9
1 # "& )
+/
" >0
" #

.& &# il 5$& A #,
/ " .- 0

American Medical Association "01 *

*
" "0( K +*1 " # 9ecld
.AMA
.&
?
+& , 0 "01 *
*
" 9P +( 9eclm
5*1 " $& G(/

) *
/ 5)
Dr.Semmelweis $ $" 0
9eclc
.($*
=#
"
5)
6
# @ " H* 9 ) .9, 5/L @:*, A ", ) G0 50( =$

/ 0

.<, .0 >

3*
0 +( J 9ecgf
.&
?
A
J <6
:6;
#
I#
&
5& E. E , * 3* 9ecgf
D &$ 1 $F 0
&> 6:A ) & $>34 6 <$ ", "
7(0
7 * # "
" *
$
61 "
H6< .$ $) L3
.1
!/1 " $# 0 G8)

?N "( (
"V G
1 9)
# 0 * +( 9ecgf
!

? /

& , 0
#
*
H6< .I(
":0
&

//1
< 6 $& !
9
5, 0 .@# 0 &
"/ )* 7(0 5/ (

.#
)
3<6
6< /

, A
J 01
" # , .@$#
6
9
!
9

) ) % ) ."0/
" eff,fff 5 jb 5) &
?
"#/
u 9ecgf
.(eff,fff 5 jgf 5) ebbl 9)
'
P

&# * 0 G"
$*
=#
!: * S$# G" M&/J 0
9ecgi
.Q, #8 ( , Y

& 3/ $/
)
", % A G+/

.0 J 3 I#
9ecgi
" %mg '

/ Gecdf A
J ecgi " .,D+ Y$# A " % 9ecgi
."0/
" %bf G#

.$ 5$1 0 J $0 ) 9/ 9ecgi
90
5 *
.$ 5$1 #

+ A
J +
"&
9/ 9ecgi
A
J 3
*
5
//, *( 0 A
J G!/(/ ? I# '
" % 9ecgg
., (! $" H39 S #
*$" A / 6< ./

$ " V S$ $/

)
Y & 5
, * 8# 9ecgg
.$&
=#

.0 J
0
( 9ecgg
6< ) ( "0
.)
H6
3#/ ? " 50
, M* " 0 J I# '
9ecgm
." 9 "0/
" el,fff " >0, &
I#
+ ( +#
I# '
.J (
.S1 " ejf,fff & " / =/ E( A 0 J '/0 M<(
+ 9ecgc
.&
?
A
J Q, " & 5:/ I&

5J 9ecdf
[D% G D" Y$D# D 3$ :)A 7 L9 J$" :"V S$ ( ">
) *
/
9ecdf
( I&
"0
." 0
; A " M\ A MO ) X# ' BS $9
A
J )/
"/ '
(
= ", "/&/
" @ J": &$ O& @$#
$; *
/
"
."@& 5. %) )
H6< 0 9> GH " ()

."0/
" jf,fff G" 9 G0 J I#
'/0 ( > 9ecdi
.6
A * /
* Y / !
9ecdl
."3:
" ) //F" _( ""L I -#" 9ecdg
5% " /(
#
9L G&#
5# P
*
5 "$ -$ 9ecdm
."
" *
"&#

&#
5# P
/
7#
) )# +( J <#

" % ) P 3/ 0 J I# '
# " % 9ecdm
"
6< ) " 50 .* E bf 9< # . 6
5*1 A '
A "
6< $ .'
" 9 M "

$ % . / el "/ 5*
u ", A
J / @ 9/ GE:% @&. 9 7/
. L "^ < I#
'
"V 80, I6
$*
=#

.W $"% 6 #

0 GA , / Y$#
6(1 <
9ecdm
D 9$F $# $& $; 0

& B% ; J)$ $$ $ /
A T 9ecdb
."$ -$ 9 )A
."/ J ll,cff " >0, & G" / 9 G0 J '/0 I#

+ " # O
> 9ecmf
D ],_N\ HD
D GI#
+ J
& m,mfd 9, ), 5. P G0 J G9; 9ecme
., / WC# ) $
D Ò,P_Z A 2>" = :)A Y$# ) , Y$# ) $ G
, G D 9ecme
., / Y$# </1 % ) $/ ZN,PZN ,
.9
)
5& & ". c & % .=#, 9
)
'/0 I#
+ 9ecme
" " G)

A
'
" %
) Q M8& 0
0 J 0
!#
=# 9ecme
.H/ &$# % , $/ %N_,\ ", & < M&
H#
., M]\,OOO " / jf 5. .I#

I# '
"
$ 9ecmj
. 0 J 5* eb,fff " >0, GI#

=$
5*1 " %cm ' 9 O& G0 J 9ecmj
.( 9ebjg P , )
.$& $# = / $ ) % 9ecmg
K>
M:>
H6 Y$ H&, &, "0
.&1
@.#/ "(0 ? "V @: " J$ 9ecmc
; >J "# / .#/ A ")* "F
">&
S 5 <) G9ebdl 9 ! 5 (

%.1 9) A
J ( <P " <L ? W: 0 # 3. 5 & A
.("/L
# 9ebdi P ,) .)
7$
+/
/ !
9D 0 $ " 9

" A 6 "6
"01
, S O& 9 jf & + 9eccf
6D$) 6D %D D$ ) $(" 9 ) J(
"%A $ ' $
9P A 6 iff 3$ &
?
A
J I6
50 # "0 6. " " . $"$>
#
/
?&
A 50
*/
" 0 ; 0 //F " 9 "0 I6
G
.A
1
)
3&
"6
"01
" eff,fff 5

& e,c < GK
E/ 5$#/
GI80/
+ " #

5$) 9eccf
.(9ebil 9)
eff,fff 5
& eb G9ebee 9)
eff,fff 5 ?& c A
J = % ) "0/

.&
?
, I#
S
& 9eccf
( 50
5* ejf A
J 5)
= %) E / ( 50
5* ej /
80/
K./ 5$) u 9eccf
.(9ebjb 9 E /
u \5/
#
5) ", 9)
= Gb " $)
" B0
1 3*
"0 9eccj
."0/
" eff,fff 5
& imf 9)
K
6
B0
1 3*

) .'
Y 5 *
/

30 ", $) 7 ) " 3T* G0 J 9eccl
<) 30 !G) 3) 1 G " J$ 9 Y$# ", H& - / A
J 5 G
Q/ A G5*
O&

."'
#" 30 "I<

I#" :" ) "0
.syphillis I<
" " I#
9& 9 5* emff " >0, G0 J 9eccl
G
1 '
#
9, '
W: 5& 9 G
1 B#
" Dr. Sobatta / 0
9eccl
D$ Y$D# D D 6$ 6 <$ .B G $ Y$# A 6: .># @ "$
.! % &>(1 &$
$4
"0
( 0

G
1 '
#
9, '
W: 5& 9 G
1 B#
" Dr. Sobatta / 0
9eccl
D$ Y$D# D D 6$ 6 <$ .B G $ Y$# A 6: .># @ "$
.! % &>(1 &$
$4
.&
?
, 30
+ $ '
.& 9eccg
8*L O& G' J ' jg,lml,imf

. 6 "
/ =/ & , 9eccd
P ,) .
& jc,bmb I#
J
& edg,mml P G
K 5. ."0/
5# " %dd 5)
.(9ebgg 9
.:6;
9P
"*/
Y 5 30 ( 0 9J 0
A K " 3* 9eccm
780 G*
; 0 $0 9>#
9
1 9 /
GK (00.9 LJ 0
20 J 9eccm
"0 " &
# 0 .(

I# + (
& M&
*
0&
5% "
:", & A 80, O& GThe History and Pathology of Vaccination "'
1 9 ":" )
.$ Y$# J$ $& $# $ 0/ (7 /(
' % . ! 6#C 8 6 $ 0

61 % 7 ! ' #
0
) 9eccc
.! #
W
*
! ) 9
)
5& <)
" )

" >0, ' 9 .anthrax >
#
S
A
J 5$
5& G/ G/, #
0
) 9eccc
.'
# imff G7 lgff
" / m
5 /# 9 .'

V/ <P ) M&
0 #
") 9 G0 J 9eccb
9)
P ,) .'
ecbc 9)
" % 1
# .9ecbd 9)
<^ "0 d %
(0, '
" % G9ecbc
.$
6A $>34 $$ 6 ; 9eccb
" G"= : $" " )

ee "
F // 30 (01 I %? B&
) ; 0 , 9ecbf
"0 ' , 0 < "1 G&
?
"0
) 9

/,
9P
/
M/ "V 06
/
0 7/ G
"0
" :; 0 7 .K
6 &/ 6J ?J &/ /
", !0&
K
6 G+( 50
EP ", (@,) +>1 A ; 0 S ."@
$/ P "0(/ =
6 ") 5*1
5#1 3$
!
9)
A */
5. " $
9P
6< !0 9 G/
M/ @ E *
"0 7/ (
5 9)
9 " 50 "V ? / A 5)
.9P 60< = 5)
A

G*
H6 .)
(
H6< A ? Q/ 5)
' ? 0&
5)# .
@& E&#
/
H6< ", A
J G9) 98)
!
$*/ G.
I %? 9P
A 50
*/
"0
@# @)# +( 0 =#

% 9 0 "6
"#? "/
" ; # I, 5*1 5 =
.L
3/&
.anti-toxins 9$/
= 7(0 " ") GEmil vin Behring u " 5J 9ecbf
9/% +( J A
J Q, &
?
A
J
5 " 7
.
, Gt< 3
0
+ 9ecbj
.K $&
:
) 9)
#
0
#
>

7 5$)
6< . *
K./? 5) % O& G80/
K./ A
1
5& 0, 9ecbj
.9ebjf 9)

.6$C34 1$ <C $ "V S$ Dr.Julius Hensel 5/ < !

#
1 3*
9ecbi
. Allopathic Medicine
1 )
2
J " .*
0< "# / !/V ecbi
-. 9 G9ebfm 9)
A&
&
H6< .Diphtheria M
9)*
W M.*J 9ecbg
.%el ; / ", A
J ( G c,bff " >0, .anti-toxin $/
) ?& =#
%d ; / ", A
J ( G* mfi O& anti-toxin ) W
) 9

& ee,med G&
!
.*
D9 D
=
9 Y$#" :"V S$
*J L )# /
Carlo Ruta
0 9ecbd
."B" ,3 $F ! 0"! [ &> J# 2$
$F "
.H
9) $ 5$1 9/ &
#
" /
0
9ecbm
A " @
/ "0 O& "J " G/: < $/
)
" :30 ;/ 9ecbm
E: "0 "V W /
5)# G":00
80/
A @ J 06 5<# ".u
G"
G5&0

!
9 <
! #
A //, 50( )
@P !/F
>
&
H6< GE/ # *& E E>/
.) O&

.= 6$ $ 0

=$" B 6A $() Y 9ecbc
Gboard of guardians + 1 !# Q# .0 J '

# " % 9ecbc
D/($ "V 0 J !# dff " >0, $) G'

"
M* A + 1 I,
9
? I, "$/D D
. -" 7) #
"
" .Y$# c 1 $ # W"%
; H39 0 .)
&
E/ H 3/&
&
3/&

" ;
, "

.$/ B$ B A #$
,A 0
/% ,A .$
.9
7(0 Marie Curie I0 I 9ecbc
:0 3*%, E/ 9

, t// )# / G ..- 0
9ecbc
.t
/;
"V 9)
= (
,) / )# # " 9< &
?
PhD H0
( & =# 9ebff
<D$ ,$ 2$)$! 6 "T A $A $$1 T9 <$ .
, Y < H0
(
.($ ) 1) ! )
D; =>"D D$ ;! " 58>
/:
< M& , AMA 01 *
*
9ebff
.( A <$ $ " $ ! 2=1 $%# ! ,A) allopathy ,# 8
. &
?
Q1
5# " %l 3/ "*/
9ebff
.eff,fff 50 5 ei < &

#
5) 9ebff
. $() & J$"S 9ebfe
W> Y$# ) =

9 #$# X# "V 5 .'
# , $* L0( &
9/% 9ebfj
" #
//
H6< 8 9 .Q, / I, K < !
G, / $ =$ $" 9 H39 2"
.&/

B#
5%
-
0 / )# %, > 50( A
!$/V GEugenics " $"
9ebfl
."
University College
G .3
( A G"
< u /
0 " $" 1 %J 9ebfl
. $ MM $ f 2$() $9 >
$
.&
?
+
+6;
Y A
J H$ " % 9ebfg
? I, K < !

.K
6 5) ? il GI# '
" % M$* &
?
? ee 9ebfg

9 3/ K
6 G/ )( " I#J ' , '
", 9)
= . * A "&

.'
)
H6<
.&
?
+
+6;
Y E 5 " % 9ebfd
.
$ S Coca-Cola )) ) ' 7 6$ 6) 6#$# g( -$% 9ebfd
/ # Y" .*/
A
J E>&
0&
9% ) G * '
" % 9ebfm
.&7A ! 9 ,3 ( 0
Y$# .$ !
.01 :6;

# %
)/ */ +0
30 !; 0
' 9ebfm
.,+ Y$# < " % !/(/ ? |( !# 9ebfb
.$() ""T .$&

0 #
!/V 9ebfb
5 K.0 .3. 5% " ( (5$1 " 0 jd J) New York Press ! K & 9ebfb
GA D ) 2" ZOO 697 # .J $ # , X# X % 7
W " )$ ":
".Y$# /1$ $3 c17! $ " ,A
9
1 5:/
) " / 7
" ", <& & & A
J ( )# G 90 )
> ,
) A
" \5/
96#
I<
, P GS
A
J @J 9 (
0
A I& I6

"*/
:=#
) . ) "*/
\5/
, P S
& A
J "I
7
" J 9 .#
.( !?0/, G'

7 50( \5/

?& <) = ." # " 80/

A 5 & "
9ebef
."

.eff,fff 50 5 ecf < \5/
#
5) .\5/
+
$& 5$, S 9ebef
6D$ D $ J <$ " [ " 4$) ""T -C) AMA $)$! $ 9ebef
0/D% ,3D $&7 $# ') ") 9A ) & H3& -C) .9 .C# A L3 2=

D $() 6 < . L G
2 # = #
&(% A $ 8 >" <$ 0
.$() ""T $ ' $ 0 % ($%#
.9
*/ -.)
*
)
!/F !.L # 0
9ebef
A
J 9ebil 9)
/
H6< ) %) . ( 50
E / 5* cj K
80/
K./ 5) u 9ebee
.(E / ( 50
5* eei
9)
5)
6< = ) ."* eff,ff 5 c < 80/
# K

5) 9ebee
.("* eff,fff 5 eb A
J ebil
.&
?
,
$ '
W 9ebee
0&

1 =
5& B , 5 I, = G * "$/
" %" 9ebee
."$/" V
. $! $F $ " % $($) C 67 A & I& *
/
9ebee
C)"D
D" :" S$ G/# " " /, 3* < GRobert Boesler / 0
9ebej
.$"+ $) < C)" '" # .W =$ A 7 6
D $ "0 A

!: ."
)# Eugenics " " $"" Y 5&
A 5$, 9ebej
"6
"01 , . 77 " "0 !: 3: 3 F "6
0 5:, &, .$ 7 2$
" "0 . 9F ) G< )# /: 3 " 6 $A 7 9 " "0 3
6< F
. / )# !: " "&
"
D% .H; L 70, @

# G"/ 9>#
A @ 9 GM<(
+ $ S
5$, 9ebej
% 0 , M<(
0 +( J ) .(D&$ $" =") J $ X# 39 '$
$1 # % 9> G(
O>#
P&
9/)

= <* 9> G) & # / */
. (! "A
. $ MOO 9% $ A < $() & J"T$ $() .. 9ebei
."*/
01 )#
50( 9ebei
L.
/# '# G"$) :6L 9P ") "#/ je 5)# // +*1 &, 9ebeg
.3/
-.)
#J 9> "
6< & ) 5& "0 Gpellagra
.$)$! 0
) $"$ F .'.8 + 9ebeg
.A
1
)
3&
+ >, #
M A( !
+ 9ebeg
.&
?
" /1 =8
& ( A 5:? P 9ebed
L3 7 &) )) ) ' 7 0

$ % % .$ $ " 7 9ebem
.$9 7 9
."/
5&
9 A
J 5" 30 ( ;/ 9ebem
.'7 H$ 6 0 -/ 0 ! $ ' 1 1" $ ) = 6$) 9ebem
.$ # M* " I<

5( W
) f$ F 9ebem
.,+ $S =) AMA 01 *

*
9ebem
., "

encephalitis t
3
( 9ebem
'") $# (1 >" " Y" 2" " $""c1 $ % #$ )$A $ 7
"1 9ebem
.$ W$#
$(1 $
$ ('+ 0
=#
u# " L
.<" )7 6# 1" 0 &" <$ (! =$) 9ebec
/:
3/
< \5/
+ ", & 7(0 E &
?
)
&

!: 9ebec
.&/

" (1 * 7
.!/0 ? ef 5% df S# 3/ (M

)
$ &
9ebeb
gff,fff " >0, 5 & ebjc ebeb " . t
3
#
5) 9ebeb
" >0, 06
3 I6

6
/ )# G3 1 3
# 7.J J
& e,fff,fff

)
3&
) ( I6
1 + # 8V /# < +
6< ", A
J EF O&1 (, .O
.swine flu virus

! 7) P
# < ":
.0 ", G(
=D 7D 0D GA ( MN`` D 0 ) = 6$ 1 =
< % 9ebjf
.; $ " 6 -$1 <" &; 61
0 " %ig ./ 9% ."/ . A Dr. Otto Walberg t
, 0
9ebjf
.S. `
% L */ . A
J
$& .
# : "#/01

#
, .K
H6< ) GEugenics " " $"" Y 5&
A > 9ebje
"* ( ; 0 ) GO/ 0 GK.0 )# " 50 +/F < < " "0 /
H6
.(0 //F 0)
.( / ) 5L.

$)
) .
A
J *
"1 $ )
> I L , 9ebje
.("L
0 ) BCG \5/
# S
* 9ebje
.(sodium fluoride $ $ < /

H6< " W ) $!
=$ $ 9ebjj
D )D D 6A 3)9 2$)$! . " 0 $!
* A >9 $) X
"/ 6/" ( 7 "A &# $ $! $/ $) L9 2' 7 4A $!
.antacids
G9&
"*% A I& 3(
6< .<, G?(, ?000
3(
# = +( J 9ebjj
.80/
" :< 0 G80
$)(, eff " >0, G9)

6< A& 3*
5# )( #1 9/ + 6 9ebjj
. X-ray !0, $)(, " W
"*/

'D/ $D > Samuel Torrey Orton ", I 5/ 0
5% " / 9ebjj
9 & , ", ) G( >

)
3&
)
F
H6< .$ 6& S" (
"
H6< /0 A 9)
H6< O& G/
-.)
9

\5& /
5&
)
3*
!

."
&

D9 "D$> B" ,3) "( '/ ) . H39
-7) $# $"( H39 J$
D$#$# 'D"! <D% $ C)7 ,3 % 39 .J(
% 0
! >9 C)7$ (6#
.$"( h
'/ I6
2 & $ "! c 1" #$ B7) => 9/ u K I 0
3*
9ebji
D A D1 2,D# % A " . " Y 39 .I80/
"
9 80/
0 90&

. $ X ( ) A = 6$ C)" L &"
0D
D#i 2 $h $$ = 0
; 0
$ I6
(
H ( "30/( "
9ebji
.@$#
6
91 ) 9L K
6 2$$ $ + 6>
D( '"D$ A C)"D )$ @ , & 7(0 ?, )# " Dr. Seale Harris !< 5/ 0
9ebjl
0D
$D ' A Y($ $) .C)" L &" $(1 J $ hyperinsulinism $$ "!
G@/ =% " / jg ) G!< 0
:0 9 "0
.!=7 W =$1 B" <% $ J$9 )
9
9
*; 90&
=*/ # , * < 3/
GAMA 01 *
*
"

.
6
/:
3/
< 80/
", & , .M/
&*
* 0 P& ' 0

2$! I.G. Farben ..,A < $ $& = 7 9ebjl
.&
?

.(< G0 0 ( jf G00 0 G - ( jg 5 M

$ S
9ebjl
GK # +

6< ( + >, M<(
S
5) 5& "/
> A 0 O& 9ebjg
.
= '# 9
@ 0
D 9 ) =7 6# 31A 6$ 7%$ *
! 0, +*, 9ebjg
.$ ! %
P ,) # = 6 ] $ 2, / Y$# /1$ </ (! %\O %A G0 J 9ebjg
.( 9ecmj 9)

.&
?
, \5/
$ '
W 9ebjg
" , B 0( " 50

J W, (t : A) / 9P ) % ..,A )7 9ebjg
E, GWelierter-Meer GHoechst /(< GAgfa L, GBayer GBadische Anilin
. Griesheim Elektron "0
J 9(L

F/ @
: 0
P G%.)
".#.I, 0(
/:
+

!# +, , ./:

".#.I, 0( 5, 0 J < G" 0(
0, Y 9ebjd
5;
G( 0
:)
K *

K !:) 5(
( G 5/, :9 " "0 G
!0
M( G

*& K
J !# !:) t 5 G(0
:)
5, / 0( !:)
) "< G(" 0(
01 Y

, &

//1 5
t
) % ".#.I, 0( " 01 Y
J !# +, " >.> .(t :)
:)
" K
.3& #0 , 0&
.
P <) & , G
, V( /
3*
)
)#
9ebjd
&

/ < S*
Y
G91 & G
>
Gt< F 9%, 9ebjm
.'
( # 0 , +& ,

H6< & .K I0 % 01 )
0&
% '

30 9 ($ A 9ebjm
9L E.*
", ) (3# A % 3/) )
6, % GK I0 A )
'
#/ 5&
G $
c17A :) < 0
< $ A "" B":5
< 5
, 30 !"+" ,
5#, " K I0 9) <) % .":) '+ G $
H39 < A /! B .B"
+(
) :* 0 5 GE "0 9
K ", < /
I6
1 .
& 5> 5*, 3# J " )
.!/
E% E
* ' , 0 G J , ./
#? :)
: A
J ) 3/
O&

< 5

."
(, g 5 im S# M
&
9ebjm
.DF D$ D$ Ginsulin shock "$ "D! " -. $* 50/ I/
/
3*
9ebjm
)
)
(
=# & , 9ebim 9)
5. .F+ '"$ $ "! => 6$) 0/
.-.)
/
H6< 9/
,
"V P&
Gvaccine lymph &
/
7
M&
#
"$) *
0&
9ebjm
#
3/ "0 &
9/
glycerinated calf lymph " /;
I
7
"
"0
G" * "/ A ebjj 9)
"0 *

H6< &* 5$, .sleepy sickness 9

. / ! 1 6
0&
3# $#, 5< *

D WD1 b D%A $# $F $ 6 6) GE0 +? A& 5+ * I#
9ebjm
. 39 / W#" $C# $
I,) "DF " (

30
30 G ;/ +%, &, GEdward L.Bernays .5 9ebjc
+?F< 5% " @ 90&
@# 9 70 #
5 90&

N
5 S( O& G(".

. $) )/ , 0 I<# 5 , 5% M "L "6

.5
$D
A D
$(1 &) &3 >% ) )7$ $(1 $
$j H3& )$ $3 T9" : 5
$ D& " $) )7 % 3A $)7 2 #
% $ . ) $#$# = # 9 .7 L
." WA &
<"
0D 6A 2WD Y$# /1 $3 c17! $ encephalitis "k '&" 6 &; 9ebjc
.$$ .$# $ $)7
."/
7(0 f ")A 9ebjc
u /0
,
Dr. Robie 5/ 0

Q GY#? 5. .Eugenics "5/
"/&
" O
>

)
A
9ebjc
D BD$ )$A $ MP :)A ('+ 0
=# '") $# A 5)
A
J /# !0/, )# "
.low IQ scores )3 $
6D " 9 P

G(L
+0
** # <) EEG # 7(0 * 9ebjc
."$F
EEG L
+0
** #
.".#.I, 0( = @0 W ((

/
0( 3& ) I < 9ebjc
.$A ..,A )7 < B$ L7$ $() .. 9ebjc
:0
:6;

& " E/ 5F/
+0
30 ) Dr. Wileys 0
30 ( 9ebjb
The History of a Crime "D$3F! % / $ *$" " ) "0 30
G(M/1 &* 5% 1
,7D" "( 0 /+ 2 34 $ # '
-$) $( Y/($ GAgainst the Food Law
+0
30 , .& 30 K < ) 9
O& M/1 " L 50( 30
=# "0
. ) A $
+6;
J" 7 @
/ @00 9 G@ 5F/ 0
"0 I6
Bureau of Chemisty 0&

9:
=# .(FDA "+
+6;
30" A/

&
30
7/ < 30
6<) "(&

+

D" & , ", A
J ) $; ((; :6L 9 , A M
0
)#
."L &" I

.E / "/ J 50
5* ejf A
J 5 /
80/
K./ 5) 9ebjb
.0( ") M G5

5, / G5
5( G2
".#.I, 0( " 50 9ebjb
Dupont Chemical 0

0( = & 0& % 9 ".#.I, 0( 9ebjb
.&
?

(; 0 ) /

-.)
Wundt * $/ I6
GWilliam Wirt 9
0
9ebif
9 ." / ) O& "* ( $' A
J 5 GE, K $# % G J "IL"
D$
=TD W ) BS &$ #$
61 $#$ A @ 1 "/
@
J " #
0
9
0
9<06 "6
(1 +?F<) .c17! $% % =$" 6 = $
) % 0 -&
"
""" 30 ,% ..XE.) " # 3*
6< "0 5< ...()
$'
A
J H, "6
96 9< @*
.&
A 7$) GM(
.+
A&
$ S
$* GMax Theiler > !0 9ebif
.
0 ? ed 5 ij S# M
$ S
9ebif
D% 2"! 0
" <# &; "$> '" 9 '7 0 -/ $ ( "V 7(0 9ebie
.$ ( " "! <C# ,A 2fluorosis J$" " $ 39 -
[ D/ D
D 6D" A$ 2= 6$ = 2$ .D9 ) 9ebie
0( !$/F ) " ,
", < /
> I6
"0
."" ,"

K
6 2$ (
9%

.(9
1 " #
) /
9

"/:
"$
&, < I6
G"9
2
0
,"
."! J " < $ ( $% '" A 0 $7$ $# 0
. 9
2
0
, 0( = ") % ) :
".#.I, 0( 9ebie
$*
&
" 5$1 5#
< 380
6< G5*1 5( $ 5 $ !:
9ebie
. /

D#$)
A O& G?, G;/ 5#
> / , &
?
)
&
J 9ebij
D " 6& % .WA $ $
,A $ .,9 7 8 POO ("$"1
H39 $$ ) ,3 ') A .
(0 ) ( & ?
/ /
0 !" PO ,A MN_Z
9 2Center for Disease Control " 0
=$" )" $ 0"$ YA & 2("$"1) "
.W$ AIDS $! l
T" B3
./ G
( e 5 eme S# M
+ $ S
9ebij
D/ Y$D# [ /1
)7 "$ '
! '& ", A ( (u 0
) # O& 9ebij
$"D 'D& D/ D D A 2pneumococcal $ > 6 ) A 2tetanus J $
.meningitis
D(! D% 0
=# B$ . 97 / X# ", & 7(0 "/ > 0
O&
9ebii
.% M:% = 0
( ? ) S
& 9 "* " 9$% % .3 ."
.I G!
/ t
3
( 9ebii
6D 1 0D &Dm . 97 X# < $ (! ", 5 E " "0, ">& 9ebii
.W$A 6$& $
.&
?
, +
A&
$ '
.& 9ebii
.7 # V( # &

//F 9ebii
. / "; * A(. M

+ 9ebii
.
, K " l,g
0&
' 2
" .#.I, 0( 9ebii
AMA 01 *

*
.L0( 9
) $ " ( 5/J
& ( 9ebii
.&

.E / ( 50
5* eei ' , K
80/
K./ 5) 9ebil
. eff,fff 50 5 eb ' , K

I80/
#
5$) 9ebil
6D& D$ )D $D" " " ) / "( Chaffee and Light "?" "(" "*
9ebil
A Method for Remote Control of Electrical Stimulation of the "D D& D D$>&)
.Nervous System
.
*/
& & , +

".#.I, *J 50 9ebil
A D) '
$ G

/ ">.>
.&
?
7) Lobotomy L
$
&# 9ebig
Q#, G// )# *
0
.D(1 $)$! ) c17 MOO,OOO :)A 4S (B$ 7
.6 " ] (A A Y
6< " &# I ,.-. ?, 0

=7 (! $ Autism &; .&

?
M/, M<(
+ S
S* 9ebid
.("$
(1 G*&
:
= 5
" 5*
=
& < $&
) .Y$# [ /1
./ ( mg S# M
$ S
9ebid
.
9 0/) @/? Zyklon B gas "0
L W ".#.I, 9ebid
D$ ( =D 1D" $ Tabun """ A/

3 1 L A
1 ? p 9ebim
.( $ "! $) 1)
.I !
/ # " '/0 t
3
+ 9ebim
G50L ">
G(9>#

) . /
+ " 50 ", A M AMA 01 *
*
9ebim
.(
5
'"D $ " 6$ $" F $ (Y$#)

$ / $ ( % $ $ '$ \n 9ebic
. 39 / Y$# </1 H39 A < 2 . 1
.LSD L$"$ <$ A (" .#.I, 0(

) & ,
) 2
/ 0( 9ebic
A
1 &
.
*J :0
#
-.)
9/ " 5$, ' Ugo Cerletti $" F A 9ebic
/
H6< E& "0 .06 5& " *
" 5 # H " ">.>
>
>
! "0
9/? !$& 8P G/
3*
01 *
) ' / I6
G0/
0 >
(6)
)
.&
?
+0

?/ L,
A :0
@)
9/ ?/ L,
"
" () E0 >0, < 2Sarin $" " 7(0 Schrader (
1 :0
9ebic
D H$ B =$) 6$) 6($/A ,3 $ $ " @0 9 % .Tabun
.W$" W$#
' 7 $ $ L3 2"! 2'7
.:6;
9/.
&
V ;
" Y eb A M #

+
+6;
$ " % 9ebic
H6< .=$
5*1 Q

7)

&
5>, \5&0 booster shots "D$ # #" 0 V( 9ebic
. )1
V & , /

" tetra-ethyl lead gas 5>J

L " "* gff /
#
Q
9ebic
."< 5. " =
9 G".#.I, 5. " K
6 "0 G&
?
/# 5, / 0(
./
;
, 9ebic
.(9eblf 9)
%ig ) M
+ ?&

= .; < , I# " &
9ebic
.
*J (/ A
J :0

-.)
9 ?/ L, 9ebic
.D$ $$"D( $D YD" "

6< .
, 6
% = $ % 9ebib
D># $# # 0
0/% #
"
6< .: *$ = 1 '
&

" E? 0 =/ 50( -.)
5:/ Y '/ I6
9
"
6< .Mn_O 3 W>% ) ,3 8 $
.9
9
)
90& I6
< * & 3<6 */
. M\O,OOO 0 . 1 6

<$ $A ,+ Y$# 9ebib
.")
A
5% 5#, " 9/
;
#& "/ F G
, Gt "/
+*1 9ebib
." % ) $$4 $ ) .%(

; / .;

;
, 9ebib
.E 6$$( < AMA $)$! $ <% #$# Y/($ "/# 5 J 0
9ebib
$ # Q#, O& "I/#

<
6;
" 30 ( GO& " /, 3* < G! "/ 0
9ebib
SD lD" 2"D+ 0
$; ) $:S J / "i >34 ; $> ' 7 >34 ;
. = ! 0 /+ $) ," 9 '" C)" 0 /+ C =) $3F!
0D PO,OOO D .1 + 6 [( $ 6) . (h ,+ $ S $A 9eblf
.6 " J1 1 Z\O,OOO
D/ # X $(1 " '7 $ ( = J $$ " #
6)" <$ 9eblf
. $" #&# 6 0 /+ "
)# G* (0 J t ,) $ 0

$ $3Fh 01 K./? 9eblf
." $"$> 6" " , A ) P
0 # " * %jm "V S$ G'
'

"/&
"P
" < GI
J " / !
9eble
M<(
5*1 ' 9 ", A

$'
, .( >.>
"/ 9& )
$0 5* cb "
" 0
"/
K ) 9< 50 %
# "0 9
5*1 9P) "1 K
6 GA, , ( =/
"/
.( >.>
"/ @ Q# ? '

G9<
Q&J " I >

W
) sulfathiazole $:(o" = 0
. AMA 01 *
*
9eble
.$$:) 6% 7 ) &$
. = H39 G(".#.IJ
^ +
Q#, 9> .#
@(0 (%
"( ,
, ("L1 %* 7(0) B 9
0
9eble
(9eblj 9)
A& / I6
) "( ? orgone accumulator "L1 )# Q&J B *) O&
I6
GB 0
@J #
6<
) 7) 9

"( , 6 <) "0
. O&
+#
.@P "( , A % #
@(0 ",
.

01 %.)
0(
" " < ( Bayer ) 2
u
/ 0( ", P 9eble
.
5? 0/) " "
)
"
9/ ".#.I, 0( 9eblj
., 5( 3

+ 9eblj
.(
H39 l $ $ 0 /+) $h <C )A Y $A 9eblj
P
5#, " !/0 G "0/
&

&
" & 01 )
&
" + 9ebli

5) ", # .
K "0/ A 3(
H A
("
+#, c u)
0 >V
.
" "
+# f,l A 3(
H & # " $ O.> M
,C3( Y J "V S GPearl Kendrick K 0 5 0

G&
5# 01 O&
9ebli
D 1"D D9 1"D $C3( X ! .$
6$" 8 . 97 X#
" <$
!
S
J 9 9> GM
S
= M<(
S
W A =$#( " 5$, < K 0 0
.( D! ) $!
.(
DPT
S 7) - J A
J Q, G)
C)"D 1D" * G 9P +

;
I&

7(0 ) "# 0
9ebli
W O& 0

=% 9 < .80/
9/ ? "6
(
hyper-adrenocortic I0
W (

W$1A 2))" . 2J 2+ 2 ) 0
=#
26$"" 2W$ $)( 0
=#
.(1 4/
.&
?
1 $ '
9)
W
p 9ebli
.)
6< " >0, \5( ejff 5 5*1 5( A& 9ebli
.
:
1 -. S# $$" 9/ 9ebli
D
=D
D9 $ (
:", 06 (li/5/ec J) 01 *
*
" # 9ebli
"$> A .
# 5)
6<
^ , .& J " .
(L, = G$ "
D $ ( A 0 /+ 2$ ( $ M 0
, $ ,3 '7 & $ ( "
" W
) "
9 1I L9 2 39 0
$ 67 6$ 7 7 /1 &)(
.(E / #

"
" "* 7
jg 3 M* / / A
J /

5&
(! $ $ &; P&. Leo Kanner 0

A 5*1 -. ! 3* 9ebli
9 :

<P
9<, " .infantile autism " ( "D - YA .$$)$!
PP G+;
= : G
? G0

*
6 7%
"*&
= )* 50( 5
A

3#
" 98)
A
9 G3)/? A
" +
G5
)/ %. G5) *
.?
D A D K
6 . J
& lm,fff A
J = "
5% " &
" .1 6+ 9ebli
.* M
J gf K < "0 G'
5>? 0/
W
, .,+ Y$# !
./
P autism "$&"
& 5$, 7 G/
G L/, 9ebll
5* +# ** ";( 0&

&
30 ", ") G";( G L !: 9ebll
& )%
L A I#/ ? 6< G
A &
H
>V A Q

Geblg 9)
" >
" 0 #
H6< , "V % G)
H6< A %

!# $% % .0&

&
?
5$, L & V .01 " /1 3* * 5% "
/
6&
9L
(";0/) Q, =
? 6
/ (
= ", "0 .? " Y
6< I#

0
"$ % .(
A
>V Q
"
"0/ <) " & 9> G
" <

O& G# ) @:;
J 9 ? "0
.Y(
6< " E?F/ Dr. H. Trendley Dean "
.<
.(9eblg P , ) !!$ L ^ < 3(
H
J "V ". 9
@
.&? GALCOA 9
2
01 0(
3 :% A Oscar Ewing f$ )" A 9/ = 9ebll
.

"1 3 "$ G( 5. .? mgf,fff I /
@ u G0(
& 3
uJ 0/, */ & (

"1 J 9/% $# & "0 I6
) 01 )
&
30 ' ,
3#/ /# G, jmjg :=#
) . A <$ $ ( /+ C;$ . "$ A O& G(

)
%.)
"0 .W " $ $!
, : l ,A .(#
&
#
#
9,
)
%.)
&# & , . .5.J A ;/
3% <
M/
u, &
.& Q&J H6< 0 .)
5% A 5 &
5#, " P ")/ %
9/ A =#(
.E# &#

u J 0/,
0

", 06
(ebll/"
&
J) Health Practitioners " (
0 O
<"
# 9ebll
6
9$F 2 ! 6# $ ! $)" :5 GK (/ " 5F/
G
L.!.!
WD$% Y % )$A A -$1 )7 <($ ! YA 2! 0
/# 1" $%
.0/ $% = A
=
I6
+
3( "V 9) "& ": :% 86& G(ll/5, "(/e J) 01 " /1 3* * # 9ebll

&0 9P)
*? ) 3/ 7/ "
" "
+# i,f A
J e,j H% A I&
HV K0( -. 9/ M* "
&
H6 3/
*
=*/ ? Gosteoporosis 9P)
5
"V ) G+0
5# " ) @) 3/& .5*1 " /, !/
'$
= 5/ (
@ 5)
."
H6< 9/ /&
M :/

)D" 6DA

(*/) J & $
H6< ' GACS 01 "*/
)# 9P J 9ebll
:< 1
"0( !: GElmer Bobst /
, G9.
*, &, GAlbert Lasker
.Warner Lambert ? 0( Hoffman LaRoche B? "< 0(
0/?
,

I
, //F ."
" )
(ACS) )#
H6< + 0&

K )" , 0
D D! D 0D
=$" =
580( ". 5# 5)
" #
0/? 5, A )
0/?
."
0/? I
.Hoechst Bayer BASF : 0( >.> A

J ,# ".#.I, 9eblg
9
%d "V 06 I#
'
) &
?
A ef,fff 5 M& / 9eblg
.#
( %.
3 9
%el " 5*1 A !0, )( &
(0 .K Gt H A
J
J 9 9eblg
(% 3 ?& u

A < I& ?
"/; 0 * =
K
6 G9P)
(%
.%m,g
MO D A ' )4$7$ # " 6$4A 2$ ( 1" =)( ) .$ " $) 9eblg
$D D&$ l> .( (1$ ) = 4$)" = $ ( / .# = " ($"
.$ F =
I# '
+&
.:
J ) :: = 9// 9> G$3 # # % $ "" $ 9eblg
.M<(
$ &
5 ) ( "$&
" ?& P ."

#
0 G/0 3&
) / G >

)
3&
/
6 "F " 0 0 9eblg
.$)$! $>34 "" 0 = H39 1
< / J M/ GEdwin Katzen-Ellenbogen "L

, "0 ", 0
9eblg
9 < J E ' , .
( 5) # H 3/ t F
"#/
@ 90& G*

5
//, @
"0 .9eble 9 ! # " P
&
?
K 9> G9ebef
.
(
'
) " ", 7 I6
(
< " GWerne and Garrow L " 9ebld
./ jl M<(
$
#
9, K
6 2" H/ %`` $ 6: "$ "$F ) 9ebld
& M.* !:
5$ !/1 6< A " %
E& K
6 G( #
) !; 0
5% " ) Y/
6D$ l&D $
J4 ) "0
.#
"/L 0
* "*/
&
7
"
6< .6 A P $FS $ # 0
4 $ W $ %A ) 2, $)
7+ 8 $
0
( ", #
0 ."*/
A +
5/ &
YJ :6L 5:/ O&
9 "0
$" 693 2L $ $ ' " B1 # @ , A
J G+/
&:.
A ) @>&, "/L
.$" '9$F 0 B
* & , (H& 5/

"/& I,) eugenics 0
"1 .
)
)
&
&J +( J 9ebld
5:/ 9
? # P
H6< G"$ $# " :< ^ " )
/ 9 G"(
"

78P
? , A
J .( *( " <L G5)
90&
GL
&#
G+0

5>
.

, *(
H6< / "6
+)
+*1 " >0
"
k '
9 "
& " 7 , *) GK G"0 A(/ " I > 0
9eblm
.. 97 / &$# $( = '"
) I, G9ebme 9)

5 :# A 5 & @ 0
."9L

" 9 # GL ! I;
3*
9eblm
./
$3*
% A :

E ' , 9
6< "1 K
6 G / jl
A B)$ W$# X# ,A " :E.:% 30 G3 1 9 9/% G*
< / " /
( 0
9eblm
$
$ ,3 vasculopathy >

9 L7 "# . & '& 6 '"$
.'
! "# 0
/# 3& #$ 2demyelination ($
"A)$$$
. * 5* gf,fff A M<(

S

) +#J , *
*
O&
!# 9eblm
mj ) #. , 9 > .(?
>& 5*, !
) ( el M 0 5*1 +?F< , =#
H6< " I, # " *
+*1 A .S
6, " 9 jc ) #. 3 , 9 il .S
6, " /
& 9L . * 5*, S
6< " & & GE0 E&# P, ? ", " ) G'
?&

H6< W: 6, &
?
", ?J G( el "/ & 0 .
) "6
" 5* I, K < !
",
.* =/, d I, G?
>& 5*2
"^ S
6< ", A u >n0 ?
, " E?*, 7

"( G*
< / " G5./.K .K.7
9eblc
6D '"D$ X# 39 ", & A ;
> 5$, (0? H6< .M<(
S
9 ) L
. (! $ =$1 $
" 0/ "# .5*1 " # >.> " P % ?& &
* #, / 9eblc
A < I&
Launton " ? " 0 >
>
#
, ."
"
< M*
&
7(0 .( ^ V 01 )
&
%
0
! ) " " +# e <% " 0

G>
>
#
.I
)
* & 9
"
1 "#
5*, " %jf " )(1
, G
K
6 P % ?& 9
5*1 " %df ", " G"
A &
H
5
.E* >0, Q,
D " = $
6/ "V 80, G*
< / " G5./.K .K.7
9eblc

Pediatrics "!0" # @#: ( 5*2
"/ A(/ O&
I#, .DPT X#
.DPT X# < 6 31$ 2=$: l> H39 7 A ($ .5*1 3*
< / " G5./.K .K.7

5% " GM<(
S
>V Q A O&, +#J 9eblc
D D% $$$ ) (! <$ ./ mj S
6, ) 9) 0 5* eg & % .*

D WD
2EA 2 0
A YA (! A .5*1 +?F< " I, = #. ?& O& 9
.X#
" "L +*1 "0 . 9& /A
% " 2: 6 2 1j A .X#
!&
W:
H6<
. (! 7 %
B C)" ", 7(0 GI* 3* G / 0
9eblc
.!X
9 A 5 &
7 *
%? & 0 G""*/
$ *
&
" M.*J 9eblc
.I#
S
5)/ = 0 J 9eblc
H3D9 2$7 $ ) " '$ C: 6 <$ A $() '$
""T 9eblc
.) $4 6 7 >9 6$) <$ )) ) )7 &($ W # ""T
K8
&/
9. A < " >0, $& % A :6;
0 # ) 9
@ "0 ? 50( >F 0 G"<

5*1 A &/
. H6< >V ,
)" G " (1 "$ 7 C)" ", & 7(0

/.3 "# 0
G
(
?0 9eblc
& A I& soda pop
3( K
60 .hypoglycemia )" c# l$ 2
6< G )
9P
A
J " )*
1 "0 ", 5% +6;
" 0
/
$ I6
/

0
C)" 0
$ 6 7 $>34 6 ", / 5% .$# 50( 5) ? )
Y6#
5)#
. (! 7
.(eblb 9)
P ,) . J j,lbc <
(
?0 5*1 5( ?& 9eblc
S
5& B
9 O& AMA 01 *
*
Y# > P&. S* / !
0
9eblc
&"D$ D &3 /! 9 . 97 / X# &"$ $ /!":", A
J / 0
( .M<(

XD# = # ":/ 7 .(S
6 0
"/ 9 1 G* , 6< ) ."B3 . 97

&
H6< ."k =$1 6$$4 0 &/ ,T$ $
A "" .$ . 97 /
." &"$ &3 - ; "$ X# 39":5 Q, 0 .M<(
+ "
?&
E (
9P
;
", > 50 E/ S$ AMA 01 *
*
=
+0
+
!# 9eblb
."*/
-. , = E, %. @
!
:6;

GM<(
S

) Q 5& ( G#

)
9/% G01 )
&

9eblb
BDS -CD$ ,3 X# 39 # 2B) 39 F .? 6< W: A + 9ebgi 9)
)
5) % %
.7
MBD $F /A '"$ 2I
)D C3D$ G80/

5 " 5*1 >0 G7
3 5*1 5( ", &
@P&. ) 9eblb
D A $ 6) .($() ) ! 6 C)" L &" $(1 $7 $ ) C)" <$ "
.(
& j,lbc < "0 9eblc ?&
P ,) . ZPN 0 6( )7 (1 (! 7 +
(! 7 6 (1 : 0 =$7 2B:A " ) 0

+ >" % J7 9 9ebgf
.1
=
&S
D$ ) D . D"! 0D )) ) ' 7 0 /+ 2&#7 ! $() 6 9ebgf
" =8
3&
80/
K./ 5) G( *(
M/
** 78>0
. @#
# ) $7
.MNPN " ,3 0
A G " 0 (! 7 6 [( $ 6) G#
D"! GD D$ 1 -& 2 )"$" " . $) W $F CE $)$! $ 6 % 9ebgf
.* & ( :
3
@( + , "0/
" >0
.$$)$! $$ 0
$ $
K
# , Q&J G! / ) 9
< G"
/
9ebgf
D7 D D+ <D ZOOO A # = X# # :)A J$":E.:% S$ O& (ebgf/6,/if)
." (!
. ( eff,fff 5 gf u \5/

+ #
5) 9ebgf
.90
$ 5$) +0 "/
9 9ebgf
$D [ /D1 [$D 0D

D; 6 # " H$ 0 $ ( = ($/$ 6$$ " 9ebgf
.$#
.+
A& $ S
H0 A 5 :# > 9ebge
+ =# 9 Y# ) G01 " /1 3* & = ")
G01 )
&
J 9ebge
+#e,j / 9/ S% 9 .$ ( 9/ =#( M/
// 9 O& 0&
" /1 3* :
D$ ( "D 6$:SD D
0
3)$ A "0&
" /1 +*, A , % G3/ )0 "

D#$ $ ( $
6 7 . A # A &($ 6 $ &($) . $
7 )
%.)
" *( 0& A
J %. .J & *, 9> . (! 7 " + &$
./
H6 9#.) &/ ", #
Y %J
.&
?
"//
" 5* igf,fff G"/
" 5* lff,fff H% = 9 9ebge
. / 0( " LSD

" # " eff 3* !
"
,
9ebgj
S " /1 +*1 & & ) @# J Q&J ( " /1 3*

01 &? 9ebgj
.$ ( = $17 &>I 7%$
9> )#
1 9 )" , 9/ . ACS "*/
01 )#
G0/?
, 9ebgj
D& D$$ D <( ."*/
& 5/ )#
9 5#, " !; 0
I%
580(
6D
"0 ", 3# O&
9
#.)
, ! D$ MMO 0 W$ " $ Mn "
9)
P ,) ." 8

" $)$! $1 '& **
) I , .! W $ $)
.( 9ebdb
5. .0&
':
#
"
H A
J
J / G9ebgd A& 9)
6< 6 9ebgj
"
5

"
P& 50( = "*/

?) , G)
H6< /
.@

)D7 6) 3 W$A "A":5 G6L? 0

& #
!: G.5., 0
G0&
5> 9ebgj
D lD "D ) $ $ = cC1 & 2(1 &
A ALCOA $h " )"
fD$ A )D" A) D
T" c17 "V 9) ", E# 9
" @ J G
H6< .( $!

. $h ALCOA )7 Y
T" B3 9 (Oscar Ewing
.phosporated hesperidin /

"/
A I& 5&
=
3& = 9ebgj
0
9/ Y
#
& G >
/#
G!; 0
" >
>
Y#? 9ebgj
"V "
A , &
) " /1 3*
01 &? Q#, ": 0
5 .#

+6;

.& C! 0
$:S & = H39 ! 20 $1 0:A B '7 ,3 $ ( ($/$
." 0
c :)A 39 $ Y L9 ": 0

B$ J $ 0
, 6# 6
-j 67
8 . (! 7 / X# 8m 9ebgj
. Simian Virus #40 PO# $$" J $( # $ 1
)# " 7
F
) " % 5 / M& 7 /
, G&
?
9ebgi
F &
") 9 .(... #
%
Y 58> $ 60 O&, GE / ".
: u =#
D$ D ":

&

L 5( . (/0 G01 5)
" Ben Fitzgerald
6
(1 <% 0
W$ q 2 $( =+ 2" & < T 2AMA $)$!
."" / $
)A A l" 2" $ 8 9 $ $) $ ! 6

7+ 6) 3":
L 5
."
!
) $ 6
< " ' 7 / &% $ [1 $
$:) $ ) 39 G(% # ) F g( )7 Tobey " 6 &
$9
"# A ^ / /
"0 6, .W W Y " % <
T $3 )
l>D .$# -% . H 1 6<
L .W .$# -% $ S F A I6
0
.! 0 6$(1A .$# 39
"
& cj "
F :% =# G5*1 3*
)
)
" u 0.! 0
G )# 9ebgi
.9
)
5& M<(
S
+#
D$ (DF D$#) .$# 0

, $ J4 ) $ $# 1$ 2 7 " 9ebgi
." 8
$ ,3 # <# =T 0
6:
D%
BD . 97 / Y$# ", " 0V
9 G 0/? 5
G
< G/
G( G/ " 50 9ebgi
.&
H6< <# &
?
, .autism " " =7
E E. 30 GAnna L. Annell 0
G/
>&
.M<(
S
A / /
I# 9ebgi
D 6) 2$F /! <$ B . 97 X# ", A
J ( I6
GPertussis M<(

<P
! K '
" #
L
3
? ?& "J .k ) 0 A 2=7# 6 2$F =7#
.E/

# A % G &
G5*1 )
:1 ) P, G
)
5.":5 5 ^ >&
0
." )
9P
3* " ?& " u
9 G ()
) . )
9P
0
fD % "0 G9ebmg 9)

.M/1 Thorazine $ : "&* GB G".0 GO/ 9ebgl
." $ ( ZOO,OOO,OOO ! 6($
.
. !
5*, A @ 9 G5*? 5(

"L "" S
9ebgl
*
H6< .5*1 5(
"
" S
= DPT S
" W +
Parke-Davis ! 0 0( 9ebgl
.Quadrigen "#0 A/ & , &
), "
F
#

L 3&
5 # , A LSD 78 DIA 01 I0/)
"1
0 " 06 9ebgl
+# K
6 G / 0( M* " ".#.I, " # " eff 0

0 3* .

."5)
90&
" A 3#
9
" :" ) G.I,) .6 $
" $ ( $ " 7 9ebgl
.(emjemf &
Gdf )
"/# 5 " # "":
Q
3(
H
.= 6$ C)" =$) $) 0

$ $4 6 7 -$:) <" 8 9ebgl
.&
?
5*1 5( '
9 W M.*J 9ebgl
DA )$ .!!

1 J$ 9 (! 7 / X# A 6:$ ) Y 2 Ò,OOO 9% =S) 9ebgl
.!=S) (
7D D # -/$ $ ( ", > G".#.I, = 5) :0 GC.E.Perkins 0.IJ.! 9ebgl
.$ " =$"
5& K( < < "&
&1 '/ G+
9)
&
G< 3
0 , /
9ebgl
."^ < Salk vaccine K
/
S
"V S$ <
.J" 7" -/A 7

(B3 X# &" ) (! 7 + 6 9ebgl
S
- J 5#, " K
6 G!
J M* / " 7
F 9% A 9 , Eli Lilly

0( 9ebgl
! ) Parke-Davis ! 0 Wyeth "O" 0( " .0 .( >.> ) E.) - , .K
/

.
! A*

#)., X# $# 31A $ ) G"

MacArthur >^ K 5 #
90& & 9ebgg
(9ebgg G3^ jj :)
G7?
'
W V*
(%
(ebgg ,) ., ")# 0&
)
&
5# ")
9ebgg
3D9 ! #$# '"
X+ B X " J$ @ V ")#
5% )
&
" +)
&, .5*1 5(
.l 39 6)7 6:" 0
W" :T$ - "
D YDA .6# L3 2 / $ )7 (1$ l 6 9ebgg
.c17 MOO,OOO ) # = 6 O,`
D$% 0
c17A A ) '/$" "": .J Q&J S$ "*/
01 )#
9ebgg
=/ 9
@ V 9)
=) ."^ I, " >0, "*/
" " eg A
J i 5*1 "
. $ =$
.( / gf 5% 5*1 " "*/
" &,
<D D# 2"D D c17 $ ],P # S & 2" $)$! $ $# '"
D DA .D# " ZZ D = $ ],Z H% [( ,A 2MN`` = MZn,OOO
", D$) "D" "6D#" D& 2/ # 6$: : 3 $ 6$ H39 6 =$
.!", $) "
D$ D D ) 6

2X# $ (! 7 6+ -$1 >& [( F 9ebgg
. %\O 0 %PO " + 6 (1 0

" X# 39 S USPHSD 2NFIP D 2AMA $)$!
+ J( 31 H A $ .MN\\ "$ Mn 2W (! 7 / Y$# l -% 9 $ 9ebgg
.MN\\ MZ
XD# <D$ D =$) XA <% 6)7" " )

G"/ ec
< "/ & 9ebgg

A A 2j" 5% GS
" %gf = </
GParke-Davis 0( 9/ O&": O& G"L "
.XD! D 0D D/+ X# 39 $ 9:" $$ [" j )$ 2 " I BS
."MN\\
L " X# $ MO :)A - " )7
,3D D 1D "V $ G/

<0 & "V 0( " G"H0( !" 0( 9ebgg
. $ ZOD # XA < 2 $ ]O f" L " X# <$ 6)7 $"
2D$ D D D D# $ $ ' 1 , $) 61" ) 9ebgg
D D+ 6D <$" g( [( .#

3&
0 " 6V "/
.1 =7 # = MZ l> (1 % $ ! $ 6) 2. 97
.
=#
& 5. ? " lm H% u <#
" 3* "5*1 5(
*
//F
" 9ebgg
&
A ":
"$
", < 3/
G01 #
" ? " jlb A # :
W
6< "0
. M/
!:
. = M*
=# "0 ", A &
. : : L9 ::% S$ GCancer Facts "*/

M:& ( "*/
01 )#
9ebgg
.W &$ A =( 2 2 $ 2J) 7S 8 2" 8 #
$3D D(! "V ;, % USPHS

", G"& i S$ $&
&
"* ( 30 9ebgg
D
S D(! D7 $A GWyeth "O" =8
(5*1 5(

) L " X# /1
.% $F W (
u
/./ # &

( ./# G/ K ., AMA 01 *
*
F 9ebgg
D [D1 D(1 C) "$"":

06 Gebgg "& eb AMA # F

) A*L I6

D/ Y$# l c 1 2$)$! $ 61 2 (! 7 $ ""T ) % &

XD# S" c 1 $""A $ $ 6 0
- A <$ < # .(L " X#) (! 7
G D7 0#$ &; ) $3 $$7"
$)$! $ 61 G ) .L "
)7 $ A 0 2Y$# l " H 4/ 9 6) 2 (! 7 $ ""T
# &
&
$/ A 5*1 5(
*
//F
, :5
u
/ 7, .W $1 X# S Y/
.E# * ) &
d 5 , " l @
) "0 !X# '$) $ 6 6" $
.-$1 )7 <( 5*1 5( ?& .&

?
> 9/ L " S
9ebgg
+#J ) .L "D X# 9 A $ & $(; ! ", " O& 9ebgg
.B ' W $1 9 L " X# ", , G% e,jff A
.:#
"
/ 1 0 " M&
9 9ebgg
.u
' , '
= 0, 5# 5$, 9ebgg
H/ Y$# 6 3 (! 7 + 6 %Z]] " [( 5 & S$ 9ebgg
.MN\P
6 D D 3D (! 7 + 6 %]PZ " [( S$ K G ., 9ebgg
5(
*
//F
&$ G
&
H6< A M) .5* eif,fff ' 9 O& 2MN\P D
H/ Y$#

V/
H6< $9 !!*
K
$ '
&, = 9
@ , < / ?& Y "V 5*1
.K
/
S
= !/(/ ? ) *

)
" 7 I6
G)
&

*

G"/
..9<L 0
9ebgg
."I BS L " X# #$ J( B$ $ X# ,A $ -$)
A A":5 GK
/
S
5& &
*

*
*
; /# 7) GScheele "0/" &
?
)
&
9/% !: 9ebgg
H3D9 F . ( &>
% %
,A A 6: )$ B$ ' L " X# "V AMA 01
.ebgg/3^ ( 5% ( " gm ' "V 0&
") .I X# S #$ 2#$#
A P (@& 3*

! 9
I6
) Scheele "0/" &
?
)
&
9/% !: 9ebgg
."Y$# $ S ! 0
YA .K
/
S 0 > I
":5
* *&
A z' 50( P : & 6 *( .=#
A
J 3$/ Rock music L 0#$" 9ebgg
D $3 6$4 5 & A
J ( 6< G9/ , " Q/ "0 ? ?1 " 50 5# ."<
5*1
(ebgd 9)
P ,).$ =&!
J $( G
(h J O& GK K A(/ Q# F ) 7 ) 9ebgg
.E " 0 5*1 +?F< " ) .
A / " +# 5)
6< "0 .) '& '"$ 7
.K
/
S
" 0&
J 9./ 0, ? em 9ebgd
+/
t.J 9 9
.< 0 " +/ A G?
* $ # , &
?
9ebgd
.*
& # >V I, "
D 6D 0D

D$ $ $ 1 6 " : B l A $)$! " 6 # 9ebgd
8 D D $:) .( 0 =7 E$ .A # .$ 2 A $ 2" 8
&D) 2$$ $(; ( E$ A &;$ 21 ) .6 &/ 2 & $F S $A
.
" (1$ : $ 0/ $F ( 31S$
< " 50
#
&
"V A ?
/
? " gi,d &
?
0& 9ebgd
."()
"/ &
2D# Y$D# /D1 $3 (! '/ (! 7 "V S$ ""/" <J &
9ebgd

5(
P G?&
" %bf ./ -$1 3 39 &$ 7$ . )"$ $3
.S
& 6,
'
) "6
" d 5*1 5( J
& edc 5 & ") 01 &
9ebgd
.L " X# 0
$7 ( c 1
+ >" - $ =$7 % <) 9 .5*1 5(
$ P_ f 81 $9 ' G

=#
I /
# M* 5*1 5(
*
//F
9ebgd
.
. $ \OO ((&

" Y < ) DDT
380
I /
- u 9ebgd
. Sabin "/ 0( H* G9

" 6F 5*1 5( # S
9ebgd
'D" ":5 -<.!.H 0
M) G6^ (
J G" /1 3*
01 *
# 9ebgd
%\O 0D Z\ D 2'
"D $ ( = $) A $ 2$" $
9 $; $ $ (
.; '"
A/
H# (
M6 $* "V 9)
3# .=
$! B ($ Rock and Roll A L 9ebgd

G*/

< =
0( =# ", ) ) ) = * $* <
"

3
5& ", L
A/
"&/ G
)
Q/
A
J -
" 9/ ?
A/
")
rD &$ G " % % #$" [+ S
% ! )$ G)
Q/ A
1
"0
.
A& GA/
M$6
*
:0
=# .( ! ") )$ G " 0
$
K < (S
9/#
) "62
/
&
A/
", < :0
0 " =# I6
K(
9/

" <L K

3
5 , K

)

#
, .* #
!
3#8

J $
&
5. " K
6 >J "0 .!
50 V >V (
" E) G:
0/.0
A/
& 9$1 = 8
$", "$ O& GA/

3#
. 56 7/ /
A/
H6< A )/ 6J "5 , K
" 5> $
A/

.&
?
< 9 &

" # Y , ), 9ebgd
X# <$ (:) $

6A (0) 5*1 5(
*
//F
01 )
&
9ebgd
. L "
"/ & < " 50 ' "V

? " i @& )(
!#
" 3* ( )
0 90& 9ebgm
$ \ :)A 64 L " X# <$ % 6)7 XA S - X .K
/
S ")1
"/ & 9<
0 ( ". l # P&. 90&
5$#/ 9)
! " *( ( .!!
.

&
A 5 & G")1
.>( " 6" :6L ; ei 5 , " ef ", 5 9 FDA +6;
+
J 9ebgm
M/
9 G
&
?
= G

"
50 # M<(
'
W 9ebgm
."*1 "
" @ , A S
7

>V A 7)
E# 0
" @ J :5 AMA 01 *
*
9ebgm
)#
&*
3/1 G(.
6< P&. V "0 % G" /1 (. @ V @ u
9 .+
A
J
.< 3/, < G)*

>V
@( >V @
+

"V M
(<

5)/ A / d A
*
) 00 0 G" " .#/ 9ebgm
+# e 5)
&
Q/ A , 6J A& .&$ A 6(A % (! "A ", A
J (,
" /1 < )8
" /? . &
"6
5*1 " %eg A ef " /1 =8 ?& A G"

.X i % $F / / C79 Y "! $ G
P

bi) M<(

S
H# * 5), " #
& efm A I& & ,
)
.#/
9ebgm
ie ", # efm
?&
H6< 5& t.9.- 0
9% G"
" A(/ .(&
?
#
D =D7 $) $#
-C1 6 i B A
J t 0
Q .9: L P,
.B ' / X# 39 A $)S ) X# 31A $ $
&; ,A ", A $( GX# $:S
#
1 ", #& A " "01 +*1 .) 60< = 5<# &
?
*
//F

.<, I,
!
; <
? elm,fff H% u

0 Cutter Laboratories 0
0&
90& 9ebgc
J$ ,3 L " X# $ < ) 0 ", 9)
= .K
/
S
# "* 5( /
.B% 6 .$() $ + W)

J 5& @% E/0 )
) t .-.7 0
( G9)
6< " > "( 9ebgc
." " " 1 $ ( % G"&#

0
#

G3(
H
$ D( D D ", 7(0 O& G" /, 3* < G"0 # 0
@ 9% =: 5 9ebgc
D )7 ') T '" 2)A
" $ ) " c '"$ % "+ " $ "
.9ebgc *( /# 5 # H ( .& c1 " B $ 2$ $39
9
) 9
%m,g ", P, G'
) "6
G
. 3( ei,fff A #, / 9ebgc
.#

G / ef
") 0 < )# @ ) &
+0
9
"V S$ Time # 9ebgc
5 & =
*
. 0
K
6 GSugar Research Foundation 80/
O&
//F 5% " "

.-. I, A
J . 9
0
.80/
5 3/ " /1 (. ?&
.K Wilhelm Reich E$ $& . A . &

?
0& 9ebgc
D "D 8
$ ": E0& S$ Gu / ?., 0
G"/
0
0
"F( )# !: 9ebgc
."$S 6)7 2
! ; J &)$ G) $ :) '"$ % '#
Ggb/6^m I6

G+

J 9 5& GO
>
" /1 3* F =:% " 9ebgb
,3D Dj $"D + L3 C: H$ $ ( / " S Y/ B" : #
06 GK
."'7
& A H$ "
GH
K
)
K./
:Q, /
K < G3(
+
0 90&
+/ A
J
.(
# O) *&
#
"0

M( / K
60 G
A &
)*1 K./
D# D 2; .E%.*J I# L "9/#
A
J
5" ) 90&
" O&
5)# /
5+/
H6<
= [1 26" % $(1 6 [ / #$% 6+ ! <$
." I 9 $ ( "
A I& S

6< .5*2
Quadrigen S
9/ A M NIH &
*
)
9ebgb
D D($
$:$ BS $ X# 39 .5*1 5( G!
GM
GM<(
:&
),
J$D($ L )7 / G
$ 9! A A MN]n . "! B" 2'" 3& 2"
.&(A &" / '" Parke- Davis
K
/ /
H6< M) G<(
G,..- 0
<#, / , '00
9/ 9ebgb

G 0 @ , # .5&
+ >, ;
+,
. " 580(
metabolic pathways 1
A .'# /
0
"$> $:S ) % 26 / $ ) 9 && . <$ " 0
$ $
. ) 4/ -/ *"( 6" # 2( 6$)
["$ "+ " $ ( S W$ $ ) q 2*$ C) 6% 39 3 9ebgb
G+
#

9/% G6
%*
A
J @# .>$ = $
7+ &$" $
The Metabolism of Alkaline Earth Metals "9P)

1 ")
I
3./? ":<
"
# "V E >, .gb/6^ ji G/ )# +0
/ G";
..7 % by Bone
9/
0
5 bf / 9/
"/ 9/# /

5> Q, : = "

.9P)

.9
M* " 6F G5*1 5(
$& ! $* "/
, 0
9ebgb
BD! 2H$ $ ( $) ,A /m Y"$ BS $ 2 $ ) 2 $A $ 9ebgb
. $ G 7 0
H$:S )$ $
GI
J G"/ 0/ " 50 Mongolism "
;
<.
" ?& <P 5& H+#J 9 O& 9ebgb
" 6( ) ", # O& G/
3*
01 /
(
" @#: ( . #
(
0
.$ 4 9 $ (! 6 [( B#$ ) 2H$ $ (
", >
" @ J .H

0 Y = 5*1 " Y
6< "

1 , %
.%egf / ?
5. 1 5) = G00 0 G"
J " A
1 O.>
/

. &
A (//&
3/) #$F >V @
M<(
S
", " 9ebgb
"V 06 O& G9/ !/# @/ &

Y I/ O&

( *
*
#
9ebdf
.!. 97 / X# &"$ L sS b %A 9 . 97 l $ 6(
/
Y$# $ ,3

" $ 39 2-$ YA $4 % . 97 ", A
J E, 9/ (,
. ( H/
.&
?
, &
$ '
9)
W
9ebdf
=/D 6# 0
G
J 5& M:&": " ) ( $ $)$! "! ' 9ebdf
0D -/D$ D . : #$ ,3 . 1" G / #
H6< " Y
G"$ (
0 G601 H6< % 9 : &J I, K < !
@ V 9)
= .=$ $ =$ E
JA L9 $ ( &9$
2"D$ 4 D9 " D $ (! 2= :A 0 "
)3 9A &) .Q1 3601 %
2D; - 6 2; 779 6 2,#( H 7 6 2C1/ "! 3 2C7& "!
.$ ( $ $3 )" $ X / =9; 6 9$F
.
$;
"< = S#
9ebdf
.
50
9ebdf
.&
?

# * 9ebdf
.()(`
)) !**
$=( 0 , 9ebdf
D 69

S $ = 6$ ( ( $) MOOO,OOO :)A 9ebdf
) G//& G7$
* G/
0/ 50( G3)/? 98)
) @ 2Y$#
.9 50( #? %.)
*&
= 5
) GF
) G9.0

9
*, 3# "
<1 ", 7(0 G<.9.- G
(
0 J ! Q&J = $& 7P 9ebde
6D D D(! 0
# .
'
& )
9
*, /#, 5), 3/ GM<(
S
Y
.&$ B9 WA #$ . r 2k(" 2$&

9/ Y B% G2
0
)
" "
<.,. 0
GAP)
* 9ebde
5
Q
*
>V
E.* O&
3# @ , 80, ."/ eg ( *
*
#

."6$A = , % Y) 9 $ ( A W$ - " :5 .9

.5*1 5(

"/ S
9/ &
?
'
# & 9ebde
;
) 7 GVietnam 9 Ranch Hand " < B " A/ , &
?
9ebde
D$ H3D9 D$ (D$ ' D$
&;) =/ &) $A 6&; .dioxin "/0
"/ 9
.W/$A $$ $$ % " = H39 61" % .$7
Z A D <D ."/0
" 5* jlf A
J % /^ ((
0
0 G
H6< B " + ? )
9,
H6
)
0(
> G9ebce 9 .! L $ $ $ )" # $) = H39 A
.(5 & % 5 & I6
.+ B0 " ) .90&

% O& G!/0 GCorpus Christ " 3

#

3&
I# )$! E$ 9ebdj
D 'D
2$ ' $
'"$ 380 < Gzinc-cadmium sulfide $) L 6$) " :# 8B
.$$) )
GJournal of Applied Physiology, Vol 17 July 1962 8# 5 ( I. <."?^ 9ebdj
Human Auditory System Response to "
) /* ;0 %* A
J / =/
9P 3#"
A -6 *
")*/ "(*
A& ", & B% GModulated Electromagnetic Energy
0
9/ G? Q&J .5/
#
< t
", O& GI)
9.0
A # 50(
>V
0
#
", 7(0 0 GY 3% 7% 0
microwaves 0 #
" "I"
.7*)
A 0 >V

t
J.
0&
" 5F/
9/
A
/ ll 3)/ =*/ @ V < )# " / @ 300 "0/ / i,e 9ebdj
.' 50(
.ib / Gib * G5

& I 5 jff
&
?
9ebdj
[D" 2MNN\ .(C)" ) Thalidomide $ $: 2= ' $

6 9ebdj
.$! 0/ ) 2. "! $: B$ A C" ;
.E / ( 50
"
L ed &
?
;
(
K./ 5) 9ebdj
."
9 GAutistic "$&
"
& "
5*1
<1 Y# 5, 9ebdj
6< .FDA +6;
+
J # K/ "/& A Y.*? 3* G+
+6;
"
I/ 5) 9ebdj
.$ h $() $ 2
6""T #$# $& 58>
D+ D < $ ( $ 6$ " ", > 9)
01 01 " / 9ebdi
."
)
/#
5)1 O& A
J 9< ", 5*1 +*, A 3#":E.:% 30 * 3* 9ebdi
. DPT S
Y
+#
H6< #, ."#

5$) Y" " ")#
5
. Q/ " " * # 9ebdi

IQ )3 G " < $ 6$" #
" # .Rimland and Larson "/? . 5% " /

.MNP\ $:) 0A 9 $)( =# S MN_O 6$A 61 67A .$$)$!
9)

6< 3&/ , .)(
9&
':( #
) '/ FDA +6;
+
J 9ebdi
.9ebdc
D& $ ."" 0
'" :A $" 0
<" )7 # 61 Y/( Time 9ebdi
.>$
6)D7 D W '# 0

&S FDA 34 =+ #$ r $7 J $## 9ebdi
.

D$) 61D" ) ' GBechtel " )" 0( !/F GJohn McCone )) 9ebdi
. CIA
#
)
+*, A 9#
s GAMA 01 3*
*
)
G5#
6)(
"
F/
#
9ebdi
.chiropractic doctors

.& , ( <) . &

S
Y ,.7."# 0
G01 O&
9ebdi
.!" &

Irwin Herskowitz and Isabel :=#

). &
"*/
$*
" * / ( 9ebdi
Norton "Increased Incidence of Melanotic Tumors...Following Treatment with Sodium
( Fluoride", Genetics, Vol 48, pp307-310.
%. @
L , Gebdm ebdi " &
/ A I& S
) "6
5*1 9ebdi
< B$&
&
!
5*1 3# "V /
&% .Atypical Measles Syndrome &

.(9ebdm 9)
P ,) .L V
& A
J 5 1 =# "0
.
@ 9 I6
G5*1 "L

" "$&
" " @(
A
J H ? Rimland . 9ebdl
. )1 >.>
%
.
1 J$ 9 ( (! 7 /) " $ " X# S 6:$ Y Ò,OOO 9% $ => 9ebdl
.6:+ #$ A
6)D7 0
6 $$ C $ " 0
61 ", 5 Business Week # 9ebdl
.$ ! <$
A
J
0 Y A
J IF &
?
5*1 "$&
" ( 9ebdl
6$"D 6$"1 " " 7 ", # GE.%
A
J )
) .5*1 "
+*1
.!=( J( Y$# l . + $ ) 6/$ ( =$ W J)$
A. Taylor :=#
) .6 $ " $ ( $ #$: %
# " O& Q, / ( 9ebdg
and N.C.Taylor, "Effect of Fluoride on Tumor Growth", Proceedings of the Society of
.(Experimental Biology and Medicine, Vol 65, pp252-255
8 $" 0
6# G / O.> "/ A 61 l I# 0
Dow 0( 9ebdg
+#n E/ 0(
H6< % % .9 $") $ = 6$:S 1 O& G
. ) k 9 "
."#/ ge A
D$ #
L3 $" 2$%7 $ $"I C)" 0
&C7 2= H3& =$1 6$:S )S
0D D
$3D $$)$! $"I $$ )" ) = ' $ 6 ! '3
.' &
.microwave 0 # 0/ 01 /

/
7 % "01 7(0 9ebdg
W:
( G#
>V
" E>& /
P
& /
W %J ( E/ 1 01
6< " 80V
9 % .")
7 A
J Glymphoma
G">L Gleukemia 9
?&
.9ebmd 9)
/
S./

0
"* ( "O&2
I0/)

)" _( ARPA
O&
W
0 9ebdg
3/ microwaves 0
#
"V )
> 8>0
/
H6< " ./* ;0
&/1 !
.K/
>V
A
A
J )
#
>V
.&
?
E6 E % ' $&
"V
Medicare " % Y( 9ebdg
Y$# ( 6$ $ 5)# 6< .Immunization Assistance Y$# % $ !; 0
9ebdg
.W$
" " ) 9: &J 9 "6
" %lb,j ", A
J ( ) " 7(0 G+
9)
&
9ebdd
.9
80/

" 8
,A " < E 9$ " % [ 7" u "*/
01 )#
9ebdd
.$ $) $ ! 2 27! 8
50 $ "N < . # &$

'%$ $
=
$ 6 1" YA G"
" )
. / G<, G
(
0 G G . G0 0 GI
J G
0 :"
.(9ebme 9)
P ,) .&
?
%.*J 9
1 &
( ' W 9ebdd
.$>34 ($ =) cyclamates 6 )$" = X# "/ 0/ )# " / 9ebdd
.D#$ ) ,3 2" =/ 6# A < FDA = 6$ 34 = 9ebdm
; D # .# 2(" $1) "$A 6"A" " $" H) ,3 2'$ X# 39 .93 l>
6
D7i 2 &7 ] 0 P 1 ,: " ! 6
# . 6 %Ò :)A
.$ $) $ ! A A
" 6 7)
" ' ,":E.:% !0 -# 0
30 G"
!0/
A(/ "/ . ) 9ebdm
D BD .'
" #
/
5)1 / " ' # 50 M<(
0 "V
.D1 D
=
39 .$4 0 " J( 0
, $ (h 0$ ,3 X# A #$# g(

#
0 ! 5*1 "*) 6
) ." ! ! " . 6$) ' & 6$&$
.(";

<6
.&
?
70
' & 9ebdm
S1 ; O& .2

M$/
. 5 " %li 9/ AMA 01 *
*
9ebdm
.? " ei,d /
K
5 51 = " = 0

#
J A *; AMA 01 *
*
9ebdm
.chiropractors E 9P)
9 #
)
. G " 0
(6
7i &/$) $3F! <$7 $

L $) $() $ 9ebdc
K
6) B-complex (3) 0 "
, " G= 6$ W$>3F W
#$ $$$( 9ebdc
>3D4 D; D11 D: + 39 .80/
" " *, A
J G( *

1 @
/ 9 0
.$$$( $ <" . 0

! > ! 0 GA $(
!:
=% #
0 ."" 0
'" & M* G"*/
01 )#
G)" , 9ebdb
0 93 $/+ ! $:) '>/ < -$ + 39 .9ebme 9)
" )
! 5& " % "/0
. ACS " $)$! $ NCI " & 0
$># ' $
+ & 3/& @ , 5 G

0 #

+
3*
)# / G # "?< 0
9ebdb
=D$ D B$ 2$ $) $ ! A A 6
7+ 8 </1$ ,3 $ ", " G%

Harlan Jones, "A :=#
(ebmg 9)
P ,) .6 H3& </1$ ,3 $ 6 < 0
A
. Report on Cancer", available at University of California Berkeley library
'
) % "
" %im,g ", *
L0( !# 0F .L0( M
+ ( 9ebdb
.M/

. / g l 5*1 " 3 1 3

?& P + 9ebdb
D$ D) G " <$ -; PN A `_ S (J4 )) r $7 J = " 6(7) 9ebdb
&% /1 6)
6)7 $ ) # % FDA 34 = W#"
.(MN_\ ;A). FDA D = &
1 $ #
50 5 jjg <

< A
J 7
"
"*/
#
5) "0 G9)
6< A& 9ebdb
./ eff,fff 5 ebg u G
" <

"

5) ./ eff,fff
"*/
?& 5 & O& G"*/
+

# " > # @ , *)

*
)
5% " 9ebmb 9)
M% 50( M&
, 9%1 H6< .* / em , ei 5. %ef /
."*/
D B J$
$ .1 5#, " !; 0
" 5
( $)$! [ = 9ebdb
" @*% ) 9ebmf 9)
5
' 9 .B$
=$" " $$
)$

G$
(
)
&
P " lm 9% " :ebmj 9)
P G*
H6
E# @ ).Q,
A $ @ 0
.(&

DDT
5& 9/ =
+# 6 G&
?
9ebdb
.-

, 9 0
) #/ /1 9
' , 5)
90&
Project Pandora " " Y( +J 9ebmf
0/.
#
M* " 5)
90&
' , O& *
5#
6< O&1 / .(Y(
;
, 9 V
.
1 "
) >0, W: & ", ) GB#

, " & ,

6D# 2( < W$$ -/$ ,A) 7 $ . 97 931$ A )" $ t 9ebmf
/D1 &A < 3& $ $ 6( 6$ $ 2$ " 3& $ (! $ 6$
. 39 W . 97 / Y$# 6$
$ " 6 2'" 3& .H/ Y$#
/ Y$# $/1 (! " %jd @/ "": 01 +
9)
&
S$ 9ebmf
.(/.
+*1 (/
5 A
J ">0
* . ( '& ( S $ $!
D [D( '" )" c# '"$ . 97 / X# ", Pittman """ 0
/ 7(0 9ebmf
"*
5% " K
60 G""<0" "K <" 0
5% " 9ebmc 9)
E&? /
H6< >, .$ "! 8
.C)" "$ A DPT D . 97 X# )$ ::
#
.
, "/0" ""/ <"
5& % le K( eff 3*/ Psychosurgery /

&#
5& >

)
F
9ebmf
0
"1 Y6
) I6
"D$ " 0
"0 T ,1( J$> .9
)
+& , =# " Y
6<
D 6 G " $ $3 c17! 4A 0
$ $
POOO :)A GA O& G""0 ","
. )"$" " "k $1" $ YA % .# $
$"(
D&%
=+ WD/ $3D =( .$ ", 6$9" ) 2FDA 34 = ( 9ebmf
9D .=
3 ) % 9 9 69A /( 6$3 H39 .
6)7 =A < ="(
.W :)A c17 B" B "," ) <1 2=7
0D D/+ $ 3 $" 1 )7 MOOO ' $ A 6$" = 6)7 9ebmf
H3D9 6" 6 0
$ MO $ - $ 2 # 6$: .6
6
.$ 6)7
.+6;
+
J "K./.
^" :% " 76& saccharin "80/
9ebme
.&
?
5*1
?& =/ Y 9ebme
.H$ $ ( / < $A 9ebme
P ,) . 0 < GI>

"*/ " E>& )(1 +/
/ "V "*/
01 )#
9ebme
." '" 7A . """ $" H39 :P&. .(ebml 9)

.&
?
Q/ A "/
O&" Y 5 5( O& W: ( !.-.< 0
9ebme
$#>"D D $D$ "V "$ .":/
" O&
H6< / " =# K( 5 # 0
W /
$ "D! D [D( $:SD '"D LD3 2D )" c# / J i /$ $$)$!
. hyperinsulinism
.H$ $ ( / < $ " 9ebmj
A
J /

/ 5 /
= 5$, ' Pepsi ;
(
/ 0( 9ebmj
.0,
r $7D JD D /D

0 & " X$ 2" & 2L $ ) 9ebmj
01 )#
GAMA 01 *
*
GFDA +
+6;
J :" 50 ) $(; ", (!; 0
)
2 3D)$ 26D$ .>D# $ $
$ G01 +
9)
&
GACS "*/
Letter to Congressman :=#

) .&D D(1 8
>" <% (1 2$ % $F
A )$
.( Louis Frey Jr
D% B/ % " 8 $ 39 2laetrile " $$ " [ / W/$A " H39 6)3
.$ ($)
. ( 50
E / "
L if &
?
;
(
K./ 5) u 9ebmj
9)
P , !E# @ )
J $ M " O& $ ; P_ % $ 9ebmj
D; 7 6# G 6$ B/ < H &
/
*
" S (ebdb
9
I#
S
W /

)
P
H6< % 0 $K( K < .&$$# l> "
HIV
c# 7( = ",
* .%1 5*1 + A
J #
!
6< 3/
A*/
,
", < Q, K < .$ ; &
, / Y$# = < *
K
6D$ <D WD .
c# $

A*/
, 5 *,
6
5.
)
&
P t. 06 .. L $ /1 $3 $ ; %A
.!/ $ J $ B($ 39 .9
() . 9P A I 50( 5) @ V #
!

2$ $) $7 6$ : 9 $ / $3F! %Ò ", 80F K
9ebmj
Journal of the American Medical Association :=#
.$3F! $3 %Z\ " < # L3
v230, Oct 14,1974, "The Organic Food Myth"
$D" $( G D &" )$ % $# 6/ ", " (ejf )
) *
!
9 # 7(0 9ebmj
viruses induced by vaccines:5
" .(6# = 6" $( 0 =$7)
NCI "*/

*
)
" 50 GBCDPI>
"*/ 7(0 & Y( W , 9ebmi
=D&! D c( Ralph Nader " -" % .9ebmc 9)
A& / GACS"*/
01 )#

G"L G9ebml 9)
P ,) .j G " 0
A 6
7 " . =&! H39 %\\ S -7)
.(K
"V u
= 0( " # *) " Medical World News "
50" # (0 9ebmi
"D 2 D$4 D 1" L 2%ZO &$ )" " 4$" A 2C)" %\ 0
, >"
.%PO f B$ )"
D& % 2 c 1 AMA $)$! $ $ '> J4 ) /
A : 9ebmi
. ) &$" 6 6)7 $ A
=
&S AMA $)$! $
G&
?
* .# 0 .J & = 80/
5& )
//F
9ebmi
JD DC)A G!; 0
3#/ /# 5. G <) .(86; I,) "<0" @ V 80/
7
.
J"A ,A 0
"$ "$C34 = 9 C)"" S
S 6
+ %
.'7 H$ $ ( / < 9 9ebmi

id / % "6
""/
" ""(" "70
0" :+*1 " 50 5% "
* 0 9ebml
$ 9 6 <$ A .9ebmj ebde " "
5*1 A(/ A
J ,
&
if
G
& GE #
?& =, ", # G
?&
H6< " " .DPTX# =7
.0 Y ?& , )
7
" "N
. 97D XD# [ /D1 S $

nO $ @ V $ "K -#" *
O&
9ebml
"V = L @ V "K" 7 .L V , "^ %ii G 5*1 +?F< " %ii " >0, .W$ "
.:/
M S
/&
; =
A ) 0
$ 4/ A 2$$ X# $/ 9A $)7 9ebml
.. 97 X# G
D7! c$17D D$

$3 #$ 28$) A $ $$( $ 2"F .. )" ) 9ebml
W ", ?J G6&
9L "0
!"
&1" 1 " '" 6) diagnostic X-rays
01 )#
NCI "*/
*
)
" 50 GBCDPI>
"*/ ( & Y(
.!W" # GACS"*/
"V E.:% "*/

01 )#
30 G
0 )# 3*
/ " "K./.90
" /
9ebml
D9 ) )7 ",: $
7 = "D $"1 " 6 =A [/1 ", A % "
"
.$% 1A $F $
+& "0 70 @ "$ G01 Y

5% " @ <) 9 GE( "(.7.-" S% 9ebml
? &
", O& K
6 .
$) /* ;0 %* */ t
.
M*
A
J 5 ", /* ;
9$

.
)
H6< A */
, = =*/
2MN]] D ($)$! " $ %

) % .$ 0
$ ($) $ 9ebml
. #
8 1 $ , $) 2 26
7+ 0
$ " 8
,A A 0
c$

Q
/
& EPA :
&
0 .&
?
" N 3(
H" " % 9ebml
3/
Q/
$& O& G
Q/
M ? 5$)
0
) .9
G+

3;/
1 ." " +#j,l
M*
3/
Q/
G" " +#e,l :
M*
c A
J )
H

Q/ = 0

0
A *; S 01 " /1 3* & ", < (H(
)
.* "
+# e Q/ # 3/ % 1 "V >
)
9L !"
+#
& % G@

J I6
5)
" >0,
Q/ = "3(
H 5& *
(/? #
"
G$
O&
ICAIR //F EPA :
&
0 0 G
"0
.>0, 5)
"
*
.( "# 0
< //F
7P H0, 3/&) E E //F
H6< .3/ Q/ A 5

Q/ =
0
% A
J Q, G
5& :
&
0 @% I6

A
J $

6< W 9
."
+# l A
J 3(
H

"/L " 0

' 06 G >
" 0 (
Health Newsletter *
#
9ebml
D , D$ / 9 2Rifampin "$($"
631A A 2W 93 >( $ " 7 )":5
D& < &A (1 #
$ NOO,OOO f 6" 2$ $) Dow )7 % B$
."$" &:A l> #m & Y" % ."
.0, ? ed / ( Animal encephalitis &

t
3
9ebmg
D)$ 'D) -; M\O A

-7)$ FDA )$! 34 ') 0

,A 9ebmg
.&% </1 S ( 6)7 &"A
A A 0

1 >V "
. " I#, / ( Lancet * * # 9ebmg
= A (7 / $$" ) ", #
0 GE%.*J 1 9
9 " W I6
>V
" G"*/

.=$
D) $
$ B J$ Diptheria toxoid .1 X# "V S$ G#

2

30
9ebmg
.5F/
K(
% <
@% "V , 2H/ &$# $3
&; % .1 "V 0V .<% 9
.B 6$

$7 / . 97 X# 1" < $ 9ebmg
A
J 7 M* " 0/
", A
J (
, Y.*/ ( Yiamouyiannis "! "#" 0
9ebmg
5& .
"

M*
"0/ =
"*/
?& " E# = 5) A I&
<
.60 /
H6< & "*/
*
)

)
A1 I0
5F/
6
"K "" 0
= "! "#" 0
$9 G# )
" ." !; 0
A
J K
6 ) 9 / 9
Gebml A
J ebib 9)
" "*/
*

H
A
J "*/
/ I, J = % 5) 5 & A
J
6< Q, .!; 0
A
J @ 9 I6

." $ ( $ #$: 80, "
.0 .I(
K./.
/
6L1
)
EP "0 ", )
A @# ) &
3 # A
J & ? K 0
E, $%
:P&.)
.(
H6< 5*
Y
360
5$& O& G9 ii " >01 "*/
*

.& M,_OO 6 0 GA . >" $ 6/1 =A _n_,OOO 9ebmg
) ":E.:% M8) GK.0

( @/ GFDA +6;
+
30
=
GM<(
&
+
&, 9ebmd
" " M ?)
>0, @
.? &
5. 50(
>J E#J #
>0, & M<(
S

#
" %jf eg @/ "J .M
? 5#, " #

30 A
J
Q1 #

".#

30 5( G=
'#
.Operation Mind Control " # ) $

" ') 7$ Walter Bowert 6 D 9ebmd
.67 H3& ) G )$ 9 J A
MN__ MN_] $D 6$(7" \,nOO '" "V G+
9/ +/
*
)
9ebmd
H6< " # *
1 " 90
5+/ %) .psychiatric drugs $#
$"( $ A 0/
9
.(9
, 36 5
IF 9
O& 1
.swine flu
1 + *
'
& = % !; 0
9ebmd
#
<( 9
G'
" "
5*1
<1 *
&? %

/
3/& 9ebmd
=D$1 A
-7) 9! $( < $" 3 A ": *( (
*
*

".$ Y$# [ A <$ $ &(A & 0
.Guillain-Barre # 5(

9 , 2
S
) ( gff " >0, 9ebmd
")
" / = M<(
?& , G9ebjj 9)
6 #
H> ) 9ebmd
YD/ BDA F 2- $F '" A $% .W$ . 97 / Y$# ) G6

K Gebcf ebmd
.,+ Y$# &$
$3 J ' $ 6) 6+ G) " 2J7 X /
& +# H%

&
9)*n % G J )# 3*
/ HF. G"
,.. 0
9ebmd
", E, # / .%eff / adenosine monophosphate P&. G
" "

$ 1 # $
Y) = H39 .A, / A
J
H6< = ", =*/
"
+# jf 5$)
Journal of Dental Research, Vol 55, Sup :=#) .$4 "! $ 0
&% 0 /+ /$
B, p523, 1976, "Effect of Inorganic Fluoride Salts on Urine and Tissue Cyclic AMP
.(Concentration in Vivo".
1" A 0 67A 6 $ ", 5 G(5*1 5(

) (
"K
/" S
0 2"L " J " 9ebmd
<D$
""! ! T" $ 26$" 3 B1" $ ,3 2$ 6" $ 0
, $ ,3 X# 39
.!MN]M 3 (! 7 6
(
"K
/" S
0 G"K
/ ! #" 0

.. 97 / Y$# l & $4 $A 9ebmd
."*/
= 5)
7) -. dd " " #. >.> " P&
= "*/
01 )#
9ebmd
.7) 3/ I, " K
6 .Coley's toxins, Staphage Lysate and hyperthermia:< #.)
H6<
,A LD9 J$ 2" c 1 A":5 G+
5 :# A :&
GOtto Warburg k A 9ebmm
.= / J $$ 6 $ 2L3 F 2" :)A B" -
/# 5. .

Y 3/ " =#
0&
%.)
!; 0
#
9ebmm
: >J 9 GY/?
.= 9 $ ( .$ " &$
" $ 6:+ <$ A DM
HD$ D$ ( D/+ " " = MO,OOO $ A L7 6:A G1A $
6" DZ
.= 6$ $3F!
*/
)*
":", 5 G
Y/? !# !: G" .<.5 G!; 0
5> 9ebmm

I# "V (
F E//, * <
) 01 &
, G"/
%
?
."*/

3/ 0J 5& ? "
I6
) "*/
*
)
" "50 "<" 0
"0 G/
H6< " E?F/ "$ I6
(
,
G5)
5 & % =% "0 .("*/
3/ ?
", 80F 806 30
)
5% " ebmj 9)

%.

/ ei 9% .""*/

%. 9 >J 5& / ^ ) H6<": E.:% 50 S
)) .""*/

" %. I1 # K < !
":5 I6
360
H+J >J 5#, " "*/
?

" ? %.
!
50 %
ei
/
"V "", >^" "*/
*
)
0, G K
6
.(ebcc Gebcg Gebcj 9)
P ,) .("*/

Y ) ? 3%
(1 '" $ GBlue Ribbon Panel )3 G " /
A
1 :#
90& 9ebmm
I, "0 9
"0
G
&
H6< /
P mb 9% .$)$! = 6$ $ IQ )3 G " $)
Y.L. Warten, 1977. :<D.9)3 0
A S$ 2'" 6) 6# A =) A .) 0 &
.(The Prussian education system is also part of the problem).
. 97D XD# =$ 6$ 6 8 1 '7 % 4/ $$ ) 6/ 9ebmm
.DPT D
H# 5)
& edf 5& / "/ "L" 0
( G+
9/% G 0/? ;/.L )# 9ebmm
.<L G , G#. G# ( K < ?&
H6< " dg .DPT S
6D $ 6:
" "6
"K" 0
"! " 0
Y/ /# !; 0
9ebmm
&

) "" " 5>
, G:

.$ ( = &9$ 0 -/ . =
A
J 5
5#, " &
A +# (+
0( = <s ) <
) 01 )

."*/

%. " /& : #
D <D) .BD3 '" $ 6" $ 0

$ 6# A 3$ L " $ J 9ebmm
.("L "" X# &7 6$" 6# H39 A ) 3 &S
D # 1 = 6$ $ $ ' 61 6> %A BS -$ )$! E$ 9ebmm
D! DA .D DA $1" 2)$! '7 -&" $
Z\ &$ 2$: $ ' 6
.= Z`M 61" 2$

A

&, Q& .&
?
"*/
Y 5& !; 0
Y/? /# 9ebmm

A , % ".
Z\ = G) " 6; % H7 B&$ "A % )$! '7":",
/
H6< !; 0
5<# .D = $ 6$1 $#
; $$(" T9 <$ "V
.!M*

Y( elb A I& 5)

90&
MKULTRA Y( "V 7) 0

0 9ebmm
."#/ i GA(/ ej GO& //F eg G0 )# ll %. @
$ D: W 1 2u& $ ( $ P,n $ #$ $ ! 1" " & 9ebmm
. $ Z_M $ ,A .H MN__ &>
% 2Thorazine
'D" 6) &; .&$ $ $ .)" $ " $

D ! 2$
! 6A 9ebmc
D$3 6$4 &; 0 GA 2" >$ 6$$4 /+ 2$$ "
<% $ 7
." 6 pleomorphic changes $& 6>) 83 )7A
g @/ '7 H$ 0 -$/A O& GKizilcaoern / $) $% " O& Stern
1 #
9ebmc
* ( ), ) $ (A $ +/
. " "A 9
5*1 =# .$ ( " "
+#,
E/ P, %
" "
+# f,m ", 9)
= .1 1$7
" $ "0/
=# .5&
"
.P)

Q, , 9P M% ?&
D; 0D LD3 GA 2D =/D $ ( / A #$# 6:A $(" ) $/% 6 9ebmc
.(9ebmb 9)
P ,) .! 39 &"$ $3 % H 6( 2" =&7 6 % .$ (
/ G

0 )# / J 5 &
?
FDA +6;
+
J % 9ebmc
W:
( % ."DPT S
6, " #
5)
3/ )* GM<(
S
Y( ?)":" ) G0
6 D O& (ebcf) FDA J A
J 50 9) K
6 5% % 0
.9ebce 9 >
"( Pediatrics #
./ 6$ 0
/ ", ) .3*

/
!
E# 0 / DPT S
)* L 5), " /
(0
M:& " (
(0
G/ O& & %J Y# A
J FDA J G( b /

. A& # ( G/
+0
5> S
H# 5)1 5& >
# % . em,fff & A ' gf,fff & " /
9 G(0? H6< +J 5#, "
H6< 5#, " .'
")
" %gf K
6 GI0
)
#
5) ?& # E, FDA

5 & ", 5)
A 3# O& / lc H% & % FDA
) G*
#
)

?) Y " $& 0
= % %
6 .S
3/ !
, ) 6 <) & "J G
H6< "
.(9ebce 9)
P ,) .&
' 9

GS
" #
?&

gD( "D 0 GA microwaves $ )$ 6 G";, Eugene "# A *8/ 9ebmc

? ? #
06 ."M
3/ L #" " &
7&
0 .=$

!
G#
& G9
% GM<J G!,
9?^ " "0/
A0( .$ ($) $ =
% 9 6 "V
. , G! =
! 5 & % ."<6
5 , Y/
5*1 &, = O& $)

& 06 5*1 A M<(
S
>V 5& OL / G0 J 9ebmc
.9 jm ) 9, >.> <) L 3* @ V G>.> S
J "

( ADA 01 " /1 3* & 9% G$ (
#$# (1 A 9ebmb
&D
<D$ 2$
D 2$%3 2$() $(#: $F &S $ H39 / 6& .3(
H A
J

H6< "? .E.) /
> 6<) .$17 & . $ 2$
J"A 0
" $ ( c 1
.(9

0(
ADA
/ <

# 5% I6
5*1 &, % A I& New York Times K
" > " 0/jf J 9ebmb
.? mgf,fff u @
) 9 % ." /1 3* Q&J
" : # 5
5) ", G";, )# &

9)
0 " GDr.P.A.Long Dr.W.L. Gabler :"*
7(0 9ebmb
6< .+
9
. " superoxide /0,/
- J Y$/ 9/#

" "
+# f,j
9
=/ #/ ? E 3/ /0,/
", "$ .;
#
9/#1 Y
" .
'0
"Fluoride Inhibition of :=#
.( >
+# e,f < E/ M

/ "V 9)
=) ."/

Polymorphonuclear Leukocytes", Journal of Dental Research, Vol 48, No.9, p1933-1939,
1979.
.M/

1 &
# S
S* 9ebmb
!
1 )
H
J !"
+# gf u
" 0 +
J 9 G >
"(/ee 9ebmb
.>&
" Y/, ) % 0/ # 9 )
. ( gf,fff 9/ A
J Q, G .
% . DPT
S
#
>V
9

& 58> / 5$ FDA 01 +6;
+
J 9ebmb
.9ebce 9 Pediatrics # <( 9
0 )# /
H6< #,
9L "0
.*
#
>V
H6< 50 3/
< P S
", # GDT S
DPT S
" 50 / )
"#
<1 ", 9)
= !9ebbl 9 M<(

P S
"%/ > 50 +*1 5? GW:
H6< 50
./
I, A
J 9
J 5% S
6 9<?, ' A
.
)
Q/
A I#
+ 5 :/ ")
)
$&
P 9ebcf
F
">&
&, S$ % .autism "$&
" "
5*2
*
=#
F ) 9ebcf
", 2
"0"..?&
" // " < 90 "& ..)
//
3*? " Y < $&
.." :"V
< &
& M ( 9 ?&
H6< =# GK
6 " 9L
A "0
G1 " E -6
."$&
"
. <) , '

) 0, 5* " j "V $T% 9ebcf
& , I#
9& , "6
5*1 "V #
*
O& " W "$ 9ebcf
<$(
, *
3/ I#
'
"V 80F - / A
J Q, .9
+
.
0
. #

A 2$ ,& & &$

" Sharma "7" Susheela " $7 "" $ -7) 9ebce
2 ! 2; ) $ ) LC)( 0 ,T$ " collagen $ ) '$) $
C$ $ (
.
"#?0
)

5*) ", "$ .$> & # 2$) 2$> 2 2-$/4 26 /
"#?0
" 0 0 - J 5. " K
6 <# " )
5& .
H6< 5)# ;
6

"Fluoride poisoning and :< .non-collagenous protein #?0.
"
,/ H$(
, %

the Effects of Collagen Biosynthesis of Osseous and Non-osseous Tissue", Toxicological
European Research, Vol 3, No.2, pp99-104, 1981.
= 5

", # G"
King's College "u 0" 0 HF. "
, "#" 0
9ebce
0
5% " ) #
H6< A %
9 % .9/#

#6
50(
A P&
*

" ""/
" 0
"I" 0
" 50 5% " K
60 G; "/
0 )# @:. "J "/"
G@
=
"
#
9P
9 G9/#
=
"
"0 @( 5. " ."
"
0 )#
7) < *
9</ .autoimmune 6 , //& J 58> 5) 3/
2 < L3)
+ 6""T % 6 H39 (1 ."" AIDS 3/0

9 " HIV J $ A =)( % "$ 2J $( # '"A 0# A & 6& H39
.$:) L3 )A # A < "$+" "$> '"
.("*/
/) teratogenic */
", P ":
A / Larez "?" I# 9ebce
"1
30
.6# '$) W
1$ 'C) 9 Formaldehyde $9A ( 9ebce
G */

30 (, GOccupational Safety and Health Administration
$&

> 58> @ V <
, 9
380 5 EF H( 9 / t. A
J Peter Infante " J " 0

5. " )
H6< 0&
*%
)( ." , % '" BA 0
'C) 39 -C O& E#
0
A
J " J" 0
30 G " jm .@ " @
%J
& " J" 0
A
,
&
H6<
=%
0
H6< ?& " H 9 " E) GIARC */
O&2

)

0
G""/ ;< "#"
.<
, 9
380
*/
)*
>
&
H6< +J
1 " > %. K < ", # G5*1 Q

L
5..
*
/
* I# 9ebce
G&
?
.'
Y
" 9, m ) 1 P O& GM<(

S8
*
)

A E/ >F
*)
+J 7 K
6 G* / lc )
=# FDA +
+6;
J $&
.S
)8
F/ " # )T / 5) ,
& ,
& " Q0( I, ", O& GS
)/
A
J , H
A
J 7U
)
"V "$ G"*/ )# *
0
" "K.0 " 0
9ebce
? +
9
0 "#/01 K./ K
60 &
580( & A 5) (H^ A
J ..." /1 "#)
9/#2
# 5. +
0

J -& 58*)
N H6< "0
GL 9/#, = #
& "0
.;

"Neutrophil Iodination Reaction Induced by Fluoride: Implications for Degranulation :<
and Metabolic Activation" Blood, Vol 57, pp913-921, 1981.
.@< 5 "& AIDS "" A +)

7$) 9ebce
I6
< J ) New England Journal of Medicine *
" .; J " # ( 9ebce
0A 0 T-cell "6" $ 1 " (1 '" tetanus ) 6# ", "$ / (9ebce/jd/ee
3/
S "
&
H6< ", "$ .S
6, " "/, ) <& A %V /
\5 O& 2$
."" "
A
)
K = E (
' W# 97 " .$ '

! ' $)$! $$)h $: : < T 9ebcj
g( 6 " 0" $ (A MO` $ A 0 $7 2$" '
!
2. 97 2.1 / : : X# 9 ) DPT X# & %]] GSudden Infant Death Syndrome" (h
%Z] 2
" ZP 1 %M` 2X#t
" MZ 1 %],\ 2T9 $ .& % (J $
.<$"A : : 1 %_O 2$
"A 1 %]M 2[ "A 1 %`_ 2$A ` 1
(
>
(
< # AV 9%
" " @
(5*2
_#

I,)
6< ", E, "

/
, .5*1 A &
H6<
E % %
9
6 1 < G5*
" =

. GUniversity School of Medicine at Reno *
" " )# $ G
6 #,
.Dr. William Torch "B 9
" 0
7(n
"
", #
0 .)
" >
/
& 5*1 ' = E % "
, G". 6< ) :;
.SIDS "5*2
_#

" " E &
""*/
3&
'
* :1 :
9" " ) E0 ( Fred Rohe "< " 0
9ebcj
"*/ " +(
?& 5 @ M8> GMetabolic Ecology: A Way to Win the War on Cancer
.(, / 5. :6;
&
YJ M* " I>

– $7$" J $ GChronic Fatigue Syndrome " .9+" 6
= !
+ 9ebcj
.Epstein Barr "
" *. # " &

A Behan " Geschwind (# <#, / (0 9ebcj
3
, )# ) Q/

9/
Y
VV
+
5 "*
, &

"0
G
?&
K 50 " *
#J A 9)
% 9 3/ 0 # /
H6< / % .( t

.5*1 ' W < *

0 "*/
" %.)
5& /
" A
1 #
01 )
&
: , ebcj
3/ % O& ebcl 9 A& /
/ .ebmm 9 !# 0
Y/? /# " G

. /
9P ;> O&
.#( " >0, * ( #(1 3 I* < )

1
+ 5 ebcj
, 0/? )

0&
9, ( 0/.L )# " Peter Wilkinson "/ 0 A
, ebcj
#< 5) " 5
", >,
"
" ; #
#
*>" " ) % %
W O,n D B$
. 6 9 ) $ O,Z 9$) $
.+
9
0
E*< 3/ "
+# e <0 .% n /$ 6$) =& " f ( $
G!
I
5/;
G" /1 "#) G3(
H 9/

"J .% ef
& E#

.I(
Y#

*< 9</ " /1 +*, G

.0
" Y , @# I6
I(
"
/ 1 M/ 9 ebcj
.K/
<( 3/
", P / ( Zhang and Zhang u < ^ u < ebci
US 01 /
&
9/% " **
" / ) ";( )# ebci
USPHS ";( ? /
&
9/% GDept of Health and Human Services
"0 .Medical Products Labs *
#
GKellogg Foundation -0 //F GMichigan
0& A >F
&
=
5& G
0
P
)

& (% " <
H6< " 7

* #/? #&
"> G
0 " Y
% #/ * 7 G
0 )
."
0 " Y
.9/? & 5 A-117 '(

ebci
.)*
&
&, < aspartame 9/ = # 01 0&
ebci
3
# (
"
& jdb 5& / Miller GRoss ! GBellman " " 50 ( ebci
"0 "6
5*1 Q
0( & @ 0
# (
H6< 3/ ? DPT
S
" ", A E.
)
5*1
."*
<#
5)
9
GM<(

1 =#
# " : +# GM<(
S
5& / ( $ > ! A 1 ebcl
."=% L 50( % 0
5)/
3/
(/
5 ?& 5) "n
"0 % &

"V S American Cancer Society "*/
01 )#
ebcl
."*/
-.)

jdj 9% < ( American Medical Association )$! & ebcl
-.)
) % "*/
A ", 70
0 )# " Shapiro ( Oye I, "*
7
/ A
J / #
1 ", 70 .91 A -.)
6< >V A 5
I, K < "0 ", " :0

=$ 2W : .#
1 H6<
) >
& 9P 50( M* W: : &J G&
H3& $:S )$ $3 A 8 1 $ $3
" 8 $"$ " $3 T9 "
.&$
W W$1 $ !
#
H>^ " /
+ < 1 -. 9/
ATZ ">1 = O& @/ 1 :P&.
.Retrovir I#
9/? M$/ G9P)
0
E 3/ @ ,

Clinical Toxicology of Commercial #

#
/

( " ebcl 9 J ebcl
. eff @ E ( 5 ", 0 9/#

" 1 " ef/e ", A
J (, Products
5
0 <
" 9; ebb A I& 0 )
G
" 9; e A I& " /1 "#)
.9
9; f,jg <
" 0 = )# " /1 7P "J . jg @ 5*
/ G )7 " -$ "+ . # ; 0 G )7 $$)$! $$>$$(
# D ebcl
5% "
H6< =% 9 ." $)$! $ $
=+ :$)$! = 6$ . "
9 >
"( 51 "( 0
? The Leading Edge =% A <( , .9. 5:/ 0&

.ebbl
.+*2
E# *
Agent Orange "W ," 380
= A 0, 0 0( =/ ebcl
Y# Stuart Nightingale 5# / +

+6;
M/
!:
7 ebcl
." )
1 5)
7J /
01 *
)#
A
J #& J "

<

.(
3 I6
"*/

K./ " %.)
5& 9
) M& A
J " ">& 5 ebcl
9 Nippon Dental College " /1 3*
" 0 " Takeki Tsutsui // 00 0
P, %
." */ . A
J 9/#
/
.
5& A E, % @ 0
E # E * 3/ ?
" ", ebcl
)
@&% I6
Q/
! < 9/

Q/ "0 GTsutsui // 0
<#,
/

"0 6J &
#,
/
United States National Cancer Institute "*/
01 *

+# e
" j " Q/
/
& % G"*/
3/ )
3(
H #

.$" $ 1 8 0 ,T$ $ ( G " 39 A $$ : $ ."

Imperial 0( .6

- J 0( 9
? ef u / #
) 0(
, ebcg
ee ) % G9
)
6
#
0(
0, &, 9
)
0 J Chemical Industries (ICI)
.ebbf ebcg " 6
- 0 0(
K ( 0
E>& Lancet "*(
" A
&
*
#
( 3^ " ()
ebcg
E 9% O& .University of Dublin " )# Trinity College 0 " Peter Skrabanek
I>
)(

W ACS 01 :0
)#
@ 9 I6
" 0
7(0
" A/ #
@, .)( I0
-.)
" G&#

*
" @>& 5. Gmammography program
M%
A )
7) &, ? @ , = G+(
5% 0
"*/
"V 9< A
J / I>
"*/ 0 " ",
." = :T$ ,: >" A 0
$ ,A L9 J$ ."*/
M) " 0 " 0
L0 GManaguaL

51 Gdengue fever K
A&
L wB ebcg
% gf
& +
3 , % .I#

&
?
) ) # M* GNicaragua
.
?& " )
#/ G
"0/ "
World Congress of Biological I&
/
3*

)
!#
<#, / # ebcg
P 5 " 9 % bg ", G&
5
I6
" 9P) GE E ( ije A Psychiatry
. )
#
# t

" Q, # +# E U.S. Public Health Service 01 )

&
: , ebcg
O& .ebmm 9 !# 0
Y/? /# "
0 "*/
"
)
/

Gebcm 9 A& / Q#, I6
G<, Batelle Memorial Institute 5 5 ) = %)
.( ebcc 9 P , ) .ebcc 9 #: (
, " O
>
|(
!# " #
9, S Edward Brandt J &
/ ebcg
." DPT X# '" $
6(
/ ( `\OOO $
) " :ebcg 9
G)
%.)
+ G"/
+*1 G" /1 & " ? " # 50( ebcg
The American
&
01 )
" ( +)
L " ) "/ "& G
5# "
“Abuse of the " )
2

(
+/J " " ) E0 "( " Oral Health Institute

)
)
*)
"# @ . Scientific Literature in an Antifluoridation Pamphlet”
A
J +/ "
7(0 30
& P ", /
" .)
H
@/ ") "6
K:
,
/ +/ & " 6 0 9/ , 9< G)
9 P, "6
30

F 3 # " " )
1
.)
M:&

)
5% " ) Electroconvulsive Therapy >&) l$1 8 0
[i T D ebcg
National &
*
)
National Institute of Mental Health (NIMH) )
&
*

A 0
W $ Edward Opton A J(
% T .Institute of Health (NIH)
" ,A &;$ $ $% 6 # W$" W" &;A ECT >&) l$1 8 /1 $3 0/
,A $# ECT >&) l$1 8 A T $7 ! ,A )$ .6 $#
1 =$ MNn\
! $7 2Mn B> 7 2Opton A B% J)
6:$ $
<(
F
=:% " Opton ",
J 5
W:
%, K
6 = .$)$! $ $
.APA )# " 6& 9 K
60 .)
&
*
)

7 E
L "0 .&
?
B Y ( HIB ) 0

S
9/ S ebcg
.>0 / @
meningitus &/
3
"0
G"&/
3
" S0
! #
> (1 A& @ , "
St.Marys Hospital I / A(/ #, / (0 ebcg
")
(1 B .
T .
*( 9
5 HIV
! "0 ? "6
homosexual
homosexual ">
K:
1 E.> "0 9

# ", 0 .
# 0( "6
heterosexual
zm &
Gmg )
G#
*

9 #) .1 " "0( ? 9 0
HIV
! "0 "6

</
0 J 2
Burroughs Wellcome 0( )
?/0
", ^ O& 06 .(ee
.homosexuals ">
" 0 "6
z</ "6
K:
, & =#
.Imperial Chemical Industries (ICI) 01 6

0( +( *
0( , ebcg
= 5 ELF E# 7)

6 ( ", A (F K < "0 G/
" / ( ) ebcg
The Body Electric " /
H6< ( % .
#
5%, % E E / G&

.Robert Becker 0 0
5%
ebcg 9 >

"(
< Scientific American (
01 #
( ebcg
Harvard Medical School of $ 9 " " John Cairns ) )
M& 9 9
@ , # % .= 6 # W ) " , $) 8 "V @
% Public Health

*J I0
-.)
" / "*/
"
" * % i ", G /
6 "*/
3/0
.&
?
E /
& 7
, :), 5 , " 9&
7(0 % ."DPT: A Shot in the Dark" " 9.P

* :DPT " :" ) DPT &
5& 30 ( ebcg
.:

Y*% G*
//F
G0&
:
" F*
" E?0(, 30

6#
A % ) 6 H39 MMOO :)A 2J") . 97 MÒO
k + ebcd
.W#" 3& =/
.DPT S
)
:
Q
M) ebcd
National Cancer Institute "*/

*
)
" Robert Gallo
L = #, ebcd
." / 5 I, #
#& ? G2
&
3/
< HTLV-III ! "J " : 5%
I6
"* ( US Claims Court 01 + 0& " 5*1 ' 5& " % ebcd
& &1 ? " j u 0&
& % .5*1 3
# (
DPT
# " E* P,
.DPT S
O/ "?J 0

( New England Journal of Medicine *
.; J # " , ebcd
< )# " John Bailar "# 0
University of Iowa , )# " Elaine Smith
"*/
*
)
"
#
E/ E& Bailar 0
"0 .Harvard University
New England *
.; J # : & (/ 9
< GNational Cancer Institute
U.S. Department of Health 01 /
&
9/% 9
GJournal of Medicine
Office of Disease Prevention and &

:1 " %
30 Gand Human Services
.Health Promotion
+ W$ (7)$ G"*/

#
) <P Smith O/ Bailar " 50 5& G

H6<
/ ' ; K < "0 9
" :@ V & .W " $ ) ! A ,A 2MN\O
3 % n " "
NCI "*/
*
)
"0 GQ1 #
G@6 %
."ebgf 9 6 I>
"*/ 3/

A
J ( "*/
)
: & " :"V "& G9)
I,
A "60 ACS 01 :0
)#

.( General Accounting Office 9)
+ & 30 Gebcm P , ) ."0 9
u The Rocky Mountain Poison Control Center /

A */
0 5# 0 ebcd
5*1 &, ." /1 3* Q

#
)
" "# 0 ?&
" " > G
9/
& cm "
E0 >01 3/
"0 9
"J .) ) , " "^ "( ! A 0 .E( ei )
.5*1 9/
?& "
Q
" "
*(
7) ?& " ( ", Gebce ebdb " @ , NHS *
&
30 # ebcd
ebdb " 5 & % 5:
? 6< "J .5* " i,c A
J " j,b " G% lf / % 5*1
.post-encephalitic syndrome " t
3
) " 0 ?&
K 9P) .ebmg
= ) % dg /
?& G% lm /
H6< 5*1 Q
/
1
(
3*? ?& G% cf / )
L
*? ?& .(
5)
V / ) .% iff / ( *(
* G1 5)/ 7/ GK/
* )
.% ejb A
J " 61 =/
7) ?& ) .% ejf A& ( A*/
"61 3
E ) "61 ")

1 / "n G
! .(1 1 <( 1 63 6
# 6) 6 L
.< 0 S
" # V
L
W
=
(
; DPT S
)
Connaught Laboratory 0 % ebcd
." !/&
* " " //&
" @/ " 6&
? " M:
(& "V 5 E% American Dental Association 01 " /1 +*, & A ebcd
", ) G9/#
" /

J #& (&

J " ", K
60 ." //&
"
L A
A E* 50(
." %., L '& L , < G" /1 3* " -.)
9
Gomel
5L /:
%*
" ) I6
Chernobyl 5 ( 5 # ebcd
./
&?
O& M ", "0" :DPT S

(
Connaught Laboratories 0 7 ebcd
."S
# " # "0 % n 3L1 A G) # >^ " " ) "6
(1 Q
A&
5& /
" " / The General Accounting Office (GAO) 9)
+ & 30 ebcm
.( ebcd 9 P , ) Smith O/ Bailar @
J 5 = W:
+# ."*/
M) : &J
\O :)A ,A ) " # ! 0
W$ " .( 6) $ Z m GAO + ') W#
5) 7* Q/ O& 9 O&1 H6< A 9
M " 9L
A .( )
%

" $ -& " H39 0
$ % .ebcj 9 A& ebgf 9 6 I, GE ">.> 5.

." "
Hib S
", A
J ( / Centers for Disease Control (CDC) :1 A */
0 ( ebcm
"1 X# 31S$ $3 :)A " X# 31A $3 (! A $ $ .% le 5)
) P, %
.-/A
HIV+
hepatitis 0
3
S M) *) I, +*J CDC :1 A */
0 ebcm
.+J
' American Cancer Society "*/

01 )#
") 6^ " ( !
ebcm
." % eff " 3 +( 5) A
J , I>
"*/ " 0
7(0
?& " :", /
6 " J1 = $ E$$ A "(7 " ) ACS " $)$! $ -$ :; )
.("(7 " $9 =$ 0 ,T$" ") -7)" m W3 2+
%(
5&/
A / & 3
&* @) G) L 3/1 +&
"&
" 0 ebcm
.
(
01
.( /, ) Q/

"/ if "/ & (1 " % ed / ", & / ebcm
.%
#& Y)( 6L1 #
) European Parliament 1 "

ebcm
.)(1 6L1 #
) S/
9/ @ , ") I 0
&
ebcm
.
0&
" ) " "
M<(
S
& " "/ / ebcm
K

-.)
& E jf Q A
s
6 AMA 01 *
)#
", # ebcm
G( 01 &
?
#
/
*
= I6
) "( "
E " @ , 0&
# / .)(

." % L ) #
5# , - I, "n
$ " $#> "! = 7 S $ Swedish Health Board ,$ " J ebcm
."! 6 7 &1"
GNational Cancer Institute "*/

*
)
!: GVincent DeVita I / 0
ebcm
=#
&#
:0
-.)
+#n S/
" 7 "*/
E eifff 5( P +#n 3
*
." 9/#
H( " P
; GI>
"*/ " " )
+/

M M<(
S
"J " :DPT S
(
A
J 7 Lederle Laboratories 5
ebcc
A& O& =%
" G?&
" % gfzig ) # >^ P .^ S
I, " >0, # V
." / #
9
) ) # >^ 9 P "6
A
Q
!? 0
9% % .6$ #$ ,: "
) -7) A $$ " " 6 ebcc
British Medical Journal *
*
#
S ", 5%
& ljfff / Lars Janzon "/
Wall Street ($ 6%
.I>
)(

9/ " &
3# @ , ebcc 9 " 51 "(
.W B$ T" % 2$# 39 $)$! " $ $ T" A k m = 6$
6 t

9/#1 " %ii " " )
Medical Tribune *
" & ( ebcc
.)* V( 6 ( (
9 ) 9
?& " %ii ", A
J ( 6< ." )*
: '

G"*/

5& / Battelle Memorial Institute 5 5 ) , ebcc
W
A
J *)
5& 9 ." '"$ $)
$ ( ", +# GUSPHS 01 )
&

1 9 A
J *)
5 I6
GNational Toxicology Program (NTP) /

*

0 )
*)
76& 7 J ) %
GExperimental Pathology Labs #

Gebcb 9 51 " 0 " !/
1 9 5& 5 # A
J
*)
9 9 .

)
&
: EPA :
& :< ) K
6 50 G 1 *)
A 5)
J " 9 ) I,
( ebbf 9 P , ) .USPHS 01
Joel "0/ 5# 0

GCalgary Health Department I;
0 & 9/% 9, 3* ebcc
W$ $ $ ( 4$ M\OO
- )$ " @ V S
*
(/? #
!: Boriskin
.( %
$ 4$ M\OO :; ) ." # <" -/ $ $3 $4 c17h

"$ ($ $ ( A "(0 Argonne National Laboratory *
"L, ">& ebcc
> O&
6< ", >
.*&
:
6L1 #
" " G1! $>$$) "
6 United States National Cancer Institute "*/
01 *
)
9% / @
J
Saint Louis !
/ )# " Norton " Herskowitz !0/< <#,
ebdi 9
91 O& "
" / ", "
)
"6< P, E ">.> " >0, 6 .University

@
+# 91 H6< O& &
"n '#1 A G% eff A
J ej " &
:0
*/

University of !/0 )# " Taylor 0
P, O& /
H6< 0F
^ O& P ."
"
/ ":
Q
*/
91 5) 3(
H
" "
+# e 0 ", Texas
.%jg
5. ."/ 5*, A Pertussis M<(

I L S
A E I# 01 &
?
ebcc
, / 5. &
?
&

?& , .5*1 " / '
" (, /
. M&
9 9
P
7 9 '
" 9,
>, .
" 1 %\O " " $
->; -/$ )" 4$ MOO [ A -7) ebcc
.
& 9/#
% " 5 1 0J % 0 0 0/
5 ", Q, /
Eat for Health, William Manahan, M.D, Tiburon Press, 1988; Robert Mendelsohn, :=#

M.D, "The Risks of Immunizations", 1988, Peoples Doctor Newsletter, Inc.
.ebcm 9 " 5)

G( " /1 (& ) amalgam 9;
5& /
Y/ /# ebcc
.9
A 5) I6
3
9P M* &
?
ebcc
.L
Y 5, # * ebcc
" /1 (& "V S The US Environmental Protection Agency 01 :

& :< ebcc
/ < G"
" " /1 (& " %gf " >0, M:
50( ./
(
" )

! 0
:">&
" 50 W / % .
G90
G
" / >0, ) .
Department of /

9/% " John Hursh B< "# 0
GThomas Clarkson "/0.0
GUniversity of Rochester /( )# School of Medicine *
/
Toxicology
0/
0 ) " Lars Friberg t !? 0
GMagnus Nylander . ! L 0

" M:
& " ", :#n %
O&1 G/
GKarolinska Institute of Stockholm 9
0/
" : " >0, "J ." M:
K
6 GI.
M:
"/ ) /:
3/
< " /1 (&
.M:
A &
(&
H6< "/ (
'" 9 MN_N
X ,3 $ rubella $! X# A $
" 6:A ebcc

k + 2( Epstein-Barr $7$ J $ ) Chronic Fatigue Syndrome .9+/
.MNnZ

'/ A
John Seal 5/ "# 0

", A
J ( Robert S. Mendelsohn "/
0
( ebcc
) National Institute of Allergy and Infectious Disease )U
1 !/&
*
)
"
&
3 1 6#
3
) Guillain-Barre @z"aL 3/ ", 0 &
=#" :"V
."( 3/
5#
.E( ec M 5*2
Hib
# S
9/ S &
?
ebcc
,A &$ &;$ rubella $! / W# # $3 (! % Z\ A 0 ! A 7A ebcc
$! 6 %_` f $ .Y$# 6 " J1 = 1
&
0
$
.$# (! G 6&; rubella
G >
"( Gc
< New York Times K & (
06 ebcc
A E.
) 6< G 6$$7 1 A 0 "$ #9 A k " ", C-1 &
ebcc 9
.5#
* 9 V
3 " 6 A )T$ National Cancer Institute " & $# ( *( ) ebcc
.MN\`
) MN_N
3 polio (! 7 6 <$ A Washington Post 6" 7 ($ ebcc
.X# &"
9 0 dffff 5 , " * %j ", Washington Post / "* ( & 06 ebcc
."/ ./ A <>V 9 " 0V

.$ / $F 6; %\O :)A A Washington Post 6" 7 ($ 6)3 ebcc
Department of Health Services &

9/% " 06 ebcb 9 G6^ Gif ebcb
% ."
+# lgf u
" 0 A I& L 0( #
)
H
",
0
.E.% "0 % H
H6< 9/ "V "0/
Kenneth Kizer 0 O 0 ?
&
6&
A& ( (&
) 9/
Malathion ">.
" "
L 7
, lm B ) 9 !# , !
ebcb
)
/
5&
#
0
9
30 J " & ( ) I, Gebbf G, Gif
", 7)
" .( Malathion ">.
< <&, ) Organophosphates )
/
Neurotoxicity
. 0/ <P 3/
H6<
Freedom of Information Act )

& " % 9/ Yiamouyiannis ! 0
ebcb
Proctor and 5L ^ 0 0( #, % 0
*/

5& / A 5 &
United 01 )

&
:
/
G(
Q
" /1 "#) ) &, ) Gamble
. *;
< %
States Public Health Service
Medical *
" & W:
H6< ( % .
# .
66( O& /
H6< P
Proctor 0( +)
5% " #, Q, / K < .ebbf G*( Gjj
< Tribune
osteomas 9P)
9, A
J J G
*/

"
> and Gamble
National Cancer Institute "*/
*
)
5
G&
.osteosarcomas 9P)
*/

E#
) ~+ "
"6
E eb "/ & (1 Q
9P)
"*/ / ", A
J ebbf 9
.
E#
) ~+
9
"6
(1 " %gf >0,

/1 &

:" #
A
J & " " ) E0 Gordon Thomas ! "L ( ebcb
Journey into Madness: The True Story of ) "1 9/ +/J 5)
A */
01
.( Secret CIA Mind Control and Medical Abuse
" : I, !

6. " dfff A Hildebolt, et al.
< 0( #, / ebcb
.sodium fluorides 9
9/
A
0 >V " <#,
/
W: Battelle 5 ) , Gebcb G*( Gji ebcb
", < – USPHS 01 )
&
: P # " – /
H6< L >01 #
.":

06
":
Q
hepatocholangio carcinoma A/
0
"*/ " E# Y O& &

@/ W: Battelle 5 ) , G9)
! " "/ G"( ) .
#
)
O

*/
91 " %. /
P, % ."6#

0 " %.)
A
*
)
9% GBattelle 5 ) *,
/
A 5) 0 .*)
#
A ) %.)
H6<

9/
"
9
"*/ ?& & M* " National Cancer Institute "*/

G %
9/ ", A
J 5
Gebcm 9 A& ebmi 9 "
5. @/ ?
K
"
& cfff 5) I, .
9/
M*
%gf A
J 9
"*/ ?&
*

@& I6
0
I
3/0
5 L ) 9
, .E / 9)
"*/ 9
"*/
.1 H6 *
:

HIV D J $" :S Luc Montagnier B$$F , -$ 2HIV D J $ (7)$ $" ebcb
."AIDS $! -$ ,3 "
& $ B)$
"V "&
"/
&, , % " Boris Yeltsin "/ ! "V 06 Microwave News & ebcb
eezm < % (n "/ 3% 7J @ 0 ELF E# # K KGB /

.<
Press Release ( The National Toxicology Program /

*
W
ebbf

%. A
J J Gosteosarcomas 9P)
"*/
" #J > *) "
( ebbf G >
" 0 ) ."6#
Q
9
"*/ ?)
", , ( The American Dental Association " /1 +*1 01 )#
, ebbf
."0 % Q# 6 0
J G" /1 A P&

) E , >01 *
<
H
#
)"
5# The National Toxicology Program /

*
W
, *( ( ebbf
3 ^ I, , "*/
%.
", P 5
I, # ? " @ , @ A$ % 1 *)
."" /1 !/
) 5. " 3)(
" /1 & "/&
) >, %
H
#
) " "V G" "/
G
" # # E, P
/
=# 76& 9 @ G6^ ( :

,
G/
!, I6
GKraybill 50 ' , % . */
91
" %.)
P
/
5<#
< GAmerican Council of Science and Health (ACSH) &
9)
01 !#
E(/
."
>
)) "
& 6J EPA :
& :<
", H E The American Dental Associations ADA " /1 +*1 01 )#
, ebbf

& "
" ( 9
(0 " K (
" /1 "#)
)
) Proctor and Gamble 0(
@%.
5& / W: Proctor and Gamble 0( ( ebbf 9 6^ ."
*/

A /
W: .":
A /
H6< W: )
*)
A 0 ( "6#
Q
) 9P)
"*/
& % .9
*/ 5T% 9, A
J IF 6L1
# ", > / / = M* "6#

5T% , */ ; 3/ ? "
"V / / = ) Proctor and Gamble 0(
." */
(X H
9/% A/ ? 9
) The Arkansas Department of Pollution !/ 0, O
9/% 9% ebbf
.1 0
:
&/
:. L %bl ", # !/ 0, 1 H &
*
&
/
&
" " )
Health Consciousness &

# ( ebbf
", 06 H.E.Buttram 9 .I .< 0
( Live Virus Vaccines and Genetic Mutation) ">

" # G
#
9:
7)
(
3/
"0 % L # 5% " 9/#
S#"
." autoimmune diseases 6

,
GHIV
! &
#6
*
#
>0
#
" 7(0
/ 9 ebbf
! E /
0
" & Y 1
9/#1 " 7(0
7 9
&
* ) ELISA
& Gebbl 9 P , ) .@& K0( , < G*
& eej Q/ >J 9 9

& jffff 5 , " .( HIV
( The Sunday Times
Lancet /
British Medical Association *
*
)#
<
&
ebbf
( 50( +/ HIV ! @/ ? Karposi Sarcoma I0 "*/ ", Geji &
ec 9% <
.( L ,
J #? 0/
W
5( < G? ebm ; (

01 )

ebbf
.> Q, *( A
J
&
01
Central Broadcast Station *& @) I6
% "/ W ebbf
0 5) 9</ G:
" /1 (& *, " O&
ebbf G51 " 0 Ged

The National /
O&2
*
)
, K
6
# .ADA " /1 +*1 01 )#

" /1 (& " " #

" A
J % " ) % Institute for Dental Research
( X / L :
9
6
X / 5%, ) ." / 5%, " * 7 G:

Immunization Practices Advisory Committee

" &
*
(/? #
ebbf
3*
01 01 GThe US Public Health Service 01 )
&
:
)
(ACIP)
50( ) DPT S
)
#
( +
", ) American Academy of Pediatrics 5*1
.Pertussis M<(
^ S
I, M*
)# " / < John H. Menkes !0 .< ."# 3 1 5*1 3* 0
ebbf
S
" # 9:*J " / mj 5. * # >s , E.* ld " E 9 UCLA
0
% A "6
5*1 9P) ", 0 G9 " > G# ( , 5*1 " %cm " >0, .DPT
. # # ( * 9 %mj J A
J J G" & , &

!
6. " 7
, ib A / John Yiamouyiannis ! "# 0
Q#, ebbf
.9
9/ "
:
50
G
$ $" % " BA 0 MNNO 2 ! $7 2`M $7 $)$!
+ ) ebbf
. *
S
) 0 ." 6# &" ) = 6 /A
6/$ $>/#
.&
3/ #)
" &
?
( ". i " 3 ebbf
A <#, / 3/ 0

A # " John Colquhoun "<0
0 "# 0
ebbf
M*

9/
M*
" " /1 (. M I, # ? @ , # G!
6. " dffff
" /1 9/ "
9/
M*
5*1 " E0 E ", E, # 0 .@/ ?

.2
A /
H6< ( 9% .dental fluorosis

*(
", ebbf G Gjj ! <
La Prensa Dominical & , ebbf
", 06 G01 &
?
9) 9 G5*1 3
0( " 3
(0 % El Salvador
.+1
0 "/ 5*1 +?F< " )
"J .K/0
E / " 5* jffff
A " +*J ", New England Journal of Medicine *

.; J & 06 ebbf
.
?&
" 5 measles &
"
5*2
& 9A " A $A 2MP = Newsweek L$ $ ($ $# )3 ebbf
) 6 $ G " $ ( $ J ) $ ( Battelle Memorial Institute
National Cancer " & ($ % 97 ( H39 6:A
.Institute
3* "
3&/ New York Dental License Board K " /1 +*, #
ebbf
" +(
A /
ebcl 9 ,? : " /, (&
n @
Joel Berger L 5# " /1
.rheumatoid arthritis
5
3

5) Y " " )

G51 "( Gef
< Los Angeles Times & ( ebbf
" %gff / % t
"*/ 5) ","

+# " )
9
= t
"*/
)
" ">.>
6 u t
"*/ 0J ", E/ ) "0" @ , G")
"
"01
.")
9
= 0J ", "N P "0 G)
9
= %
, 9>
$ # ' FDA $)$! 34 =+ Y"$ $ 39 ! ) ebbf
34 =+ $ 39 $$ .L3 &
c17! 0
$ ! '$ < $ $)$!
. ."
& X $F $% 6 6# A $ S )$! E$ # FDA
. #
A 5 &
"I
" !
" @ , H6< )
&
01
*, GM)
Operation Desert Storm +&
+ >, ebbe
6< A M*, ."*/
3/ w) ! #
" 7?N 3 , (, 5. .#

&/1 #
E&
#
" cfff *, .1 6< "
F/ 01 0&
0 , ." W
3& " 9/ !

9 0 Ganthrax vaccine >
#
E&
#
" E
, egf " >0, *, GBotulism A 9/

H6< =# 0 % .# 5 < Pyristigimine S
I # 7
, gff < u

0V
+*J
.3#
* 1
" " )
ebbe G6^ Gem
< New York Times K & (, ebbe
0&
", A
J( US Vaccine Plan Uses Welfare Offices) "
30
9/ 01 9)*
*
.
)#
H6<
:
" 9)*

.:)
"& %

The US Public 01 )

&
: (ACIP)
" &
*
(/? #
ebbe
.Pertussis vaccine M<(
S
9/? )
.&
A +
#
^ = Health Service
E, 3/ S
", A 5
I, K < !
" @ , !/, A *;
#
>N 9P) 0 J 5>
9% >
, &
)8
0(

$
/
" )
A
J 9% / % ."L
.Edward Mortimer J 0
James Cherry I( !# 0
5> S
"#$ (,
01 0(
(/? " ACIP
" &
*
(/? #
" ".#
"6<
1 M<(
S
" " %. K < !
" @ , >1 0 L & / % % GM<(
S
)

CDC :1 A */
0 < &
?
&
// " 5F/
"J .t
3
/

5<# A ) //
H6< :P&.) .American Academy of Pediatrics 5*1 3*
01 01
.(s
? A G"#

A
M*, Pentagon "L
A 7% A
J Carl Campbell 50 50 5/ ebbe
.Y

'/
*
Edward Higgins ;< J < 01 &
5F/
."@) 90&
%% @ & " % CIA 01
",
0 @&/ M*, I6
Campbell 50 A %
'/ % ."( ) 5*2

@/ ebcc 9 9/.
5, I6
"30
" Hib S
ebbe
.01 &
?
? ll @/
=#
Hepatitis B 3 Y 0
3
&
9/ S/
, CDC :1 A */
0 ebbe
.?
6 ) # 5*1 " )
A % .&
?
5*1
& ) . ^ :
" /1 (& "V ") National Institutes of Health &
*
)
ebbe
(W.Post / "* (
Eco- /
:
**
F 5. ) 9
Cobden Club Document 30 "0 > ebbe
.
&
"0/
" 5
E/ & ", 5
A 3# @ V F
+, & Conference preplanning
.
/, G 0 ) Second Immunization Conference
" &
>
F
ebbe
= 6 W
$7 :)! '" 9 6# " A Viera Scheibnerova $$7 $$ ) X F

." (! G
" A
1 #
5*1 +*n The US Public Health Service 01 )
&
: , ebbe
.)
" //
/
)
/
" 9> GE( ec d l &.
#
G"(
DPT S
9/#2
#
#/? 3/ " (, / 5*
# A& " P " 1 5
@ 0 I6
%

." E* >0,
9<# "0 "6
5*1 Q

Annual Conference of the Society of Homeopaths >

-.)
)#
I /
F
) ebbe
.ebbe 5, .0 J G/(
+*2
" s0 " = English National Health Service *
*
&
: ", ". ebbe
.&
5)
# 3/ 9<
S
" "6

" Lancet " /

British Medical Association *
*
)#
<
&
ebbj
9
M* " A*) "0 I6
polio vaccine 5*1 5( S
", ebbj G6^ Gm @(

G*
)#
/
" ) E> "0 recurrent herpes !0
2&
-.)
)/
7
."01 " HIV ! ( + 3/
"0 %
gg +#
& md "
Peter Duesberg t/ :#
+&1 9
( G * ebbj
1 "V :
P
& GPharmacology and Therapeutics -.)
1 9 30 "
0
"0 .P
0 50 50(
#
A % HIV ! ", " w) ! " @/
HIV ! 1 " # :
P
3& , 9< +)
" HL Robert Gallo
L
5. " " ) "6
(1 ) Q
# !
6< ", < :* P
, A 9P / %
# %\O A &; & 9A 6$> Duesberg k$" % .
9<# 9 P
&$ 6) %Z\ " m Duesberg k$" W# .HIV J $( =/ "A &$ $! $ $$)$!
."&"A HIV J $ L3 $3 $31 2$! &A 0
&($ $
A $F A W#"
HIV ! # " A

) Q
T .
6 ?& (CDC) :1 A */
0 7 ebbj
American 01 *
)#
& " ebbj G5, Gb
)
7? 6< % .9
.Medical Association
&#
9/% !: " ebbj G >
" 0 Gjg
< Vancouver Sun & ebbj
50(
M -1 0
* #J 9 @ , @
% Ronald Young u

0 )# )

M) "0 Young u
E . )
.
*( 7% t
A
J @# ", -1 &
"0 O& E# M%
.%*
" A, / 9/ % )
.

0
)#
U.S. National Academy of Sciences (NAS) 9)
*
01 01 ebbj
%, % . 0/

" &
@ "
* E0( E& " Royal Society of London "
" Population Growth, Resource Consumption and a Sustainable World " " ) "0 I6
'

: 5:
Malthusian paradigm !>
-6
."0/
" & Q/ 5& @ 0 ? 300
"J ze
.:
0/

"J zj
A & $# )3 American Journal of Epidemiology > ! $)$! ($ ebbj
.DPT X#
&$# $A : : 1 -/A $: $ . ($ $ (!
.&
?
Diptheria M
" ?& =, 7(0 ebbj
I6
Health Care Decisions Act &

& " % # ? )(
:
ebbj
.)
/
$&
" +(
& 0J I, "0 ? " "6
A
A +
7/
. (
* " " ) 9 %ii ", "& #
O&1 " jff A #, / (0 ebbj
(
G" "N 9)*
5& " " ) G >
"( Gj Washington Post &
+# ebbj
51 " 0 Gel National Vaccine Information Center *
9)*
) 0 "

G* >& emfff " >0V @ I6
FDA 01 +
+6;
J @ , I6

A
J (J
.ebbj G Gie "( 5. >& )# G9)*
G
& igf " >0, "
.>& 7
, em # % I6
&
9%
" >0 5%,
H06 I6
9%
"J
.? egf 3 P&

01 1 K./ % % ebbj
=# E
* FDA 01 +
+6;
n Michael Perrone " 50
/
5 ebbj
34 = 6
&7A " .:

&/
) ./ )
)

" 9 , Perrone " , 0 . A I $ ( 6/" A 6: 6$ $A L &S FDA
."M/
" &/
H6< "&//

= 6 6>
$ ) $ ZPN < MNNZ MNnn
$ ebbj
G9)
A
# :S
" #
1 " .; G1! 6 -I 6 26#
< 9 M<(
S
" #

?&
&
)
" )
.5(
A
J J G 7 G# (
.Sudden Death Syndrome (SIDS) _#

" #

(Agracetus) /
01 &
#
0
0(
& Y + ' 01 0&
% ebbj
.E> 5)
"*
# K
6 0

#
0

/ #
) W.R. Grace 0(
)

<$ $ .# [ A $ [ ,! W$
W) = H39 Y .Y? + " , )
$ A <$ $
$ 2 3 H39 0
$$/ " < 0
#
.>$ $ " 9"$" ,3 ! 2$7 6$ 1" = 0
.P&
1 "/ &
?
( " ee,j 3 ebbj
(! 7 + 6 %n_ A (CDC) > ! 0

=$" )
$# )3 ebbj
ebcf " ?&
=# ", E,
06 .6# &" ) MNn` MN_`
$ = 6$
.&
# E, 0 ebcb
7
, gf = @ A
J William Marcus !0 9

9
)
n EPA :
& :< , ebbj
I,
9, &*
3(
H #
) :
// @ 1 @ " 5%, ", ) @
)0 ?
.9)

" E.
Gerald Geison "/#
# Princeton University "/ )# |F
7(0 ebbi
*
)
)
# % Louis Pasteur / !
", P GLouis Pasteur / !
P&.
.%., L P) "0
G<#,
3#

*/
0 ) .51 9 9L 5% 5*1 3 measles &
?& " %jg " >0, ebbi
.ebcf ebdf " 9)*
")
1 < <P
H6< 3/
", CDC :1 A
0 ! # A measles /
)$ 2X# " $$
0
/# $
. (
", # " "& J HIV ! (0 &, Robert Gallo
L 0
7(0 ebbi
9/#
B)
)#
/
=# # HIV ! # A E.
) I6
( jl z3 ) "
& ( / (0 % .ELISA !/, jlz3 " " 7(0
) .Q6, I, 3/ ", "
jlz3 "

9/#1 ", ebcc 9 iec )
New England Journal of Medicine *
.; J
.E ( egf 5 , " & ( #
% ) & %N] 2J$" 7" W ZMn '$$ Epidemic of Pertussis . 97 ebbi
.Pertussis . 97 / W# 31A
.National Childhood Vaccination Program 5*1 9)*

*
W
" " 0 J , ebbi
?
+& , =# 5*1 9)* '/
( S732,S733,HR1460) 9% "
!# 0
, %
*
9)*
.&
.#/ 9:% = A 5)
A
J .? 5<1 M& " ( & G&

.9: , 9)* " "6
5<1 &.
" " ) E Mediaeko Investigative Reporting Group /

*
M&
# , ebbi
9/ 0 " 5

6< 06 .9
0/ 51 "( ( " X 5) 70 X < :L
5%

." t
> ( 9
"&
:/

6 <$ S & $# )3 MNN` 2$ 2MO *$ 9
Seattle Times ($ ebbi
.6# &" = 6$ polio (! 7
G
$ Z,N H% $ 0
% $ A CNN News A A " 1A 6
A ebbi
.$ . $>/%
Hepatitis 0
3
S 9<?, 9)*
<1 " 3* ( ebbi G3^ Gee ) W ebbi
.vaccinations
myeloid
0
?& " %jj 3/ "
", CDC :1 A */
0 ", ebbi
.leukemia
5 & @)% " 5, " 51 Center for Disease Control :1 A */
0 ", ebbi
.
6< * 9)* & 3
* Beijing flu " #

.#/
V 3
* I6
( S.732) "
Y( Edward Kennedy I 0 J /
9% ebbi
I 0 3
* ." 5*1 9)* " % " "

&, A
J J G / d "/ & &
?
5*, =# "
" 0 S% K
60 .9)*
)
/ = G@? " 06 %* " 5* 50 +*n Kennedy
." * * %* " H/, Clinton
.%mf / &

?
)*
3(1 # ) ) ebbi
& 06 .E ^

7
9/ ) / :* u
=

7
% ebbi
W: ", University of Utah H )# " Om Gandhi I L 9, 0
" Microwave News &
G51 " 0 Gef USA Today & /
H6
" N" W:
( 9 .+? 6< 9 ? /
H6<
.L E, 3/

7
"V )
9)
M
" 5
P
7

& ebbi
A * I, # ? " @ V ebbi G3^ Gec

Associated Press & , ebbi
National Research Council *
O&1 !# S 0 G"
#
)
H
K./ " W &

K )# School of Medicine *
/
" Bernard M. Wagner L .9 . 0

+# m 0
E#
) ~+ "( 0, " eij " ", '
+# .New York University
." "

9 7
, eff " " jb ( 7
,eff 50 " " jgf &
?
+ #/
u ebbl
.ecgf
%N\ A The National Academy of Sciences $ $$)h $# )3 D ebbl
2$"" $ W:I '" H39 $ A 2 6#7 9 1" $ $)
? FDA +
+6;
J "J ." 0 / 2J( 2,) & W/
% .# 0 =# 06 " ) P L #

"n "
E @ 1
H6<
J =*/
.!/&
3/ G )
#
/ , A *)
0 " )
7 9
8+ [1 = 0

Agracetus )7 .
W.R.Grace and company )7 6 ebbl
H39 8 #$ .""A >3F 0
=$" &
A 9 .W$: $
.W$ " $ Z_ D

$ " A University of North Carolina $7 $ ) 6 ebbl
5) 5#
! ")
5#
/
, .%`n " ,: " /
:)A $>&) 6 ! =
.)*
5)
" 7), /
Western ", , Gjj "

The Sunday Times & @, 06 ebbl
.HIV ! "0 ? 9 , # %1 A
" %cg / #J W: A*, HIV ! " 7(0
Blot
", "0 G, ".
3 , I6
Gleprosy germ 96#
/
9>#
#

"J
.HIV
# " 0 *)
? " if 3<6 % .&

#
0
5

/, ? " ejf u M
/1 0&
ebbl
Commonwealth Scientific and Industrial
/1 &.

)
O&
P A
J
/,
% . )/
5:, 6 6
>
5)
5& E>& #,
GResearch Organization (CSIRO)
.recombinant DNA biopesticides E>
) (& 9/
5,
/, 0
Y"$ 2" 6$ # 6 [ A $ 9 : $ ! $1 :;
?
? d 3 M G%
6< .34 8+ , 0
;( # 7 $"
.7
6< M&
&

DNA
" ( > K
G &
A Q#
>
5)
O&, < ,/1 "0
.

&$) B7 $ $) 6: A " j )$ " A Science News 6)3 ebbl
+ <( # . )3 G $ " 0
:T$ 39 ., :! "+ 9 , $)
.=$1! $! 6 " 1 %\O " $ 6 $
(1 2$1 "
.Population control and disease production). Science News 7/2 & 7/15 :=#

A :& " 9L

A " ^ Septrin + Bactrim + ", ) FDA +
+6;
J ebbl
>0, 3/ 0 30 A "+
"6< I& .+

)
%. ? L 0 0
? g " >0, $ E%/ G2

)
=
" %ef 5>
&
0
( 7
, "
0( < .// Hoffman La Roche 0( Burroughs-Wellcome 0( 5> G%$/
0(
.E "( " >0, 6 1 M/ 5)

A
J 9
#
) % &
?
", Greenpeace 1 9./
)#
06 ebbl
. % L 50( "

. 3# +#n 9 "

ebbl
M* " "*/
/
(&

9/ P& P
** " :
& :< , ebbl
/ 0 id 9/ P& ", )
H6
"0 .K/
& P = / L %
9

0
", < < 9
1 .
!
/
5. )
H6< 9 ",
" ."

.Delaney Clause "
" " ."
" # A

+
J 9 @ , ebbl G5, Ged The Associated Press & @, 06 ebbl
", 0F 9. 5:/ ' 5, 6< "0 .
*J A
J &
?
" "00
"
5 0 )

.7
M/ # /

< &
?

US Congress )$! r $7 J 0

4/ # Clinton Administration $) = D ebbl
% r $7 J $! 6$ 1 1" 6) % .Health Bill % [ 7 %+
)$! '7 <$ 2($
7 $F $" Hillary Clinton $) , $9 6
&7) #4 $"
. 1! # W#
7 -$ A '$ .
0
&%
# 39 /
$F $ % $F &)S $" $ H39 $ 2r $7 J % ,A 0
6$ % J 7$ -$)
.$
7
9
)
I#
//
F
A
J %.1 L (
L 51 H6< 50 ", 806 :;
/
$&
#
5% " @ %
E % @)( 5. " G"$) :6L - , + M/
;

3;
)
5)
@
J $ ^ @ , A ) (O
>
9
)
5)
J V 7/ G( // M*)
G&
.Q, # I, 5% "&
+*, 9< &
#
H6< M/ ( "<// "6
.$*

."& "#
) 0 ", 5% ("# "%$/) 5$1 9
+*1 P < H6<
70 V( 70 O&

3*
Y 5& 0 @( 0 "$0 % G
6< A Y.*? 5. " Gp
"V
I6
$
A
J P
< @) 50 "0
G

6<
5:/
9P) (% 0 ? .@/0 9
A
J 3/ I6
:6;
9P
6< ." *
$&
$)

&
= ;
5
/
:6;
9P
@)
A& # "0 9
, " " ) !
" ".
a"n 9
, .!/ # 50(
&
."()
"
P $ ?& < 5>
5/ A 3
, $I0/
./

"

: & /$
Q&J a"n 6< = G
"
" >
7 ?J ""
+" '* P 9
50(
" )
>, % ."
+ " " ) E.> ";

";
"0$/
" %mf H6< , ", 5
%)
"
9/? , 3)
% .9)
:6;
9P
I<#
;
# 0 0 50( >&
&

.K
6 E/: E &8

Y 6< "0

.-.)
9 I6
(
-.)
* " *
S/
0&
51 " "0/
$# F # <#
A I6
9P
6< !/
*
9P
9
? " *
A 9
)
5 9P)
0 " "$ "6
"/
"0 &
";
"//
A/ ? ", .>
1 $3*
9<+& 1
&" )( & & " % M* M* " 3)(
" @ "
"#
A 9<
.I
*
9P
6< !0 / O& G"3)(

#
E) 3;
"0 . .3)(
& *(
3.
6< 5& 7 ", 0&
A "1 "^
9< I,
!
*( / 5& P @0& I6
3;
6< .">0
) 0
>
%

# "0
51 3/ &

//F *
9P
A 50
*/ % .
&
Q/
.HF "/ & 3/ !

% 90& A 90*/ )/ J &$A $ ;#$" G90

*, & 90& 5#, " :< @
% 50
, GK
6 5) ")*/ * 9 , .:
%? 9< !, A ")
"#
"/
A
+?F< 9 "
"=D "
& " ) "& .
- M =*
= S/ G"
" 3)( " "& .j %

.!/
E: < "
", 06 ...!%
-% ." & $/%
0
P +
J 7%
" )/ "0 ? * # P&? G5*

6< / 5.
9> .06

/ 5*
& E: "0 I6
5#

< <
5$, .E# /
EL 5? @ , ?J G"62
E
V ' , O& =/
H( 9L GY
6< "1 G1 % 7% /
A EJ E<( /V/ G / 6 9
)
;(

" # % , .&
5# ")
) A A&
9P

E.) "<F +?F< 5< G5$V )# G=
//
Q/
I#

F/
9 3.
Q
GE?
? P) ", 9L G 3#
%J &
'( % 06V/ ..X@ ">& I6
#

)

A * E& E?> 06, 7/ G
. 7)
3# >0 M:& 5& , ?J G1 6
E//, 9 ?
9
(B(&
) 38
< G3)(
06 " E <& 5# " :J )% 9

)

3/1 < 5< X7>0
80
7/? 6< 3/ < .1 @# A 1 #1 =# 5% " 9
/
.X" 0 %.,
$ (

A
J 0 n 5> ) 5) " 9# , < 9 3. " I#
)
O0 9 "J
G" /1 "#)
L A
J :

9P) A
J 9
J 6< O& GE.> .:6;
:

9
"0
.)
" ( >
" "6
(1 " /1 !/
= ", 6< 9

9
1 = " W $/
( < 9
", < @ 3)(

K
6 #
:
:
> &, ) @ , 0 ":
9/0
&, 9
5)/ % ./

.("1 * A E ;
>0, " ) ) CFC ;
"0
0 0 9/ *
#

#
:
1 A& /: "0 , < :
1 9P)
/:
0
&, < "

I6
Gbenzene "
A , K
I&) .@( ("/0) K
5> 5%, <>V ",
.""1 # " # I, 7h)U ? G) */U " G
)
&
P @

G)
5 :@
(
0
#
@>V " " 9
)
E( 3:0? >0, < E
& K

.(/ #
#)
(
" GM, GM% G G7 K/ G& ? &
& 5#/ <

K
6 G""

9, 0&
* A #`
@# 3*" " 6V

)

3&
+, &, G"/ 0
< H
, I6
3*
6< Gebcm/m/ej *
9)
!# /#
: #
" * " 3:
0
"

?# O& < G 0
J
( 01 &
?
0& /, G >

)
3&
"
" 0(
)
0
=

F/
5#, " G1 9 !
9 &
+0
+0

@%, 3&
+ >, 9% " @) 9 ** " "
1 ":0
@, K <
( "0 .
, (Farben)
.3(
H
#
) 5. " * , "0/
) 90&
0 **
" .
, &

.@ 0 9
5& G**
K
6

A */
A
% A
J "
IF/ ; 0
" 0 # 5 "J
"6
K:
, E)
" 5)#/ 6< +* t
" & M* 9/ M* " K
6 @/
K
6 3&
+ #/
A*)
3(
+ A
J 9
n "
1 !
" 50 9%
.@
"
." A& +L, 9)# */ 9J 5#, "
I(
":0
A F 0, G

0(
" )
+*L & # " P 0
I.G. Farben $ ,A 0( K0 9 3&
+ )
0(
H6< GProcter and Gamble 5# 0 0( +( J A %? K ( 0& % ) )%
D Crest "6"D$)" %J 5. " K
6 9
A 0&
)#( % "6

V $ 0 " )#
01 0&
(/ "n K
6 A . .ebgc 9)
&
&
H6< $ ( G # "!
' , % GDr. George Estabrooks !0/J -# 0
G/
0/
A */
/* ;
9
5#
/& >01 =v $ U
5 #
0 0( 0 .Colgate #
0 )# !
9 : !: )
0 G9/#
0
)
5) .
)
Q/
A " /1 "#) A
J
J <, "

( 30
9
)
S Gebgl 9)
.$

) G1 % 5 )
IF G; @/
:E.:% Charles Elliot Perkins 0
J
J 90&

)
<#
J 5> +
A
J
J )
&
7
"J"
&
" "
! O&, E "(
& A% 9
)0 K
6 G> # 50 5
=*/,."&
& /
E "
@
J 7
+
3( ( I, :"V G#
>
!
9 :0
G:0

."/
&
" , )
&
" +/ GE, @6 (
A "
>0, ,

=(
..." /1 "#) 9/ 5% E# 80
A J G

3) "0
/

&1 9 M/ "N :0

5# Q
' ,
.
/ */
"0 ) E)( 9
)
"0&
Q
' , GK
6

c# J $ & $+
AIDS & HIV

!
"$ 9/#, # 9"
& 58>
"( /
1 &, @ V 7a)
5 @8 , E, 5U G
9
5> /# 5:/ 5 / #
K0&? 5. " 5 @8 , 5U .HIV "/

& .3
9
5 A
J IF 0( & n ) 9/
& 0
9/
1
Peter t /

0 )# !: 5> G" +*, 9 G9
)
+#, 7 " 9
:/
Eleni Papadopoulos – !
J – !

J :

/1 G$:#
+&1 / GDuesberg
Kary !
I0 0
G($&
+0
M/
/
) Charles Thomas !
( 0
GEleopoulos
"/ 0
G(9/, )# +0
/) "
K < 0
Gebbi 9 +0
5 :# :
Mullis
! @/ !
a"V "N 9 % " , 9)# G(K )# :%
3*
/) !
" (1 " )

# :5>
5/ A ."L3 0 $7 .>#" :"
Q, ) .HIV

" L HIV ! 9
"6
(1 " 0 .HIV
! " L 9 0

Elisa /J Western Plot
"/ 5> – HIV
! # &
? , .
"0 ", # $#J # P ", "0 @ , #
% L HIV
!
# =
P

Q
90
# , G96U#
G5/
G$)
#/ 1 38 G) > Q G6;
+/ 5>
& 3 (

. &
A& , (

9#/ %
P 9 @
Q# G
Q
#J @8 , A
! & 9
#
" )* #/?0 T .
9 .9/#
T . / 50( /,
<P
9/#
T . / ) .Q1 $
9/#1 , /
, 9>#
L 9/#

* $) G&
"0
.
&
#
)
5)
+
5 +
3# @ , A 8(F *
)
" )

" S E& 9/
(
T .
) a", O& G# L * " T .
)" A ? (

British /
P
& 9P I6
Ian Weller "J /
M .I)
w9
jfff A
J jff
:E.:% G#J ! I6 "$* A +
#
arm of the Concorde

7 ", "0 O& / ; < $", < (T – Cell) CD4 T . ) " H806 ", 3# I6
+(
"
A (
5> )
+(1 8>V ", "0 +/
) S
"0 G9
%, Q A
."H^ A
J .. "
!(
$)(, K
60 8>V # 30 !0
(
" >0
# A
J G@ )

&
G1 5# %
L ? H6< =# &,
" @ , O& , 5&
< 0 GK
6 L 1 ", 9L (1 HIV # A
J (,
:*

) 6< GA
0 "0 E
L GK <
:1 " >0
K < .>0 +
6< #

#. P , A
J "P A
Q

( 9 .:*
W:
(
+/ /: 5
. 1 ( #
>V " )

Septrin – DDI, AZT 5> $/

, 5 5>
=# .9< HIV

* < "0/
+?F< & #
z # ? 1 K " I, "0 9
5& K(

!/F
Robert Gallo
L (0 A

&
H6< 5
O&1
! $P
!/F
K(
Gallo
L K( S$ .%
K
6 6 a @8 , # I6
O&
6< Y +
:ebcb 9 Luc Montaginer ; K

." "
(1 P I6

9P 3/
HIV
!
"0 ?"
0
< w / ">.> ! " >01 9
)
+& , 0 3*
5# & / "6
+*1 &, "a
"& M* " K
6 >, GE 3/ ? HIV
! a", 50( Robert. E. Wilner .I,
( 9
K
6 = G$)( >01 /1
(( A K
6 9% G
! 3 9 @/
. /, - &
3/ ?
! ! #
a", >J 'Deadly Deception"
Y
" ) @0 Wilner 0
',
< HIV
! a", A E, `
$/:
3/1 &, < AZT
", ( E,
!
! #
M* " 5 ? a", /#, #
Q1 /
5> !
$ L W/ )*%
.50(1 " 50( IV I)
:E.:% G9
)
5$1 "0 9
"J G!
+
&, @8 V 7)
Dr. Duesberg t/ 0
So
B . T . 5 O& G $ ?
L Q)

.
:( 5% AZT
)"
A .+( 50 '/ @8 J G+ >/ " .
v50 DNA
//
$ < AZT a"J ..
50 +&
.

" 5F/
"0/ " .
A
J
IF

G/#
+1 =# A
J IF $ G)
Q

(
)
@/ )
L 7?N AZT "N "#
) E
, "( a"J ) "
(1
" AZT #
)
3/
:E.:% K
6 A 7
(
M1 50 a", < ( v50
/
<
0
a"J . 3/ ?
! a"J "
A !
.&& L < HIV
! " Gallo
L 0
$ 1
." M1 H6< !/,
! " 9# !

.`
3o/U !
HIV
! a", M& A +)
+?F< ",
3 ? .o) /, 9/#
& %* /
> /
Q, , " 7
F @8 0
G&
9/#
a"1 G$/#

A +
A 9/#
% 9 < V
$/:
3/1 &, a",
.
=% , =
A*)T
/ 1 3/ 7) %
$
)
1 5 " 78%
5(
K < `
&

$)
#.)
a", ? P,
H6< K( .", / "#/01 -. , GEssiac K/1 #
)
5> G$
L $)*
#.)
A
J +#

. 6)7
$ ) 6) % W$"
&$ $", < & )*
#.)

A ) 6, "0

1
Wellcome )$ 0( A
J ( )
H6< Wellcome to Hell 9&#
A
J K E.<,
:Dirty Medicine"6
+
" :" ) I6
Martin. J. Walker 0 .- ." 30 "

=*
6, .^
90 I < eccf 9 //, $: 0(0 &

?
Wellcome Burroughs 90 0( ,
) & Rockefeller 0 *J = * 0 GSilas Burroughs !./ Henry Wellcome
Sullivan and Cromwell 50 "
/ 0( John and Allen Dulles
"
, "# " v50
90 I < ")
. 0(
$ % 5:/ $, " "
F/ +?F< ", O& $

//F & , "N) Wellcome Trust / 90 & oT( Gebid 9 Henry Wellcome 90 I < )
, 0 = *? $) , *
O&

oU
//F
9, Q&J & , (Wellcome 90
( A
J G"
)#
A(/
3*
$0 0 "F( J 90 A8 /

0( / G&.
)
Q A .:/? &
o3*
"
/ M* "
O&, K(

&
$&

/
-. 9)
-.)
< = $:
$&

<P a 90
)#
7 $*
$01 9. 5:/ 0&
= %. .$&
#
0
$>
/

5. " K
6 ) 9)
$*
$)
O&1 <P 50 % 9P )#
//,
& :

G#
0
9)
$

//F
G9)
9o
*
& 5> 8P
H6< " )
< 9
" ? 7
, "), =, :
$%
) `
*
& //F #
0
9)

30

$/
"0 G5>
5/ A . =% : $)
>&, = M* " K
60 (ebbj – ebcc
0( O& "0 O& #
0
9)
//F !: 3:
Q&J Alastair Pilkington ""; 0 /?,"
.90
0( EJ EP :/? &

3*
"
$0 C. Gordon Smith O/ "L .! /
"0
(
$/
.90 0( E, E >
BBC 6J Lord Swan "/
"0 .90
90 //F 90 0(
!: "0 ACST #
0
9)
I(/? !#
Alfred Shepperd
9)
$* $0
$*
+&1 !: Roy Anderson "/
I /
.ebcg 9 A&
.90 0( EP "0 #
0
9)
I(/? !#
"
#
0

$:
90 0( 9/, = % 68 a9 Gebcd 9 .$ .)
01 ) 0(
)8 G >

&
$&

?# $ E, G&.
/
/
./ 90 $0
0
, - J a9 .&
- n < G9 L1 " I / - ICI 0( = K( Y(
#
0
>
5> E& >0, ?# >/ v0 , )
" %el A
J 90
5)/

.$/

$&

+0 /
I0
30
6< * a9 @ , 9)
= G? !
0 AZT )
90 0( $&
% ./
$ */
.
"
A @% 9 P O& 5$) L $/

@8 , > @8 0
"*/
-.)
, G /

@<, ", ) .E;
"0 I6
!
a

) +
6< A ? P,
. >
-. 5)/U
AZT

58> A
1 &
:"& M I# GE)* &
A # ) G(
A %)
:0 # ,
"0 "&
0 .Q

$)
A Q
*
$ #
>V
A v0 >
&
.$/
Q 5&
(, ), ) % % 0, >
&
3# 0 AZT +
& . / "%;/ ",
0 +
# 5. 9 , A
J G % +
' GK
6 9L G+
6< / " &
3/ 6< G&
$ #
>V
7
K
6 G#
")
(1 A
J 9P 50( 9
5 "#
.$)
7P
v5P G#
W: % 5* 0
I,)
/ @ # " eeij A
J 7 90 0( S, (5
) AZT +
_#
=/

5)#
1 &? <) *, G0 ? 6< "V0 .* / =, 5. (E # ">.> " > :
.@) 7 ", 3# * < AZT + 5 > < a9 ", 3# @8 , < /: *(
) 0 `
), 5% K
6 G$/ $, " UK &
0
E *, % AZT + ", < 1 3#)

$)# +, " E "( ! " " a", &
3/
) $ .&
?
@ " =/,
&, .90 0( '
9 / Q
G1 "

"(/0 ")
1
" " .90 0( *
O&
Trevor M. Jones # .9 L /
< "
+1
.90 //F Q
'
9 " > Q
G
&
1 ./ #
E "( &
6< M$/ 90 0( 0 .9

)
5&
">.> ! AZT +

' GE# % 5.
+*, +
J
&
F
5$ & G&
9. 5:/ M* " I>
+

H6< 5* $ $ # >V 3/ +
6< $"V 5 I, aI1 Q & G
)
Q/
A "
.

0
$

#
E # ef,fff 5. " 0&
9. 5:/ A 90 0( >V /
A AZT +
# G*
O&
!# (/ & G90 0( , APOGA Y A
The Concord 0 0
3# /) H# A
J ( , "& ? "6
HIV
"

" ) " "6
+*1 9P) "0 E
K
6 6 .(ebcc 9 " 0, ( trials
A 5)
0 9
+*1 +?F< .3#
H6< E, "0( 0 Y A 0
$

#
G9
"%
I,
3& , "# & O& >0 K
6 " ), <6 5 G* $
9>&, W: W
, $ *
M/
E, 90 0( 0& .>0, # "0 ",
"0

#.)
# A
J
G"*/
O&, ) " Angus Dalgleish B;
!# , Robin Weiss ! " 0
/ .
Y
a &" / / )# @%, O& A + K
6 ? , " >
5#
M/ 9
/ /
< (Healthwatch "$&
%
" "N / ' ,) Campaign Against Health Fraud "&

7 " A I6
@6 9/
GSurrey I/ )# $&
+0
9/% !: Vincent Marks !0
(
! 3 oI, @# a9 a", " 5#, " .ebcg 9 6 90 0( " @ # "
? 8
5:/
A 7$)
E# E& E. ")
+*1 *, GAZT + I +*, A
J E &
90 0( >V & )
$)
(/
9< 5/J Q/ 9
"0 9

.
6<
UK &
0
$

? $) = = 9& 9 I6
%
K
6 G"
STD /
.M*
( -. 3 # 50 0& " 90 0( 0 6 .ebbj 9
HIV 50 A >0, 7$)

A
J E
6< Y 5<J "0 ? G5&
)* E)*
$*
:
" E & "#
+*1 " # 5
@ # egf,fff = 90 0( $ K
6
G
", " E? .
9*
6< 5 A )
$ "6
GBritish Medical Association *

< 3#
+#J + /:
3/
.50 50( 90 0( >V & 0 G8/ / 0 0
3# "0
.HIV
! "
A
$* = AZT

) >J
$:
0(
9 M* " 9
0
G3#
H6< 5> $
./ " $& I6
9:
9P

90 0( " K(? 0 0
# +#J 9 G(0(
5 ") 3#
9
(/
=
+
$&
9/% , G? #.)
7
0 MRC *
O&
!# = .$&
9/% MRC *
O&
!#
5& @8 , ? > G ( oI, =#( 9 "0 ..
./
"P
= "
(/ / 9/ '/
O.> 5
@
" 9 0
G #. 9 , (% " #
A
J 9 ? A G
!
#J
9L 6< 50 .E u efff <% AZT + " # A*)U/ @ V 9)
= G$&
)
" # /
./ #
#)
9
G.)
(. 5> *
$ #
>V
" O& G& * # " G
6< W: 5

( I & M& A 5 &
*(

H6< &# 90 0( #
.90 0( " I6
< H( '/ I6
&

.?
O&
!# +% 1 " )
/ A 90 0( & G*
#
A 5 &
" 9
80V
= 9
>0, #
51
9

? '

" >0
9
"6
MRC *

%
! G*
O&
!# #
!: GLord Jellicoe K#
"0 .$0&
, $*
//F

GTate and Lyle 5? 0/
0( A
J GMorgan Crucible 5/0 "L G0 0( E
.&
0( !: ) ' ,
3*
0 $0 5)
ebbe 9 @0 @8 0
$&
9/
Donald Acheson "/(,
$/
5
"0 (90 = 0(
"N) Glaxo /0.;
/:
68
Austin Bide "/, $/
"0 .$&
9 :/?
&
0(
E David Crouch B0 "0 . )/
J. Lyons CO &

0(
E
0( $ , E, %
K
6 AZT +
0
9o
&
=v U
0 $: 0( < Pfizer Ltd
9 6 $)
$&

E J. W. G. Smith 0
"0 .Kings Way Roland ? I ; 0 <&J 0 $
.ebbd 9 9>#
9 !:0 90 0( '

5)
@<6 5% o3*
$0 E& "0 ebcg
.
O&, E, 5 90 0( *
O&
&
E "0 I6
D. A. Warrel 5 .IJ . /

5 a9 I6
0/
a C. N. Hales < ." .! /
.0 90 //F 5% "
$

.90 0( $: 0( 5% " E
L @>&
Lord Jellicoe 0#

9/: `
*
O&
!# #
>
+1 O& H., 06 =
w? 50( ( $ #
@>V I6
G8% H 9 9
I6
E# 9/ $ , I6
+
"0 $", E;/ !
" (

+
) ' , @ 0
. *
*
$*

30 H06
E G 1 P
. / 50 ? " lff $

90 0(
:*
S1 A P& )/

Martin. J. Walker 0 .- ."
Dirty Medicine "6
+
" :30 "
A 5 &
J. W. Hodge -<..- 5% " @ $9 % "*
– :
" 0&? *? " ^ 8
: 8
6< +# .K –
L " 3*
H0
EF
0&? >0, /
< GAMA 01 *
&? / /
G*
0&? * $"J .."

#.)
5:/
$"J . )
" I, &1 " 3)( "F( ", "0 E* E#) <>0, 5 *
01 *
& ";

5% " 7 ) #U "0 7/ )* */ ^ 3
/, 9/
7/ *
& = 7
& ? 3* 50 $"J .9s A
J 5
5&? Y
7
A
J "F# "6
AMA
( ", I6
$&
9 50 $"J .!
& 6< +*, 5% " $U * 5$# @ 0 98U
5% " E @# $9 7/ GS
A& , 5 , $/
1 A
J +#
" )* 5:/ E/ G E
E % @&. A
J 3*
)/ 9/ "<( G" S# 50( @ O& " )
+*1 +?F<
"..E
L ">
= O&
>V $%
) 5& I$# 50( 5F/
, G=
* Q E, K 9)

' , G5& \50 A
A &
"0
G#

6< A 5* % 9L ./
>V
)
1 H6<
.5& I,
"L3 ' 3 0 c17 ,! %
A - ""
*, 9/% "
( M* " G@ "

3.
#
)
I$/
9
)
I# " ( 0 "0 0
$0 = #
NGH )U
1 & 9)
5/0 A(/ "
:< 5) Walter
A
1 0( */ " "&
+0&
+*1 & 5%, " M
(
H6< .:/? 3*
"
) 9)
5/0 A(/ )U
1 & A -. 9
)
a"J . :
)

K < O& 9
)
5& * *
&
H6< &
&
H6< $"V aK(1 3/ I
!
E# /
$
)

:Walter
$
$%
)
)
# < .Q, >0 &
3# G(/

)

*
I0
!#
5% " @ A

9P
K/
"
E .."
38 #
& 9
9
w> 6 "0 ", @
9

$F
$
$
"0 ",
"..@
& +( I, 5)
" " 5F/

.:*J * +
J < %.1 K/
6< *;
$
?#
Q&J
.+
&
$ #
>V
W:
" H6& " E, 5F/ +
" &&
#
+*J
0 +/ 3*

1 50 "
*) NGH 5/0 A(/ )U
1 & "0
I6
2
$&
)*
E 5<# +
7 I6
3*
, .? 9, 8 +
>V " )

E
L . /
2
$ #
>V
>V
" "
:< 9.J A % L K
6
@
" E? 7&, , 9%, // A$/ E
L 1 ": I 50(
)
" )
P
, % 9(/ a"V "# E G)
L 0
H6< 5>
9 3/ " +*1 5V/U .+/,
.K
6 A M)
5#, " "# L E "(/
.:*n
0/ GE>0 /

1 &, 5>
5/ A) .E# Ea < 1 H6
$ #
>V
a", P&

>V
.K0&? Q
@6 $
+ A */ G
" , 3% E( A*)U I6
Foscarnet
" 5> : V 9/
A
J A
" )
5 ." #
A)
Y
5( +
6
):(
$ #

U9o/, 8 J :Walter

5 .+
6< 9/ 5. " " " % & , "

HL ^ ( "# 7/ @P // < 0 1 *) ", 6J @8 0
GB)
5#, " !

9 "0 6J A1 9</, " @
/ I6
3)
" " "6
;
+*1 A M* +(
6 .*)
A I6
O&
# $ M, = =*
6< $% ", ) A& "N A& w& I, I# 9
."<
=
I&
. A
J IF HIV
! a", */,
+
9

&

a", 9 )
9.J 9 !
" 98 , A A
( 9
&
.9
$
1 / $", < &
% A 5*,
.
#/? #.)
9P
= ")
" E# ": G% , 9
"6
A

L a", '
"
.#.)
9P
6< = 9 ) # @) ( E:* E " =P w50(
" ) 9 0
9 , = .@, :
9P Q# >J *
M
$% GWalter
$
5% " $&
" )
A w0
" )
3* G? H6< A E$ .&
A
+*J 3L ? O& G 9:( @ V H
9<&, "0 9
.@& a/& , " H#
( I, " * & 5> A& H*) ", +*1 " /

.K
6 A E& E?> *) ",
6J &
" $J / " ;
. $/& ? 9& 8; V 9 5)
6 G!
& $ 6J A&
K & ", 0V
5, < ) G
"$0 )*/
A& .X% ?
5& ? 0/ 0 /
K %
."0 % 9& p< "0 0
&

*
H6< . )
Q/ , O& " 2

&
# G/
Q&,
50 E & 9
*,
* /
1 =# $ 7/ 98 , *( A E # 90 0( $%
"
F/
"(/
0 +( 50 9 A 0 "6
"&
(1 $", .5
O&1 W: P&.
5% " &
1 W: " I, Pn 5 "0 9 &, ? G0(
5% " " )
O&

5#, " $ / J 3# ": 98 V0 , + 5% " #
% &
H6< A
a", #
) 6< .0(

.0(
5% " aU
1 Y , 7
,
$) L $:0 9/ "0 ", 5&
" !
, X #
)
5#, " ^ 1 H6< a", 7) ",
70
.X-. " 5)
">& 5< X #
)
) P
# L
&0 O&
=% A
J
A .* , /
$) L 8 1 Q, ?#
)/ =* % 9P
9/? 6 )
1 )
."*/
"
A
/
E/ ) A. Z. T + "0 G5>
5/
AZT +
, HIV
J :)(
30
90 0( 5% " 9/%1 $
$
(

" %lf / @ 8>V @ $ I6
9
G< +
#
>V
" >, >.> * *) G"&
K"
9 G"/
" %jg / @ 3 I6
">;

."/
" % ef – e " Y
G"/

:E, %
80F G#
)
" =/, $ ) E: #
>V
6< ",
38;
M* K < $ # >V P 6J .E0 AZT + "6V $ # >V " " ) ? !
9P)
5< G5+/, @ +(
"0 ? 5. "
@# $ K8 , 0 6J .#
)
" 7%
J "0
X&

*n 5, *) @8 , A E J ' , I6
+
6, " 78% ", K
9/ 30 I, " $ #

>V
>0, $
) 5%, @8 , P "& " " 30 < Septrin "/
9> E 5%1 $
$) >01 //1 9$
" E $ O.> AL, E, <) 50(
.+
$
@
jg S #
"N Thalidomide
> 9/ .Trimethorprim

$)
#
)
" 78%
* $&
)
" 98 , A E: 8T( "6
A
" )

A
5 Toxins 9/
/ "6
+*1 5% " w/ 50( K
6 5<# a9 .
5& ^
.A1 " 1 ") 98 V "&

06 9
.& 3/1 %&J 5$ O& E# * 9< ># "V 3%1 5<1 9.J 9 G

" #
>&
" >0
=/

", 9L G 9
? O>#
3.
" +( I,
$* O& 6< 5< .(
"
" & "6
A
O># A 9# 9(0 " "0 O& +*1
!X9/
K
6 @& 3
3*
3L v5P Q, & " 3* / ", Walter
A "0 G/1 Q&J
1 $0 "
H, G@#, " +# I6
@) 5;( 3*
6< "0 .:*
V/ (/?
@&%? 3#/ * : $0

"V Walter
= 3*
6< M .@& A
7
*

5
" ) I L "0 +( "V

E, 7 .
1 9P) " 5
, =*%
H6<
L +*J a9 9
H 5 , "0
GK
6 A . .@*/ M* - < G5#
6< I#
A 0
G( " 980 ? GE( =/ ? GE( Q ? ", 91 H6< K 3# G5& $, A .E%.*J 1
.$
0 K .&
% A
$", GHIV

! $P >0, >0, > $", O& .E# # )
H6< 50 a"J
& 5# 5 & E/ 50 "0 6J .
@, *
9P
6< 38 # < " #
&
*

H6< 5% " ";/ "#6/ "& 90 .X Q1 ?#

&
"0 70 G>0 ?# " " *
# A ( >,

$:
0(
+*1 " !
0
+ " I#

" 90 X0(

.X
1 ) 5. " SV0 #
". 8 O& G51 #
0 =/ 5# 580(
**
0( = E, * Wellcome 90 0(
) Gcondom I06
%
) A/ ", " GM/1
"6

>
I6 "
(1 " A1 3$ )
)#
*/ 7
/L
.("
' 0 P )# +( J A

J (Q0

)
6< Q,
. " 3 @8 , A "

O&1 5 7 < 51 H6< "V 9:? 9
)
3)( 7 " #
#
".
%
! ... 3)(
" /) !V !F " //
)
H6< 90 .*

6< " 9
)
8/
.X+
%? *1

# $/%
BSE
8>F # BSE $"J .(

3 U < BSE
* $#/U
& 5$, P Gebcd 9

8 ."/ 0
A/U
)
5.? ( , 3/ (
)
#
A
I& I6
7)
M* " (
3 U M/ O$ 8 , A $/

&
MAFF +6;
K/1
BSE
1 = ebbd 9 5& .Scrapie (B
) A/ (
9P 9&
" # A
.9&
A I& I6
7)
" (
9)*J 9& a9 ebcb 9 K
60 jmcfff A
J
9?^ 3/ # + * 50( A t

' O& ) CJD A/ (
3 A
J
?&
U
.3 U 9&
A I&
#
" 0
)
A
J (
A
J IF 3* A
J $* 9>
BSE
3 , % 0(
H6< v5&
ebbd 9 *
")*
( J #, w5& oI, A
9&
" 9)*T
"&
M:& #
&
K
60 &#
*

1 **
5> &
" )

.3 U

"/ 3 T
?&
$"n GE# 5% A
J % BSE ?& $", A
J " :*? " 9L
A
.ebbg 9
& gg A
J 9> ebbl 9 lj A
J ebcg 9
& jm " * CJD $/U

5> $//, 1 <

= >
5$1 "
@( CJD " ) Y , >.> K <
M/
J " 7 # O
> Y @
' , ebcg 9 6 CJD $"0
G06
" )
3*?
."
.)

9&
# " # F "6
"0/
" 6 $/ 9. 5:/ */ $)
#,
$
< H6<
!: /\, "0
, = ( $# 3& ) 8 , A &
3/& 8 , A& .$ *

.#6 , ! ! John Major # "# *
+

, 9&
0^ " "0, +/ ( v50 A 0
E# :$/
G>0 K
6 " 0, < 1 & a"J
$", G$)

A ?
W < GMark Purdy A Y 7(0 % .+/ w& A "
"
1 "& "6
+)
</, Q)
# 50( 3/ "0 9
CJD " O
>
Y
K
60 BSE
organo-phosphate $ $/ /, */ 9/ 3/ 5 (Q)
3/ $ :#) ""$
"
.fertilisers
: $
H6< &
A "( 0 " 5% " P
@8 , " 9L
BSE "
&
$) (
0 $0

9/ ? ) I Y I, # ? – e
./:
3/
@ , " I6
7)
! 9/
" K
6
$
BSE " ?& P K
6 = 7)
! 9/ , 50 a"n K
6
– j
XK
60 !
, GScrapie B
O$ 7 < 3/
"0 ", 3)

= "
F/ 0
$0

$ 0( <) I, G, Farben 0( % >
$
)
3&
5.
":0 5$)0
Auschwitz 9$ + #/ / O& G;
+ #/
5
/
Zyclon B
GW
3& E, M)
@/ I6
Sarin 7) "
" Y 3 , L * ($0 3#
(
")*% 5 &
B
5% 0 "
@/
( < OP $/ $ " W <
.$
6
S# " ")*
#
)
E.% A, 0 9/ 8 0

S# =
"
A $
6
a 3& MAFF 6L1 K/1
, ebcf 9
A 30/T 80 OP $/ $ " &/ < E / " K
6 "0 #
)
3/, " *

.=*
P
6< " ) L $0 $9 ) .#

*/ 2
@ & 9 K
6
"/
" &/
6< )

6
OP +
6< 5 G )
9P
0 I, 0(
Y
<
H6 >V >01 *
&/

.
6
# M* BSE
?& # " u, % )
#
# M* "

A
J

5$& t
#
"
" 9 BSE
& @8 , & A
J 5
9
; 3/ "

= 9& OP &/ $", A
J E, 5
9 % .3
t
)
# /1
Thalamide "?
" " 7(0
9 GOP &/

& " @# / 9 3/& .t
. //
5 G )/
/
, 0 T H$( ?& 3/ I6
Thalidomide " +# < I6

." " A E, I& I(
5)
", A
9/ 8 , * = 5

H6< K( $
(

, // P& 50( A, BSE ?& 0
., $ 9/ "0 $ $ =V Q%, 50( Phosmet /
0 '#1 A OP &/

F
& " " ) & OP &/ / "6
" *
"
" )
G / $)

)
+? " 9L
A ( E/ 7) ;
) 1 H6< < & $/
#
=*/ 9

0
6< =
1 , .@/ 9 I6
OP &/
1 H6< " # 0F
$ )
*? " )
"/ 0
A
5 & I6
@( 7# K
60
9
, M<J
F $&
$) 9
( )

A ") ) $:0

"/ ? "6
"
a"n w5& oI, A .Q1
/ A I&) 0 J
0 #
Op &/ " 0 / #J a9 .;
1 H6
#
" %c a", MAFF 6L1 K/1
& $* % .(@ S/
" jg A,
7) t
Ops &/U 9# .MRL $
)
$/

'/
&
" A, $0 A I&
)U
1 )
%

&
5> "()
"
, $* //, 5 K( . ) G
#

. 5>
#
,
=
MRC $*
O&1 !# <#,
Purdey O&V $P
H6< 9/ $<, ? >0, #,
@ V 7 MRC $*
O&1 !# a"n w5& I
o , A .) U L 8 , O&1 H6< P, "0
* 0&
5< . " " A ? "# 0 9 0

O&1 H6< &
"
" 9/ "0 9
&/ 9/ )# K

6 /
< 6L1 K/1
5. " 0&
"0 ", "0
.XBSE P A
J $,

E#J Op
u
) = 7/ < :< :% Q
5#
'// 6 G 6 <V* 0&
$%, 6J
Wellcome 90 0( 5> OP &/U - J "
F/
0
0(
>/ ? 6< G<& "0 ?

! $) $// L M&
BSE
, 9/ 0 0&
", ' 50( "$
. ICI 0(
.."0
a* CJD
&
3/
%

$ 6 $ Y$7
Vivisection
&
M& % $# 0 " 0, J
.50
I(
! #
A " &
3#" " #
:/
>V
M)
9
< Y
6< S* "

I, +% , F E# "&
" "# ) "*) &
"
(1 " )
", & K ,
$ 5 *, ? ", GK
6 A ~+ . 0/
:0
H6< A * 9
)
" S(
a", 70 "&o(U
@ 9 I6
)
Y
A K
6 " E? 80V/ &
A #
$
3#
"
P, 7/ .1 A
J
@
/ * *
9$
/, % "$% $
=A 9 Y$7" a"V 7&
9 %
"6
(1 ! 5% " K
6 G3)(
.;/ " E//, E+# 580( "$&
&
'(" 5# a", 70
.(+
% 0&

) E/ 906
? .'(
" &
(
A/, E
, 3/ 5 I, # ? ! &
'( " ,/, , K < !
9
)
" "0 I, $)
$
//F
E
& / $%., 5%, $ 5%, O& * $, #
.'(
0
" = (, < K$ $ ", "0 ? G &
A # 5

9., Q 30
, 9

>01 (
K <6 &/ ", )*/ 6J . &
A 3#
$/#
9&#
36)
$&

9
)
5& E & >0 ,/, $ G*
9
O& 6< $", " 80V GM.* A (

G+
E > )

V 5 & K
6 50 .$ 0( 0
O&
)#
!

" E "<# A ", A &
50 &
0(
H6< .<6 SV %.)
+
0(
.2
&
-.)
G3/ G)*
>.> 3 G / 50 " jgf I, G<

3#
H6
# 9
)
5& "& jfff G$ % 50
"0 & 9 . " " Q# 3#
H6< " %mg " .<& * 7 ".
.5#
&/ 5#, " < 3#
/
&
" %f,j .3/ 50( # L E
L
.'(
9
8
(1 " E
, "( "% * E( ( )/ * #
O& 9
8 , 9L ecff "
6 #

*
O&
$//1
&
A 3#
/ )
@ G<

9$ @ & 3* 3
* 50 # 0
K
6 = .$*
9)
5# E0 E& E
7*)
" &
&
9% / !L "0 70 . &
Q&J A <#, # W: " 9 ",
$)

&
< 0 G
3
)
9
1 5<# 98&
/
5. " F*, "#
3#
X9 " +#0 &
% A "0
&
9P "&( "6
&
?
+*1 $

.!WA L3 )$ :E# */
" J .E/ E?.;/ >01 $:

@ /

#& " &
A 3#
" 5# )
3# 9
M* " 9
!, A ")
"#
</1 5
" :< u
=# 60 $ P
.I(
9/.
/ / ^ < 9, $"V 9+ 9
/ 5#, " * $ ($&
06 Dr. Gallagher L?L 0
Dr. James!# 0
Lederle Laboratories 5
O&

:":% Gebdl 9 6^ 01 *
& &

A ) ? F
<# /
H6< % $"J .$ 3/1 !
$ % 3/1 &
" / #, .."
"..A ) I,
!
O&1 H6< $", ) G"/ /

"0
. &
A ", 3# $#

$:0
0
1 a"V , , * " % I, 06 9
) ", 5#, " L

W:
A "&(
5 & ", &
A ? H6< " G5& $, A
%,
:
0&
" A & ? K < .E.) 5 & " <#
<#
*
$:0
9<
50 #, :< N "&
" 9/
$
$) >01 Y
"0 G0 & E, $/
$:
0(

9P) "0 9
> $#& H6< .@ K0(
+
./ " 80V
5#, " &
A *
$)
?
(/? 5#, " 0&
A
J 9<* "6
+
G5& I, A "0
.< (%
<F $)(
*/

3<6 Y, " 9<

1 0( 5% "
?0 , Q, , 0( +, 9< H60 5:/
." &
A ?"
G+
" , 5 & #
:
K)
" >0
&
A 3#
Y 5 9
/ % .! &
A 0 #, @8 1 )8% L O0
H6< 5> $", 0 " Y
/
> ( +? 9
Gebmf 9 " >
" 0 Thalidomide
$% S# $#&
H6< E.>
.(
/ #: "0 ", "0 ? &
$",
+*1 , @ S$ 6< ."/ 0 < "/ 6 "0 ", "0 "& A # 61 0 "J"
0 " E 7 &
/
#
/
I
30
$"J ":5% O& G3*
E>V 9<>0,
$
&
H6< ' "0 .
) &
?
& M
6< M* (0
: ) < GM*
"/0
$0 > /
9/
$) " < G( %gf
#
I, ) "LD50" A/
?
5/ A G&
50 E * "0
&
H6< 9 . &
, 7 5
*
Toxin
A
"/0
# "0 G0
@(
6< 9L "0
."
G9#&
G> GE/# ( 5>

9> . # "0
#

" ) %
7
K G( * 5 GI/
&

ej K < .(
$
N /
" *)
(L
&
3/&) :( 50( W:
H6< 9#
" ' , % .E: #: $;
G &
3# A )
(
$:0

./ E: &J & *
W: ", ) 6< .?&
" %im "*/
/
5)
& &# % &
a", 5

A F
$ )*% A " ,/, E: &J < .&& "0
K " >0, $ :* "0 ?
$*

" , ")
*" (
@0 Hans Ruesch B < 0
S$ 0 .$/ @# I,
:"Q0

5$& ", **

3.0
"0 "0
GE / J 5 ($/ $% @( $) scopolamine "?0/
" 9Lj 0 "J .."
&
&, G3 2
& 9)* @8 0
0 : A ", 9/ *
"0 .! $
: A, #

0
5) ", 0 3) " 9 ", (
" K:( "&) 9(
=*/ .!
$

...B#
" 50 - 9/ 0 K/
& J 0 E/ @) G"/J "

oU po I6
"
.(
9/
5)/

H6< G
" $0 = ", 9 L1 =*/ ...

=:(
!
!3)>
5 ",
&
"0 Q, & " .":
**
Q
$ # >/ 3/ G"/
I

<
5$ ^ "& 5 G:1 " ( I6
"/
G+;$
*
9/ )
"..guineapig
", , 6J .* @8 V )/ "0 O& I

A
"/
a9 9
@8 , ">0
P& "/& "
3# & K < .<+(&, C " - J =*/
3.0
" @) < K 50 G= L C " a", >
>, ", ) " /
:
8% % &#
)
# +(
surgery "&#
" / ", >J 9
:<06
*, @) I6
,
$& 9 &
A 3#
5. " (I.
>
"
) Galen "
L
3*

*/ & A
J ) $&
)
!0 P
A &
$#
6;
$", G(.
5% !
"
)
H6< P
# " Galen "
L = .-.)
K
60 $#
$&
$
5)
< (E: ( )*
a", <
/
.$&#
+# ?
=
Q)
`
E?& 9// 9
&
(9
) 86(
)
G$&#
)
(@ ,) 9>#
" 9)
+/ G*, p 9
E &
A Galen "
L 3#
", 9)
P
"0 70 0
7(0 ) ( =/
"
@ P
, GI6
9)
9a
5< 6<
? $ A I(
K./.
M/1 &*
1 +/V :% .0
=
:E&? /
1 &
A

" @ 0 (3
1) Eraldin "
,
.ebme 9 * A(/
A
J ( 7
, :/ " 5 (9
1 5%) Paracetamol 5/
.% W: = $0
E, 3a/ Orabilex !0,
(")
/ 9J) 5 #
3a/ (9
*; Y?
) MEL/ 29 – jb / 5
, 5
5. " G
& idd " 5 ? A
J % * * 3/ (9o ) Methaqualone "
0>
./: 50( & ?
.5* 7?^ ( @( 3/ ("v0/U – poU) Thalidomide

. /

& :/ 7?^ >.> 3/ (
+) Isoproterenol 5 /
."/
;
+/
Q
"*/ 3/ (/
"*/) Stilboestrol 5/ 5/
./ 0 3
3/ ($//&
) Trilergan "L
.HF;
J a9 A& / 50
& 7
, 3/ (I0/
) Flamamil 5.
.+)1
0
, "*/
3/ 3/ (5/
0
) Atromids !,
.*$/ # " 3/ (poU) Valium 9

. )
#
3
A * E, / (& %,) Preludin & Maxiton "/0 "
.M1 3/ (M2
) Nembutal 5
.;
5*1 " >0
% (:$) Pronap & Plaxin "/0. 3
.+&
9
0 A0
* E, 3/ (9
1 5%) Phenacetin "/
.9
, 3/ (9
1 5%) Amydopyrine ",
.5*2
E 3/ (">L) Marzine "
#
"
&
!0
t
"*/ * " (9
*; Y? ) Reserpine " /
.,
+>1
. -< 0
3/ Phenolphthalein (po) "
>

. 5( A 3/ (5/`
) Clioquinol 5 00
.( 9 +)1 7 3/ (0
9
) Mehtotrexate /0>
.9P)
((< ":
0
"*/ 3/ (9
) Urethane ">
.0
E, 3/ (9
) Mitotane "
.0
0
E, 3/ ("*/
) Cyclophosphamide /0/
.0
E 3/ (5/
) Isoniazid /,
.0
9
3/ (5/
) Kanamycin "/ 0
.
$
1 9
3/ (:
) Chloromycetin "/0
."*/ ?
<$( 3/ (# =
) DES
.?
<$( 3/ (">;
) Debendox !0
.0
9
3/ (3(
o3&
) Accutane "0
30 % .Dr. Roy Kupsinel 5 /0 I 0

" , 9:+&1 '(" 30

:Hans Ruesch B < 0
")
*"
M* " &
>&
G*
$*
" )
5
9
a"V &
'( A ":
a .."
! P,
&
'( /
3#
/ "(/ 7/ . &
'( "
5:/
.'

V/ < K
6 A >1 Q&J . &
'( 5 "

% %$/
3#
P,
W:

5/
0
5)/
GI#
5*1 5( 5> * "
I(
! #
0<,
1 " )
$", '&
a", : & 9%1 P .&
9/ 3/ !
6< "0
.
"
E ( % G0

? 6< / 8% % G&
9/ +
5% * 6 # *<
& 0 1 H6< 5>
"!..&
5)/ a9 #

3/, < +6;

& $)
$&
) $&
)
|/

P
>V Q 9 0
9$
a"J
( ", U
1 " )
3/
"
F/ &
.500 9
)
$&
"/&
/: &
E: &J P 0 9< "6
;
5*1 $ )
9/#1
#, =% "
F/ 8 , A
J
9<6, " =/, 5. Sudden Infant Death Syndrome "_#
;
5*1 "
& "? $% >0,
.$
1 &
5# %. 8P 51 " u

">/ .0
";/
9< '(
3<6 A ":
a"J
9 , A
J . Research Defence Society in the UK "&
0
O&
" Y
$)#" 5> )
%.)

5 0 " >0
Anti-Vivisection '(
$
0&
3
" )
5 A 8/
.$#
#
H6< + &
5& $)

The "+1 '6" :" ) 30 < G$&(

&
)/ 0, H "0 K
6 A 5> 06
:Hans Ruesch 0
Slaughter of the Innocent
/: 9% .// G5 <$

Animal Protection league ""&
& " 5 > $% K < .."
"//
" :(

& G$(
M1 9 6/, Dr. Rudolph Schenkel 50 ( 7
0

: " ) 30 &
&
& G'
6< ) .// '(
")
9 , "6

"..'(
$
+N 0 / "&
M& " ")
A&"
: "$ G50 ( 7

0
& 5 A
J % P )
B? "< 0( " (? eff,fff
&) I// K jff,fff & /,
P
– e
.?
Hoffman – La Roche
.9
;
9/% &
A 3# I# @# 0 – j
) Q
5% . &
" = @8 V @+ 50 Schenkel 50 ( */ GM:&
H6< CIVIS 8P (0
:SPCAs $//
"&
& #

F

"..+( 0 ) 5) ", 0 / '

5 - <
& $", .."
P 0& =# =/ 50( ( 5 G3/& ? AV P A

J 3/
//
/
H6<
"/ RSPCA "&
,
0
)#
+1 " 0 ", & (/? "0 ."&
M&
.( * E# ) ) 3.0
)/? "?;
3
)>
5% &. A
J G

< " &
A 1 51 "" @8 , < &
'( A ":
)
>
#&
,
9)
9

8
) >01 *
J ." &
, 90
*, J": & ) 6< "(
A
) E (
A 1 50 9 @ , & < @ S " ") I6
1 , .>
:
9
.@ ,
) " "0 E
L &
A #
E. /
I )
9$
" I +# 8 V 5
")/ $)
G &
'( % $
" 6
9 E# 9 _ 50( % "#$#D" I, 5
M*
", < =
6
3/1 &, .M.* AE(
GE# > # y M( ^ Y # '(
)
8P
A "n GK
6
.
/ 3)

I6
"?.
" 5 A
J G+( 0 ".
5) 90&
0 O& (9. 5:/)# Y %J 5:/ K
. / A "s
"0
>F M,
? 0 5)
H6< =# G(
@
*
" G &

A 3#

W:
A ) ($& L 8% >0, )) $& 9P #n
M .2
&
#.)
$&
3/1 E, 7(0 "
O
9P
6< M @8 J "
6< 0& ;/
A 5 & ", "0 G, 1 /# */
/ #
) 0(
& : H 6<
:7(0 #&
:
. &
A 3#
/
"
) H 6< G@&* I6
+
5 &
5
3/ – ,
Q, 3
/, " <L G*
H6 .M/
&*
1 +*, W: #
)
1 "
– 3
"0 G5& #J A $&
#&
G

G=#, 9
)

&
A "s
";/
+?F< G//
.
& & =# $*
9P 58 9, < 5&

D$
38

< =:(
/ GCannabis (B(&
) 38
$
K < M:&
7& + F 0, Q&J
"

L "/:
"(8(&
Q
5$
"8
, < 9

H6< " @) 50 .MARIJUANA #

6< 9
/0 9

H6< .
> (
& "
H6< " 9% " "6

/? " E# 5:
90
A
J
H6< @ I6
5*

K
6
_# 7/ "0
.Y

.E# ) 3)(
06 ", E& .E, E& E % )

= "/ "0 GI(

6 9
)
5& / 0 , <
H6< " ) 3# ) 5$,
.E &
@/ 50
.
M1 K
60 G*:
G30
M =

/
G7
0

= G#(
0< " =V >0, 38
" 0< 50 " M 0 - J K 0
.(
&
M
< ) 9 gf " E? 9 efff
9 G () Q%, , 0 G)
I1 7
.I)
M
" =, / >0, <0 J "0
.38
" :#, 9P) 0 E/ P)
(
"/
=#
.300
'*/ A )*
7
1 Q%, < 38
7
,
.>0, ( / @ >0, 9 G$ "( / "*

" Q%, 38

.
B#
/
, K
60 G38
"
= 0 #
5/
B&,
@ 0 G)*
% @:V G@: 0 (& , I0 / I, 38* ?
H6<
.!*
:
O& " M*

. =V 6
" Y/, G1 '*/ A E
Y/, )
.1 @# A ^ I, " 50

"
A, 8
" #/
6

: ) G//1 &

"<
A, ) 38
6 ", < G> 7(0 A
J EF 5$
9%
50( 5/0
" "(
7P A 5) , O& G
/
E# &
"<
) .&

' G!(
)(1 $) 0/. , "$ 1 :/ ) #
)

=# .)*

0/
3/

G9/#
5/
0
90 A
J IF saturated fats )(
"<
" ,/,
&
.) ?& " <L
9&(

/ "0 O& G0 0
0&
0 9/ ", 38
6 " W

"0
.*
" #/

38
7
, E/ Model-T " 5" (
/
A G(/
0( !/F) I <
/ % 6< .3
&
" () >0, % 5$& 0 ./
50< # A $

"0 I6
38
% A 5) 0

% <
/
H6<.9
O&
" #

J GPopular Mechanics "!0 0 ?" # )# G&
H6< % 0
.@ )/ Y K
.9ebic 9)
" *( (

"!..
$

.." V 38

!X5&1 $; 70
G9 egf

&
?
E/ 1 >0, > 580( 0 38
" #/

5:/

GM< G")
+%
+
:5> ?&
)* + 5, ) . 8 eff " >0, W
) 0
.Y
G
G5
3
J G">;

3/
.9
)
0& A ) ?

)
M/
I# W gf,fff 580( % 38
"V $
", < //1 3/
./ 3/, " K
6 L , 0 @/ 3/ !
<
H6< 5)# I6

3/1 .3)(
06 " <& ) 3/
" @ , # 9
)
1 # 0&
>
.:)

:*/ 50 <
. L 0 ) 5#, "

.I L * % ) 5#, "
.
# &
$ , ) 5#, "
.#(
>
@</ 9L .
' *
#(1 " /
M

u
38
# 5)/ ", 9L .E / ?
"
>
.:)
#
H6< =#
"&. 6
"N 5< ."<
=
A */
" 9, " / 1 ", < M
"0
G>0,
.>0 K
6 " 0, 5 G " :/
B(&
A +% $# /

V/
.X38

$ $ % 0 1 2$34

&
//1 )
5> O& E# 9 Y 9/
6< 9 G&
" O&
/ E% /
5%
A @
, @: @( @ 3.
9 I6
Y
6< .6;
Y , / .% # Q $&

/ 5. " .)8
:6;
9#
& )/ M/, #J 5#, " * G9)
9. 5:/ A "*/

", < 0(
G:6;
)
) 5& 90
:*
01 " >0
# 90/ V "(0/ G*/
#
6<
.9. 5:/ <6, /0 /
< ) % :*
01 H6<
6L1 ", 0 .@

J @
J 9 ( * I(
9/#
& "J .% M& /
6;
% "0 ?
O " I#
P
&
% " # (0 /) >&
=
"

0J 9 9

&
%*
" Y K )*
#*
)
6L1 ."#
5% " ) 3.
,
& # O& G/% (0 "0
%*
H6< " ) ", .:/
#
9)
5% "
L < , A )
L 6L1 I& 0 .+6;
0
"&

" Q/ !

, @0
;

*/ )*

1 "J .8)
*
)
6L1
"0/ G6L1 M* "
1 A 9/#
5 & 9
6J .@6 & +6;
K
6

>
)
5> G9&

7) 9/#
" 7 /
%*
6L1 " 0 3* < . 1 H6< "= " ", @
z@& 5. zI( 9/# 50

", G)
5*
J Q)
)
H6< "/ "6
">&
" )
) .@%*
.5 @ G&
":0
Q
- J . - J " E> E*& & 0

&
I, – )* A 0 6J &

A +& >0, )
)

"0
A
J J # "J .> .
" H# 9/ +6;
A = I, +#J # .)*

)*

"&

)
" , #
! &
0 ? G * ? 9
*/ :6L

A
J P
.:/
3*
6;
Y6 "> "6
G6;
: , @0 V* 0, < 6< .)*
&
", +?F< (... HL G/
G9/
0
)6 & 9
)
?J 9< "6V ? G6L1 0
+/ 0 "0 G 1 9
@
& 9)*
)*
@ I6
I&
*(
:0
6;
A 5 &

.&
" "0 ), < I6
+(
.+6;
K
6 A
J @n , G+6;
3*
)
#
) K
6 ) "J .
:6;

7 , ?J G&
?
:6;

0

9L
A
J O&, *
..
:6;

9 % 9

6L1 ", 9< " ; "01 "1
H6< 3/, A
J @) 5
?& & 50( @
" = B% , 0 .
&
)* 9 " !

*; , G>
, G
A
J J ) 3/
.3/, " @
A * ^ 3(
9)*
"0 G50(

.3(
9)*
@ J ... G9% $ "0
.9)*
+( IV W$#& @ J ...#

, G#
, G5)

/ 3/& :
A
J 7 G
=
) , 7/ G9<? =/ "V( < 6;
Y "0
P
.%
"
$34 =/
6;

& /0) A 5)
(
6L1 5. " )#
J ) < 6;

= W N )
.:
# 86; = W 6;

H6< ) .&
*

6L, A
J #& M M* " 0( 3/ ) .9/#
7:P " <L 9
P
.

#
0
@ 90& I6

.9/#
- A
J 6L1 )
/ S* ) 3/ .&
7:P
A >^
H6< " >0
.B< 50( = @
J ) I6
6;
Q/ "J G

"0/
H6
)

@) K 0 50 "J .( L , ( 50( +/ 9/#

.0 , =
9/T /02

) BHT 5> G)
"<
G:6;

G0/
" 50 7

"V G&
?
ifff
& < u

9P) G(9)*
"<

P&
G9 50 (&

" 5* 9/ 01
", Gebcg 9 .> " .6;
>^
A
J :0

H6< IF ."0/
" (.* , , , .# "0, +/) ( 50
I0 J 5* l,g 5) I,
Q, * 0( < ("
) ":0
.">0
H 0, < /
50(
G/0)
>N " >0

G % -.)
"0 .6;
" 9< ^ Y < ( ?
) *
%)
.">0
/ ?
>N H6< 6, " ? G / , (, Q
* -.)
"0 "0
.* >^ )
9# ?
W
)
K* "0 6J .&
H6< K* = B% ", ? -.)
) "0 .6;
) A "/&

" $ # .? ") <6V ^ 3* " B ", K # G2
:6;
>N K
@ 5<#
.*
%)
/ >V
6L1
W" =:S $>34 $$" , $) #
Vit.. K, A, B12, Mg, folic acid, C, K+ 0 Q &

B1, Vit.. C, K+ A& G9

, "/1
Zn, K+, folate, B6, Vit.. C, D, Ca !/& G3

"0

(
*JADD "

Vit.. C, D, Ca, Mg, ‫

ا‬ * 5

Zn, Ca, Fe, Mg, Vit.. K, B2, B3, C, folate Q "0/

)D"
A
J I(
:6;
9P
A 0/
5 Q, 70 30
6< ,
.
A
J */ 0/
IF
G
(

0 " G
/ " :
3*
30 Gebge 9 .K
6 ) :, P O&
<
"V % A
J
3 1 A @# )
/ . 5
.5*1 5( " :6;
&
: " ) 0
G eblbzlc " 5*1 5( + ( 5. .5*1 5(
>0, ":0
5)# 9)*
0/
" >0
@ &
)*1 , 0
0/
9
*, 9)*J = A +N & 5(, *& A 0
P
9 .&
7&
@6& ( 0 .(?000
) ;
(
, G00/
, (90 !,)P
0
G "
/ &" ) eblb 9 G
& jlfj
(

0 5(
J "0 Geblc
.1 Q/ A 5*1 5( 0 Y (
K ", = .
& jel A
J 5)

Y IF 5< X?

K 0/
K./ 5) = 5(
5) M ", # 0 5<
3/, K < "0
G
K# / A
J 5
K 0 X5*1 5(
"/& A
J :6;
P 1 " 0/

American ""( 50 0 7, 5 # "0, "# @( .
0/
K./ "V )
G5
5/)
0/
0
0;
" W
0/
" 9L : ", Journal of Clinical Nutrition
P

6< / % .0
Y.? +
0
. )/ P& /
.0/
5 ) / !

<, K
6
) ? % .0/
5 #
P
"
Q1 /
" )
K <

9P
3 3/ G 91 Q A K
6 / 6J G "0
. / A 0/
5
0/
"1 .K
6 I ", "
L G )* Y , 0 A
J zs , 50( – 5/ 0/
", < 0(
.K/#
/
0/
" 5* egf A */ u

01 K/ . M/1 @) 9 9)* 50 A
J 7
>0, < .A 9 eff 6 K/ "0 ( =V >0, < !(5* jff A
J M<
K./ 5 % )
.@& /#, =*/ >0
):(
3&
# >0, I& .3&
A I& *J 5>
5/ A 6V / G0/

>N Q "
K./? A
J +6;
0/
" 0 / # IF .0/ 50( A &
" %gf A 5*2

G1 6< = ., "M6
!/&" M6
K
5) = .9/#
K
#

" .0/
"
n K
6 9 ."( >0," @)#
9)*
0 A
J >0, #&
P
0 !0 A
J 5*
5 O& .0, 50( M6
H 6< G9/#
@/ K
K./
.5
6< A
&
/ .@
3&
M* M 0/
" 0
", !
@ J :( 5 &
+0
9
5 Fighting the Food Giants "+6;

Y
" @0
0/
K./ ", 7(0 " 5, 9< 6L1 # "J .0/
" 0 0 A 5*2

3&
I&
G0/
;
3&
M/ G+?F< "0
.M6
A
J H IF I6
GK
# A
J IF
H*n
* #
' ;
@* =/ 9
+N " " .9# A " " Y M "
X5$

? .E& #*
5 G#
? G8)
!
.#*
@0
" 5 & ", 5 G&
5 L 6J
0/
" 5, < M)
*% 5/)
0 0/
" )*
50(1 "V 9< ? "0
GK < < 5/)
" 5
!V
"1 P .fructose 0
A/ 50( @0
0/
# .H "0 0/ < 0/
"J .0

(0/
) 9)*
0/ " 7 50( 9/#
@) 5) Gmonosaccharide "0/
& )* 0/ < 0

@
0/
" ) ? " ' , I6
:# 50( 0
0/
" 50( K < ."0/
" H# 9 I6

" #
:6;

"J .(E.> 3 )
!) I)
!
<
./ ) 0 "0
50(
.0/
A :& / 5 /& M G!
( )
" HL))*
0
&

! 6
( 50 ", " .(9/

50) "
> +6L" @ , A
L
. 1 3& M/ 9

GK
6 = .+*1 ) A& " )
@
% 9 < "..9P)
(( 3 / G3&
3( 9
"J.." .@#&
< 1 3& 5 " >0 "J .1 3& 5 A
J Q) =#
):(
&
50(
" >0
", "
.1 " Q)
?& 3/
/:
5)
, &,
50(

V/ 5&
– */ z "
1 # )/ A0 G"5*1 Q
"61
" @0 ( . @

# &
"61 7 1
"
. Q
Q +N H6
"0 .5*1 "61 3
0

"0
.&# 50( "61 +(L 3 , Y < & ;
"
. " A
0 "0 . z
" 5*1 +?F< Y, >.> "0" :#
0 ."
1 )/ & A
J =#
YJ 9 G&#
Y
5%
." 3 1 " + ;/?

30
&, .Y
6< 5& )
" 0 0 # 7(0 7/ O&1 ) &, 9% 6J
.ebej 9 6 K 0 ".0 "
G"# " @
F
"6;
p"
6
" .+?F< " ej,dji G9)
5% .9ecbf 9
.* lb,idj (
, /
7 jdd &

eff " >0, 6 I6
30
6< "

)
7*%V/ .1 3& "
.* cffc "0 "
"
:
G.* ( >.> " & ; 91 3& A "6
5*2

/ ", J : &J "
."3&
## A ") 0 "6
5*2
7
A
J /

3& 3/
50(
"J .5*1 A 1 3& ? GK
6 = .M) A
J -& ? 9%1 H6< "J
=
3*
0< "# 0 5*1 3*
0/, K . (
/
Q, >0

( L , ( 50( +/ *
&
?&
) ."3&
5 " 0 G90#, "" ) 30
:""#0 .9. " 0
MILK IS GOOD FOR ___ " D D D $( 9 '$" 30 " 6, .1 3&

G+)1 7 G
G

!/
G"61 "

G//& " < 5*1 Q
50(
"
."5*1 I0/ G ;
GA0

>0, 5:/ 5& G3#

G//&
5
3
G3
, 5& 0 G";

Q
50(
"
."(9/
G
G
G/ G: G"
0 ) */

1 0
5> *
")
3 I6
1 , M1 +
9P)
((< #/ 1 3 ?& " )
" K < ", " 0"
." > # " 1 3& K./ G# "
$ $
6;
9P A
J 5&
" G1 '*/ A 5*, &

"/ &
: >0, K < !
.."
"..

$7$A 6A
6L1 " )/ 0( A

6;
) .# & A
J 5
)
) *
:6;
9P
)
5:/ =/ >0
", 9L) "#
K/1 9&
"
3 # .&
6
+0? 7

G
"
1
9# A
J " " K < .("
5#, " &
K/
50, 6
7>

=# "#

K/1 9&
" ") "
, . lacto-ovo vegetarians "
H(, 9 M*
9
5 O& GM.* A & >01 9< "
", ?J G
) "
H(, = ."
1 (
.&
50(
" 0 #
.& 3/1 .3

, 9< 7) ?

G9&
0^ " 5%, "
Q
5/
0
/ "0
EP .5/
0
" ) , 5%, 0 A I& )(
"<
A +&? % "
# "0
"
6L, "
"
G
"
1 9&
0 &
#
?J # ? 5/
0
"1

"
5/ ", /
.Q, <
# "
Y 50( ", "0 0 .5/
0

K " .
& A #
"<
Y 0 6J A& z9
5/
0 / 5 &
"

.<L " ' 50( 5, < G\5%, "< A &
"
# ", /

9
*; 5%, 3/ ") "
", " G
"
" ()
A
J )
/
" (< "J
50( / @
9
*; Q/ =
# A
J 9&
J ", A
J /
) ( G=%
.9<L "
">0
G & YJ .#
9)*
' 0 M) : A
J
&
>^ 5 .P&
.+
#&
" "& 9
*; Y A "
:7) ", K % ."#

"

$1 )
" " 6 <
.%e :3&
" 0, # /
(&

>N :
/

.%l :
" 0, # /
(&

>N :
/

.%ji : "
1 # " 0, # /
(&

>N :
/

.%gg :9&
" 0, # /
(&

>N :
/

?
3& O " ig 9&
"
.
1 3& 3/
(&

O

.9&
"

. &
) % 9&
: ", 5 U.S.D.A. 01
: @ "J
: . . .
"/0
/
:0

" < " 0V
9
':6
:
/

.(0.00004%) ". ( 50
), " 5%,
D
G 0/ " < 1 "J ."/ 9/# +
I&

"/ ? 9
3*
")
5?"
.-; .7 0
z ." I(
9/#
3
1 -. ;
!

@0 ? .!

9P) H >0 0, & A
J G/
6;
" E//, E+# +
50( GE*/ E
O& "
&, .1 " 0 )
I L 50( ):( / +
) G:/
3*
")

."B*)
" | 9/#
" " )
@0 5
Y
6< S( I6
G-; .7 0
< G"
6<
:
#
+
<, " 7(0
G06
30
* ) 06
? ", "0

."/ 9/#
"" +
", 9) =#
. '"$ A )$ c# A 9 $" #$# .."
"..9)*
"
@#& 9/#
M 9
6J O& 6 7) &, ? .1 " 9/#
+. @<, Q K &,
)
(
"V 7
V
? < G*
)#
0
A 6&/ >0 0 V* K < .."
G+
A I& (
K ", '& .
)*
+
" 3)
9/#
5, < 5&0

I(

"0 I6
+
" 9/#
3/ J .7#
, +
3/ 5 < K
6 A
J @& "0

"..9/#

+
*& " Q, 0 "
A
J J G@ 6
."/ 9/# +

F
)
:0
9
#
3*
5 " 5# G&
%
.."
W <

)
( 7 5& O& G7:P
) " A
J
IF +
",
9/#
I) , ?& A . A
J G+

(

?& 5. 9/#
+
5) !%
3*
"
" = 3/ .I/
3*
/ A >, I6
//1 V*
5> 6< "J .) L "0
"..I(
9/#
/:
1 " )
*/ : -. 9 , :% +#J +*J "
", ?J ."

" 9/#
&
= P , "0 O& +
9/#
3# G.)
H6< P .."
V*
6 M) 9 I, 9
!
=*
.:0 0 9/ .)
H6< 0/J 9 ", ") 3*
*
+#, ) B* A (F " < +
= P " #

.)
H6< "J .0
=:(

_* 50( 9 #. / G@/ +
.)
H6<
J "0 G
.9/#
( 7# 9/#

"..1 P 1 5& 9 #
& A
J P A& # :0 # 9/
. " 0( 0 6J K

6 " >0, G +
" 30, efzc 3( -; 0
'
-$!
" )

) ", " )
5& "& .F 9. 5:/ =:( 50( G (

, G7
1 P
"
.# & A P&
< < 7
1 ;
3&
", "
) " /& G#& ?
+(1
0 ! . "0
.Q1 ?&
" 3
, G"
0
, 50( A >V 7
1
",
. P&? .J 5:% A <#, O&, A ) H "0 .#
&
9</ 7
1 ", 0 S* " 5,
.3
, "
0
"*/0 3;
(
>&
1 9P) ") ? 5:
, ", 0
):(
1 ! / , G;
9)*
3;
A
J %1 5 G5
@ , =
.3;

)
G
L V 7
1 ;
)*1 7 .0
" 5 ? 5*2
7
1 "J
&
//1 6;

0 =# G5>
5/ A '
6V
.//1 <
&1 )

"&* 9 (6;

L V 9
6 )
)'
& , A 5 50( &
Y .endosperm
" A
J IF 0
"&*
- <0 9> 0
&
"&* "J ."&*
A 5 &
Q, &

" lc G
0
" cb GK
" mc G90
" lf G ;
" cd G9 ;
" cg :

:
3/

. .//1 1 &1 ) E " 9 /
P& Y A
J G!&
" dc G9

GP&
+/
) ."&*
(&
0 "0
)90
0 >
")
A GK
6 A

&
0
9/
9/.
*
6;

"1 P ()
5. 9 zK
z90

//1 3/
"0 < .6;

# A
J 0
6L1 " @
G0/
.0 &
P&
#
9/
"# A # +#J 5. " 9 (Q, 6; ") E

) 0
6L1
&
?

" &
) Q, # = 1
" &
"#
Q&J YJ ":
"
.#
5% K
6 G9 ,
)
":
# >> #
0 .(I
) 50

"0 .# 9/#
P A& / 0& +)1 & +J A / 1 , < 7
1 )
= / G9/#
5 A
J +)1 # )/ 0 / < W "n :* 0&
.
5 & "

+& .Giardia lamblia ? L Y " * M&

J 5/
" ' G7
1 9)*
"0
", 7)
.* 60< " & 50( = >0, / +)1 & K& G7
1 A 9)*

!/&
9
+/
7)
J Q) .&
?
( >01 < ? .t Y " *

)*, 5 5. " *
H6 Q)
O
" & ", "0 <1 " "J .Q1 50(
" 6L2
.7
1 "
A I&
IF ", "0 :

"1 G, 50( 3/ ", "0
"n G0
;
7
1 ", 0
. !
G7
1 < !
3L, 0(
GK
6 " 9L
"0
.

- :6;

'(
@0
06 7
1 ;
6L1 " .()
&
3* (/ ) ?J 7
1 L &
.* = ?)
(.. G)(
G1 G'
G"(
) 3&
5

>
"
6 .5* " 6 9
)
": )
A ) :6L W " " #
:
)
7
9/ 6J )
>^ ) A
J G"/ # . G0
G" 5>, " ">&
" 5 G

G"/ 6; //, 0 9 ", )
"0 @ , +?F< / . :6L 9P " +#0
. )
)

"<

0

:6;

9 G.0 0
5 " ? G )
5. " .@0

: " )

" 0 # 56 " – M:% 5. &, – 9/#
A
J 5/, 50( G0
#
0
0

.:6;

" 0, 0 9 GK
6 A
J .
#
5%
9
0
.
" 7?N : M.*J < 1 . 1 L "0 #*
@0
", 0
A %*
- G9/#
#/ , & :6;

5&
G+6;
9
)
//, J 9/#
"
* .9 50 9/#
O&
9
+
9P)
//, 1 ) G=%
..
Q/
9 J .#*
: )
(9
) #
)
L 6L1 <, V < " 1 9 G6L1
.
1 0
:> $1 67)

ellagic acid #. &
G#

beta carotene " "0" " .0 ", >
."*/
*> 5 A I& G-*
S

( 0 G"
(% & # / +

Limonene ""
" ", >
.
&
) , 0 G"*/
" # A
J GC " ellagic acid #. &
= GS

"6

7
1
.@ A P& 9/#
$* ", "0 G?0
)
)
A I&
!0

G
0 G(:&
#(
M, A (&
< ) "
$"
" #

. & %* 9/#
A
J 3
?
J 9</ ! 1 0
" > "0 .K/ @) I6

)
& 7) K V , I#
)
A -*
)

G5*
"
:
/ 9 #
: )
" >0
", 0 . " <L 8&
0/
" H
.:6;
% ", "0

5 6
M/ .
/ 7(0
3) Q0 Y
"
6 E* /
*
9P
5?
:

01 ? A
J <#

Q1 -.)
M* 1 =# GE$ > 1 &

1 < /
#.)
1 a"J (e)
.> !/, A ) ? 6)( . " <
"* 5 "#

) /
9< &
."#
) 9< I )
*
9P
")
"/
+*1 ", (j)
." #
0(
# M/ +.0" , "A
"F( J " A/
:

50(
A I# @ ) I6
7
V
"

=
"/& 5#, " * 0
30 ... )
0(
@
S( ... 3*

. G*

, .()
M/ - 50
@
:/
&
3/, &. ,) .
&

0
A
J 0
@
) ... $) #

& "$/& 5 G50

A
.1 "
7 9> " ...
&
5#, "
=#
- .( F
!/, ) Q0
0(
5% " )
1 = 5;( I6
?
)
H6<
.!1 0(

'
... * & 7< 5# " )
H6< .!
E& )
H6< "
"/ //, " ) ' , &
"
", O& GF
H6< E,
"
0( ",
.#.)
1 = 9P

3# G0(
H6< 5 9P 5# " .I )

+
+6;
J 98P
3*
$", 8?J .
#.)
= 0
% G
$)

#.)
" )
K <
3/

$*
#.)
H6 $)
) 9 "$ ( 0
O.>
) $:

A "*/
*,
/ +# " :)
?
"
/ 0J 58> ( $/ ;
) )*
$#.)
5:
$"J :'
.1 0( /
3*

$)(
:
A >V

/ mf
5. $* F : 50( 0
O.>
&8
" G:
)
9/ ( / " " % J 5#, " K
6 G

, &
) A "0 "J
" &
, =
E
(
...

G ) 980& *
^ #n @/ %

9 Flexner , % 0 $:
L #.)
$ F
K .$: L $#. / 0J
.9ebef
#.)
9P

& 9 G0.."# 0
I %? B&
5% " E80 "0 " /0 9<"
3&
//F
01 W<
) 9
-.)
5:/
) >V Q / A
J G
K :/

. #. " =

G5
: # 5& &
M/1 =# A @*/ */ 5 / !
0 7< "0
.9
*
" /
*
"*
" M( 0
*
1 G0

1 0( M/, A */
90&
5#, " F
= **
9/
K 0 "0
0( < 0 0( ", 9)
= GI.G.FARBEN %.)

1 1 0( .91 K :/

.<*
6
5
=#
K <
* "0
G3*
, 1 %.
!
*
9)# GJ.P.MORGAN CARNEGIE ANDREW 5> M/1 +%1

)
@/ " 3
0 9%
&/ ( / J 3/1 ) @** A
J Y ?
Q1 0(
, . >
M/
H6< Hh+0(
.!
A
J <6 9> " & M/1 " # !E E&/
/0 9<,
:
" (jj) &
5 G" 0 &
?
*
9)
" " ) "0 /0 @% I6

,
".5L1 " "N "6)(

, Y(
" "
")0/
<h+*J "0 ? *
!

? "J"
#.)
9:/ 0
A& G#
)
3<6
" "#
"#
)
A (
+J 9 K
6 )
.(#
A
J "
% <, Q M%
< @ !& , 3 ") 3# GE "N "" :5
/0 50
."(

H6<
A
J 9 0 7
G /0 )

H6 5) ", !; 0
% .5)
5 & 6<
J < 9 .(5
5#
9
Y ? ... $&
*
9P
"//
5) 70 9) )#)." *

& 5#, "" , ")
&
5#, "": 5> 0 " ) 0
G<#
&
/0)
"

..""*

6< *, % .01 *

&? > G
H6< A
J "
<, M% 3*
!& I6
3
,
..
#. 3/, , * 5 I, = , 0 &. &?
9<
# G9eclm 9)
V( , / L //F " &
G06
*
&? 6< ,
M/
< +*1 +?F< 5 "0 G
0(
5% "
(
) %)
-. * ") +*,

#.)
3
/1 5 :/ 5. +?F< 5 70 ", 90 0 .0(
K #
W

.9*
0 ."(
"#
)
" >0
" 5)
&/ #
"

*
!
" >0
L,
.!K ? # " E>0 7 ? & #
9)
cg < ' ,
) .(9ebfd 9) 0, 0 edf *
!
"0 G /0 5% )
" E?F/ 3)>
' , ", ) 5 & ", )% 6 .(9ebll) 9)
/ dg A
J )
9> .(9ebjf)
.!X##

G % L * 6)( ) A

#
) )
1 9/ ? #. 9P I, ' , G!; 0
% )"
."> !/, I, A / ? 1 Ga
) " P,
, :0
#.)
,
*
9)
) )
# 5
*
!
=# u 9 %
E?& 7% ", !
H6< " 3* G L Q, #. " <L , 3(1 -.)
, Homeopathy >

Y
9
"0
G
!
) .E % /& 9 ?J
L
H6< ! "
.(L, !
" >0
) #
=
6
$ 9 G * , . 0 5*

$ 9> G&
?

)(
"
H6< P 5,
#
"
"0
#.)
) A < 5$1 < "0
0
/1 58 3/ H6< =
?&
./
G *; 60 ) (

)/ 8>0 & %, G0
"

"*(
= O& G0, ,
#.)
0 +J A
J Q, G/
*
9P
A "
"#
)
&
#.)
=% A
J 7
:5> P K
6 K( G9. 1
01 H6< ( 9 .9)

" )

The American Cancer 01 "*/

=$# GThe American Medical Addociation (AMA) 01 *
&
?0 G Local Medical boards &
+*1 !
# GThe Diabetes Foundation I0/
A //F GSociety
National Academy of 9)
*
01 G(NIH) National Institute of Health $&
*
//F
5> 0&
./
9. = ")
$9 K
6 50 ....<L Sience
M&
!"/ & E.) "
" 1 "#
)
" :
&. 9 G
*
)
5. G
K 6
#/ +?F< M&
...+)# / 9<? " >0, 5
"V ? "6
..."&

3& ,
# +# I6
"
6< ..E % 8 L 5:/ A
-. < &
9# "& "#0
..."#
< " "0& 5# 5% " 9 9< a ..F
..5
5# 5% " "
"a
5#
G& 50 G
9. 5:/ A P S G@/ %

:#
':
+ >
9 5 XX! "/ < &
9< 1 9 V <#
") ..9.P
5#
...<#
9
M ..."(
9< " ...s0

A 5 &
J. W. Hodge -< .. 5% " @ $9 % "*
– :
" 0&? * " ^ 8
: 8
6< +# .K G
L " 3*
H0
EF
0&? >0, /
< GAMA 01 *
&? / /
G*
0&? * $"J.."

#.)
5:/
$"J . )
" I, &1 " 3)( "F( ", "0 E* E#) <>0, 5 *
01 *
& ";

5% " 7 ) #U "0 7/ )* */ ^ 3
/, 9/
7/ *
& = 7
& ? 3* 50 $"J .9s A
J 5
5&? Y
7
A
J "F# "6
AMA
( ", I6
$&
9 50 $"J .!
& 6< +*, 5% " $U * 5$# @ 0 98U
5% " E @# $9 7/ GS
A& , 5 , $/
1 A
J +#
" )* 5:/ E/ G E
E % @&. A
J 3*
)/ 9/ "<( G" S# 50( @ O& " )
+*1 +?F<
"..E
L ">
= O&
>V $%
) 5& I$# 50( 5F/
, G=
* Q E, K 9)

' , G5& \50 A
A &
"0
G#

6< 5% 5* % 9L G/
>V
)
1 H6<
.5& I,
" $ &
&
<
GPasteur / 9
)
)
"9>#
P " A (I)
) I
+
5#

*
A @8 , O& G"
+*2
/
5/ O& "

& ) . % 9 "
GP
H6< & .(
... #
"*/ G:
"*/ G>8
3
? G")
3
G"61 3
) :5> G P
G(&# ) )*% 3# O&
9/# $ L 50( 91 , 9>#
G) L 3/1
*/ 5&
!
$9 GI
*
-6
6< .
" 8
K
6 (+) / , ()(1) %&
50( K
6 5) 9 9 GE//, Q)
$/# 6

6
/:
3/
9$
& , .:0 0 0 3
/,
"0
.1 J 9 1 )
)/ < G9
=
G?&
H6
&
#6
5&
.I#
5& E E, S% O& Antoine Beauchamp 3( " AU I6
Pasteur / 9
)
) 9
K <
.? 9, P 7/
"0 "J %J E//, E 3) @: 9
)* $", )(

5&/ 0
/ !
5)
G:0
5)
GI&
, #

5)
G:
)
& <
5)
7(0 5
3*
,
P '/ H I6
GH/# "$) %* 5# 7)J A
J IF
(7*)
!/&1 G?) ? G/

#
%*
P , =# A 3# G# &
& A P&
5#, " .)
*
K

&

&
9
& A
J H6< %*
5& "
9 ", O& G"? "
"
& "0 ", 9/#

7?^ 6 9
6< A
"
+*1 5
. J $9 9
6J
50(
6 7/
.@ ? )# #. 5:/ 0 &# O& G" /

, 0 A 5) 0
( L) % # 50( A (%)
) $/ 9/ I
3*
$"J
5 .
+( " 5F/
0 A
J ( ? 8 , 0
3/, A
J ( ? *
H6< $"J .
*

!0 A 5) @/ %
G%F 50( G5
, +
#
<P
+n 9
+
6< 9/ 9
& 58> ' % * >0,
& & "0 "0
G# " P
K
6 9/#
E

.
&
3*
.
A 0
" E? 6 &

&
A 0 8 , < I
3*
* ;> Q&J

&
/
G:
%*
" ( I, Gholistic (80) 50(
( A 5) 5

.

/
P
# 7. " * < 5
3*
I
3*
" &
M
"V $"P %
@0 G
6 @
** $ 98P W K < # &
"0
.)* , 1 V( 5
L 5 -. 50 " &
=% 7 K
6 GI
*
9P
A ":
= ")

)
1 0(
X3 .. < 0
5F/
.!
$) " HP, I)

Q/ !
< E A( I6

!1 -.)
"
E* 9
J / ) ", !
" 98 1
", O& E % I# G* &*/ (< 50( @
& "/& $9 I6

, .9
/
? E)* .!:* E?, /
3*
*, A $ (+
+( O&) *

# )

@
O& GY
B;
M&/ 1 E& @ J .!A
" ".
: )
H6< 5( ", ) ?J
3)/ 90 0
.!
M < /
3*
//F #
S1 ",

.

&
3/, E 5<# G* %F $& -
$ A
J I
3*
5 W 7
H6< $"J .

" :(
*

# 3*
)
$0

" 0
W
6< 9$
..
)
..!9 9
9,
.. 9, < 0 , "J ..*/ & )

$ (7 A 8
:# K 58> &

1 9/ $"J .1 -. +( " 5F/
< H&

#
$"J
"0
.-.)
+(
=/
E0& E% "0 % 1 " ") Y 9/ $"n G?&
) .
#
3/ A 0 ", =*/

)*
# )* 0 G5( I/# >V
G)* #. 9/
9/#
$ / )*
= 9L 5 $)* 8 1 E?, ? ") <6, 3# G5$) 50(

.
2
>
#
>V
" ) G@/ (
@#&
8 , 8?J .E< E&& EP !0 < *

@P ", O& (@6 @6 () 6
+(
A
J 5$ "/ 9/# $"J
A ") G :6L ( /#,)
: "> & L 9)* 5 (*
) )
H6< *>
.$
?& #
)
$/
K/J +
H#? 5. " +( I, =/ , Q "

K8 n GQ, : > I, , (E.> L
0) "#)
1" !0 A
H6< * ", =*/ K8 , 8?J GK
6 A " & 0
O.>
", O& G < 06
#.)

L " 9.`
:/

#.)
H6< ) G A
)% 30
A
J 5
3*
5
8#
" )

, O
> 7* #
#&
" 5
* "0 L, $", 8?J G9 9
J

#, 3*
50( &

1 K
A&)
$)
#.)
" )
.&
@8 0
5<6 +(
@8 J ./ * %
.K$&
F/ 5$& K/ 7> * K 3# G5
* "0 */ Q/ /
< ((
+ 5> "*/
-. # >,
9
/
#.)
" >0
# < *
s8
A ^ 5>
.) $/0 $ # >V @
!
5%1 A ebjj 9 6 E/ "0 Essiac K/J
-. @( @ % $%, ebim 9 .5<6 50(
# *8( U ) 3(, ), " Y <
Rene Caisse /0 @ @(0 5% " "*/
a $ *
&
A
J -.)
6< 9 9 0 "*/

($/ "0 E
L ) & "0, @
9 GM/1 #
5 ? G@0 K
6 9L . , K
6
.9
)
5&
.#/ =# % 0

&
"0
."*/
-.)
3(1 " 0 / "B$") B$$" 0

.#
) 9
?&
7?^ 5 A & .#/
H6< .9ebmc 9)
) ( >&,
5 &
/
$) #. 8 , A / $%

#.)
)
)# < $"J
7 J $9 7/ M$
%
3/ K
6 50? " ) :
H6< $"J . 0
)/1 */V E
L
.5$ 50( #.)
H6<

$DD")! 6D D
4/
$")! 8
Hyperbaric Oxyhen Therapy (HBOT)
/ =/ =*/ @8 , " 9L

A O2 I)
"#/01 9/ " >0, A 9 "#/01 #. $"J
.*;

)
"#/01 #& 9/
0 *;
&
0 @/ $9 G+(

80 50( $/

J 5#, " ) ?& I 50( @/ $9 % HBOT *;

)
"#/01 #. $"J
G5(
)
?&
9P) $"V #
L
0/
& -. (
@
) {x, >, @8 0
.=/
-.)

) K
6 E0 :;
J , ?&
H6< 5 "0 O& L
0/

(M*
/ t

v5/ -.)
Y

0, 80 .0/
O& " A
1 / id 5. 0

)
"#/01
W: P, % 0/
O& " =/, A& , % 9,
?&
A& .5, W:
0 80 0/

.L

" Q, 50(V 8) ?& @
$) E, 0

)
"#/01 -.)
>,
G&#
,! $")! 8

Singlet Oxygen Therapies
H6< .&
"#/01 " & 6
'/ O& / @( 9P , 3 "#/01 6 30 50( "0
" O1 "#/01 " 6 M.*J "0 #. L1 .O1 () &, 6 9/ M* 6

" 6 H2O +
*)
K0 I6
H2O2 ("#/01 +) hydrogen peroxide I/0
"#

.O1
"#/01 A
J GO2 I
"#/01 *)
O3 "1 K0 E, K
6 "0 0 G O1 "#/01
30
(5*) , 5) /01 ) 9
w5 50( 5 8 n 9/#
O1 & "#/0, 6 M.*J $9
.) :E.>
.
A
J (
...L G0
) 5> 3L ;
:0
:#

#
%*
" >0 >0, #. % K O1
"#/01 #

)
%*
$"J ("*/

. O2 I
"#/01
,$") $ $&

Hydrogen Peroxide ("#/01 +)
"0 & ? " 5%V

:
%e/j i A
J H0 5 I6
#/01 +
" % $"J
5*, 9
HFJ 5& 9
5/L E: 5&
6< 9/ 9% ) 9>#
" E
E)U 9
+
@/
$"J .E 9/#
3
(
&
GS#
" Y I, *
/ 50( @J 3# 0 .( 0
/ A I& @8 , 8?J #
9/.
#

#
I/0
"#
:
Y$

#
I/0
"#
?$) A
J +#
51 " @8 n
9/.
/
"0
.O$
"
?$) " %ig 7 5. " %e/j i / K I/0 "#< 30 =*/ V .)*1
9/? " K) ? ", 3# K
6 $", 8?J .*
+
*/ e A
J ef / )*1 I/0
"#

.)*
$&

&
K
6 #
I/#
-.)
("#/01 +) I/0
"#

)

E< >0, 0 ", 3# "*/

, AIDS 5> * , " )
"
& "6
(1 "0
I/0
"#
9<$ ", "0 " O&
9 3# G(> )*, )
5&
>

$9 6J (< W: 9 ", I/0
"#
" %ig
"0 G0 50( E0 "0 6J @ , O& G)*

, (E.> */
91 () ;
"& 50( E @
"0 @8 , 0 .0& 06 * /
.:. * @ $9 6J 9
M* " @
E, "0 .9
Q# A
J (
*/
$) $ 6""T % ! 6"
Medical Cartel Sponsored Studies
3/ % E# 5$) H2O2 I/0

"#
"0
)
0

& .@) I6
7) ", K =*

"/ "6
+*1 " ) A 5 &
K 0
$&
& +% " 0 6J "0
.#/ 1 M&
E.) =8% . ( /
) I
3*
# , .5#
6< 9 " <) /
#.)
H6<
A)/ 7/ GQ1 0

, $#/U ;
$)*
5&
9P) L A) .9% " E%
* ;
& E % "/ .9/? * )# A
J 0&? *
//F

.E: E% 9.0 7/ (0& 0,) /
#
"> 9 , GU 5J
50( )

"*/ , 8 V P
":
A %, / A
J "( 7/ :5>
5/ A)
", 0&? *
//F
G(
) /
H6< ( 5. " .H2O2 I/0
"#
& )
K, % "0 .I/0
"#
K/ & 6J )
"*/ 3 7/ K8 , H& - /? A
J K
I/0
"#
0 5> J ) H6< 9< .' ( 50( K

% "
/

$
5
" <L 9/#
" = *)
#
$0 , G#
, G/
K
$&U

.:
#
5 J $9 * G<#
$
/
<06 $9 9
? ":
A U
3#
$"V ")
O&1 3*
5# E# ")*
">&
9P) $"n =*

&
( Q
= &
":
A
3#
$"J ."/ A U
3#
= "0
5% " $9 3#
=# $"n K
6 5#1 ."/ M8) & W: , $* - /? * $9
@#
" )
50 ) 5 W "0

9< GE &, 0& ?0 = ")
0&? *
//F

.( * # < 9<, ) M
)

) M%

O&
("./ " ( <) Linus Pauling u
!
Ralph Moss ! 7
9%
0&? //F
H6< $", ' 50( >, $ % 0&? *
//F
5% "

O&1 /

5% "
$
O&
# )
<
%
$"J .H H# I, O&1 W: 7& A %
$&
8P
G$*
)#
G3*
! =# $"J . */, Q/ /
< 0&? //F

*/
)

G*
0&? //F
5% " 0
9.
8P & 5) 0&

.(

!
O3 Ozone
5 ",
/ =*/ 6
H6< Q&J G) = 8 * "#/01 " 6 O.> " 380 "1 $"J
) 9

"#/01 6 =*/ /01 5. " .O1 "#/0, 6 O2 I)
"#/01 50(
5% " 0 * 9/ , #/

M + 9/ ( , &) ( "1 - J "0 .:< +(

.
* $"J ."1 - Cold Plasma
.
9/ M*,
Nicola Tesla ./ ?0
50( <F( "0
.
?^ $"J .#.)
?&
$
*
< "1 " 0, $0 W
< &
?
$/ ) $9
&
9#& $/ & K < "0
.* &
?
- %
8 0 "0
&
?
% 50( &
H6< .
.
" ;
"
."H
" &
$"J .3L

@
5/ I6
, + - J
/ =*/
.
* "1
=# $"J
EP& E /& " 7/ $ ?& " " ) "6
(1 .>0 < , + 5
# >V

< 1 +
3( = .)*
$&
") "6
(1 " >0, & ")( % %
.? 9, " ) 0 +/ =#
5% " S P&
"1 = 9/#

$ O& (%
+)1) )
9
Q# A
J 5 1 +
#
"1 $"J
"( K
6
, (
@() 3L !/&J " (1 ) .0

1 #&
"
I6
"#/01 0
< 3/
G@
" A
1 $
) * 6< O& %F !/&J @8 J G 1 +

;

E/0F 9/#
. M, A
J G50 50( G"1 5/ 7/ E 1 +
5 "J .t
5
.9/#
%
V$
1 / $
# 5 ? E( E( 0 +

, E.* 0 I#
K , I6
!
$"V
V# %
H6< $* %
K# $"J .(I
)
% E.> )
)
) 9/#
M, V$
" $0 ) ( I, 5> E .# L 9>#
H6< $", ) ? 6< $", 8?J %
& %
9>#

3<6 7/ (^ 5 -. I, ,) "1 */ *
$
G0
50(
& % 6J "0
.+
+
.1 A
J
- " Y < .Ozonated Olive Oil 1 "

A 50( @* "0 ^ W K <
' A& (=/, ) %
"
K
6 (
1 =%
9/) "
"1
Y/ , /

M*
9/0 W
M* "0 K
6 ) .0/ >0, ' "1 =( "

.+(

O3 ! .$ .
9/ M* G / df " >01

, / GM*
9%, Q&J .E$* M* "1 M* "0
9/# A
J @J 9> "1 H 9
"
e/j 3&/ A
H6< ) G(Autohemotherapy 6
9
#
))
= # 5
5)# < $: #$ ."1 $
*
A 8 0

$) * 8 J G

Y6
A
J 3 1 9
) 9> "1 H $9
#

Y6 " 9
- O&
3/,
E 3/ % *
H6 9
$", 8?J G"1 " 0, $0 A
5 & *
H6 .
Q1
$", 06 ."( 6& +* "1 "& $9 O& G 1 "&
< :: #$ .+&
9
. (L1
+
!0 A 9
Q# =% 50( ? 9
36 "#/01 $"J ."#/0, 6 O.> " "$0 "1
M*
" 50 "0
.*
H6< " "1 -.)
9P) ."#
" %cf "#/0, " "$0

.<L A "6
F
/

$"$4 &) 6 " 8
.#. /* ;0 5& 8

"0 G , */ ,
6 G)8*
9/#
)
H6< 5$, .scalar waves
) # - J #1 H6
"0 G/ * 6J
Y
+# H) .9ecmi 9)
"5/0 K.0 !#" :
/ K
6 "0 G 50( #

/* ;0
#
H6< ", (/
L) O&1 5. " " .@>&,

"./ ?0 " 0

7/ .">&
@# 7. 3/& 7 Q, #. A
J GS#
+( =/

=/ =*/
$ Y A 7$) "0
.
&
/* ;0 #
8

#1 ) A >0, ")
:
& " )* 50( #
/* ;0
#
"
h $" 6#
Q ! 9
5 : /* ;0 %* " < "
1 "V # A
J +)
&, Y/ % "
" 5%
&1 "
@/ I6

7*
5/, #
+
. , 5*, 6 # 50( A +

7 G lmf
* # 5 7*
$
3
M1 G dem 3 # 5* 5
>.>
/:
"
1 H6< *. . gij # 5* 1 "
# "/
"
" /

"
V 7) W * "
1 H6< 7*, 5 ., "0 @0 W GI/ 50( G)
)
.7*

? "
, K < "0
.E:* >01 ) 66 &1 "
."
1 " Y/1 ) 66 #/
"

E
, ) :
Y)( M 66
", G+&
& #/
M $)(1 < G$#
")
Q
.6 &
" /0)
, >)
:

#
H6< A 7$)

A

", +)
5
5& I6
+
3/ 1 ")
+ E.> +

", 5 Q, * . *&
+(1
7)
6< "0
. @0 G 1 +
6<
J $ 9> " G@/0) G 1 "
"
1 =#
.1 /
# M:& " P
/
E&*/ E*/ ) @ , ?J GE> @ , 9L G"
2

,
.t
$/# < 5 ")
* !
# "
1 ", P
$F 6+ &%

!
H6< GE,
"* 9
0

V <P / " (

)
0
Y G ? .<. ", 5:/
(
G0 50( &2
:

+ & 0
6V

", <& <P

"#
+
+
! )*
@
V
6
+ & V H @6
+
"0
A& ! *&
+(2
&
"
1 +*J A

", W / !.. H, A
J ... +
!X ;
7P
K S "
1 H6< K 70 :< 5F/
.! 9P @( , E
#. >0 ?# </ !/1 6< A ) ) .+
@
% 6< "$D" 6% h "
" > K < @ , 5

/ 9
, .(1 5)
" +(
6&/? +L) &/
. 0/ G 0 G # G /#, A M >V
$) "
, ", "0F +)
, G
"
1
G/# ) #

0 .#
&
H6< A \5 ? % " N "& " , &
:
(9ebcj 3^ J
6< "0 G&

?

0 "/ *(
0 Q&J A
J
A "
&, % .."
@ 38;
*( ), 3* E# E/( "0 G("K.
L" PCP) * $ " # 5 % "

A 7
# 98*& "0 G"P
9# S A& K < 9, " , ", O
@ 0
G0
A
J H%

H6< 5)# I6
"0
. H #/ ( 9j×j ) &/ ; L A
J H% @ */
" 0 9<&, !,
) "0
G7 ) "#
A 3 "
,
.=%
<
" * 0 # ", < <L "
"..9: @( 1 A E/ "0 % ( / 5. G+ E/
# "0 M:% /
W:
>, GI< "
6 9<) G(
7 )
" + #/ A 3#
" >0
I#, %
A "
1 >V u ", "0 5< !9 +<
& )
? 5/ "0/
A # % @
"
6< ",
; O&J A

"
1 ", A
J 5
9 !>0 K
6 " >0, K < @ , .!X #
H6< A
J (

.E, 9/#
#

# ! $ $(1 %

%.)
K # )*
+ P&?
* .Q0
<P
H6< / )
0 ?
V/
H6< ", "0
)%
"
1 6 :/? K/1 ", E.> P&. .&
:0
"
#6 "
2
;
:0

.!/1 6< A ) = 5) G)
) 9/#, A "
1 K M/ = *
E# //& <

5:/ 5& (n0 /#, A #
"
1 -6 )/ 70 IL 50( 7) &
=# K
60
50( ) 3# 5
5:/
K 5&

9/ ? Q1 &
K GQ, &

? $&T ", "0 . G>V
H6< A ") / , ) ", 5$ "% (0 "& , .IL 00,
L 0, = K& A 5) O& "
1 " "$) W F ) $) +(, 5) A E)(
.XIJ ? 50( "
2

>V
= ", "0 5< XK
60 "& 5< , ... /#,

3/ I6
!X( & P&? ", $# $) , A
J 36# ? , *. A EJ? 5#
$& ", "0 5<
+
./, ", 5) 5< .X-
E)/ * W#V 3/ *;
Y " W
9
"# < &? 6<
%
" 6 +/
" H(
&, 9/? =/
( ? !X
<P
H6< P&?
(0 % GEF ?J <P
H6< ">&
P&. 9
!EJ? 5#
;

K K& "
.& "
V ( %.
"/ L 5), " >0

$ $$( $ !

Q#, ^ O& .
$) "
/#

&
Q
) ; 3/ <

", E6J (0
% G9/#
. & 7)
& 3/ % <
"
$)
" )/ # ", A #: 8
3#
5 GM, "
(
) " < G
&
H6
+ # O&
6< "0
./ 7
9

", < <

Y 3;
1 "0
.<
"
<6 /
%*
<) )/ +?
&
!E//, <
"
KJ ")*/ ? 9 , I, !"
1 A " " ) "6
+ #/
A "80/
>V
!
"
, / % G "
, 6 +, & (
":
" E?#, ">&
V( , 3#

":
G*(
7. A
J Q, "
1 7. ", 0 . # /#, $) +, &
" .& >01 0 &1 +
& (
K .& E*( \5% 0 1 +
& (
&, +
5*,
$)
.< $ >F 3
&*
5> % :0 A &, +
E* E*/ ", E,
!":

Q/ = *
-
= K$&
" "N " Y/, 9) "0 &, + */ & ") "6
(1 ", /
/
8

"
!
+)
=#, % .0 50( 5
9 9
, +, 9+0 "0
5)
*(
( / ; A
@
&1 "
", A G.
H6< #,
? 5. " "01
", & A
J ' 50( ( :0
A >V 50 Q1 "
1 , .t
:0

9 </ G &

5# #,
O&1 W: , .@ " 0, <, "
2
:

>10 G / &
5# 5$) -.)0 "
1 9/ 0J
M1 &1
9/ G * G )# ;
9
/ " ">& 9% G9ebbm 9)

", (0 .58
" #)
(
A
9
& G&
@
& -#
*( A <>V )
.9/ 50( (

A
A
J GE*( & >0, "0 G9 ig
&1 "8
$) I6
-#

."/
7)
<( " ) "0 M1 "8
$) I6
-#

7.;
9/ ", & G #
?0
O&1 0 " G/0 50 O&
>, %
/1 "
9/
K " %jf eg / # J 5)# G"*
9**
& &1 0/.

K " >0, M6
9)*
$* GM1 "
6 7( 0/. +*L &
"
" , .I

" A, 0 A I& M1 "
&
", "
H6< 5& ) .1 "
&

. 0;
G"-" "

E, K
6 A 80, % .

(&
90&
"
1 "

GE, /0 50 7(0 %
50( 36# /
/
(
%) $"
(& ", >, O& G / )# " K
, 50 O&

>0, 6 *, I6
"" : >/? 9
)

80, 6< .&1 M1 "
" 3 0
1 "
A
J 9
:"% "
."
A Q6;
(&
A 5) M1 -#
" 9
+
<8

+0
"
'
3> + " < I#
-. / G )
K
6
3)(
O 7) "0
$* #. W " E; ~+# 5> -.)
/
H6< ", . & E?) E#. )U "0 G"
I<
"
1 9/ "0 G / jgff 5% B I6
OL> "V 06 .

5&
Q&J E:/ "0
O& G $
?
/ V G"

5>
&
" E) "0 .-.)

.%
" &
G@ , @ 3/& 50 G=#
H6< ") A
"0
#
1 0 >V
"1 ", & O&
3*
5# E 7
V ' V G )
6< G9
,
bilirubin "
Q/ Y ) "
"
& -. @
) M1 "
>, % .9 50(
.(?
>& 5*1
F </ 0J O&

$*
5#
"
1
) Q A #,
O&1 " >0
K <
+&J J 5 G# /
< (0? /
H6< ", < Y
9
F
1 "0
)
#.)
5:/

.E 0
G>& G% 9
M %*
>V G9ecmm 9)
7(0 ", ) .K
" "$ $ 9
)
"0 "
1 -.)
5# :

9:
=/ +
>V 9/ 0J ""/ " ! G0
*( A !(
)(, " /
#/

H/ !/, G9ecbd 9)
GI#
" #
3
580( " &
&1 +
9/ .S#

."
1 */ \5/
+ -.)
("L 0 "/ ) "N @/) "+
)"
9)
9
)
- I6
6$ $ A 01 9
)
0 #.)
% "
1

>&
/
(,
9< O& "
2
E# E/& ", "0 .""
1 +
p" " ) I6
=:
@0 9ecmc
G

$/#
"
1 / 9% . :0
#

+# >V -.)
#)

.
9
I
I0
"
1 >V 5 (0 A
J 5 G@0

"0 G5 1 I
G5#
6< .$F.' 7$ "0 #.)
% "
1 5# ": >/? ">&
,
5#
6< "0 .Y @ 0 A G GE# 78> G$* G$& G# ' G! GE
GE*
.(
P <,
# W: - G<L # ?# O& G&
50 " E: >/
" 0 # M* # < Spectro-Chrome "90 0/" 7) "0 0 " @
J 5 9<,
01 9
)
O&V 9< @ , ?J GE* "0 @ , 9L .1 " >0 Y , -. 5) 50( 9/
"
1

#.)
5:/
Q&J M* A @% < 5#
6< >0, E @)# I6
."
1

6$ $ A
51
& O& #. " I
3*
#
A
+/
Q&J A @0 <06
I ! " + +% ## " ) </# A "
1 Q&J */ 5. " & 6 , .
7D$ , G
-. * "
1 9/ ?. " @& I6
: >/? # 6< ) .("/0
A 5)
P </
>
@P <) - .#.)
"
1 >V
. ! 9 ji O& &
9<? K
60 E< " F "6
"
+*1 " # 9, 3#
9 &
S . / `
9ebjl 9)

)
@.& , I6
AMA 01 *
&? 9
6< "0
.-.)
#
"
6
)/? "

( 0
/0
)
0&
A
J
. " + G 7$ 0

.. +/
A(/ ""
0" 0
5> "
+*1 " >0
@) 7% H^ O& &
E# E) @)# #
#.)
@/ ( J Q @% *
A FDA +
+6;
30 5 "0
" @#, ) G1 0&

O& 9ebld 9)
0)
/ G"%.)
"0&
"
0
"< 9,
S I6
7$ J $ @: , &, ?
3)(
06 " A&T ", : >/? @>&, 0 .+*1 9/?
I& I6
Let There Be Light " K < "0
" :" ) 30 < "N

@
F , .# " 9
)

."
2
#.)

5& &/
)
" >0
A

$ – &) '
Bioelectro Medicine
.
A& , +1 G#/ 1
& , P 5
:0 5& 9/
#1 " )
K <
@ 3L L ":0 I, '0 , /
.
+( )
# "0 :0
5&
H6< .9/#
/

" 5
$"J .^ A
J & " # bf 50 $;U /* ; 5& E, # :0 5& # >& .()
/? G#
50( G
$", 8?J -.)
" Y
6< E E 3) /* ;
5&
:0
5&

9<? )
A E) -.)
5( , S# " M
&
E0 E 3) )# 80 G
....
*%
.&
)
H6< %
" )
Y + 5#/ Nicola Tesla ./ ?0 9% G( =/
"
G# /
H6<

9/ A ) ) .+(
A /U (< P,
:0
0?
%*
9/ M*,
>1 " )(
%*
" E W

A 5)

(*

) #

.9ecbi 9 K
6 "1 W I6

.
8

Y + 5#/ }E, ./ 9%
.$)(

./ ?0

-$ $ )
Dr. Royal Rife
San Diego

0 – ; "/ " Dr. Royal Rife 7 5 0
9% ebif / ebjf /
" E E 9/ . 66 M*
8
E @/ %

# * – California
% " @ 0 0
" #
H6< .$ df,fff A& 0
" Rife 7 # Y*/ #/
M +
Mortal Oscillatory Resonance MOR 5
366
"
@/ 5. . 0 +, "$&" /
) 2
/
9/#1 Y , 50 " "0 G8

=
.
3 , Y)(J
8
" M*

5&
M* 3*

6 '&
"
A 5 &
8

* $# K
6 ( */
.
K
6
..
)(, & */ 66
:0

M
7 #
@8 n )
,
A E& "

6< n % 6J .
@ @
( , &) "0
+( \50
5 & E
L O& ) 1 ; 6
!V0 E)# K
6 , % .( K0 98*& A& <? 9 7/
/
@6 1 @8 J ( 98*&

#
!F0
Q&J = ;
Q/ M ",
9
, O& )
6< A& &/ )
? %
" E
# $ df,fff E0 $"J .0
.*
+1 3% ", =*/ @8 , 8?J #

E0 9$ ", 0
#
=*/ 9
.E, =/
$ * H6< $"J. -.)
O&
(
L1 0 <, 6 $& 0 +, F 0J )
.)/ 3# E#
.5#/ 9 A H^ 5$#/
H# A : /
^ $> 7
:0
5&
>V % @
'/ @8 , 8?J
/
9/#2
)
7. E 7 # 3) 9
& *
0
/ $/ % " "80
.9/#1 K A *8/
)(1 & 3 , 5. " >

.)(1 & 3 , */ 8

/* ;0
5&
" >V
/* ;0
"
*/ /
5
7 #
#
?0 )# $ Gebil 9)
.9. > :
Rife 7 # J 0

G(:
&
) "
"*/
3 ed A 7 0
/ W: %
* O& #
) G+&, 6J GA

& & < 9 "#
> +*, #
$ . / A(/ "#
) 0
, .E ( % el "V #
$%, G-.)
" ( >.> ) .7 0
-.)
+ " 9 bf
90 1 +*, , " ll 9% G9ebie/ > "(/jf .=/, =V <) E #
G"N " >
."1 50
" )(
5& G"/ # K 0
5 9%, +( 5& 7 0

A M8/
"# Q/
)
, +*1 5% " 7( 70 @/ $ @( A ?&? %,
"0
."*/
A +
E, Y*/ I6
5#
(# ") 9 0 /1 3
1 A 5 &
#

*/
3& , A
J (, < G0&? *
//F
"> "6
"0
O.>
" 5% " @&. $ "/
Rife 7 0
, ( , $# G5
" A ; .

:

98P
3*
6

:% 90&) !
? " >0 @ ) *&J @)/ @( % 98P
3*
5% "
A @& $ A&
"0 H* @ $/ " >0, $"J .(
...E0 < H M& GE
H @J G5&? J G L
Journal of the American " AMA 01 *
& 8# & !: E, < I6
01 *
&? !:
$"J .@& E& E W
) 9
I6
Dr, Morris Fishben "( ! 0
A I6
."Medical Association
.!
& 6 J L I1 # I, " */
"0
@)(# @( "0 7 0
//1 @&
$"J .( !% 9 7 9*& ""(" 9% #
#.)

&
@%& = 7 Y %J 5(
30 M)
8%
" >0 </ $9 0&? $*
//F
""(" 5% " 7 9*&
9U
= (
9P

."The Cancer Cure that Worked" "5$)
"*/
-." A I6
Barry Lyners
I
0(
" 0 G#
% !. S I6
5#
& "6
"
+)
+*1 =# G9ebib 9)

*;
# "0 50
3. ? 6< .7 0
") 9 V "0
& G#
6< @0( E
: >/? /
W: ". & F %J " * & 9 5% .E, 9 / O& GE
/ 06

9> G"/ # K 9P)
0
9/ 9 G9ebil 9)
G"*/
A -. 5. 7 / A %,

7 9 G@
H# M& "
A 7 Y %J "( ! 5( ) .!@%, =#
@ $3( I6
H 5% G7 #
@( # A I6
" " 0
, .3
>)
M&
*/
0
.7 -. / / / "0 I6
" " $ ^ M& .@, @%, @
, M&

", ) .9

" : # @:*J ) G /L A(/ H# 5. G9ebme 9)
5L @/ 7 5
"0 9P)
@ .. E?# "0 1 .. &, @ K ", " + E, .
3( + @& ^ A,
.)
0 &# .. K
6 A 0 //F &
... E?#
A p% 50

@)% Gary Wade IL < Rife 7
:
K < P&
"/&
7 M* 9) ", =*/ 70 5$ M% 50( <6
@#: 7 M& 70 S( 9 @8 J .
A * E# / 9% 5 G7 5& ):
@)% $& , %
=$ ? ", 3# GK/
(5$)
"*/
-.) :E.> Barry Lyener
I 0 @ 7 0

30
5, ).

( % New Mexico 0/0 " Dr. James Bare I !# 0
(
The Cancer Cure that Worked
.K/ 7 $ + $0 5& *( MU ) 3$0

)" ) 8
Georges Lakhovsky
5 P 0/0
9$%
.Gorge Lakhovsky 0/0
-# 5 1 /
!
< ^ =? 80 O& K <

50 I O& ()(
) 7
5 5)
$&

" # #
*
$"V
(
)
+1 K
6 $&
.
=# $"V E?# 0/0

.(
G)/
G&
)
.

<? 5/U ( 0 5) ", =*/
A % <

L .
"
<? "0 A $&
,

& ) G@P
E)
"0 @8 , # .("? 9)
/
.
< "? K
6 # 9 , "? 6< A P&

*/ ()() 7 50( A !# 5 K
6
A 3;
)
.
< Q/ B) J )
5% "
)/ $9 % <
" @ 0 !#
6< A
J 0/0
(,
.
*

.9 )
5& /, 50( A A& , G
5& &, , M*, % 50( A :J M* " A

9L
*
A ( 0 -,) <0 9 ."0
< / # -, * !#
6< $"V A$,
.)
$
//1
= <
0 G(.
) < = @6

( 0
-1 ") J < %* 5J $9 80
$"n 0/0

E) .Resonanse ""
" A : <P 5. " Q%, .
K <? & ,
9/#1 < A */ ", =*/ "/ `

.
"
($%
) #
<?
.E# A(. A& $% 7)J 9 O&
$/

9)* 9%
.@P A "<
5

%J @L "0 Gebjl 9 K
6
A 0/
9%,

/
% O& &# #
0 . */ E, 3/ ,
$

) $/#
H6< 9/ $9 E.> E&# 0/0
M&
.& 0 */

Multi-Wave #
) " * 8
*
5 A& @>&, E&? =$/
."&
"/ A (06
/

.Oscillator
6 )" ) C
&
"
" ()
K
6 /1
* G
1 G$/
;
$<1 ( E0 0/0? (
3( ebib 3^ A& 0 ;
E "0 9
P&
+/
"0
The Secret of life (&
/,) "
5
"0
@)# A& , @P&. $9 ", " 30
A G
3&
/s E.;( G >

)
3&

)
0/0? 8
7(0 n 9% 9
">&
" )
5) 0 I6
Dr. Bob Beck K 3 0
A
J )
5. "
%* =(T

)

( " Q _( U #
6< $"J .#

" Y ( ) A
!# .5/
5 5) N 5/
5 5) " G
" -
%
! $&
.
" >
%*
H6< .% eg
%*
$) " I#
/ @ ( O& , 0 >J @(0 >&, .
/
$&
9/#1 "0 5. 3/
.0
#
) 0/0? #
-6 5$,
A
J @* M( % "0 G9eble 9)
.
)
Q/
A )/ @& 3#)
H# # J & G% )

#
" " ) I6
@0 " 0 K" 06 ./
I
5.&? " E< G&
?
GK
L

P
(
5% " 0/0? A )
5 0 70 The Waves that Heal "(
(5# 3* A)
K :> 9 - J 9 % .#
5 M* " #
@#. >/
" )
" >0 H+# % .)$#(
)
@#. W: 0/0? # # J " >0
@
.3#)
H# " ", "^ K (/
0/0? # #

) ) 5% */
>

0/0? # #

) ) 5% */
>

A
J ./:
K (/ Q&J =/, )/ 5. " W: M& %
"&
/," 30 " #
)*
."0 9
5
9 "
, &, %,
?
8

" 5. " -.)
5# %. > 0 $* ) "0 .#
# H6< " >0
A &
@ O& GK 9eblj 9 =% L _# 50( 0/0? ", ) > A(. % "#
)
" @#, =# Y 9 G( @ ) .H " ")/
>
>
& "0 !Y(
/ "0 /
GK 9%, I6
#
? 6< + >/ . ) 9
-.)
"V ")#
A
5% (/

"/
) % K &
: >/? W:
A& .01 #
" E
# 0/0? 5,
06 " !
G#.)
@/ 0/0? & %
I1 ", .E: 5&
< 0 G/
.E,
06 " 5 G* 3)(

9+ )" ) & 3#$ "L$ ' " )
" #

)
0/0
#
E , E#6 "K 3" 0
# G
"
" /

&( = @>&, W: ( 9> G5
/ 00 9% . #

0 )
(/ Q& = ,
) .9ebdl 9)
K
6 G=
(
Borderlands " ?" 5% " ? // 50( A G
(
& G,
! A ) #
6
> 0 .
+& , P , G?
H6< (
.=/ M* A /
"() G( 0

? &
)
A ? ) -6
&, + % "6
"
" " >J
O& GA
-. &# #1 H6< ", .M/1 ) > #, ") & G;
5&/

* G=/
=/
( ) G< 5 I6
Y
6 FDA

1 J ",
" @&/ @ ". @) " % ", #
) " 3* .5&
"* ( A
J V ", "K" 0
"
!!! ?J .. / 9 3* 6 ", 9<, ... M/1
1 =# " A( 7/ /0

H6< A !#,
I6
GN =8
, .("; 0/ ," @/) #
) &, K
60 G1 *J Q/ E./ K 0
# 9
!$/, O& G&, 5 V 9

5) 9% @ 0
G#
@ = E "0 G"//L 7
" @/ "0
" /
.'& @,% "J .. I/ 9) ..!! #
6< )
"/0 Y1 " 0 @
& =# / 0
5 @ ) (
% A Y
) "!$
" #
6< 5& ")# / 0
A
J "V Y1 "0 GE
G5$) 50( A
+( / &
6< "0
.@ M> 0
(0
) (

A 5 &

"
5# A

M&
5# M*, ", A
J K
60 5&
.5/
6< %,
(
!*
9L
G#
6< = = $/ G" / ) "#/
" - @ 0
.#
6< "#/
@) #

5+/ % ."; 0/ ," H0 I6
-6
A ) 9
#
#1 9P) .E# / % 5. " "0
.X!
" Y
6
5 :# " ? 6
:E &, (

&)
Blood-Electrification
", % G #. 9/ :0 #, " * .# 06 G

91 5.
9
0 # < >J <>0, &, .30
" )
( A
J G & & .
# " & A
J G

" >0
K < ."K 3" 0
blood electrifier
"
" 7?N +( / , /
H6<
) 5& "K" 0
+ % 9
) G
/
H6< 0
7(0 % .! )/ , " <L "
M< K
60 G"*/
G1
.9ebbe 9)
K
6 GScience News )
.#
Q&J E? @+%
-7)
0 5. E> E(0 G"
0 "/" 0
""
9
" 0
:">&
M& G9ebbf 9 7

@$) ) ( @0& 5( @*) "0 1 ! ", & A
J . .K *
""(
,"
) ", ) # 6< & % . ? ( "# = low voltage direct current #
/ :0
:0

6 H$ 9> GHIV-1 ! O 9 A I& 3 , G".
") " G:0 3*%,
, .E#
) W: M& @ 0 50-100 microamperes (uA) , 0 eff A
J gf 6
", # G

G( "0 9 G/
, !/ >V I, "
& A GE. , 9/#
)
)*
9
.
Greverse transcriptase / /
2
@# J 8*)

!

7.;
7.J # 0 5
.9/#
. A ;
, <
I
&

s 0&
< CEM-SS A T cell line () 0 A 5
A !
/
G
( -6 " 7?N |/ /

!
9/ ) .DNA reproduction machinery #
" $# 6J "0
.!
( 60< .
I#
#
/
M* G9$ ", )

#
G() . L " # 7) !
' G( / /
1 I, ) |/ /? H/

N
.9/#
)*

# A < 5/
" '
-7)

+
Science News # GThe Houston Post (Mar 20, 1991) # " 50 50( 7(0? 6< " ". 9
(0 5 ">&
9% G <) .Longevity magazine (Dec.1992 pg. 14) # (Mar. 30, 1991 pg. 207)
.1 A -.)
/
H6< 9/ " "* &( % .9ebbe6^ el "* ( * Q
.9ebbj 3^ ec #5,139,684 9%
6 Y + "0/
( " Y
"
0" O&
" 50 5#/
"
?
? G(A1 06
.#
) 9. 5:/ # 6< 06 9
G5 & I6
50 9L
A
J =#
5
.!:
: &# /
", ) Y + A "(0
5 & ", = .*
A& ?
9%, I6
*
F
6 =
, .Q1 (0? % 0 E , % 7(0? 6< ", &
0
GK

6
-. #J 5/ ( 0& ) 9
)
5& #
O&1 0
."* (
5& .#
=#
A
1 &
P1 G(@ "0 ^ 6< ) & # A
J 5$
" E.) "#
%,
&
# " , ..E: 5&
< H6< G
=%
< 6< "0
.9P)
7(0? 6< " ". 9
)

:

5. " @ ./ "0 G7(0? 6< =
A/ I, Gulf War Illness "W

3& +" A/
+/
Q&J G9jfff 9 " 5,
(0 &, ""? 9
" 0
= ( >& *
"( , 0 ,
H6< GMycoplsma Incognitus
: 0 ""?" 0
3# "0 .:( -.)
6<
) 5& >0, 7) " , G#
-.)

? @ , A G30
9
) M) 50 0
6< 0
!!".. @ ">& " 0 I, I
!
.. / "
% % < 60< .! 6
Y
6< 5 Y + A & @ , 9L G) ? ) < "0
.... :
0&? B&
[ / "L$ ' " ) 9
Y
6< 5 5 A
J "K" 0
H Walter Schnitder " (
" /
A 3* 9%
*
= ", % 9> .Y? + 30 7(, #
06
Y? + " O& % .
%J ?&
0 ) .3/

0 0
J 9 .
) " 0V
6 #.)

6 G<i,bj @% M* " * H# "0 G 1 -6
" 7 # 9 A
J 0
5 G
5. .@/ A ? 9 S G e 5* 50 5/ ! /
" ")*% 9/ G)$ #
@ ' , (, m ) (5* iff @ "0)
@ , G5*, ) G
*(
)( , */
%J A
J G5 " E # @>&, ( S ./
H6< S# ) .!5:< *( )( "0 G5* egf
H6< "0
!&

&
0 "/& #
0 G1 A A 3#
%, % ..
5& &

.0
G/
G
#
) Q, ?&
) >0, 0 /

$>34 6
% ? &
"& G"@0V 58> ,":< &
< ) G You are what you eat :5 3;

K <
", & " 9
& % .' 50( @0V W: O& G)
" >.>
"/ # ", ) ?J 0&
H6<
Standard 9)
01 :6;
9P
A )
6L1 < )* # $& 0. 9, //1 M:)

:

0
"0 "0
G5
E.* E% ", 0 .American Diet
9, (<
& ' K Q/ " 5 50
K$& $ ", 0 G)8
#
)
0
6L1"
."/
0
9>#
L
6L, 5 " E?& 7% ", I

"
@ J G
"
Q/ = & AP& ", 5#, ""
5
G& > GE # #
) L 5 3& G#* G)* 6L, 5 , G#
) )8 $0
."7P

+
" >0
G &
"
$
, 6J K/
"
W$$ $$4
.E E ;
9% K
6
G#
9P
9
? 5( 7/ <&
" 50
:6;
KP ;
& 6J
.N )
A
J 5 ? 5% ;
= 9%V
5& W
H 50 L
*
&
,% 6J .&
$ J .K&

)
58> (
H6< =# .;
(
,
" ; M. ef A
J d 5) 6< .80/
" 9L jl em " A I& , P&. 7/ )
3 # A
>0, 3( 0 6J ./ l
@ Q/ " 5
A 5) K/# A
J 3$/ )# . 50 80/

9 0

6 (1 .) K "0

3/& K 0 G9
"
) ;
(
5 " ">0 "6
(? A &
H6< P&. 90 0 .*/ 3/ I1
)

.( "<

H6< .PHOSPHOROUS /
" )
0
G;
(
0
Q1 0(
,
A& %
5* <#& ( 9/
0
0 ) 9/#
#
")
= & , O& G9/#
Q0 )
" <
9/#
GI ") < 9/
0
.
")
K " /? " 9/#
9& G9/#
" .
-J
.9/
0
A 5 &/ E6J ", " G")
6< A ;
(
0 6J .E 0 0 @
J -&
, .3*)
% 8(< ' E L 7/ 9/#
.!" /1 9P)
@ J ..X9/
0
5

7) 5<
"
" ) 0 A
J ) ;
(
3 # 3# G9P)
5
& A "%
+/

.

Y
)8
9/
0
3& A 51 7 " E? G( &

)
:% , .* +
)
6< 5/ K 0 GE
/ K 3#
)
& A 5> 6<
("6;
" Y P ,) .E# *
/ 3#
Q1

8
The Water of Life, A " 5

-.)
5& &*, G&
+" :" ) 30 "u /,.."#" ( G9eblg 9
@
" 3( I6
(
", & 58> &/ L L 0 30
O& .Treatise on Urine Therapy
Your "
50
K:":" ) E.> E0 "/0 >" ( % .!
&
) +(
/ "
G "& ( O& G>0, "/0" 3
/, 0 .
"
" >
K
6 GOwn Perfect Medicine
.."/
& 5
*% 5
? GK
" *% 50 3(J G&

$
?&
A 0
:*/ >0, "0 G"u /," 3/, ,

>0 ?& "u /," 9$% G@0 .!!E A( ", A -.)
5* 9)* , 3( I, 5
..<L ...% , G) , G */
5> >0 , .-.)
" Y
6< 5. " +(
>
5 A
A 3$# E# * ?& K < .E 51 O& 1 &
0 )#
5 "0 @ , A
J "u /," (, % .5*, K < .!E egf , ejf , bf
GL ? * G5

98P
$/
K

, .( "/ , / ) $)
5
9/ 9/#
K
) =
M* " 5

3:(
"
!
9 ' #
5)# A
J #
1 " -.)
A / G* 5

01 "0 "0
G06
30
5
&( G-.)
A 5
% / , .<(

:

.5
5. "
<
&
#/ 1 ) 50/ "0 e
&
80 A 9/#
/ G
*8( Q,
9/#1 GH0 G5
5 J j
58>
)
"
9
" K
6 G
/
;
#/ 1 )
:0
=#
J G=% G A
.9/

J
^ 9
)
" 7 "5

" "0
. 8
9/#
&* . " "
" 0 < "5
" "V ) E)* "&
G)*
9& 9L E 5
"
!
" >0
.K " 8* '8( 5:/ @ 806 .E 98) @ 1 G"
"
GI " G/
H6< >0, M)
5& .P
/#
9<<P K
60 H6< &
9
& A P&
K
6
.K& 6 J E/ /
H6< "0
G / *(
Y, =# I#
>/? @) I6

3/ ":5 @0 "u /," 30
K0( "
+/ )#
50
3& , " *
1 ' , G#.)
1 5# < E& <>0,
9 9
G(9 gf ) " /
H6< 50 ) 6
":5+/
= ."
-.)
3
/, % Q 5& 3
G%
6< 50 9L !X+
6< #
/
)(1 9
&#
*( Q/ "*/
-. " ">&

5:/
K 50 9L G6
:30
5+/ 9> ..X@#. 9> " @/ 7(0 5/ 56 I6
#
G5

*/1 ) 9
5 ? K
6 = G9
-.)
Q# 9 " G9
)
5& +*1 " 0 %

-. O&, A "/
":
5) 6
:5+/ G
.!X&
5 9
"J E/: E?) E#. /
*

)
-.)
3
/, 5<# )/ A ") G51 " :< 0
*/ ")# "6
G"*/

.!X/

-.)
3
/, A / ? , #&
0( O& .E+/ %

&
", A& .+( $; 9 G"u /," 30 " 9 df ) I, G9
,
1 3;
.A % I, " (
A E* >0, 0,

& V G//
5# A
J %.)
1
G " * +L1 .S # 7) & , , < M
"0
.!S*
%
? "u /," :/, ", <
" 9
98P
3*
1 0( @/ I6
Y
3601 "%
? I6
9< G";
K
60
)
H6< "*
=# ", 06 "0
.1 !
* 51 " <#
# < &
7
.%
E&, # "
7/ ... 9<L G")
G
)# G">&
G"/
G"P
G"**
G*

.I>1 5#
&
H6< % ", ) G1 )
" 9

$ & &7 $(1 '
(

/
( ? 6
GE.) # 06
"$&
" #.)
H6< 50 0 "J :90&, 5+/ %
..X(0 9 ", $#
J 5
Q1 #.)

I6
3/
, .7) "0 ", @ 9 1 7) < K
7) -. , + I, ", < 90
I/ 3#

*
9P
6< !/F) 0 ", 806 !9.1 5:/ "N Q
K
)
#.)
K 5)# ?
9P
6< /
$
@** / 50 ", 5% 9. #, 0 A @*/ " A & % (/

=) Q0 .J / I, A P ", @ 0 ? :/
#.)
W
% -. , + IV .9
:/
*

M
#
3# @ , A
J E)* 6< G(>V
; 8& 9.J 5:/ + >/? )
0 G5 &
5&/ M
6< G&
5# "
F/ / # " @ 5 &/ I6
0&

.30
6< " "0, ,
G#
>
01 (0 "
" G9
A& :%
? G )
<& 3& K <
/ 5#
>/ ? 3&
H6< .E# E// GE
@ ")
E G:/
I0
W
A ":

G / &
" +( 5# 5 !
!/V I6
G9
:/
$*
W
.&
3*
5>
5

)
*/
=# A 7 5:< >V 9
"6
"#
+?F< .P
#
)
5# 5 5
!
G
9P !0 9</ 6< .(
Q/ A 9
& ,
) 1 :
//

.9P
6< <P
%

#
#
" GK ? 0?< " B)
? , ?J G )
9
)
I&
P
6< 9L
& , 5

^ .// E% >0, !/, 3/1 5#, & , 9

", < M
"0
.*
(&

& =% ( : 5% " M
) & =% /
9
)
+& , =# 5* =/, : 5)
Q
9 **
GI 6& + 9 J .(X% "0, "0
P&
! ( : 5% GP&
!
.)

)* 9P 9/ I6

" "$F J)" 0
" @ "# I6
%
G #. A 7)
90 0 70
@ 5%J A AMA 01 3*
* @L, I6
G, " <L )
38
"*/
W
)
" E E H 9 I6
G"*/
-.)
7(0 "") 9 ,9" 0
, .!"
)/
7P .( ed 5. $ egm @
9 O& G@
AMA
A
J % +#J 5.
&
% G"*/
-.)
3(1 /
"B$") B$$" 0
, .5L`
) <(
?&
7?^ 5 A & .#/
H6< .9ebmc 9)
) ( >&, .#/ =# 0

0 G<
# 1 ! ( @ , 5 $ @
, I6
" J " 0
, .#
)

@, I6
")"$ "$"" 0
.:/
$*
W

-. / @J < &
@#
9 <
H ) G#/ 1 9$
W * " E 7% "V 01 +
+6;
J
#
#

9
.9
A& )/ " "0 9

@.#/ )
@%, =#
E, E % M&
% G/ " H* 9 E % M&
G714X @/ "*/
-. $* I6
2"J" -" F"
*
O&
" H M&J 9 G6$ .J.8 0
, .0/
A #V $F
"#/
H 9 0

@>&, ( S/
9 H 9 $ ,9 .9)
K
6 %, )/ & 5. 9ebib 9)
" 0

"#
)

" Y )" ) 8 . / %*
5& 9</ 0
1 "V >
0
.@/.J A
J , :% 0&
) $ 8 .9ebli 9)
/ #
%* 7(0 ED$ $D& .0 <J ) & ? % G) " (
#
A% GE E 9

$) G-$ $ 0
." #
3 , A..J ."#/
G"L1
# G#.)
7 0
/ S# 5& 0/
G " L$ 0
.
3( @& %
/ 5& M:&
" >0
( $" $ 0
.& 9 &
F
5% 9ebll 9)
9/

.1 A
J
6? 5L
&
@) ) "0
G9eblg 9)
#.)
7
A% / ef "#/
@ 90& "0
G /
, #.)
7 / +&J
& 9% $)
G#

G
9 G+0
/ G3* < GE ) $ 0
.@/ , 9> "#/
>.>
) @: 9 "0
01 +
+6;
J 5% " @ 9 G"*/

>
-.)
".0/0;
8&" Y
@
L 9 G""
" -. $* GJ $$ 0
.9ebdm 9 9$/
@
L 9 G@&

3* dff ( ",
G"#/01 # -. Y : G6$$ $ $" 0
.B0 0
@ 5% I6
(
! @
9,
-. E/ 1 A jgl W
GJ$ $ 0
.5L ?& d " A# @ V 5% " / l
"#/
6< ", , .*
@( &/ GE/ M L -. 5:/ @/ / g @ 90& G"1
G&
(0 &, " 8
9 G/ 50 G 9 50 .=%
&

P 0 #
)

:9 806 .)/, ?L #< !(1 #

3*
5# $) G"
")
,
% ", ) G&

?
.
@# Jose Trias "! @/"0
5L 9 G9ebbl
.(<(
) +/
#

=(
@ HHMI "*
< < )" '
", 5% G= * / O& 5% GL

CJD G C. Bruton "./ 0
G9ebbl
.9.
" >0, 9) ' , @ , .)
>&, # ")
E H# G
0 G?#? ;
@ J =
@ M*, GTsunao Saitoh "/ /" 0
G9ebbd
6(

5# E "0 ."0
" 3
% 0
3

& @ ", G/
# 3 #
.Alzheimer <

&
! 9)# GI* 3* "0 I6

H/ G@& GMark Purdey "I K" 0
G9ebbd
A
J @& / % G@
M& .L
CJD I "0 .% O& "0

G0 J "
" #"
& ! "0 I6
I*
H/ K
60 .9* >& ) ( M*
-
5
0
"V S " 0
5 " 90 G5 I 0
5% .) / >& #
.9.
" >0, 9) "0
/ "0 G(E/) 9

0/ ) # G Sidney Harshman ""(< /" 0
G9ebbm
" )

, 9/" @ 5. " 9
)
51 @ , A
J G#

9 #
0

.staphylococcal alpha toxins
0 ./ %, + >, / O& % GE ld < GB., O
, 0
G9ebbc
O&
0
/:
#
E, < . .0 (/ # :
-. 9/% /
, " <L G\5/
0 GHIV
5& I
O&
0 A
J G
.)
!/F

"0 . 0
1 M // :* */ O& 5% G / ge H G" "> # G9ebbc
=/, )
G1 :
"/" W !/F @ , A
J .`

)
&
P W
G&
91 P G
)
&
P " 50 ) 0 A
. Y / O& 5(
*
&
<) 9, O& GE)/ E?# 9ebbc 9 9. 5:/ @& /
.0 " <L
.
.
&
#J / 7
" /$) 5. " "/ M& K 01
Q&J " 6V $ & " 9, ) GL 3/, " G / ig H G"!> 50" 0
G9jfff
#
#

"0 .#. & ) E ( % G / ej < G&/
3
n A

.5/ &
/0 0
" 6, " 9, >.> ) GL 7P G#
#

G"
" 0
G9jfff
.9, )/ 0
5%
*
." /" / G&/
3
J G";( )#
*
E "0 .) L 3/, # GJanusz Jeljaszewicz "0(# ! #" /
G9jffe
" Y
6

1 5
^ / 5# < : >/? @# J 0 . )
0
0
Q
.9 # J ".J K( A G@ "
3/& G"0 .0

) GM.L 0& L E # G / ll H (5 1 ) G""; " /" 0
G9jffe
"0 % , G#

&/2
S
A 5) "0 .
/ G0 ? G@ 5) "0 I6

.E#
E&./
5# @ A
J .< )# G:#
#

G" "" 0
G9jffe
A 7* @># # ./ G! - /# A # @/ E0 GL 50( A .0
/

.5 iff @/ "0 " ) G/
Q&J H '*/

Q
Q&J G@%J "0 " 3
E? # G9 dl G"K (/ ." /
0
G9jffe
&
/ E?;( "0 .FSU #

&/1 W & 9% 9
)
"0 ./ "
J
G0 J
.:/
&

5 5$) -. A
J 5$
I "0 GI

. )# *

/
@ "0 " 3
G3/ # E? # G"I0 " 0
G9jffe
G@0 6< 9L .5/ 3 5& "0 9<&, G5# ), 5% " S
3
$) @ ", ( 06
5 E# O&, A 5) G
#

"0 .!")*" "0 @ 3/ "V E/ ",
.91 9
E) "0 .Y( A 0/ 5% .#

5# G"7L "J" 0
G9jffj
.9
)
#

+ =# " E#
A 0/ E, 5% .#

5# E, "0 G"0/ ( /0
," 0
G9jffj
.9)
/
01 + G9
)
#

+ =# " E# E) "0 .Y(
@ 7 .%* 3 @ V0 E*& @/, G@

5 E? # G"7 (0 ." 0
G9jffj
.#
S./ I, $ S
0 A
J 5 @ V
E>& "0 .0 J G50
3
)
@( @: E%L E? # G"; ? "J" 0
G9jffj
"0 G//1 @ , .@ *&
:
"/ & " %.)
/ E G:
"F( E
.0
G)
1
9./? 3
& 5. ) M.* ) G / ld < G"
< " 0
G9jffj
7% # , 0 A 5) 0 . 1 >V (
:#

A 0 >&, 0 . *
. 3/ I6
!
>0
" 3
I#
/ 5. / # 5% G / gg H G"
" " 0
G9jffj
% ! "0 .:
/
0 = 5) astrobiologist E: E#
"0 .0 J G-0 @

0
& 3/
#/
M )( A
J GA/%1 # :
= 9#/ ? A 0

.1
1 +

, "0 .&
?
:* 98*& >& G"/ "/" 0
G9jffj
Dr. Flu 9/? @)*, % .
0 )# &
9 0 @ G bioterrorism < #

)

. 1 " -.)
A :
@
+ , "0 .&
?
G /

Y% %;
@/ E # G"B 50" 0
G9jffi
5)
K
6 G+
6< >0 & , % "0 G5 @ 5% . West Nile virus "5 /" ! & .

.
< H( ? /:
3/
" &
A
GE? # G@ O&

* & *, % .5)
A
J @<6 5. E A G" / (" 0
G9jffl
.
E "0 .& @ V E/ ",
A
J / @># # .#
#

5# 9
)
+ , " ) G";0. 9
" 0
G9jffl
./# K/( W H '*/ A 7* O.>
3:&
G& 5 )*% 50 G=*% >.>
5, 5 & @

, </ G#

&
9
G"K.0 "#" /
G9jffl
.0 J @
E% ( # .(
)
|/ /
)* # Q& = /

7% 0
@/ # >& 5% G""/
, >" 0
G9jffl
.#

#
0
G:#
#

5# E "0 . G?0/,
M @># # GH "0/
)* # 5% G/ #
I0 G"9J .< u #" 0
G9jffg
@
G
5# E:0 "0 .
0 GI/ )# " E E>& "0 .50
%& /
.5#
6< # J
G H

0 7* ># # G"
"
", ) G"; , >L" 0
G9jffg
.K )# " # G+0
5# ( 0 ./#

/, ) "0 .HF. " el = G; :* */ O& G"!0 " 0
G9jffg
"
/ 0 O& E& E "0 .& , :, " "
/1 & 9% I6
" 8
"
.2
/

1 9/
E/: "0 .@/# )* # @
E? # G"5
" 0
G9jffg
5 .0// "/ *
=#
01 )#
"
":
E/: "0 .9)
0// "/ A(/
.5 @ 5% E>0 H0 ;( / ) A 7) @ V @#
M
Q&J L G ( ## */ @/, A # 5% G"0/ (/
" 0
G9jffg
.#

&/2
0 +( J E "0 .0/
H6< 5)# E& E "0 @ , 9L .t
*#
@) ) G" u #
" 0
G9jffd
P "0 .* ) , " <L G G*
, 0 & "0 .)/
&

.9jffi 9
)
6
)
&

"

+*1
)
O&
" 0 )
E# >, " < :
H6< ", 06
" / ( 6 9
)
5& #
O&
" : " " )
H6< + % G&
.&
5#
" <+J , O&
H6< " 1 >) <
V/
H6
< 9 0(
.9
A& I#
? G*
I6
*
K ", " / 0
G+)
, +
&, " 9 50 =/ "& .9. 5:/
:E# 9< 5F/ GE# * & A
J 5 7/ ) )# 6J "0
.5 50( &
O&
H6< =#
D D $ 9 Q #" ;$ ,3 .!Q1 T9 % 1 HT(1 B% $ ,3
.!Q
)7 ,7 >) 2(A
.M:& ) A & G=

& 5#
? "& :E E, 06 ", 3# G@0 6< 9L
"H B) $:) :)A 9 ; $ !"
(
0
.#
Q&J ", #
1 )
E# ( "#

+
?L 0
:5 / " )
L W/ )$ % $ $ )$
A Career In Microbiology Can Be Harmful

To Your Health!!

) 8 9 ...#$#
9P
YJ " ?
(0
1 7 I6
I
3*
) /
#
3*
A 80
? a"J
< " K < ! .)
$&
"
A>
& A
J Q, %
& A
J 5 I6
#6
;
:6;

A
F/
? ", K
6 " 5$1 5F/
K 0 0 5 3#

.K$& A P&
K >0, 9
)

F/ 5&
9>0 9 9%& 3/ E> ( ) % !
" ".
".
a"n ."N
."N I, 0 9&
K < 50
", I, .)
1 " $) -6 "
F/ $) 9># K < a"V 5 9
:/
0

Bechamp 3( @/ U 5% " ) 9 "0
Pasteur / /
9
)
$P
H6< $* .
@>#
>#
"0
$/#
?& 50(1 ) " O&
Gmutation (*
) 5$&
$P $F "0 I6

&, 5%, 3/& G@/ Pasteur / a"V /
30
5. " % .Pleomorphism
. " P

P $P
% Q, $P '

$>#
@$P A;
, @, $L % (Duclaux !00 0
) @ )
A ) G/
$ 1 $>#
$P
5? G5&1 =# "0
.Pleomorphism ) 50(V >#

.9/#
0
5 9
//1 -6
G1 "
Q
9/#
, Q/ , P ? %
50 (0 %.)) /#, = B)
0
Y , " )
K <
M* .H^ A
J..*)
I )
/
*;
M< A
J $&
L &
$ 3/ G!0 ?
, #/ 1 I, GI/#
"<
"
&
H6< " #

>/ $& 50 0

Q6;
/
( * G0
@ B) I6
366
Q/ ! A
J 5.& ?
$

H6< 0
S* K
6 ) .( I

!
Wilner 7) 06) 0
H6<
0
H6< @ >0 ", "0 I6

a"J .*

0 Q, ,
, 9
M8 0
9
G) 9)
)# I6

9/#
L A % "0 ? % G Q6;/

A
.0
H6
E0 E)* K < "0
Q, 50(, A
J 0
H6< 5$& ", "0
" G7 5 0
5 P 0 GK
6 A .
"0 I6

0 # H$&U 6< G:
*(
E K
6 G"*/
$/ A
J A&
, E.> # &
3
50( A "0 G0
5% " &*
$/
.
H6
&.
/#
5)
$ .@
E: E< A

, 9 50( < H6< G(0
J )*
9/#
*)
)
&
#
.//1 3/
A +
!

1 H6< =
1 "*) G
&
$*
/

$)*
+(
$ + >, 9/#

'
5

0
5 E
L 9 G$&

+*n
$*
Q)
5>
" Q, 50(1 /#, ) 9, )/ 31 ' 5)
6 .9/#
9

.0
)*
#
9/#
A
fungal infections
"6
"N ">&
" )
) L @#. "*/
%
3/1 $", ">&
80F 9
6< A&
.
//F
$0&
:
5% " =% F & E: 9< 3/
") 98 , "80F

9/ ", 9
" .@
:/ "
$) "0 ", "0 6J
$&
)*
9 ", I
"
", 3# .* &
$
) # !
G98P =#0 $/ 5)
9
) " 50

O& ", $# !
XA "& 6
5F/
A 80 ", 3# .51 +
" O& M:&
A '
!
@8 J G$)*

& " E+# !

.@ ? 98& +( 8 , A <
1 , O># "
$
F/ .@, " >0 $<, >0, @/ "0 I6
G@ 5 &

3/ # I/# @8 J .&
.0&
+*1 $
F/ * !
G 80 = $&

3/
" L 9 1 9
2
E#. ")8% E +*1 A
J "/ (
" ".

>
< H6< GE, $: F & 9 X7$
6< 9 " X* 9& " ">& 5 I<#

9)# >J , 8
, # ? G*
9P
6< " E. "# "6
+*1 +)
@

E . F(
.9<J J 9 60< .(I0
+
) 9% " 7
+
L : 50( I, A "%
"00( "0 ", &

" .9* " 7 Q, M* #
"6
(
+; "L L 98 ,
6< $
K0 )
@ S " = % 3* aI, "J .@ K0( K(
' ", " * K < "0

"
5#
!0
F # @8 , aK( ? .
& W
)0 H 9

@& I6
30

+*1 9P) 5% " % $$:! % $#.)
$
5<# 9 @8 , ?J E >J 9L .;
3*
"#)U

) A 7$)
5. "
&
@ O&
5& 7/ I6
Y
< *
6< ."#

" G * &

& A
J P 7/ G@ + G & " # 9 "0
. " "0
M:&

.P
H6< A ? ) 5)
9>

‫ﺍﻟﻘﺴﻢ ﺍﻟﺜﺎﻧﻲ‬
‫‪ ; .‬‬
; .
D> 9 ) G " T$ ...E E E# < :/

I
3*
@ ) I6
)
W
", 9) 0
)
3<6
, @& I6
)(
6< ", O& G#J * )
H6< A
...J ,
A
J $ 70 :< 5F/
"0
.E, K(
"0 ? % 9 . P "P 9)# I

X1 6< " E# " " 6
X&
H6<

9 , A 1
J =8*
P)
@ ( H @
GH^ A
J...E// GE GE "0 "J G3<6 50
#

H6< ?
G!/1
9< E, :* ?
+?F< "V :
" $ 6< A1 5>

./ P " @ 9< & ,
)

)#
)
//F
0 A
3<6
)U G9
9
)
+& , 0 / I6
)
3<6
,
,D '93D @
J (U G/ 01 //F
K T
?J @ 5)
3# O& 0

!
30 9<L " 9<<( "6
96 9< H )
3<6
6< 5*, =# .MATERIALISM

" / 9 E)* G@/ 3<6
6< !0 A / "$/
+P)
+?F< ./
)#

< ("&
"/ ) &
:0
", 5:
6)$ 5> ( .(0
" %?) */

)

$* I6
D$ ." .* <) #
#1 " 7 0&
6 0 0 #, "
3& G
./, A
J
, , I6
$ $/
.9

:
9)
A */
0 0
W

E) 3<6 I6
$ 4$" /
...&
$ 5)
# I1 )/
G=#
Q
)
$*
P
0
.
8&
* 0 58> & - / Q/
- 9
@ 0
:
3;
& !.
A
J E
9) 9 "0 + " 9<L ...E/ # E66( H "0 Q) ? 5) ""*
5)
" H/
..."
+ 1 3
" 90 .@)* : A& . L )U G"/

+?F< @) I6
)
M*
6< " - 50 "J
M) $6#
>
/
Q&J " & , A& ...0
*
H6< A V(
5#, 5#,
8/
H6< 5$ & , )# X
/
/
J 5&/
" ' ,

"01 ")
"#
!
, ../
% Q B% ", 9& .% $& Q 7(0/ , (%

& I, " E:
.&
0(
"0 *
< G&
..XK
60
K
6 "0 5 G@% 3/ 01 &/
H "0 ? % :/
)
M*
", 70 $
06
&
06, 7/ .1 # A */

) / L > 5:/ $U F #
06 A V &, ? .)#
!

)
>
" E =* " E# U
K
60 G &
)
P
) GK
6 5. " .& ) //F I, E, &
H6<
. 0 * A */
)
8/

$ = : *$ #( <#

G
*/
P& A $
3)(
9) GI
)
"0
/.
+)
- )
E
0 G"6)(
"
, "
5# /
)

< &
", ,
5$&
6< 5 & 5% "
" "%
(
/&
&
K 9
@) "
.I(
0
* I6#

I6
*
!
? Q 0
K
6 .&
K 9<? " E0 E% & 3# E# * K <
.9
H 0 , '93 " 0 9
/ 0
A $ "6
5:1 +)
.9
@) " )
M:&
* 5 & 0
"s
5% " @/0 9 0 !
K < .E. , , '93 K < "0 9
G&

K
6 " * ) +# 9
)
M*
90& I6
, 3<6
.&
Y 5# "

9/ ) @
J (U ' , I6
<
Y
6< I6
)
3<6
./ 0
=
Y

<P " P 50 H# >, I6
G9P)
"0
6
$ 5 # 0 9
3<6
6< ., $ '93
A */ ", 3<6
6< 0, >
"0
.
//F
@ " E 7 5)
6< ", 9L G&

2, 3<6
A K
6 G1 A
J H> &/
" H)/ A
J Q, ^ 3. 5 & A& / )
&/
&
F
<
//F
:3/
0
!
//F
" / 9 "0 @ , < 3#)
1
"1 G5#
6< / G0 , / , G# I, A Y G
:
3 #
A &

!<#
E< E 580(/ 6<
VITALISM , $ '93 & MATERIALISM , '93

)
K
/
=# A
J <) 5/ G( =/
"
01 &/
A
/
P 5%
3<6
6< .(I&
3<6
,) &
/

J "( GE 7 Q, / / 0 G+/
A 0

"/
"< / GI
3<6
+( ) .(1
) ( !
"
6 E:/ "0
.( 9 %
" )
9#/
"&
"F .&
< & %* A : ) &
:0
", 0F , $ '93
&
$ 5 # " ? G :0
+
^ # / 0 ? :0
:
"
"V
.P 0&
/ > : :0 "
) . A : ) &
:0
", A , '93
.(! L) ^ 5 I, 5 "
GY
6< .E " > 9 5* Y .9 0 Y V( A& "<6
5# " 9#/ ? 6< A % 9
S +( 50) F

Y
5:/ =(, @
. / ..E/( E "0 G"/
A
J @ ) I6

E<6 ...01 &/
" I&
3<6
* .E I
3<6
- 7*
.(3&

L GI# L 3<6 ...9/
#
9)
A
J @ >0, :
6)(
A
J 5 ....E/ L
A
J F
3/1 #
.&
/

" 5:
90
K
6 9L "0
.)% L G
."<
#&
% %
%.
!
E 7 &

", ?J GI&
3<6
A I
3<6

A& G0&
G %? //F

'
"V @ 0 ...:< % % 6 @ , I
3<6
P,
//F
K " I, I; % I, P 9 GI&
3<6
, .....(/?
#
1) //

G

...((
& " :
3 #
A 50
*/

//F
E* E/ 0 A
J )
3<L A
J <6 GI&
3<6
5# , ... ...I
3<6
5# A
J
9
5
3<6
."/

//F
A <#
$ # (5:< I) & t 5 &) &
01 @( I6
0
=#
)
">& ("
) I
3<6
Y, S G01 Y
&/ " E& , $ '93 - K
60 &

", "/ G (0 " @
J A ) G(&) / */ H/ G#
<P
: M:& *; 9
< G 1 G&
/
.0 M
G"0&
" !
")
" < "9)
"
<P / E)# P
3#
)
" >0
<L %., & #

5. " <6

P
H6< "0 .M* 50( " )
@<# 6< .
@# #

>0 " $# P G"0
;
A #, #n 9 S I6
GHaeckel "50<" )
7/

" W 01 "J 5 .H^ A
J ....M.1 S
A/
"
)
0 G<L # &
5 .% % # !
G%*
:( ; M / #
+( 50 G5)
< t
Gt

:Riddle Of The Universe " ) 4" @0
@/ 50 .Y I, " L , 7< @ P&. 9

, O& G( 0 0 < "0
", E& ..."
50 ....:( #
/ 5)
# Q/ !
< I)

(
9
) , (
M
)
Q/ /
< G )* < % G= Q/
< )
/ )* "J ...
5)
# < +(
, 0 , G/
,
% " >0, "0
/
% @
!
G$>
:0
&, Q/ !
< "/ G / J
"...1 G&
G :O.>

p
$&
< :()
0
%*
+ "J .....30
:$ 9 $)! ) 6A =$ =$#
< //1 &
, # A [ L 0& G&
9 G/% G(& ! " < &

G5% 58 " :( 50( G1 V( ", 6 G6% 1 <$ $ ,A [ < &
.'"h #
...!(
36 G:( 50( 1 A& 5&
H6< A //
9 / #

G3*
G+0
G+
9 V( G%
! *
G&*/
)
H6< A +
.<L ...!

, $ '93
VITALISM
.3/& : !/, A 50 50( &

/ "0 !
@ ,
!
&, < I&
3<6

L = , >F
# ?J /
G: )0 I
9
)
P
GI&
3<6
1 E G&

", */, 0F .&
M
+ A P&
< G&
%* S
", */, ) .(&)
.:
A )
@ * ", " &
M
A >F S

L A I& 1 &

L +(1 " I<# 50( 7 &
:0
", I&
3<6
, Q
", Q I&
3<6
"J G*/, 0 .&
L #
90&
"
K L "
= 1 , I
.&
& 9/#1 5 % ' &
S
. "S" , %* M A I& &
%

" @ , K / I&
3<6
, >, =
& 6J .&
%
=# @ K( E EP K < ", I,

V/ 0
GI&
3<6
, &V0 @)# &
<P
*/, / "J .
E) )
3#

.&
&
Q
", Galen "
L L S$#
Q, .
5% O
>
"
.
#
/
<#
@ J .E# 9% 9 < &
L
%* " 7
&
9/#1 *&
%*
9 "J

& %*
)
0
9%, "J .$
7)
"
K:
, (
5:
Q
&/
) " (
0
– < .Prana
A 9 A 0
H6< 0 ..
5% gfff 9 E
&
A
J =#
" " "0 Prana
", 06 .#
50 5
&
# '/
%*
– 0
H6< 06 0
.Sushumna A O
> P "&/ "
Pingala ?;
Ida N < "/0) "*% ,
.%*
, 0(
A & , * =/ 5. " 9/#
M* Y O.>
%*
H6< "V 5
A/ ; , * )
H6< = M
9/#
" & M* A
J =/
0(
H6< %* = )
.H 9/#
* '/ I6
< ;
)
H6< %* Y# .Nadis
9
& ("
) A*/
0
%*
H6 M) / I&
*
>
*
#
06 .+(1 =# # < Qi ( A 0 %* " O& A >)
9 G.
5% ifff
** " 9: " < Yang u
Yin "
%* < "/0) " " 7
V Qi "("
",

./
H6< " &
%*
M Y 5 <
3/ ", .%*
/ A
*
) 5% " " /
7?^ Q A H* 9 % Chi Kung " u 0 ( "
A 9% 9 K <
*

.)

*J 9
1 "0/ 1 = &
A P&
" /
7?N S# 9/ % ."

*;
:/
7P
"J .%*
/ A : L / " & Qi " ( "
M 9/
9/#

G
1
5# .
A
J

&
%*
M 5 , %J A
J IF %
) ?

.&
%*
M
%J O&
"01 %*
/ 5* A * '
) , 5n W
)
9
? < .!
9P 0
M* " + Qi (
= 5)
@% Chi Kung u 0 (
W
)
9/
) / K < .# & %* /
H6< +5 E, 9 5 %*
/ /
M*
' * 9
'* 0 +
5,) ")
G1 G
:< Q, A
J * " 9/#

%*
H6< A M*
.
I
3*
06 < 3(
G+
G(")
5 #
.
9/#1 *
&
%*
" O& 0 G.
5% gff 9
& "
K
6 ) P
9
G, /
9.P
5. .2
-. - %*
H6< 9/ ", @ 0 <
(
", 06
*/
.)
L =/
3/ K
6 L &

&
;
*
O " 5
Q/ W
GI.
( >
"
G5& , A ./$
9
)
> @ 50 $
G
//F

/
5& Paracelsus H/ 9/ 7)
:
30 . > <? 9)
" 50(, ,
P A
J IF
< &

"V 06 .Vital Matter &

Vital Force &

GIlliaster
.Y W
) # #. 7<1 &

9/ "0 .&

=% " G/ 0

" / G 80 GE// )

"
' , G, "
" A/
G) )/( 0 0
^ " V 0
7
K 9)
S .I&
3<6
Y,
# & A
J ( 9

.)
" >0
K < "0
G
&
A& #
H6< "J .&

(1 "J .7) ", " 50
< E:
;
< &
.
( >0, P A
J
P
K "
.
& " #
& " 7(0
9 0 "6
* 9< :/
)
)
" "&

/
, .( =/
( !/
"
O&
9)
P A& '& 50( I&
3<6
9 9 9
.@, " H) A, " Descartes 6)$ M* " &

P 1 5(
=$/ $ )*
<P
0 0

#1 " 7 0&
6 0 0 #, " < ("&
"/ ) &
:0
", 0 A %
0 (=#
@
V 9 M* " 5 E0 E ' , O&) I&
3<6
* 9 .* <) #

/ M* "6
(1 " )
P G&.
>.>
"
5. .0 0
P
H6< A 5)
3<6
% .&
*
K 0&
/
"0 ? @ , O& G+&1 9 A 0
0 0

.@ ")
" >0
# " 9L
A "()
"
@ 0 I&

G:
9)
A */ % emjm – edlj Isaac Newton " M&/J H* I6
I
0 0
W
", =
U 9 , = .&
" w5 "0
9 @ V H > % ")*
+)
" )
", ?J
."* + " ">& 0 +&1 9 I&
3<6
> 9P, ", ?J (")% L) "V "00
(emil – eddf) George Ernst Stahl 5/ / J -# < " I ) &, * G5>
5/ A
/
< ( ">
"
+)
9P, &, ", 0 .I&
3<6
!/, A E.( E* EP E* E#
, " "0 G#/ 1 9 !/F ecfj – emme Marie François Xavier Bichat ( @ / I
=/
"
I&
3<6
(
8P
Karl Ernst von Baer " / J 50 A
J J .I&
3<6

.>
@(0? ecjm 9
5 I6
(
3<6
A ;* )/ ( 2
/
9>#
P /0 G( !/
"
#
Y )
&
A P&
< '(
9
+1 7:P A
J H ?
9 K
60 .;
3*
I&

&
Q
//1
, G7 5 0
O&V0 G8% >0, # (0 "0
) .&
Q
50
.(

& GDr. Franz Antone Mesmer $ A 3*
< G& 5# 5 58> G( ">
"
5.
/# 5. @ " M> /* ; M @ 5& Mesmer 30 .
%*
5# "
6< 50
"
."^ (, -.)
@/ '/ M
6 &
L &
9/#1 ""&(" ", Y*/
.-.)

.
%*
5#

0
Carl von Reichenbach r7$ ) "
5, 0( G( =/

H6< 7 % .Odic force 1
@ M*, E "()
! % H
=:6 E
"0 %
( W 0 G&
:0
" * W )
0
", ) "0 ./*0
%*
M* "

) # J "0 G5
5> G0
H6< " )
", # :0

9 = "0
.&
Q
#

/ B A
J &.
&(
:0
(0? , .)
L 0
W
K0 :0
0
' , G
&
<P /
&
)
&*
9/ I
" ' , O& G&

.9/#
)
)
) 5( :P +, +1 ) % 3/ 1 3/ ) A
6< .@>J " 0 9

9 1 G L E( @ I&
3<6
" P
"()
"
+ 7
# !
GI0 @$# < I&
3<6
"J .I&
3<6
M)
9
+/ P # >J A
9<, &, Henri Bergson "/L I < G"()
"
" 51 7
5. .I >J A
J -&
B < K
60 .&
0
%*
Gélan vital 5 ". 9 * I6
< GI&
3<6
" ")

B "n G+&1 9 > A E/ Bergson "/L "0 "& .Hanz Driesch
)
7 7.n % 6J @ , &
6
A <#, # P, I6
G# +&, 9
"0 Driesch
; , "0 "J E.0 E # W /
" %
7
"n G3

A
1 I
9/ ?
& /
E ) E* = &
",
'

J " Y
6< "n Driesch B P # " .E#&
.3/& 0 0
:
7P

) ."()
"
# (9 50( )(
Q/
A) 3*
5# I&
3<6
(
Q1 : >/? (0? K

60 G@60 "0 ? ' :0
&
%*
5& F &/ 8) P
"0
" )
-
>
P
A
J GE# $*
)

&

8O& A
J Q, 6< 50 G(<L ..K
#
L P GK(
#
5&
P 5>) " )

:0
)
)
9
", " 9L
A .M)
)
3<6
6< # " P
J A +)

//1 )
H6< "V K A
J J G0, 50( E) ' , % &
L
" &

&

;) &

Q/ A 9
)
50 5( 0 */ P = 9 9 GH 3) 50( )
A "&
+)
O&, " )
L "0 % 60 E, "n G3L1 A .(0V )
9/#1 " P

%
G&

0
"

**" H/,
9) " 9 ) O& .:#
Q/

.K
6 " "
@ # I6

<*
G($$ 5&
@
J ( 9% 9 A ?) E.> >&
$ # P "J
Q% M* " 9L 9P M * )*
", I&
3<6
)
0
0F GRupert Sheldrake K(
I
A )
(0 0 ? G/ &
@( 5&
H6< "V "K(" Q . L : L "%"
&
.(E&? Y
6< >0, M$) 7/) .<# ("
) +&1 + !
"0
G0
H6< .E:% @:

//1 :0
80( O& I&
3<6

)
9<
A 7$) 7/ G

I&
3<6
" A
J Q, G01 )
O&
&/ " GQ1 &
G
:/ 9
:0

(E)*
) )
)
(0? " )
06, 7/ .5%1 A E/ ...H# $

#) G<# "0 ?

<P
) P G@0 K
6 5% "0
.E0, 9$&U
)
@$#
6< 9
3) (0 M:& A
J G&*/
)
@* A ? </ &( " I
3<6

.9/& I6# 50( )
9# ; E# 80 "V #
9)
5# A G
/ <#

$>:" $ $
</ "0 ? )* <P
>& 0
#, ,
:E# */ < "
" "5)
" < 7(0 " ;
9)
"80 9
I6
3/

.
? 5)
# ? "0,
)*
#

0(, %*
* , =# ", A ")# G*
9>&, / ) G+
+ ,
, "0
.....)*
+ Q% " < (<L ..: G0 0 G0 G/* ; G:0 G&)
.
)*
3/ $& -6 + M A +)
Q
H6< 5) G
<<P =# G&
#
.E & , E "0 "J G&
50(, " 50( v50 E: O .)*
"0 v50 # $#
%*
H6<
$& $% # " $? XM.
5)
6 9
5#, " +)
Q
H6< @# 9 I6
5#

6< <
@ , " $ ? GE6J . * 7
G0 "n K
6 5)
"0
6< a", .&
J A 5)
50 M> ...#
2 G< ? GP $% 3& B) V G* 6 9)
5# 7 .5%
.#

@<
I6
#
9)
a, ...9P 5 5% " %*
I1 M> ? 6< ", A
J $ /.

7? " 8 V0 5. G * / / 9
)*
<P
#
<P

.E# &
&
H6
+ 9$ G%

! P G :0 " )*

$)
& $*
"J
"/ !
G/ = G) # A
J GK/
+06

8 # " 5 /
!XK
6 3$/
%)

K < !E, :0
% 5 G*
5 :# A " & 9)#) "9< " "5L I I

" "7/ @ ," "K 5" 5> ": +
I6
0
>1 a"J "
.+
9 & A
J $ G"
+)
" >0
9<L G(+

P 6J ..!/1 < .."0
<# <
H6< a"J
% .:/ @( . I, G"" " < @)
! .

H6< 5) .#
&
<
H6< ", Q G($0
) :#
, Q/
E: #
A
J
06 "0 $/# ", "0 .6 " > : %* M* " @0V "0
K& 9 G )
#
5
. "00 )*
$*
)#
o0
o
=#
.M.
!
.
I6
< G"0
#
I<#

6< a"J 5 # 9 A
J GO&
)
@$#
)
%* */ G06 * :#
0
#
9/ M* " K
6 9 ."N :/ < 0 !0)

.#
<
<<P
0(, 7
"0
GE:

+&J , G(&
5$& 5& 5> )*
<
&/
<P
) 0
E 90&, 5& 5<
X # 5& 5. "
6
,
I0
3 )
E %
G(( ' ", 5% %
@ = I6
A/0
7.;
)

/
(
6 M.L 90& 7#
6< 5 ."
, 3&/ A
J 50
5$&
G
3 1
!
"0
."*
/ # 7*, # +, / $/# G#
:
= 5 I, " E
)

%
://
B
O& G"/ % M Yn /
G):
"
1 " # 5 G3/& 6<
.
!
( 50 @6 0 -6
6< . !
7*
E#
( ' ", 5% %

=

7% ", ) "0

.P
)* 0& @ 5)
Y O& 6

= 9 6 )

I<# 5F/ A
J M/ G<P
H6< 50 + "0 I6
9P)
5)
6 '$/ &/
<P
H6< 5$V P&

"0
3&/
K
6 */ $/#
7*1 +1 +# ", " :< 5F/
.. <6, *
!X# >V I, " E 5)

" E 5) 5:/ A Q/ I& ?

@:, " #
$/# 70 :5+/ G
5&
0(

+# ", " G
M>
6
= 5&
K
60 .!XB
+# ", " X#
:

!X" L1 M1

Q/$ (1 B>/
A $ "$ -$)
5#, B
" +*L 8) P , " 78
F $& ":0 A
J
5 5:/
5$& ", "0 70
!
5 580(
* &/ " # (/
A
) !!XH^ A
J....t "

5. " Q/ K
6 5) "0 ? .:/
)
@< A ? <P
H6< / /
#
9)
=*/ ?
"6
Biological Transmutations , $ K
60 Morphogenic Fields $$ # 9
@/ I&
3<6

//1 9:
" " 0 G"

& 6 )
&/
" >
.
@# #
<P
" @/, = Gt ## "* V .E# */ # 9

< @) 50 GE# 0
H6< 9 0
M; .+
" 0 G"*
* A ) GE.>
& G 6 V ."*
" * 5

!
, GE)* E, 6< % .; '
6
P&. / G9, ) . A& 9, 6
K G"*

:< 5F/
"0
.XK
60
!X:
"
6< +# ", " ."
5 & P&. / G6
) 5% "*
" % 6J
XM.L 90& "* <# 9L 6

:

+# ", "
70 !X
" 0
H6< A I& ? 6
", O& G
50(

+# ", " :N 5F/

...!XM.L 90& ## "* 5
& /# 5 & "0

& 34
E. 580(U 9/#

&
%*
5 ", & 0F %
, # A )
5<#
K
60 . 9)
9L
5 I6
( 0
>1) 0
%*
0 A *( &
$( ) G@ $&
":0
& E//,
"6
"/
"
" >0
" )/
.( (
>1) "/ *&
%*
5& @ 5. " 9/#

.3(
A& 9)*
" ": *
%*
"
6< A ? 5. " 9& A P&
>" /
% "J ." L / <" 30
""L
&1 6
/
" " ) 30 >0 >, 0T6
H6< .5#
6< A ")*
=# Q
E# ) ebdj 9)
A& ecbc 9)
"
, (
""
9/%, % !) A
J E:( 5 ", " !* /
9)*
" 9
A % 5. " !
(<,

!+
Q/ </# A
J E:( 5 9

H6< "V
& ( 5. <% < & "6
+*1
"0 9
5#
6< G9eccj/l/e J 6$) # @ %
"I( (
" AU I6
I
5#

(
9% G/
Q&J .)* 50(
@& B) "0 @ 0
. ", A
J ! / "(
3( , 50V
I, " <% "0 "(

) #& I( (
#& G &

A G/)

!$&
@
& $; 9
>V 9 !3( , 9)*
Prahlad Jani " 9" ,& -

!!9 dg
3( , 9)* "
? = "V " # .<" I

7$
5% G$#
78

" 50 9 ) G9jffi 9)

%
" 9, ( ) ."H( .7.</" 0
9/, G : , "( " 78
F $* M #
"0 ?
#)

H6
E<( $*
M
- G$( +#J 7P $/

!E, </

"0 ? 6 ? 9& !
.# >V I, " E
) ## #& " #" $/
)
"V $*
M
80, G
+ ) ./
A $/ %
@ A
J .## 3 " Q/
l 5. +
5 " E& +
=*/ ? I)
"/ "V 9)
=) $
H6< 5* 3( 9
50V 9
" #" /

!!9 dg 6 3( 9
50V 9
" #" /
", 7)
" .(9,
lee ? $ $

H6< ."K " <" AU ^ 7$ A Q, E>&, "H(" 0
Q#, %
9)
#)
>0
;
<P
Q&J H6< !* E; ~+ "K " $/
5 G*

H6< 5. !!E
.</ I

30 K < .5#

6< >0, A
J / "0
G<P
H6< 9
<06 "0
>1 " >0
K <
JC(D
" :@ G"/ " I
7
V " < G"
/>
=#
5% " G9ecbf 9)
(T 9%
.The Science of Breath & the Philosophy of the Tatwas" ("
)/ 3) E# * 9 A )

"V G$K( A , " " G> GE.) =:
30
6<
& A <>V
)*
Q
" GE# % 0/ / =# " 9#T I6
G30
6< O& .
/
$
0&
3)/ G5 , 50 " G@ 06

/ 5. @ , < < I6
.H% "/

=
9P, .K
6 5# I, " ^ E ( ' 7/ ..( ) 0
%*
"0
)*

! & .7" 1 34 <

A ", ? "& .@ $&

":0
& E//, E. 580(U 9/#
>1 %*
5 ", & > 6< 50
", 806 .&
A %V /? (E #
) )*
<P
H6< 3)/ 3# "0
GE)* 9)* .
.$&
:0
*&
"

" 9 , &
%*
7) ? #
3*

A$ 7 @ )
H G@ "& < "J . ; 5 & # < G /#, O& G & O& 50
01 H6
G@ )( G80 $ , .Q, E0, G $) 0, " @$ , .&

I6
S? , # Q &
< (
01 H6< "J .:
K/# A 0 >V (

3/& I, G@# # 6< Y 3/& /# , P
IF 7/ G# , .K/# A& , )
6V / G# !
@/ &

& 3 ", A
J (
0
H6< 3)/ 5#, " .

&
: *&
=%
" >,
">V ? (, K < G" ">V (, # / < "0
."0 v50 # 9>#

1 = "# A # 6
G
*
)
(/
.

& 7. < 3#
...XE%.*J
K
9P "J .

& 7. < 3#
X1 = "# ? (, K < GE "( #.)

.N ( " -.)
A " # G 1
$; #
", X9, g 50 $; K
"
", X( l 5. 50
$; K/# P)
50
", 9) 5<
5. 50
5$ K/# +, " 50 X=/, d 5. "# ": K
' X" 5. 50

8) 1 A 6
GQ, " E# E/#
' O& / $; /# ",
* ...X $)

& ", I, . < 0 $; ? I6
&
+(
"J X0
H6 5$V
90&, 5& 5< !X/#
:V
50

9L ":
E) "*/
5)# I6
3/
.< 0 A / , "
) /
)

.:
/# A
J
. " P
*
< =/, d 50 5.

& I, /# 0 # %* .6 & %* < ..@ "& " .. / , H#
P <
50 %*
H6< . /# +& , =# ( J .t
* "0 ? %*
H6< ..
" ~+ 9/#

5% . /#, # #/ )*% 50 50 = 5
0 G(%*
)
6< M* " . . "
:/#
5)
"
%.)
K >
<P
) 06 7/ G E% / ",

$" (
Placebo Effect
% +(
", < 5$1 5&? G?& O.> # V % S#
6< G-.)
"0 GS# $) 8 W
)
% +(
", < >
5&? .I& 5. " 0
5%
&0 G9/ I6
-.)
" ( # "0

^ 5. " @ ", )*
9/#

"0
90

& 5> G&

)* 3/ $/#
#.)

"J "0
G#. %
!

+*J GO
>

, .9/#
)*

.placebo effect /. 5) @/ "0 6< .@/ +( 5) 50( 9</
9)
& (/V/ "0
.7)
/
7. 9L =# 06 ;
5)
6<
* '
+
A I& n & "0 I6
*
, " O& * # O& G9ecbf
.S
9
1 " E A( ,
0 G+
@/ 9L "0
."
" & & @ , @ ) I6
%

1 ", 5% E0 E?#
H6< >,
.+(
0n "0 9
Q& " 3*

' , 6J "0
.#
< 9
/& 0 @ "V H0V 9L 3*
90&

& "/." 9/? +*1 @ M*, "& G9ebgg G
"
" /
Y
6 P
,
I, G
"< G""$
+
" 30" , " L
/0"
"*) 0 .@
& ? "#
6<
5 G@ ) I6

A +
@# >, 5$) + < @
@ "V G) @ )#
.E$: "$/&
, "
" ) G$& A <
+

9 0
G@( ", E.) =*/ I6
&
+

+*J " < ."/ " @ / !0) 5) K <
6< ", < <6
#
GL
/0 , "$ + $# <
) L " < +
6< "V @ )
5 &
K0 Q, ?& "/ " 5) 58> .@( ? @ , I, G+
= 3# "

5 &) # & = ^ ( A
J "$) ( 5& # +*n @ ")
9 O& G*
5&

.E//, @
) ? 5&
# ", = G
6< V E.) 3 (
6< "0
G(V*
K
6

.60
&#
I, /.
&# A/ P % .<P
H6< >V " ? &#
)
,
9 GI0/)
&
"/< 0 S$# 9%
#
K
6 A E?> 6V !&
&#
> W:
H6< =# G5
3
3/ 0
& 9?^ " " ) 5# ( A G"/ !" A G9ebbl
& &# ) S#
6< 9% GN & G)
L A
J 9
J ) "0
.&# 38* ?&

)
) , )#
O.> *(
90 S# 9% G"%
, .5#
+?F< " * " >?
#
(%1 9#, 0 A " / E)# 9<

9
()
5#
- .5)
&#
.E 5 % 9
1 "V 5#
+?F< =# S$ G( / ) .*
6
#
$&
M&/ K V , 6J K , I, .X(" %)

& 5. " /#
A 5)
>V Q 6< !0) ?,
E6J 70 G&& L 0
H6< 0 6J .9< !
& =%0 $/# ..E.) 5 &/ @ n K
6 5 & )8%
X"0 50 (
"/." 5) <P $/
GM&
9
, G)
* GP
=# G!,
=# 5> , " " ) "6
3*
I 9P)
3*
6< 9 J 3/ 5 G-. " 3*
3/ !
1 H6< " "( % G<L 3) A& ,
A Y 3/
6
.E: <>/ 9 O& :< -. %

3*
" (
%.)
H6< .@0&
? GK
6 .Y @ V H)(
3; 6 GS
5
A
J 3<6 L @ V
5 ", 3*

50( A !
"0
G/
3*
5# # (<
) /.
V G3/
6
.+ @
7 ", 3*

I,
!
" <L , E.> *(
5>
8 A I& 3& , 5
& 50( A 5 G' +
" %lg %ig 5) "V $% . "F
"1 5$) #J >V
"0/ GK
6 9L "0
. # >V
0( /
)
H6< .#, "
1 A #. 5) I,
!
9

1
< @) 0(
A 50 .&# , 9
:%
? ("&1 9P) +*1 " 9 ") +

.-.)
A #)
1 H6< +& 9 . H6< 5. " G9. 5:/ . >0 "

.0 >V
E# &# /
H6< ", 0(

= %
Imaging
5
@# M* " -.)

G / , " 0 <# 50( G5* % 0

9/ 9 $0 98) ", 5% 50( G(.$
) $)

a"J
% ) >V . / V 9<.
)
$0
" @8&/ 8 V )( G9
)
@ 5$ I6
50(
"
. Q1 #.)
1 >V Q & G"$/& )# G

& A
A #,
O&1 a"J .9/#
)*
+(
9P ( 5
/ A I% >V E, 5$

5 G+(
* ")( ? !
.-.)
A %
$ M) > 8
V # % placebo/. 5)
.-.)
, +
9< Q A * ) K
6 50 .=%
A $/# 9<0, ", I, .E, E/# "(
5< G(/. 5) = 5&

< 0) IJ? 50( P @ , 9L G# /#

&
A I0
>V
",
*
5) = 5&
< 0 Y
&
+#
" IJ 50( 0

H6< 9/ " (
"0 / "
.X/.
01 9
)
9 G!# , !
*/
92
)( -.)

G" / 50 0

9
!
+(
% L */0 9V " A A @* G@>& Q# GE# 9% -. 9/
.A
51 , E0 E&# A%? #
-.)
"0
.* & 9 " >0, B)
5,
lf ", O& G-.)

A
"0
1 F $
-.)
" / 0
9/
eb GE/ E /& P, :
jj G#
H6< p " / =, ) &
% A P A
" :

"0 (5$
) $
"J" :" / 0
5% G:
@# W: A @) .0 50( 9, )# :

"*/
. % + 9 0
G$/ 50( G@ <6
5$ ", $#
# I ",
.")

/
3*
6/, ""/# ! " 0
5> G#
-.)
6< 5#1 9<# 3;
+ " )
!$0 %
E 5 "& G !/1 ;
< $
" :5 G-.)
6 * ( I6
G"; "/"
=
5)
1 < G A
J <6 5$& /

01 "J G
+( 50 =
, Y 50( A &
<
H# 9/#
#
" $; ", "0 /

" #
G /#,

# ", I, G'& < !0)
G3
, A& G

#
)
S% , 5

.")
=0 5) #
)# 3*
0 /
&#
6/, "5#/ " 0
06 #.)
$
< "6
+*1 " "
>, .I0
-.)
A "*/
A
E# EJ 8 $
", O&1 >, "<," )# ."5"
. G)
/

.
< G
#

.
= $
",
, /
.9/#
;
;
9/#1 0
G91
; S
H6< $ +# " ) % 9
S "
A
", "$ G .0 3*
0 O&
-.)
"/ " V +/
" # A O& >, G"*/ 9)
!/(/ A(/ .
% .
)(
3
? A " # ", 3 # )# ">& >, .(
" P $

)(
3:0?
?) I6
G$
-.)
M* " )
9
& $/& :
| "

", "0 $
-.)
", >, G"0" )# *
!
9 6/, G( ! , 0
, .*
K
.
7
G /
GM1 '0 G3
Y/ _* G=
9
*; "
O& @>, 6<\ .+*1 +?F< @

J 5$ 6< "

= 5 0 )%

= 5
"
.0 0 & A
J @(
*( ", " 6J G(..I.)
O) # )*
)(1 9/
% .& )% 50( /#
$/# 7/ $) &
& $ 6J , I, .()%

) "
&

@%/ . "n GE.> 0 @ V @
80 "/ ", " 3# 5. GK
6 " >0, A
J
.J? ; ;

" 6$ ,+ C)
" ">.>
)/
, A / G"O/ ( .-" /
3*
*
!/ 0, )# " ">& 9%,
"
<# 90&
A ,
H6< % Q ) /
H6< " , .(L) 5$V
! G)

6< H#
<# 5) "% & GI#
! A I& n G< G & % .0
M*
) >0 A )
8
A
1 &
G &
+# " 580( I6
9
=% " 6, M* " !

) G!

0
5 9 ", ,
" * >
&
"0
G+
9
0
. 50( < % +

0
", K
6 ) 6,
)
8
.$
M* " K
6
9/#
# 980& (
%* 0) 5$V

" 8 % GE, K

6 ) G!

0 " ", ,
" * G>
>
&

."! =% @ 0
!M$ ? ," :E(< <P
H6< A O/ 0
M8 .Q6V 3 ", " 9, ) !

.<P
H6< 5&
3#
" 7?N %, ", ) ">&
+*1 " :
@ S$ 6<
9#, 7:P 90&
A 9 ") G<06 /,
,
0 "
(1 +?F< " >0
K <
G9
*; Q/ G9/#
& # G3
/0 G( L )
/#

.0
K
6 50 GQ, /# 7:P " <L G!

<V*, !%
elf A
J
@ / = Y*/ I6
(9ebji) E.> $ <* I
" >& %
.!E 7% E &, !%
lf / A
J

@ 980&
=*/ G" ": >.> 5% " 8>0
/
= I6
G$ & I
K
60
*) /1 @ ) 5)# 9% ? Q&J .!@% " 7 / 5)# * @ )
0 GE, %
! G%
cl / "1 @ ) 5$#/ G%
! G%
efj /
.!%
mj @% /
I, P 0& ", $) V " / 5. ")*/ "6
G"
"L
9
51 K ,
" +
, G)/ , 3
+*J , G) J # A
J !8
+*J 9 0 .9</# +, "
/
(
" &
# "0) #
*/ E +
=*/ " 9 G*
3( 9)*
.91 H6< &, A ) 9
M:& H6< .0
K
6 50 G7
V
M*
" # ) 5, " <L G
5% " @<# 9 9

)
6< "0
.: >/? /#
<P
+ =/ 0 9
" * % H6< "V 806
.K < <
5 & <P # @ V0 1 )# O& )
//F
9. 5:/

"$4 $
0
% 5. " /#

&
#
# 5#, " 9:

!& A 9o
@/ G(
=/
6&/? 50(, " 50( @ V /* ;
9
7$)
) .("*
5)
)
5)
= ( 5
9> " G(E)( E/& 9
<P
@ ( )
@
" < +&) 9:
+& M* " $) , 0, , % Y "0 G5
6< 5 &
.(N 5)
* *
<
&
H6< <P 9<, G(
" 0 / / "0 GI)
9

&
@(
3% /* ;
9

.(9:
5

1) +&`
3#
A 0

9, E.>
( 06 . +/, 9< E.0(, 6 @ , 9L ) " 6 /* ;
9
x7U
9 5. A
"& 0
"0 .Aesculapius !?0/ L +
@
J ) 0 O& ML
@
"V E ") !) & ")( 9< E& "P/ G&
9 ) " = +&n E.
)

.9, " 9#
9 + >, 9*
<L K 90&

G"806
A :

" 5> E/* ; 9:
<P
:
0

A
J
:5> >0 /#
9:
PJ )
H6< >, G"N < /
% "
:Anesthesia )(
!&
3L
.K
6 A @>&
$) +( )( ? Q ? =/ ?
:Hyperesthesia )(
!&
$&
(
@0J " #) #
E; "0 @ I1 3# @ , O& !
/& =/
F
P& a&
.I)

:Hypnotic Analgesia 9
1 5<# A

.&
9?N
J A
@% 3/ ( =/
"
E# E):( /* ;
9
"0
9
( =/
"
+*1 " >0
")/ .@$( 0 9
1 5<# A E/* ; 9:
% <
*
H6< / % .A
&# %J 5#, " ) , 9
& / 5/ /* ;

G */
G9?N "0/ 5#, " E, /* ;
9
9/ ."
7(0 9 ", 5% %
"
K
6 5 & G+( )( ? @ V
+& M* " K
6 50 .& 9?^ " <L GM&
" #
K
.E.)
:Altering Biological Conditions #
; O&J A

J.
0&
A& GH/# +, " IV 0& ", E/* ; 9:
+& M* " +*1 Y*/
# 90&
A
J .aJ ? a/# 7:P " <L Gt/? M$)
# !
# 3
0
.9/#
&
.E/* ; 9:
Q
/# ; /# & P
( =/
"
#,
3#
Q&J
3*
, ./
A :

@, G
*
"1 3 #
A /* ;
9$
P A1

9)
= !* 3/ I, " &$ S% < A P % !:
&

A 9
1 $/# Gn

!&

!

$)
<
",

:Self Healing 6
+(
A

.a)
/#

&
<#
@%. 9/#
5)
9v0& % (/
<P
A
J ) <P
H6< >,
.: 50( +

9
0 P& 5 & GE/* ; 9:

# ) ", +*1 Y*/
5)
/* ;
9
* P, & #) " <L G 50( S#
9:
=/ A
J
."/ `
/#

&
=
P E.) K
6 5 & $)
& B) @ V @ %J
+& " < G*$/
G)
H6<
.S H
&
K

3 "+
Possession
L *

( ", @ .+
0 * E/ possession 6&/? 9 "0
I6
P
"0
G>0 <P @
6&/? 6< . 1 @ ( " E 7 GL Q, ( 0 6V
7
Q, L :0 " <L , 1 , 0:.
,
N , "#
,) S2

< GH "&
" !* " <L %

%J ) IJ 50( 9/#, A
J 5 ", (>
7. 3/&
# J : >/ 5V & " (L , "&
& " ", ) .;
:0
H6< &/ 5#,
.#) " <L ,
A (
, 9</#, 7/
!;0 %
)
(
0, &

5:% ) /^ M( 3 # , E
& B)
5:
" # K <
H6< " =# G
/, "5 #1" 3)( " # #
0, "1 & " *
5:

L @( , (L
. " G !* 50
G / " 0(
#

(
0 G</ "0 ? % 5, 6 " 9> G( :0 " HL , "#
, S
9 6&/ O&)
=*% V0 -#
=*% 50V " 9 !&
-#
/0 " =*% A "( , !
5 , 3
#
A
!06 Q6, IV ", " G
#
" =*% ") G0/
"
H&/ 5#, " $) E/* "/ G!

S 5% " 6&/? <P ) &/ 7:* K <
3)
% .Q, : >/ # J A
J 1 5)
" "/
" >0
+( A 5) 9 6&/
G
G*/1 M(
G"01 G0
# "0/ )

!*
E/: E 6&/? 9
.&
9% 5. *
H6< / (
, * /
/

0) "
, .,
./a

%*
9< 9 6&/ 0
GAIA 91
N &/ 5#, " /

< @/

3*
(
:)
< 9#
)
0 ( #
?
S1 (,
!"*/
" A& GE.) "( +?F< ", < 1 >
GJOSE HERNANDEZ

")! 7 9 #"

*%,
G / %*
5& <P 5 >0 O&, ./#

5)
%. A ) H., 06
<P
=#
A
J IF G

& ; I, 5 & ", (0 G"/ A
J P
#
*
H6< @$#
6< 6
H6< A# .:
9/#
; A
J IF %*
5& ;
6< .(/* ;0) I&
%*
5& ;
:

0 >&

)

:

&
.... &
%*
5& ....

&
>, .(
) 5)
< /:
/ :1 1 " :
mg "V / "J 9
+)
+*1 90&
>0, A& .
" G&
/0
5)
/:
3/
< G5)
" W I6
M< # ", ">&

?& " & 6 ",
"0
"V " F /#

5)
%. E00( +*1
" "6
A
" :
lf / 5) ", E, ") 9< .
S#
A& G !:
9 V0 9 &
, "0
&
" /
9 , I, G< V " 9< (/

.(
&) E.) " )
" >0
7(0 .&/ 6 G# 1 5)
#
) "5)
" 5 <P "0 9
#
0, &
"
.-.)
*
H6< A
J (

**

IF %
I
$
", A )#, 3)(
H6< =# ., " 1
/, "0/ ML "

G9)
5# */, A
J "
#

" 0, 5/ ", 5% G
A
J ? 6< $ .E) @, P A
J
W ", "0 G3*
E E 3) ", $

"0" :5 "!/" (
I//
3*
30 O&
."@#
) ", "0

1 H6< a", 7(0 7/ G+

./, )
#.)
3
/1 & 3*
A )/ P
, 6J
58> #. &
@ ) E A(
"0 .5%, ? >0, ? /. 5) Q/ "0 9
:
-.)
M*
) 5/) H/# M* Q&J S# , G& < 9) H& , :( * $& , 5
5 5 +
5 !
+(
> % !
+?F< ", < &
.' "$/& <) )( @)#
0 (9
"
7( I6
3*
, -.)
6< " F 0 "J ."$/&
9<)(
w70 6< !#.
9
(
" E
L GA
-. 8&# >01 ")(
+*1 ", 9P&? 5<) .-.)
6< A

!
&
5)
9 I6
+
6 & < 9 (
H6< X"/
%.* &

.(A

K 58> G "% A

J )

K (/ ", "0 G&
(
% " O&

I, G9( A 9# 9 < G* & 9 K
6 " 0 .!!
M* " A
+( A ,
.( & ) "0 6<) ! " /$
*1 K
A8 ", )

;
&$ " < G8/
)
3
"
+( A "0 E.> / K "0
+?F< $ ", *( G@# 9 @
" "6
A
" :
5 ! K
"0 .\5/
+ /
9 jlff !
@ , ( !/
!
K
" 06 ."K( GK/ K
": +/F
A

0 J K G6&/? "6< " "( 0 /, K G"%
"
"( 0 G#
K , !@#
5 G) *

9% K
!
A
+?F< +( + "0 I6
3/
... Y
+ " "( 0
+(
A @ M*
9 J A
J GK
& "0/
+?F< 3 "0 I6

<
)(

.E.)
" 6 I, G( =/
"
A& G
)
9/ 0
1 ", < ^ E, P&. %
&
/ L * 9
+*, 5% " ) & , G"& " +*, 5% " 7 0
G3%
.* )/ , " 9<6 !
( & 0 K
6 = G"/
* &* +/, =/ & , G*

5#
H( I6
5:
9
O& G )
6< G9
,
% E , >0, V )( 6< )# G&* " <L "I
&
" "|/ /?" "I(
9 #
" 5> G#
6< & Y 80F
+ & <(
? "0
.1 A
J P
)
K @: K % 3*
", "P
./ 50( *
9P

7/ &
1 " 90 X#.)
9
5:/ " +*1 5/ 6 G9jefl 9)
I, G"N " 9 : )
X
E: 5 & 6< !
, X"
K
6 9/

Q
)
#
>N G0 5
#
>
#
3.
" #

&
"J
&
@&, I6
9
# A 7$) A& 9 : P 6
.E%.*J K0( L & & , G/
X
&
$

V )

"J ."
= / $; $&

)
M:&
"J
H6< .9
A 5$ )
H6< "J .$&
* V "&$ ") O& .EL $; % G9

0
*
9> ") )

0 .(
" 5#, 5#, @ $ I6
=%
< 6< .&
<
G
)
1 0(
> A*) J G )
6< G"N , ."$& 0 K
6 9L G"6)(
A& " (

.&
% A : $&
&

) & A
J @( , M/ * .3*
%. I,
!
5# 0
%.)
//F
K
//F
H6< A ":
.3)(
A E>V E)% >0, 9, =/, M* A "0
G"6)(
0
3
/,
5, <
"
G
9. 5:/ 5. " "* "6
"&
+
+*1 " E(# " #
((< Q
P G(1 0( " 5) <%, / A )* GK
6 !0 < &
...!

?&
K " 6
J $ # , 5 & G1 H# &

/ $# $& ) G1 H6< A 3)(

"n G@0 K
6 = .E, $; +( ? ..E: 0

* & E:( "0
.1 5 M*
@/* -.)
3
/, 5$ 9L G*

/ )
G"^ (, @) A */ ", 6 G
5& " $) & G@/ @ "/ " < G$;
= = "/ S .0 , " )* G ) % @ " & G9<L 0 "6)(
0, A G0 5#, V( .@& M8) E G: & A
J -& 7) M @ V %

)
< & , A& &

& 980& G:* "0 E
L G>0 % G5# A
J 5# " > )
.
&

=
H6< "0
..""*
9?^ K
3// 6< G"
&
- ?" :5> 0, A V( J
."60 60 5 " , ";
= )
5 G"*
9
V )( 5& " :(
+
" < Q, %
9?^ 3// 1 G

!(
)(, & - ?" :1 0( <(
/

5 G5&
K
60
H6< Q&J V )( 5& " " L # */0 >0 1 , P G#
!,

06 P& G<L 7?N
H6< O J .."+(
5#, " G # " 60 60 5 G1
I, .IJ? 50( K
6 5 & G<6&
H6< 6 /#, 9 .E%.*J K
6 ) ", " G :/V P& 0
@ = , 7/ G* M:% )

Gp* 3/
'*/ A "
& &, A( 7 6J
@ J G, "
@ ;
+(
K
6 "0
!"*
9?^ " E.) ) 7/ GK
6 )( ", " G5
5)

+(
K
6 870 G@ = ^ + I, , G;
= )
" E.%
5 G
A
J / ", &/

50 <6 3#/ G& # " J .
'/ "*
=# G, 5
" ;

:@ +(
K
6 5 G"
" *
% !( & &, 7 6J .0 , J "
.60< ....!,
=# 8.) (
)( G"!,
9
, % "& G!(
& I#
5* %
"
& & " # ) @# ", A

J G #

/#, 3# I, G5&
6 $/
+ 5/ 9 ", "0 .
K 5$) )# G / I% >, )
H6
"0 G & $)
.9
1 "0/ 9 G+*1 @ I6
!0.
5> G & >0, + G"*
=#

G;
= )

!E%.*J "& ? !+
E: $
)
.+
< 5$ I6
G6 A &/
"0
< G
$)
?&
H6< " Q%, , G>0 @ "& " Q%, J
5 " # I, " =/ 9
"&
O&
G+) E.) , A
J ) 3/
5< . / 5#, V( 0 V(
/# Q/ /
X+ )
M&/ ? Y
6<
O& .A
1 >.>
(
G

& G0/)

% "6
"0 3#

$ % *
G @( 5 G"
& * !
G
( !* 7%
A " #
"#
"6 1 ."$
*
+& G1 90&

" Y
K
6 S P&. !/
GE0 | " 9 GE " 9 .." * 9

V )(," G"
" 7/" G"5% 6<" "
9 , G"
"V ? 9 ," G"B& 9 ," :5> ) | 3$
# G%
! . 5), " <L
@ # J A 5) +&J Q/ /
&
< " <L G">0
" Q%,
6 # 0 G5
B# =# @( "
*
+& H6< . % " 1
^ P " )
H6< A
J P 6J "0
.5$&
% A 9/#1 5<V "1 K 6 ) %
1 +?F< "1 G(

& 5) .5$& ", =*/ 9/#1 "V
5<V " V 7(0 7/
"P G5, " <L , G%&
!(
)(, & , GI# !* 7%
0 G
H6 " "6

"0 ? G) )*
& ' (
)
) #
H6<
" " , )
.+* %
3/ 5
< @ " ) 50 !<L , 9
1 ,
0 / /0)
O& GE.> "

"u
(" 5> GA %1 M(
V(
5
" ! @ ) 6< !
,
/0 ")*/ X7
A 38;
/
5$&
A :
/#

9
1 980&
0
%* "/
)( I, " /# ) * /
+
, G!F
5#1 I1 #& S
,
X<6 5, " K
6 L G3)
, 9
1
Q B) 39 l" 3
3/& W ..HL " \5/ ..
" 9P " < 50 .X<P
H6< + "0 I6
/
<
$) # M &
/ 50 .. V( Y 0 P , " <L I0
#? 7P

9P < 50 ... "^ " )" >V <
#
Y 3/&
H6< & 9 .. $)
"
.(06
$
)

3/&) */ # 9 .. 0 %* ...%*
"
..%* " ,
* ..+( aI, W
) ..+( aI, 5) 0 G <# #

9P
6< */ "0
= 7/ ..# 9> " .../ * "J ... 7$)

< K 50 ...@#
% %*
.#)

.................................
=$ ," 2
+
0

)
>0, J . 0 ,
J @ ", " * ) 5) n K
6 = 2/F =
.0 ? 7)
6< "0
H2O < +
:0
;
.1 @# A )
+/ K
60 9
+/
E)
"J .( K/ 00 "n G+
6J .
&
%* +
.1 "( J .&
+

580( 9> +
5&
" <L 0/

")
=# . /#, " %mfzdf 50( +

=# :0 & %
=*/ +
K
6
. :0 &( 5& <
Gcolloids L
P& G&
:&
H6< 5& A % A n G3 , &/ A
J +
5& A& .&
:0

#& G&
) +
", .’ *% ^ A& #’ 5>
5 0 E J .%* A
) A

H
0 >0 "0, 0&
H6< F 0 G & 50( 0&
5. " /
J A
J :
.E.> !*;

" -
# " & , .: l & # & >0
& "0 % A %, +
u

& .)# %*
A % Q
% " =#
, +
"n GH6< &/
&

G"/ +
, "0
G: l " % +
& # "0 G#
5#
, ;
Q
%
GE > G &
0& & I# "V E?,
'/ ", 3# G& +
A 0
.%* . /^ '
.: l u

>
& # A
J 5 0
%* / $ n 1 5& +
7* .&
%*
=# " 0 +
)*
0&
"J
.&
%
50 A
J E # %*
H6< ' 9> " 0/
%*
H6< +
.

"0 ,/, ", G: >/? @>&, 5. "

"
L( 0 I/
)*
9
7(0

1 A
J ( 5. " K
6 A 5> 3 .9/ )*
#
0& 5)# < +
@
&
, G8&
A
J Q, 6< .Y/, 50( M )# 9/ 50( / +
5)# I6
/

:

#J’ 9 .5 &

/ "0 ) 9
/ >& / & , 8&
# #

O& "3
" / "9P " A
J E, "L(" (, .
, +
"n ’9/ 50( /
A 1
GK
6
.$& +
A % +
}5h)h# 6< "/ = " % M ", A #,
.# 50(
Q/
.
7 A
7 A
J <+( J Q$,
G9 L( /
* ?
Q&J
.E, )*

/
&
=
9 . A
J / 3 , 8 < +
( >01 M*
Q&J
0/
<F0 %* / +
"n G+
*; I0
*
% A )

9/
5> /
0

M* "
3# 0
0
E E) ' / 60< ./
E *, " "
"n G, .0 #
)

H
H6
" L n P&
+/
."
"0

.0 50(
& % A
J IF 5 &
A &
%
+
H6< "
"&( 0 . 9) ", 0 P&

"/&
. 9) ", " E? 91 )*
% 5 )# / /*;
"J
5 )

. = O& )*
&
0& !
E 7 )# 5. " &
%*
+

.&
&
% G#
)* G:0
%* +
/ diamagnetic /* ;
%*

&
0&
- J A / 0 3 1 5 A
J
( ( 3 1 L(
# 50( A )*

* M
+
'/
3 1 %1 */ 5&
A
J +
# 9
vortex a
"#
,
E *
H6

+
"J .%lfzif / 5&
# " K
6 "n G &
H6< " / 9
6J .&
L # w, A
J &
/
&

) /
5& A
J Q, % flow
/ ", &
"0 ? . / , A % % "0 +
A % 6J .+
A 7/ O
"n )

"n K
6 = .&
+ A + E# I
" 6
.P & H K < "0 9
1 H6< A

)*
A
J IF

0
6
Q
, A I & 50( )
&

.1 A
J
3 # 0n "0/ +
)*
0&
" ) 6J .91 )*
<
!
A
J Y/? 3#
@ I6
!
9) ", "L 0 6J 6< .5.? * !
-.)
F 0 G+
.300
50( " >0

.)*

:/

:)(
E//, +
"0 G
"%*
" !$/& A @% I
)
6< ", 5%
!
+
3( GM
"*
5& */1 G3&
&
&
QF
G!

G"&/
Q
)
0
K " M G3
= < J
"/

^ Q
# .)
, /

Knossos !/ Minos ! K
& 0 I
)
.I L 3# + <

9 0

&
! 1 A
J ) ", 3# +
", , A E 0 B) 0 #
H
5) ..$&
..
&
, ./ H , A H
Y , =# % G )/
.3(
H " @ ) I6
%
6< .6
I#

u
M* , A *&

QW# - 9 .. =)3

.+
A 01 >V " "80 9
5, < G(
, & GDavid Schweitzer ( 0

51 H#? 6 ( A % .)
"
E.:/ EP " "0 ", =*/ +
"V P 6<
A
J $) / < .0( 5. " / " Uoh)T 9
. "V 9
.9
5& E ' , ", )
" :/

K 5& >0, O& G+
0 A 9
. "0 ..0(
H6
L
"
1 50(1
E)/ 3
' E(0 ebbd 9)
7(0 G9
@% " / ( ) .0
5& #, #J 5#,
*) homeopathy >
#
)
/
K )*
1 0
H
axU

G+
" 0 0
& 0
G
1 /

" E# ; 0
+*n 58> -.
O&
& G(5) >V - 0 ? 8&

0 "1 )
+
06 A ? "0

7#
5% G?) ? .
t
" %.)
@/ ) .9/#
5:/ /
, # 01 >V
5/J 5#, " */ 0 ) )
#& # ) A
J
" :0 " Joseph Duggan "#
0
/ .)
5 A % L <& ")
G"@ Q, * A
J t
" * " )

Jacques / K# /
9
)
"0 .@/ +
< 5%
"0 6J )
3#
+#n (
)
K# ', % .homeopathy >
#
)
<, +
06 A E/ +
A
, % Bienveniste
.@ ./ 9 ", 5% M/ % @ # 0
:#
Y 06 ", =*/ +
"V +)
" HL
@&( 9 6J G
9/#1 A I& I6
+
"V P
9# ebcc 9)
Nature # (
@ V0 +
6
#/?
. // G 9/# I, " E E
' ", A
J
@
+)(
&
H6< "0
."#
6/1 +)
+ */ 5
K
6 >, % . 9/#, A I& 5?

, 0 06
.# > * 0
" ( 0
> ", =*/ 9
#
9
6<

P/ S 6 P/ .) A
J 5 9
M* 7 ":
9/#1" "V 5
"( ^

.& + % *) + # A 5)
( , 6
GF
% 9/#1 H6< 5)# 0 5& 0 H*
" <L 01 = # H
#
somatids %
.
9/#1 ;
Q ", ,
%*
, 01 A )" & .0( h"0 Q, G#
': A +
8 ", 5% E .>V

"
"a %" .<& #
3/& E, H; "0 0(
9P
6< "V P&? % "*&
&

) 01 0 6J M
V =*/ .#J 0, # +
#
:
9/#1 "V 5)

Jacques Bienveniste / K# # % ."/ 9, #J ?) 0
0 50( 7 G?) ?
&

/* ;
)( "V G+
)
" =*/ 0

"V
@( I6
0
+
5& E6& M*, ( 0
", A
J .>
#
)
A %
M( 7# <( "n G/ * +
6< 3( 9 .=*/
+
@) 9 I6
( 0/.
(L1 7#
IF * +
30 ; =*/
+
"0
G9
7# ? +
3( "n G" .3(
."*

0
A G

, 0, ", "J /"
O&
%,
: >/? 3#
0,

H
:)
#
:

O&
! !+
:# A >V
0 G0&
+

G>
/
H G)*
=
H GE0 #
)
+
:E.> ! . ?& 7P
$)

/
Q#, .< H
Y 3/& G<P 0 7 #

", 7(0 ... <L
=
+
#

<) 9 GI#
, 0
9> " #
* E) +
A @>&, "J"
A 5 &
Y*/ $*
s $# # & <0 9>G & + * # M* ") ..
$) I6
7P

&
3/& +
*
#

@P, I6
50(

5. " E# )
1 &
" G>
&
" G)*
=
" : >0 " H 0 "J" =# .@
0 0 G

A/
) 5> ?& 7P
) $ % .<L .. #
M*

90
J .<P 6# ; 5 & P&? G#
) .<L G+
, A
& 0
) 7P
$)

6 H
" "J" 5 &

)
:( 50
0 & " H

( / = " H G#/ = " H

) >$

"
GI/ "

(<$(
" 6V)
H
" 0 ) 9 .H
A A/
>V Q " M& ", J /
,
$ ; 9/%, A
J
+
" 0 9$/% :

0 0 G*
, .A/
" Y , A
J (&
" ## 50 = */ K
6 GA/
" Y A
J ##
H6< " & 50 $ .## $
:W:
" -6
) 90
J .#
& 9% 9> G/
G"/
$) H
A/
$) H Q& $) H
(0
A/

" /

", J % GA/

= =/
@# A
J G@&
:
= / 5 +
", & >J )
0 A
J /% G
)*
+
" 0 +# .:#
+
A 0
0
0? >V Q !
9
.##
A
M, A +/, 0 9% G## 9/% 50 = G;
:>1 ) 90
J .!8>
)
3/& $; 9/% 50
:#

", P&? GH
& ) G

30 H 30 H 30 H
"" ? 3&
" "E0(" .. $ ,"
"K%, 7/
A =D) D) 2=D$ &A $ 2 $"" G $ $> $$ 6 =3 1S H39
.!&$ & (
I6
+
"/& ", @/ =*/ ( I, "V G<.0, J " GRandy Ziesenus ! / I 5
5)
) )
K6 " 3* K0 & " @0/ +
" E/V0 6V O& B< 1 @ J" .@/
< 6< ! / ."*/
!*
6< @) B< 1 @ J G@( 9> .@ @#& +
K
6 5) ", ("*

5#, " radio-frequencies #

9/ &

*
90z 0( !:
5. "/ 9/# ) 7/ +
6< "n I(
9/#
= 9L ~+ ( 6J" K V ! / 5 .+
;
.
=# @# @) 5& 7/ (9L
) +
"J .&
A
J 3<6
K 3# 9> .% egzef
.("& *" 30 5
Y
6< ! 7/) ."0
9/

B $ 2

+/ 5F/
L
)
9/? "J .K
6 K ", " & K
6 n G% # I6 + 9/
: >0 5 & K
60 1 8( O
E ' , @0 300
", # A
J 5 % H
/

K)#( 9 % G @ ) I6
"8*
7P
+
" " "/ 7/ "

";/
" )
.&
:
? &
!
#
.&
@( I6
+
6< ", 9L G9. 5:/ 5. " @/ K %J
9/ +/ 9
F/ 9 (
5# "n G&
%
, !!...K/# &/
0
#
?
? G*/
)
H6< " .
+
+
I, ... 00 /:
&

$ 7/ /

P 6
."/ J 50 M& " <
(
&
, /&
&
, +
5 & E, =% ", 0
:
/
3(
'

+
& M) L( 0 P # A
O& G 5:/ A 5 &

5#, " @>0 9> I)
+
5. " *
+
A 5 & :#
3&/ ", A
J 5 7/ G<#
@)* 3/ G+
"n G
&
H6< .:0
&
" 7P @ V E<P
"J . )

5&
5
<
... <#
@
^ 50J 5#, " @ +( I, G@ h3o6 G@
J
."6

+(1 !/ 5#, "
@ ' ? I6

* E* ~+ A 7/ *
+

6 ")

7/ 5/ A
J IF 7/ !!* , < *
+
3( A ? "J
...3(
5#, " *
, 9/ ? .&
" +
6< I( ? !! H$# 9/#
E. ,
0

.!K6&
" E0 E+# "n P&

+/
"0
G)*
@& + A , < *
+ "n GO L #
"0 5& :
+ "n G*
+
0 .)*
= 5)
<#
M*
" #
&
*1 @ 5* 00
.*
@( 3 # 3# 3(
3/ L *

A P % ) A2

)
A h#U O& 0 M, " E
L G1 "* " V +
6< :<$
A
J ")
" 0 3 A
J @ 0
. ^ */ '*/
& hU , (& ) = 50(
.?&
"/&, > % @ G3(
@/ & " .@ 3:6
"0

#
O
"V 06 .@ )

5& 0 E?# K
< "n 6
1 !. +
6< :$" H$
" #& G(
!(
)(1 9 50( ) &*/
+
. #
+
+/ ) *
)(1 3(
+ ) 9 3# :P&. .+
&
>V 3/ +
%* % "n G(0 /
!!...E, (
!(

.@ &

")
" >0
K < "1 # "0 n G(
) 1 " -/ H
H6< "0
:$ H$
^ 50( A , G; = 50( A #
S/
P ", 0 G#
*
M
@&
.&

)
G")
L < .&
A O)
3(
H
//1
H
H6< ) :<$$ H$
G=*/
M
"

V 5. " <( "0 7

)
&
#
"J . 5&
"0

50(
5#
"J .: l # " @& 3 B) @ J .P
6< ! ^ + I, P ? O&
6< "n G(
"*/ ,
# 5#
O 9 9
6J G3(
+ =#
/ M* ) =
H6< "
...@ O&
3<6
E M&/ GE 3(
&
A +

(W$#) $F ,A 1" <$" I )$ [1 #

&
N H6< 3/ .<$$ ) Y$ 0 B
% @ "0 @# , I6
+
", K
6 "+
&/" 3
A 0
" ( I, #
) A E% 0 "0 .#
)
0
5&? @
*/
9* "/ @ 0
G"*/

!*& @
^ A #&
9 .#
)
/
5<F L @ 0
:'7 $1
G+
K6 =# ", ( K& , n G# # + , & = + " % * "0/
PP& 0 6J
.H/ 9/ ? K A
J H6V ",
I
50(
6 L( 0 A , % .
50( 6 8
" +
@ 5. +
& A P&
3/ @ 1

$) # $" H$

:#
0 ) & " 0
.X)*
0 = Q&J (0
&/
H
)/ 5<
"
=/ 9
, E)* .X3#)
<>V ! G 50( 0 0 - J A "% 9)#
) 6J G#)
H
H6< !&1 /
6< 0 7(0 ? ", A ( *; &
?
"1 !E, =/
.!< , H
Y , #, " % ) >
H
' 7/ GO$ 0 : */ ; 0
X!M$ ? W:
0 &
?
0 " 50 #
H6 %
..!5
" 3L, &
"0 E
L
? GK < < 5 & E>&, (/

3*
) #
9)
<) 5? E/ 06
<P
H6< =#
L
? Q, 5 A
J G)

5 " 0 / 5 3/ # <6, "0
!/, A ? &( <P
H6< / =*/ W K .E%.*J '& L + 6< "0
.E
50
&/
" A ", A
J G"
" * 5* + % =
$) % )
W
6< .>

)
9<
) A "$)/ G
&
.I&
3<6
@ J ..I/ 9) .
"

.9 50( )*
$&
:0
$/#

<P
/ I&
3<6
5#

:DD$!
AETHER
% $ ) %
:<$" -$
M*
t
A& # < G"0
+& , 50 5;; 7>0 %* 5# < (ether >2
!
) Aether >1
G6

G6#
Q%
" 5F/
@ , 0 G50(, ) @/ $/# ", >2
"0
" .( ? O&
.//1 Q
" <L G/* ;

"J .&/

#
+
<)
Q
" )
90&
" 0/ >1 9/ 0 98) "J
. / , 9 "

0/ 5, 50( *&
9
)
9 " 0 7/ ">1" 9 A 7$)

.(E # L * 9/ E

L) "N 9/ E '*
6< GEther ">," &, ">1" 0 P
"

H6< 9/ 9 @ , " 9L
A .E.>
# H 5 I6
5%
*/
7
9/
.
& A ) ? O& "" 0 , A 0/.
5#
"
" 9/ "N , ?J G9)
5#
.">1 M 5#, "

" 0 - J ")*/ "#
:
5/ # "J" :E.> "

."6 >, 90
& 5/ ":
V
@ 5 5/ *& =6
=/ %
" 0
%*
&" 9 1 9, =#
> " 7 G(I
3<6
) "0
0 0
P
5%
O& /

/ K
6 P&. 0 .
-6
50(1 =# @ $/# I6
Gsea of energy
M(
" 9
Rei-Ki "0 I" 9 K < G"0" , "(" 9 Q /
6
Gprana " "
9
7) 9
6< .%*
" 9P)
&
6< A
J (`
ML @/ ">," '* , .E, A %1
< " ~+ G9
)
5& Gshamans " (
9
J (
G"
"#
)
=# Q
' 50(
@) ) 9
6< 9)# GH^ A
J ..G, A
J G/
(
3*
0/1 A
J "01
. M*
" "

%
) $&
%*
5# K
60 6#
<P / 9</ $# 50( >1 9 3)/ ",
.E Y
9
6< A /
)
*
" >0
1 /
, % G(I
"%*

K
6 G(P&
5 ) +
" Y/, 50( )
K
60 %*
5 % G9# 50( G
3#
>,
)
/
: "/
P
" 60, A 50 50( I6
#
5#
6< .">1 /
" 5. "
."0
9 :

%.)
58> , A
J Gsuperfluidic %
/ 6 */ " V >1 7 "0
.6#
+0
/* ;
0 : <P $/#
0
<P
=# "
<#

-
G9
) ")
G":0
":
"/
"
" >0
'#
9/ , "/ "6

I
)
W
M ")
9<F. 0 *(V "/ G5#
6< E# $* W:
.9&
")
=#
"
- J ' , O& G@#

90&
% 6#
5)# #
A& G@/ < "0 G# >1 "V 3#
>,
G(>0 +
" Y/,) P&
50( ^ A
J "0 " %*
)
5 # J 9 % GE 0 $&
%*

&*
<# "N & , )# G? ? G.
G%*

5# )
0? " K <
.M/1
.
6 @
% 3# >0
K G#

&
" ,
% ) :$! '
< <(, =$:) "S 7)T G

%*
" : L !/, A G7
s 9L "0 3& B) "&

0
%*
" Y 60< # S )
>
0 G"()
"
A& .AETHER :$!
" 9%, A& GA
ML /.
9, A
J <6# O& E# >
H6< .
#
<P /
"()
"
"0
." /
7?s 30

5% <
= &
O& >0 K
6
"I
3<6
" Y, 9% <V K0( 3# 5. " # L @ V >, O& 9 9
6< A 90U&
"D)$" " 50 9%
(
#
0 G"I&
3<6
" 3/& A 01 &/
>0, 9* /
1 ", 9L G:( ( ? && 0 #

H6< W: "V ")
? 9
A& +)
9P) G",
5%1 A 6< G&& L : "I? "/0" # 5)#
3/1 " >0
K .E K
6 !0 "0

7P
6

K 5 5
M:>
K G9 ) E ")

M:&
@
J (

#
M:&
= 3/ I6
&
)
-6
< :$!
", 9
9) & , .#
#
9 !/, A 5)
>&
)
P
" >0

' , .</ ^ -6 I1 "0 ? E>&
L &
" GSubquantum Kinetics "$0
" K:&
" GSequential Physics ")
+
" : G>1
"

9P
P " GGeneral System Theory "9)
9P
P " GNonequilibrium Thermodynamics "

0/5/0 +" GHarmonic Universe Theory "9L
"0
P " GReciprocal System Theory
GHyperdimensional Physics "%
)1 +" GMaxwell / Whittaker scalar-wave physics "?0/
#
I

", & = M )
#
H6< =# GUnified Field Theories "$&
5#
" P " 0
K/
0 G

.33 5 5. " @0 H 50 M
G
%*
H6< " E> $/# !

6< ", A
J ( #
*)
=# .<& , <# P& ? , ?J G *& %*
H6< "J G&

50 5. " Q#
G/ 66

%*
" 5:< 58> G>1 A/

/ @(
*/

=(

/ K./
&
)(
)( 0 . > P&
50 ) , G"0
9/#1
M8
" >1 6< 7% ", "0
.9
A # :% A 0
G+
&
M* 9> "#/01
_* G:
%*
" /
@
& A
J ) "0
+( 50 A(. 7/ G0& % * "

.9.P
\5& )(

< G:#
$6
I, G0
580(
+
#&, ", (5
"
+) #
:
3<6
6<
5
I#
I>1
6< 0
% $ ) 6 " < K
6 " E? 5 GM.* A /# /
... 0
5)
5
^ S( 7$) $/
E)% )
5:/
>0, < :$! 9 "J ./ M

.
G*
'
0
" "

G0
3)/ "/ @ , , " I, &
3)
"
Q
H6
80(
)
O& 0, #J "0 .t
//1 0
= 5) @6 9:% -6 ' ,
</ # 9 6J 6< G
;
%(
&
" 50 > //1 &
%*
:&
.0 =/ 50(
.prana " " 9/ &

Y , \5T0
//1
6< A
J (
h3)( ", U#x G.
5% gfff
&
"u " yin """ :"*% "% " "0 I6
Gchi "(" 9/ @/
6< A
J "
(, .
5% ifff
5% 50

& "0 @ 0
@
50( ? +( @ J ...":@

H6< Lao-tzu " ?" 7/
x7 h % .yang
5, 9/ # 9)
."0
9, J GE, E: # G: ? G$; ? G
Gt
G 0/
J .."0

",
@ 0
7) L < 0& ..:< L * )*
5
^) Tao "" <, G9/? 6< "
."..(+(1 50 M

/
#.)
$/# "}, U"0U &
%*
"
"0
6< a"}V "!L>" 98 G.
5% gff 9

H6< 7
I.
( >
"
illiaster "/
J" '*
Paracelsus "H
/" # % .2
B)
$&
:0
=# @* 5& $& ":0" @ , A &
8
"0
6< "*., Q, .

."@&
G"0 50 # &
.+/
}, 1 t K < !
@ V ) 9
)
5&
)(
>
=#
+(1 =# "V &

G6< A ~+ .+(1 =# :& %*
!
F "0 .
, :

G0 0
)
=
9$ " ;
9
)
@ $ 50 9L .9&? M&/ n 6
G() P)
S
5
A& G*
:
@ : (% 7(0 9 G
HP 5. " .&
)*
6 ">1" A/ 9
.I# L E.* ">1" 9

5.
"80
" )
5& G(</ " 0 9
"0
) +0
/* ;
6#
Q% 7 9 ", )
(
@
) "5/0 K.0 !#" t A& .
&/
9)
%*
" #
50(1 H6< *
%

+(
A
" O&
F % "
"0 Gecdl 9 /* ;0

5&
6< A& $/
?
H6< G" / +0
" }, " (
/* ;
" 5> &* "/
">
"0
Q

9% % , .(","
, " / %*
5&" 58>
O&
9
)
.5
" H6 % 6 G )
3/ 0
M)
9
6< A E: # &* M.*
)
:
3)/ 9 9 ) "0
./ 9$ /
7)
#&

? G6< " 9L
A
"&

/
" 58>
9
9
3/& A # 7*) 5 & , G0/.0
/* ;0
5#

.">1".. vital fluid
5
" P = 7
) /* ;0
Y)(`
#
)*
>J )/
/ 9 ", 6
.@
. " Y)( ( 5% */ 0 E# h)*
" "0 G(:#
" 9/ * 5 +
"V
L
">1" W 9 60< X+
, +
0 GH 5 .
E E*/
#
3* ?, G

& ( . 58> ">1" # 7? "0 .;

5 &
> :
9)

5%
*/
@ V ">1" " )
9 "0 E
L (:
)
&
" .(9
5 & < !0))
"/ "6
3.*
/
E./ "0 .">1" M *; # 8
E, 6#
% "V V( % .
5# 0( GK/1 & #
)
0 @ , A
", 1870’s ( =/
"
)/ +

.K/1 5% " @/$/& , @P&. "0 ? G(+
) : L 5:/ *&U
/ ) "0 G)

I&/
" &
A =%
5#
">&
GK:
, ,

H6< 5. @ J

/* ;
+0
p
)
&*
A ? : >/? / 3<
"&
%*" 9
9
) mesmerism "
" @/ @/ * I6
GFranz Anton Mesmer $ A .3)/? /
5&
, "&
%*
" 9/ ) 7)U/ 5 G . * !/, A ) 3# +#n , G(/* ;

.morphogenic field " #
"
O& GI(
9/#
" M 5& )(J %> A
J Gecec A
J emil " xB I6
I/
G (,
.">.>
>
E* ' , @ , ?J
w9&0 " @ , " 9L
./* ;

" # Y 580(
. 0
Q/
A Q
= 5
A % @& "/ 5 Q
"V )( G"
"6#
" P E>V "0
#U < ./* ;
A
J 3%, : 0 9/#
5)
%* "V )( O& GH6< @P 5) ) 9%
.H6< , ):(
animal magnetism " &
/* ;
"

Q
<#? 6 /* ; 5& */ 5. "*
5) A
"" 3#
G
.)U " >V
0 0 G#
&
+(1 h"&x( =*/ "/* ;

/
" H6< "V "^
.9
O& ! 1 @ A G5&? 9T % .B) "0 O& G *
)
=#
= "" 9*
)#
" <L ! )# $ )
=#
h3L @# Q, .# " @)/ @# ,
P 3# V hh)x( )/
1
H# 56 % ."" 5, " */ <0 / "
, A .Benjamin Franklin "0 "# 9 " G )
K
6 +)
0 " "0 !# 9, *
.@
, W:x @+ @
/, & 9 #
, G '

"0 9
G5&
)
P
) 5( & ? ") 6, 6J G/
E> #
@6 I6

6< "0
P G(&
P ) caloric "K
0" P 5> G% 6 %> )
=#
<
Q1
"!# )(," # ""0 "# " + A& G(M&? p " ,) phlogiston ""/#
"
!frigidiferous rays
Baron Karl Friedrich von r$7$ L$$ )

1 "
= "" A )
% G(
%*
5# <P,
;
>V
( / (creosote 0
* Y) Reichenbach
% G"| (" 78 ./* ;0
5&
= "1"
H6< 9 % .OD "," 9/
K A
") 0 G ) " (, A +

?/0
* ;
>V
#
W:
G<
."% %" 9

J ( : >/
essential "//1 )
" '* Wilhelm von Leibnitz "
" 9" = G( =/
"
K
60
0 "n G( =/
"
.0&

< A I& Q% 0 < " >1"
>
elements
9<
6( 5. " % Guniversal essence " 0
<#
" , Gdynamic life force "
:&
"
0V
3# < .#
*
.&
& 5 , G

P

Theosophists ""/>
" 5>, " 0 #
&/
0&
)#
) 5 7?
.6< A& "
01 H6< 5)( 5&

DD&
AURA
17 :$h 7 L+
G)
/ 0 "1" G"/ 9/# *&

< G>01 E
V ' , Y A 7$) "N
O& & ":0 50 5& >0 >0,
& $/# I6
(
>1 @ J .)
&* " / %*
5&" ,
">&
"80
GE/ /, 0 .+)
#, */ , ("&) "/$/&
) 5% " ( @<( "0
HF. "B 9
" M8& % .&
%*
H6< 5&
9P&. 5#/ " G"| (" "" 5> G$

$/# ", (E&? H06 A V /) ""L,"
"0 70 3% O& P
#&
<(
" >0
H6.
<P $/# ", =*/ G@/ "0 , &
%*
/>1/"L1 ", "$ .$#
")
: *
A :
2
0$&
%
/#
+ # M, A
J -$

M1 "
" S O&
) K
60 &
&1 ">&
%*
"#
)
"n G5&1 =# "0
.1 "
A
J G9

/ %*
5&
:

& & " * 6 80 % "#
+)
+*1
:

&
@ 7$) / 6< .(

)
DDD"+ DD% #D
%*
5# Q ", G"
! / A(/ GWalter Kilner "$) " 0
Y*/ G9ebee 9)

"" /
" ; * ## S
, 5. " P
M* " K
6 "0 "
<" I, AURA </ / >1
: * , 9/%, >.> 0( % 9/#
5& + 3 Q, DICYANIN
. / = 0/ 5) #
. % * ze
.A, A
J I 50( * 9/ j,g (
0&
() * * zj
50(
! (9
A 0& #)) / L <& 9/ ec Y*/ 6 # * zi
.>
N ( " 7 "

" H6< P ", (9ebdg K 5* % ) (T ) @/ " 0" 0
06
0(

A E)
(
9P 50( % .)
G*)
G:
@
& A K
6 )
, :5> >0 ?& #
) " "0 G

/ M* " &

&
,
& ", @ 0, %
A& , :% @
, A )
O&1
? ./
G
:
3
GY
G91 G

.6<
@0J "0 "/

"I>1" 5&
, < )
* 5, X"1" , "

" H6< & < GE6J
&
;
0 ", "&
+*/
, %*
"#
)
"80 (3
) E)*) )
/& */
O& 5#
6< ">&
" )
<0 #, K G%
! .A
( 5.

H6<
(
Y 5& >0 , P
.Q, <P
0(

$( !% " 9 80
50( , * " 8
F

H6< ", A =#, 50
.

P 5& */ /
/#
1
" "0 50 (
0
>1 = W , E A& @ ) 0 E# A(. 9/#
5& 7>0
", A
J E# 7>0 9> +( ? " , $&
":0
*&
"

" ", E&
GE# 0
3/ 0
.
&
.:
/#
I, G!
I
0( $/#
$$) $ #$
$ * 7(0 9 ", )

H6< <P 5& %*
"#
)
"&
+*/
+ $& " 80V
P&? G/
& /1 &
+A*( A /0 9ebib 9)
.Kirlian photography $$)
: :# , + M G( ?) @# GSEMYON DAVIDOVICH KIRLIAN "
0 "/ :0
,
(L

A +1 H6< P) "/ 9/# A
J G
# 6 :0 3*%, 3% / G %

P G
# * @# = "
0 Y fE80 <<# 9 0
5% " ! + P&? %

50(1 / *
H6< / % .KIRLIAN PHOTOGRAPHY "
0 * U G' 50(
/# , # 9 3/
M*
) "0 ? E, (0 % "/ 9/# 5&

<6

G"/&
"0 9
>0 M:& ) " 9 0 7(0? 6< .

50( M* " <& "0 :
."/ 8)
:
<P
K
60 &
#

5#
$$) #$ 0

7*1 &

G %
..Q, %
@ 5 I&

"/ *&

P
0
GS ..$

<
")
A&
6>) $ $ $ & H39 6 6; 697

& (
5 5. %*
5& &
;
GS "$ ", " /
H6< 0
.(0 L GL @( G(L G <6 ( " ?&
H6< S)
, I0 5 I, ? GM)
? G#
& %.
!
G9/#
*&

M> ", >J " 0
.#
9)
5# / " <L
.
5: I/ M, " *&

P G/ & G)*
& (
"0
"
A
J 50
5 , +& *

5 G
& , GM% , G* "#<
& "0
.("#
# 3/&) &1
P&? . /

H6< 6,
/
!
& / ?&
H6< 58>

@
0(, *&
.
5#
W< " M

&
%*
5 5 5 & # Q&J (0 G"/ .7.I" " .." G"0 ">&

./ jl 6 *% Q, GE>& *% % " (

)

& 5 (
", "$ G(
G
3( * # ) 0/

& 5& >0 O& #,
I, G&1 "
A
J 5$& W<
"0
.0 #
@ *&

#$< G( , 0/
&) / Q,
./
&
9
& = 5
A
A
J E.) %*
5 A GI1 = %*
5 * "#
)
) % >J 9
.#

/
*&
.
5#

& ; %

=
H6< 5>
./* ;
@ 9:
M$) 0 #< @ , (0 GE/* ; ":
*&

9
"
6

W< G(L I,)
& @
) @ , P&? G"&
+*/
&, 9
.
5: M,
/
&
#
3/ G@ *&
%*
5& 0 @ -6 @
"/ J 50 ", (0
.(
" 0
#

.' 50(

*&

W$< G) / " & 0
@%* @# +*/
&, 9% 6J
9 .K&

) @% + >, W$< @) , !F ", " G) " K&
3<
*/
,
.K&
+ >, @ >
%*

%*
" 0 580( 7>0 W$< G

>V
A G(*
#

6) :
A/
5)
.9/#
5&
& 9 G(1 0

=%
; # ) %1 3/& / %*
5& W$<
?& 7
#< # A , "0 G(B L %) E )/
/
# AV W$<

", "$ G%1 H6<
.(B L %) E& )
/

."
&
" M
& G

& + >, K
60 ./#
" -

& + >, %*
5& 5 9

6 GT.> 30 0 6J .@# "/ 0 3/&

W< ; 5 & 7(0 9
.^ W< 6 G9 0 6J G"$) W<
K
6 9 ", "0 .30
K
6 5& . W< 50( P&. GE.> 30
0 G"$) +( 0
(
9% 6J
E0 /
9/#1 *&
.
W<
", < 1 >
.0
7?^ @ ) 30
"0
A&
5> GE0 / I6
(
; ! ((
#
5
, G78>0
0
5. )
.!8
0&
3

.(
" *) (
*&

W$< G 3 # @) J 9<&, 9% 6J
H "V (
6< 5$ 6J @ , " .
9</#, 7:P 90&
A
9
(, A O&V 9
)
^ ( G3<
(
6< !
6J .E.) M&
5 & + >, "0
*
!

W$< GM&
.E.) M&
& @ V0 )*
(
5&

W< GM& H ", 5$ G)*
# %

%
50( 6 6
8) &

A G % " +# $ 9
)
9<
" 9< A ) >0 M:& >, 0
G& / < & "0 ? Q, >0 (0
.
)

$
$1 A
"

"9
9
& (I
)
W
" "#
) "8/
+)
$/ G"()
"
6
life field "&
5&"'* +#
"
" /
. / /#
= 9.
%*
" 5&
%* @ V H GF.S.C. Northrup 3> ./.!,.7 "0
Harold Burr
< 0
" 50 H/ 0
$

", "$ O& circadian rhythm
Y 9 #, % .&
":0
Q& :< 9P
^ 5& K < "V S
L.J. Ravitz $ .8. 0
+# 9> ./ jl 50 5.
$(
" P ?&
%.)
H6< ", O& "%*
5&"A 9/& I<# >V @
G5% 0 I6
thought field "I0
5&
" H/
./
?&
( # 0 /#
5)
, P "
F/
<
/* ;
9

& M Q !% 5#, "

7(0 #" L.J. Ravitz .-.5 "0
9/
Q#, ", 5% .; I, " < 0 L
#
K
60 /#

&
A /* ;
9

& 5. . (

+#J ) GE, 7(0
. E/* ; 9:
9
M Q !% 5&/
" "0 G>
@" "0

(1 "0 ) .) %*
$( P J # G"/ J lif A !% # if,fff
0" :$/
&" ")( 0 G&
%*
" ) # !
# 5$#/" $#
&" ")(
H6< G 50 5. "0 "/, M;/ ) %*
( "
H6< ", .) $(
#
* %*
$(
I
Y 6< "V "N ">&
) Q
"$ %. $&
:0
=# <P
&

" # AV (
=

& "0 .1 Q
(%
) &

P&

.H &
%*
$( Y A ? @
&

8)
(0? )
" 5:< # 5 & G
"
" )/
>
)/
,
*& /* ;0 5& @ V0 !% " "0 I6
" Robert Becker ) 6 "0
O&V0 .5#
6
.1 $&

&
@* "/ 9/#
G9/#
8) :0 5& A \5 * 9/ G$*
/, / " ROBERT BECKER 0 0

THE "/

6 980&
9P " 5&
6< A/, . )
#
=% 9/#
50( 6 *
H6< 0
6< ", 7(0 .9ebdj 9 H( I6
30
" @6 < 9/? 6< "0 DIRECT CORRENT CONTROL SYSTEM
G9ebmb 9)
5. Q, 3# 9%, ."/ /
/#
$;

& 3/& @$% # @0( $; 5&

.5&
6< 5 K$& ""0
" 9#& :# K < @ J <) #
" human / %*

5& "?& $; % :. " #" Barbara Brennan $ "0

. * ?& = @# 5.energy field
( G" :O.>
">&
" / %*
5& !
M* " " ) / 9ebmc 9)
(
G5% P L ( igf 3 # 5*) +
Q/ ! 9>&, 5. % .!0 "# G"
(1 # +
Q/ */ Y K < ", A W:
8
. (, # ) G5.
% .;
+
% GM< , s0
E ;
#
(
"0 "0
G;

*
, */ 0 .' 50( G9/#
*&

G ?^ M* " G*/
.$&
, $/

&
3/& $; , # O& G

acupuncture

* , chi "(" %* !% ""Hiroshi Motoyama $ 7 $9 ""80
.M> 50( %*
H6 *
meridians
$
L
/ "6
(1 "
7
+
! GHIROSHI MOTOYAMA (< 9%
(1 "
+
E, $ ", Y*/ .P L G : / 0 K
6 9/ .* /
G(5/
< N 9/#
5/J A/ ^ 9/# A
= )
"/
(1 A
J %*
"/

5& Q, >0 <( 06 % .# " Y.
) 9> EV# "&1 3L, 5/
%* Q/ "0
."9ebmb /#
%*
* L
" %.)

^" " 5& I6
@0 / %*
5&
.I&
5#
6< . "^ 7(0 " "80 Victor Inyushin $7 $ )$ 0

6 Q#, % "0 G(E/ /

& ) "/0 )# " GVICTOR INYUSHIN ""( J 0" 0

. %* 5# # & 80, % . / %*
5& <P 5& 8>0 E>&, G
"
" /

)1 ?&
) .
/

&
< .
%*
", S% .$& 0
, ^ " 78
F
.(.
G;
G5:/
G3
:<
, 0 G.
:0 . +#J 5) 9
A $# .
:#
", "( J 5, P,
G$)*
@
& $/ < I6
.
5&

/
#
:#
" " K < .: 0&
&
P 1 +1
& K
60 $&

& ; A
J K
6 I$F G"
6< 5 O& ", $# "0
.+
& 366 )# 50( .
%*
H6< G$#
& $&
0 6J ."/ 9/#

! t
" /1 "1 9/
5 " )/ " "80 GJohn Zimmerman $ O&
,
=
%*
5& -. /# 5. A
%*
"#
)
" 50 ()*

&
"0 L 6< ", =) %

.
.GUSTAVE NAESSENS J"$ -" F /

9
)
" 50
O&, E, K <
? 9
E# ; +#, @>&, + >, <( G#
+&1 9
GGUSTAVE NAESSENS! / 7/L /

% 6 G"30//"H$/ E E# Y G

#1 9/ M* " 7$)
"0
@P 5 .0&
:
;
:
$:#
@/ )
@/ G($ if,fff) 0
I6
%*
+I#
6< , &
$
H6< & " 9 ", "0 ?
5 ", GSOMATID"/
"
'
%*
80
%
*
K < G&
( < /
", ! / ). /
H/,
. 0
%*
& /# 58> G0&
:
%
*
K G/
", E, 80F ./
EP # G JOHN AND EVA PIERRAKAS!0 J "# GBIO-ENERGETICS :&1 %*
"
)

7$)
"5
"9/ <(
A K
6 ") G$/
* , 2
T# E#. T (
G/
-.)
# * A
J <(
K " /
)
, G(

) / %*
5& A
9/# " +
O) ", @>&, 5. !0 0
>,
"&
%*
9" @/ 580(
)# )#
"0 @ , O& O)
+
9#& !
$ % ?^ 9/ 3# Q " 5, < .$&
%. @
"/
$ ( G$&
0
=# ?N H6< # ", 3# @ J 5% G"/ $&
# $& ", *
H6
.#.
(
" $% A $) / 9%, G
"< ?")# " GZHENG RONLIANGu u <
0

E )* 7(0 # M* " K
6 G
"/
"$
&, 9/# " >)
"("
%* ! 9 G"u L
(
"! " "("
%* M.* ! G
9#& !
% " < G
" O&, F A
@
I6
"/ @ ) " /
"" >)
%*
! K
60 G"u L
0 50( 7 "u L (
" ! " >)
%*
66 ", # .(
/
!&
" IV )/?
%* K < ", P&
G SINICA "
I; (
$6
/$/F
0, . /
" >)
K "
%* ", E &, P&? . $ 6 366 # 7 8 %*
H6< ", Gu L (
! " >) &
9#& :#
H6< "0 G+
'/ MICROPARTICLES # :# " 78
F 9/#0 P 0 "(
"
. >
9/ gf A
J jf / ("0 df)
8>0 3# %, GGORDANA VITALIANO

L GDEJAN RAKOVICB0 "# ">&

. / "
"
&
$:
)*
/ 7 G./L

&
$:
)*
/ 7 G./L 8>0 3# %, G
L GB0 "# " ">&

MIND "7 " /$/F V( , O& G&
?
"*/ "N #
0
. /

GL
#
G )
0(
/ A
J /: 50(
O&, 7 .(5)
#) I, GWAVE
5& *
, ( %. 6 / J %* 5& # "0J &% % ."/ 1
.
$ 6 /* ;0
:50
/ G"7" /$/F G!
+)

A.S POPOV ALL-UNION SCIENTIFIC AND TECHNICAL SOCIETY OF RADIO TECHNOLOGY AND
ELECTRICAL COMUNICATIONS
3
/1 " & GE.S.P "!&
" -
K" <P A
V
L 9>&V 9ebdg 9)
F
", ) "7" 0 + # , .(*
<P A E ) 9# >&
:
)

I&
5&
%*
H6< / . jfff iff " % $ 6 66 M* $&
:0

"/ '# Q%, ' I&
5#
6< ", (0 .BIOPLASMA .
, BIOFIELD
" P
H6< .0/ $*
9)
0, 7(0? 6< " , .9/#
- A
J .
5/J
. * G
< G
G
, <) %, $) O&, W: 5%
:. " # = Valorie Hunt " < I

" 0
<
K < >J O&
?# >0, Q&J
K
)
")
(1 &, 9/# " >)
#
$#/ G>&, 5. .UCLA
0 )#
# = M (
9/# " >)
#
H6< ", "$ G(%*
-. = .)
K
) Rolfing &
.$#
9 V <( 9 V "&
+*/

"
1
@ $#/ E GUCLA

0 )# :. " # = GValorie Hunt " < I
" 0
%,
9 9> G(%*
-. = .)
K
) Rolfing & K
)
")
(1 &, 9/# " >)
#

*/
"0
& 0 %
! G $) * (*

!T
) #
H6< 5&
9/# " 50 *&

" >)
"
1 9V <(
Rev. Rosalyn Bruyere" "
" <

)/ = #
0 9 % .%
= < % @<( 5#/ % GK

=
(
K
60 K8
U

.8% #/ %

,

F " 9)# 0 O& G" "
" <
L "& +*/
$#/ <<(
"
1 = " <" 0
$#/
#
!E.) <6 W:
0
" < "
1 ", 9) )# G>0, 0
'$ 0
.K

/# 5. "&
+*/

= * 0 0
$#/

G

."
7. 3/& 7 G $) /* ;0
#, 5. " 0
& % G"
2
//1
5# .+*/
<^
"
1
:"
1 <( 9
, 9L
! # A !

< ejff E, < jmgzjgf " M1 "

< lmgzjgf " 1 "

< mffzgff " 1 "

< efgfzbgf " 5
"

< ejffzefff " &1 "

.< cffzdff Glffziff G<jfffzefff " #/
"

.< jfffzeeff " 1 "

%*
H6< ) %".

" "&
+*/
@
J ( I6
@6 <" &
%*
5&" +)
@/ "J
0 % %*
H6< !% " 0 % G EKGG EEG5> #, 5)/ 5. " % % /
&

5> G$
">&
+ $& >, G" SQUID%
M:
$0
5
"# 5. " 1 )

F
"0 @ , O& G/
@
& "/ $& > %.
&
%*
H6< "V GHL" B 9
"
.$&
":0
*&
I&
5#
6< 5 P 5. " * @
& 5%
" 5 G$6 " 8

F : $# !
< G(Q1 :0
) I(
":0
", O&
9)

80F
"J ./
L $
$;
H6< "/ +)
G&
0 # $
& G9: $;
& 8 J .%* 5&
*& '/ 8 J .$ )
O&
/
>0, <& @$#
/:
#
< " / %*
5&" <P
8 J .
. $ G " M* G
& G$. $/# 50(, G0, 5& G%* 5& " 78
F 0
.$) M* ) )
&
H6< ./, 7(0
..
" 80 >) $# "& G366
;
, " # ;
G# P G# KJ G# P&. , 5 G# <P /
< G(0 ) "& G"N ,
.< .
5#

, $
Biological Transmutations
(I0
)
, 0
, 50(
GQ, A
J
& " 5$&
< *
)
" M 5&/

" @ , < J ) ">(
E( )
>0, Q&J G
+0

< &
P 1 &
.
=# "V E, "$ ":0
9P) .I0 5 M* " ^
7(0 5% .&
<P =# $/ G", 3# G=*/ <& +0
"V " F 9 .)* 0
6 G)(J L * # : >/ <( "^ + 7(0 G5* % ("( " A)
?
.")
A& &

" 50 ; )
G %*
, Gbiological transmutations "I&

*
" 9/ 7) & , $&
:0
" &
.
H6<
)
9
/
E# < )
.
" Y
6< .nuclido-biological reactions .
"J .
G6;
G-.)
3*
G:
9 G#
#
G+&1 9 G"0
9 G+
?# " 50 /
"0 ? # I&
*
"0
.</
P S* 9L G
#
? I&
*
6< 5
^
.@ " 5)
=*/ ? <
G&
)*
!/1 <#
580( @ J G@ 0
von Helmont < " # 5. " ( =/

"
, I&
*
/ "V 5
"0
9% G / ! ) .
" 5* jff G5
" < 7 #( 9% O& G(

G+&
G3(
" 5* edf - E0 "0 H& +
", " .* , j ", #
7#
@ V '$# .(:
"
/& 9

" /
*%/
#(
M1 A
J ) 6#

.#(
Q
H
#
")
< #(
H6< //1 5)
"0 %
& "0
G+
#
"0
/0, " carbohydrates 80/
580(
"V 9) & , 9
"&
6#
+&
3(
" :
"
" 90
6< 50 +# E6J ", " .+
!
G
" V )
)
"
!XM1
5) 9% .E -#

<
&
0 Vauquelin ""0" /
:0
B< G9embb 9)

" 0 # G -

5& ) .* "(
3& " 5* )*, & ##
5 & 70 "0
G * @ 9 % &
", W / .##
0/
0
" $ ! >0, 9/
0

.XK
6
-# & 5 9/

0
0 / Y G A I0 J : ! G9ecjj 9)

.X+# ", " .
( @
%. ? 0
Y? 6< ", "$ G$
A I& $
6
", "$ P ## , ##
6 ( 9
)
9% G9ecie 9)

!X")
+# ", " .E. , 6
# "0 9
")

@&*, #
H6< !.-.- 06) I&
*
A <( 5L 9
)
# G9ecll 9)

/
"
"&* -# ##
6 n 5L 9% :(9eclb ""&
G
G")
+0" " )
E>& ;
#
+
5& 9% 9> G## % <*L 9> G8* + </ .I/ I, , sulfate
" * = %& 9% G# 6 A I& ;

& , ", ) G( ) .8>F 5 I, "
#
H6< .6
#
0
& " 0 # #
0 G9/
0 9/

.E?# 5? /
W , I6

", , GE*/ E !
@ , J /
", P
" : 0 P,

G9ecgf 9 L ! # 5> G
K Q, 3# #, %
.%&

9/ L

Albrecht von Herzeele 5< "

,
1 #

9
)
Q#, G9ecci A
J 9ecmg " G / c

0
" @0 =#
J 9

GE>0 )
=#
#: #&, O& G"
H 3#
% &* "0 ? $&
V/ 9
) 5? H+. */, I6
Y
, .5
" E @>&, )
."X
#
")
V ", "":< 9$&
5F/
6< .86
)
*/1
% & !% A 5 O& $) 5

& K
6 " E? 9/ 5 G
9/ "
5< 9%
I6

# # 7(0 G
, * / " 50 @% " + = 5 & 0 .0
E* O& ", =*/
", W / .

& 5. $/#
0 ? )
H6< .@%& 9> H
E "/ ) "0
G1 A
J = ", 5< 0 0 .(^ A
J 5& 0 I,)
)

.# " <( I6
Dr. Hauscka 0/< 0
A "
9/% # GE
iodine
V( O& G!
I&
G
/ I < /
G9ebld 9)

"
) & L H < B)
H
0
A&
= 9 3
&*
", # G&
3(1
* A $& aldosterone "/
1 "< ", # G! )# " G
/
!!(

0 5 % 0/ 5 & .
/
E.% "0 ", "0 6< G9/
A
J 9
(5$&)
.
50 9; igf A
J 9
5 9/

A I& H @) 6J tenches B

K/ ", G"0 / )# " G"
# 0
>, G9ebgb 9
!* / =, 5. %id / 9/
0 " # J G9
0 " %el
"0 !
0

6< @ GI&

*
5# E/& ">&
>0, G! )# " G"0 !
/
O&
)
7
V
:0
M*
@# & ) 58> E. "0 ( G /
.5 :# @& 5#

. )
" *
/ =*/
", 9# 50( >, O& @>&1 >
W:
" "0 7(0 . &
K
6 5) "0 ? "0
G )
" * O&J K 0 G9)
:/
M*
3/& ", < Y
I>
1
G3/
6
.E/* ;0
5) 0
0
,

!
G%*
" 5:< 90 "
(I&
*
) <P
H6< ", "0 5 .>0, !
9<, < "0 O&, ", &/
/
H6< +)
9P)

G/ 5( G * B) I6
-#
58> E?> 3 .)*
&
P 1 =# #

G)* 50( E
= ##
9 GK
6 9L "0
G9/
0
A E, I& ? *
H6<
I& 0
G
" 0
* ##
"0
.9/
0
" #6
0
A I& 0 50 "0
)
5# & # H) I6
, 9/
0 A
J 9/
5& =*/ ##
", " G9/
A
.#
9
6< & ": A& "00( +)
9P) G@0 6< 9L .0

! , $ ...-$ A -

& A P&
#&
)
- J =*/ ?
&
", A "$
? +)
9P)
0 .E&& !
6< "0
."
60< ...# " :6;
)
H6< V ", " ? O&
*

^ < H (0 9<, !E.) > #
5
N P&. GE) % )
O&

% A +

:6;
)
M A %
:0
=# .&
:0
=# I#
I&

! *&
:
# )
H6< "0 9

A& G&

)
6< 6n !3#)
E> 5? I(
":0
9/# (&
) pH "+< +"
Q/ 980&
9P
A 3) < G9/
0
A
J "0/
5& 9P K < .!X3<6 ", A
J G "J !XA, ", " G /#,
+( =/ A / 9/
0
" E? organic siliconI)
"0/
9/#
"J .@)/ &
:0

.P)
5
S. J 9P)

.*
*/
)
H6< 5) 9 O& G9/
9
/ < /#
0
?)
9<, Q&J
9/ ;
" ? "
", 9L "0
G/
#& <
/
! 9/ ;
)
-&

", 3# !X9/ L
V I, " .
9/ ;
") , I, # 9
, ?J
9</
>0, "& ... &/ # :0 " "& ...7) 9
, 9)
7 ... "F &
H6 7)
K
6 "/ G9(J 9# & & &

& /#, ) ", 6 ...
H #
9)
5&
./ $/# &
50(
, G 0 I#
0&
%)
)*

N E.

$$ #
.+0
+
" % 0& G) ?^ ?J /
&
:0
"V GK(
5 ? 50( +&1 + 9P) ) ..."
"0 9
, .60 3)
" @ , / 5. # 0
GK P
#
0 / ,
:
9)
(0 9
5 , " % A ) &
<P
) ", 0J K G5
9 " Q/
"...)
:#
&
9" :" ) I6
51 @0
G-0 )# " GK( +&1 9
9 0
H6
.ebce 9 ( I6
GA New Science of Life: The Hypothesis of Formative Causation "80(
/

Nature )*
& @ G"I& &" @ )
@ 3& : 5) 30
@# %
&" :"

@0 @0 K( * % ." / )
M&
'( 5, .. .3;
E> E0" :@
The Presence of the Past: Morphic Resonance and the Habits of ")*

"
:

The Rebirth of Nature: The Greening of " 9)
:)*
#" Gebcc 9 ( I6
GNature
.ebbe 9 ( GScience and God
, 6 0 +/ G)
/ =# A G #
&
, G)*
P 1 ", < //1 @0 0
5&
*/ ") 9P & n G :0
" )# , :0 , +, , . , , :#
" /
+(1 =# " )#
06
H6< )*
P 1 O .> 06 A I&
G #

50( ' K/
*
* , ", #
"0 Gmorphic resonance I
"
A )
5&
G0/
5&
5( G #
5&
" E/ E* K < ", K( Q .0
5. "
.>
#? 5&
G)

)U 6< Gmorphê < "50(

" Ggenesis < "$/#
" :", O& G"50(
$/#" E& Morphogenesis 0 )
'
*
& 70 X
, 6
0 */
50(1 K " )
&
:0
V( 70 .E& E;
9:
" Y
G#
A
< &
:0
(<

"J Xu
"/ J A
J & , G#(
"
N" ", E, 06U 9 G) ?^ # /
&
:0
", '
" .Y* 56 , 7* 5/ A
J S#

G?N !0) . 5* O& ) # , machine egg "
^ " " : 50( * % machine
<* @# G 7<
( +( K < 5 G) 80
+#1 " # # /
&
:0
"n
.& 7<, ;
$/# 9P " 5F/

< I6
G:
L #
5&
" &
&
+1 0 580(
:0
"V 5:
, $ '93 I$& #
E V( % O&
0 0
+&1 9 ", " 9L
A
I6
"7
5%)
9P
"
V/
3/
5&
# @ , ?J L & 5 5% " 9P
= &

genetic " #
#
" '* 8> G@ < P p 5V G :0
580( @
",
* :< 5F/
"0
.0
# "&1 ) " #
#
" H6< @( * 9 % .programs

5 # )# % #
#
",
" !
, G% :0 5% " % 0
#
+)
) S% 1 /
X(I
3<6
3/&) :()
)*
6 &
/ $

5>
" 5> &* A %, % #
#
_*
9
", : &
+0
5# "

7 1 , .>
H6< @> .internal description "
7
" , internal representation "

.K
6 " # 9 0
GH/ 3# <
& DNA
:# " >
(
", O& . #
@) I6

<, " 9P)
+&1 + 9% %
" .
G.
"
9P
*
& ? 0
G
1 &
3
:K( 5 .&
":0
" +1 G+1 " #/ 1 G#/ 1
&
":0
9 ", G*/
=
H6< =8
P 1
#
",
.."
@/
", P 9> G3/
%
+
=% A
J +
5 n @(, 6< G: 50( @/ =#
"..: 50(
+1 #/ 1 50( 7:P 9 n K
6 = G>
(
!
&
":0
.
=# "J
7) .7*1 +1 50( 9</ DNA
L ^ >V # A
J &
H6< ( G
A
6
A I& L A
J 5&
A(. 0 0
9/ "0
G
V/
H6 : +&1 9 +
'complex spatio-temporal patterns of physico-chemical interaction not :5> E%.* L &*
.")
L 0
.
" 8) 0 -6 " I, Gyet fully understood'
9 A % . #

5&
5% " @# 9 P&
&
:0
9/#, * "n GK(
E
" 7
V E
L GEL E, 5&
H6< )* "0
G=/ 50( #
5&
9 : +&1
< G+
7) L 5 5&
" # Y , K( ) .
:0
:
&*

Y
6 " 50
J 36#
)#
06
" Y A I& GP
P
5& " =
.%
= E: * E, < 5&
H6< "n K
6
. 9/
")
9P
/
A, # & " +# < G

#
& $/# & 50

H6
>
06
"J .6
5& < I&
G:#
5& I& .
5& "J GE.> .:#, "
I,) .)
H6< $0 0 9
)
" +# E>& 0
:0
0
% / 3/ E.> / 5&

" Y/, 50(
# )# 6< /
# " / 06
0
0
",
.(/
$

", U , E #

5&
< ' ", # G #
5&
" Q, Y , A
J P ", 5%
" E /
V 5 G'fields of information' ") 5&" V 5&
H6< K( 7 .5&
6< "0
H6< "V 6J "0
.E $/#
P
A >V 5. " Q/ 7(0
"0 ? %* /

A 9)
" 5& >F 70 9 ", 3)
" GE #
, ) 6 G L #
5&

G %* K % #
5&
"V K( 7 David Bohm 9 = & .I
9
)

A(. ? "0
"
5 ", "0 #
5&
",
* G0
(:
) I
A )
!
"0

"0 ? #
ethereal >, < G%*
" E# E% E.0( "0/ #
5&
"n GA )
6 ./

quantum 0

5& > 6 "0 % 5&
H6< ", K( Q 0 .)
1 (0
)*
9
)
9% 50( universal quantum field 0
0
5&
"n G)
9
E .matter fields
2 % 7
V */ < I6
ether >1 9 O) 5) < G&
%*
< G:
,
.@0V +

*/ 50(
/ A
J (`
formative causation "0(
/
" '* 9/? K( I6
3/

)
:
5&
>&
< Genergetic causation "%*
/
" " <
< #
5&

/
>& I6
;
A E 0 E 0(
/
"V 5 ./* ;0
5&
6#
5&0
"0 K( ", 9)
= .E ) /
%*
L %*
/
" H K( ,
: >
"J .%*

", 0 G(0
: >
) I 9/# A */ I6
I
L 5)
0 5> : >
" Q1 50(1
. L )* " 90& I
9
)

6< ) O& Gmorphogenetic fields " #

5&
" '* 8>
0
H6< S% " 5$, K( "0 9
% .
"
01 )
1 ' 50( $/# @ 0
GE# ) A
J )
9

A E>& # 9 '

E @
<J 9 ", 5% G >.>
()
5#
6< 0 $* &
5&
" 9 $) 0 G#
5#
6< A
J 9
5
5 .">
#
" @
J ( 01 &/

!
5. " 5
) A 7$) .
)
# " HP J ?
"/
" #

"0
Developmental Biology ": +&1 9" " ) 0, 30 5 Q&J " 6V

5&
9 + %J 9 70 "0
@ S( .Susan R. Singer "; / .."//" Scott F. Gilbert "L .7.0/"
50 5 O& 01 &/
A
J $ 5, # 9 '

E/ */ @ 1 5 G@$& 9 3/ !
G #

./
0
)#
E E)# 580( O& G@)* E0, ) 30
6< ", 806 .5
9

$$ # -7) =

The "Re-discovery" of Morphogenic Fields
Developmental Biology
Scott F. Gilbert & Susan R. Singer
/ < 9)
6
/:
7
"0 G#
#1 9 E.:< E)/
"
>.> ( (

, Q#
GGestaltungsgesetze 9/
1 ;
@ M* <) " #
9P
50(
&

H6< A*, I6
9
.(
, < &*
=# ", Q 3/
6
G5#
6 ? " Q0
/

M* :
L 5&
6< 7) 9 % .morphogenetic field $ # 9/ @
J (U 0

5&
6
.E ) E: E )$# . 50(
.
" # @ V E 5
0 "0
G
$ 5&
6< " )%
.
.&
H6< " #
.
. # +1 50( & &
= ."$) 50(
=$#
", GE & 5&
6< " +# V 7) )# * )
-6
@ 0 6, 5 G9)
@) I6
//1 I0
-6
< $ # ) 9
G
"
" /

=#
, % #
5&
P 0 GE& &
?
GK
6 5% A& . #
/
;

G5& , A .'(
9 (+1 7:P 9) #

" E? >
9 A #1 9 #
.:#
Q/
<# A 5:? 7(0? # )/
# " P
#
5&
9
$ # &( J"A
6< "0 .<1 u
E* #1 9 ( G@ >.>
7 A&
"
( 6
"/< ' GOrganizer ; # 9 Spemann's laboratory "/ )

"0 G 50 Y 3 1 5& Weiss ! Hamburger L< / G7*1 *
Harrison
#
Rawles !
Willier ' G5
5& Child ( Hörstadius !/< P
9< " 50 "0 ./
;
! #
& 5& Witschi ( P&. G(

) )
.

biochemical I&
:0
" #
9 ":( Brachet 0 Waddington "; Needham
I6
#1 9 5& 5:
#
O&
, .P
, "0 #
P
!/, ", Gembryology
; )7 90&
"
7(0?
& "0 GGestaltungsgesetze 9/ @ M*, I6

, #
@//, H*, Gembryology #1 9)
//1 I0
-6
"J .(ebie GNeedham 9< ) ordered form
.morphogenetic field $ # P "0 #
@
"
P)
9<
K &, "0
.E/ E% #
5&
9 "0 90 K ", 3)
"
Needham 9<
/
.(ebdd GOppenheimer ,) >J
& %
J # ?
/

O& " 5, .Gestaltungsgesetze
9
"
= E0 E P
H6< 0( (ebgf)
Alexander BL /0
, 9% 9> G(ebef) Boveri I "0 " #
5 #
5&
9 "
GKraftfeld Geschehnsfeld 9/
M*, G' 50( ) (ebjjGebejGebef) Gurwitsch
3# 5. " ):( 0
H6< 0 % .Embryonales Feld ";
5&" 9/ M*, ebjj 9 E,
+
5 / "& " # ", 70 "/< )/ % .ebec 9 <#,
7*1 A "/<
." #
" Q, * E, E* *) ", 0 .
" " % A I&
+
5 /
% G" A
J 7*1 $
5&
)*% 6n G/ 9P ", 5&
6< " .
"0 GK
6 A
J J
GH#? ! ) = "
Y 6J .E.0 E* 580(/ E.0 "n G" " 0 "
"6< Y
5# " & L # #/ , , . 5n % 6J .E)* E& E* "0( "P 7/ "&
"n
6 #
I/ 9P
)
H6< "/< .5&
K
6 5 580(
)
" 5 9P n G5&

."self-differentiating equipotential system"

"P
5&
" 9/ @ M*, 9
6< 0 n G"/< M GHans Spemann "/ < 9%
5 .60 EP E.& V( , % dorsal blastopore lip P
(
&
"V 5% GOrganisationsfeld
.(5% ) @(% /) E EP E//, 9
6
A*, G( / 9< A
J G(ebji) Paul Weiss ! 5
" 0(
5&
H6< 0 M .:
9
*
G #
)
# M* 58> 5&
H6<
.

5&
" )% 5. " P 50 < &
.

G" (1 ) gene >

homology ! #
&* 0 #
5&
58>
&*/
"
>0 5> ) P A '*
6< M* 9 .@ MU > A ) @
"0 9
A
J ( 5&
6< '* "n G/* ;0
5&
'* 0 .7*1 & G )
&
Gplanaria
% G #
50(
<P /
5&
H6< 9/ A (ebgf) 9< M % .E) )
0
%.)

:

< G& 7) "!" ""; " ""/" " 50
P
" -
* G9P
" +# $; "0 H6V "0 I, ", 5> 3
" 9P " < #
5&
.."
=%
" " 5&
>V V( .9P
6< " Q, +#, $; ^ "0 H6V I6
=%
= & %.)

580( $) +#J //, A V( G ) & , 9 * 5&
"J . 0
H6< <6V

% @#6 A P&
@ 0 G M* @
G3*%1 ) &
) 5&
6< ."0
:

H# "0 ", *( "0
G7 I& 6 @( -6 = - ? @ 0 ./* ;
5&
0 E G , @0
".. #
5&
" &
& < #
>V
-$
& .E:. &

.& #1 "
F/
G6 % " )*%
& 9 ; G9
+#
,
.
9> " I
$/#
* <
*
P %

. * 5. " $#

")
P G0 6 %
; " < 9
9/

.I
$/#
* I6
)
9P
P & 9

G"5&
" 9
Principles of Development "*
p" :" ) ebib 9 ( I6
"! 5" 30 -
= , G" #1 + 5% "0 50( @ 9 % 5&

9" ", ! P&? . #1 9 9P ,0 @/
5&
6
", W / G& # 5
A 5&
6
@ / % .**
9
6
>
GK
6 A
J J .(&
" % 0 E# (. 0
7>0) "#$

" "*
)" "
"
5&
9 "J" .& I # 5&
6
5 G5&
6< : P,
< <& *
<P
/
G"O&
M&/
=
" A
J 5&
= A
J 6< Q, ."I
=%
" ) @ 0
G S( # !
_* 50( 9U # '* "0 6J" .7(0? >& )* <P I, / 3# 0 E @/ 3#
@/ "n GI&
9P

V/ M)
# " V( I6
I0
* :
H0 9 G
" Y @ , A
: #1 9 E# ) >, 9/ &( 9> G5&
//, =/ = % ."E, @ 0 "0 "
.I
9
> 50( * 5&
*( "J e
.@0 :// !
@6 9:% "0 " < 5&
"J j
.5&
>V
& K < "0 E
L G)1 >.> 5&
i
0 " IV >V
M* Q&J 5&
>V
)
)
" I, * "0 ? G!* ;
*% 5> l
.5&

.>V ? 5&
"n G5&
>V * 0 % g
.//1 5&
@ _0 50 5& A
J 5& 7 50 5)# G" A
J 5&
>V 5# 9/ "J d
.& <# A ) W: *) ", "0 "& >V
# - "J m
gradient -$
5&
< @( -6 K < # G

P 1 @(
5

! 5& A
J J
Huxley /0< = ebil 9 H( I6
30
P Gavin de Beer I "L 0 " "0 .field
9 " 5&
6< 5> - .Elements of Experimental Embryology "#
#1 9 " :" )
6
"n (ebbe) @) ")
De Robertis ! I P&? 0 .gradient -$
9 #
5&

<

0
"V 5
GI
"Gefäll" -$
< 51 :>J >.> 9

7*1 50(
0J A %, ", P,
(ebji) Swett / <#,
3#
< >
.
&
, .5&
A
J # 50( % G1 7*
5& " P
1 *
# 1
.
" ) # 0, ", P,
planaria &*/
"

A #,
3#
O
>

50(/
* " 1 9/
.
0 6n .
.
A ) 56
, !,
50( A
H6
5&
(
)*
H6< P, % .56
50(/ n
* "
9/
0 6J , G!,

E# E/, 50 50(/ 9&
? J " "/
) 6n G!,
* M( = M* " <P

.E.0
)*
0( .

* K
60 .9&
? J " "/
= !,
* M( O&J ) # E/F .
"
.
/ A , "$ < 0 56

A &
% / % .50(
J
E& E#$ K < ", (eblezebeg) Child ( " %
.-$
#
5&
* ! % .1 9/

* " /
# !F 50( J
0
* 9< K < "0 GK
6
.5&
*( % / H#, A
J (
? # < -$
"V Q
#
5&
<, "0 9
G5& , A .
P
5&
6< < 5& )1 =* /
.<# " E "0 =#
.B =
# &( <

9 ", G;
9)
E(<J *
>0, " & " :@ , A
J (ebcg) Opitz , (, 0
=# % G #1 + @/ 0 Gepimorphic field *
+1 # 5& , gradient-field -$
5&

.";
+&1 +)
I0
O "
, 9 9
. #
5&
+( I, 9 9
@ , 5> #1 &, X #
5&
9 I6

6
3/1 " )
K < "0 G*/ @<# H# 9 J .E# "0 9
@ , , :* @0 "V 5 *)
.5<#

*% 0 5&

<P #1 +)
'/ O& w70 50( # &
+0
"0 9
GE?,
6< / 0 5& >0 % G! 5> G #1 + =
.HL )
/
-6 7*1
" (-$
5& !T 0) 0 / M* " !
0 00 5&
! ", 3# "0 6n .5&

H6< / #1 + A 3)
" @)# 5&
" ! $ "J .5&
6
0 & #J 5&/

>
9 @ "0 % GE% EL E
@)# =% #1 9 = G&
:0
Q/ 5&

.+

@/ *
0 , 5;/ genetics #

I0
0
5> 0
G
, E G, &
9)
5 0 =# K < "0 GE >
. #1 9)
//F

E& ' , *

", .9<1 < 1 *
H6< .580(
5
@# = >
9 +( GE>
>
"L) #
u
;
! I6
9)
@ V 7) ' , #1 9 "n G #
3 ;
/
H6
#& K < ) 9 G #
u
" Y0 7 & , #

", .(ebilG Morgan
Sol ";/ 5/ - Geblc 9 5& G.

#

& , G#
.5&

, :
0,
/ @/ "0 G

- 7 .
", 0 Spiegelman
H# ", ?J G"/ A E* 50( ? @ , = G+)1 B) 0
" Y ) E. Coli
0 (( 0
+1 50( "J . &
#, " E? (0
" * Q, Y , # A E(F ) 3(
H
*
;
90
# ?J < *
;
", 0 G>
u
* ;
# ?J < )

.>
u

(
EF "0 I6
Morgan "L . #
5&
9
E E: +&1 9 >
W
"0
", "L O& .#

9(0 (
@, ( ?& M) , G-$
5& 5& <(
@:>
" 5
5& E# E( "L ", u
/ / " W /
=%
.# L E E% E# 60 E.
//1 &
@ #
E. ' , % >.>
"0 #
5&
"1 G5&
9 <,
G#
*)
W: !/, A <# 9 % G( #
5&
) : L <.0 "0 G)
&

50( " ":0
"0 I6
-$
>
)
P planaria &*/
"
.>
"/ <.0
50 "& 50(

O 7 50 "n G 5
.Q1
56 "
Q&J !,
"
E ) )* , O ", 36
" ) 5#1 "0 GDrosophila 0
6 ."0
'&
.(.
Q #
)
;
# )# G : &J
E G# 1 )

1 " % #
5&
", (ebbe) HF. ! I Q
G #
" E# >0, #
5&
"0 9
G5& , A .E# ?J (0 "0 ? E< 0
9 < #
"V ") Goldschmidt (
L Bateson "/ 5> #
+ ) ", A&
% 5&
9 ", (ebdd) Oppenheimer , Q .5F/ K( =
@)* 5 E,
5&
", / G5& , A .@& >J
& &, 9 9
/
" , A @& 9 @ 1 =#
/
P
# #U& 1 G) P 9
&
.

"1 )
1 " % #

1 0( %
:
*;
A/ ? ", 3#) .@ 5&
) 9
I6
*
#
, >

( #
5&
3/& A #
9 '

$$ # ) =
: 0 A
J #
5&
<P
" )
</
K = expression domains </# ?# M* :#

+0
"#
# GE?,
. #
5&
#

'*/ A #

./
A
J P
P&. "0 morphogen 50(
:(
5)
#/? % GE >
G60< . #
5&
0
&
K , A
J P
"0 ./
H6< 5&
.
.

.& 0 < 5&
H6< ", P
7*1 5& 9< GE# 5&

9 Gdevelopmental biology : +&1 9 & )

#
M*
K ", < &
+? "0 G>1 K .)
1 # 3
5&
A
H6< 50(
(
H6
0(
#/ 1 " 9/#
/:
+1 9P) 50() " #
" A*/

, 5&
0 +&n : +&1 9 5# +)
" )
9% G&.
/
.* &

"

" :# 30 (ebbe) H/ ! I 9% % .+(
*
//1 <,
.
0 G%
K
6 ." #
-$
5&

9<
5& : +&1 9) "
+)

+( J >
*
/
#
@) I6

A ! I 0, % G
# 5 5& I, +#, "
9
Hox proteins "!0<" @/ I6
-$
") " " K < "0
.5&
H6< 9P
.7*2
0(

%
H6< G& M* ) - J A $& ", "0
H6< -$ ", < G51
.(B
9 5& , 7*1 &, 5& 5>) 5&
+(
*(
_
L +)
5 "N A& .+1 H6
*
&
_( %
H6< -$ ", G >
9
,
homologous >
K
/
7(0 "n G5& , A .5&
H6< _(
.
& A "%
./ 5&
H6< +( 0 5& # P & %
pathways
0
A
. Drosophila 0
6 5&
H6< 7(0 :#
+&1 9 ">&
, %
.
" # , G-$ 5& , A *
(&
imaginal discs 50(
: ?
"0 A % A P& G I, 5/
9P , GE.0 E )
) = . 50(

.%
" ^ = 9 &
0
6 " +, +( 9</
G %
$/#
5&

O& % E ) E E<( ", .clinical geneticists *

>
+ 5% " 5&
9 7(0 , K
60
A
# ", A
J 6< % G , " E+# "0 (E.>
!/ = ,) * #
.dys morphogenetically reactive unit " # 66( &" )
) = 50( <(
&(

50(
5&
7) 9 % .)*
7P
E # & 50( &(
A
# ",
9
)
9P
6 #
5&
:0 V G
1 !/, A GE # 6(
#)
" )
<(
! O&J "0 @ , P&. 5. "
)
H6< 0/ % .I
#1
.)*
*
5. " , E# (7*1 = 1 >0 , & "
E/ ' , GK

6 A
J J .?./
* 9 +(
*
9 +#0 #
5&

E6J
< pathways K
/
H6< Gpathways K
/
" +#0 5) #
", .*
H #
.*
#
" */ "0 = 5&
"n G #
5&

:
&

......... !%? A ...........

# (1 [ A
K( = =
:K( ( 0 .0 0

&*
M 06
9)
I*
, I;
K/
5> <P / "0 ?
+0
G:#
+&1 9 <$
M:&
" <P
H6< =# " 5 5#
" $< K < .."
#< , 0(
30 )
+ 5> 7< IL K/ / "0 70 ".. )
#

G>
9 G&

!X"
= DNA
M* " G8%
M @$# /& A ? *

)
*(
O& Gbehavioral fields 0/
5&
@P I;
, )*
K/
", K( Q
> A ) Y 2
0/
)
< :;
"J .mental fields )
5&
5. " .

morphic
"
M* " Y
! "/
1 " )#
06
" 0/
5&

+, 50
"# 06" 580( I6

"
A ) "&
Q
0/ +( "J .resonance
Y
" Q1 &
A
J )
H6< 5 A
J )
)
"&
3/0 _ ", E, "0
" .@
5)# % G "0 # &
"6#
9) ", / 6< .5
5 .
/ I, # 9 = A& G@/
.5/, 50( &
! 9) A % ()/( *& & 5 %) Q, "0, Q1 "6#

.5(
t
06
"0 &
?&
=# + % GI
3<6
Y1 /
0:( 0( 06
50(
", Q GK( , .t
" "0 I, # L %
! "0 50 # 06
", "#
Q
K>& "J" :7 G"E. , K < # L J" :5 GE# */ t
06
"0 & /
5(
3/
#
7
9 G3/
!
5(
90&
Y/1 <<( 0
W
>, "
# 5
G * 06
E) O&U % t
" ) M* J ", '& ."@ $ ? @ 0

O
5/?
" +#, 3 I, "n G*
! .#/ 1 K )
06
", > ? 6< "0

.

, +#1 5
", > ? 6< "0
G; ,
H( %

", Q .5&
H6

"
A ) 06
", G #
5&
= M 06
", K( )
"
E, >V 0
G
= % >0, "0 &
:0
" ", & " #
06

)#
.
9
( < G*
, 0(
06
" Y Y
! " "^ , "

."^ ! + Jung u H$* I6

O& 0 3/ ", 3)

" @ , = G%*
!
)
5 " <
"
", K( Q
"n
/
&*
.supraphysical "I M" "0 % )
%*
Y ", GN " <&,
GK A % 5# - %* /# "
F
>1 9
)
/
" # @ I
9
)

50 " 50(
Y* ? .astral light #
+

/ A
J ( .âkâsha (01 E &, A

K < G> * .)*
06
" E 50( n K
6
G 0
(0, \5#/ A @* 9 O& 5) 0
.
>1 ?&
" "0
%
"9/#1" " # I
9/#
5& "
M* " .#/
H6< A
J 5 Gsupraphysical M
/
>1
A =* 06
"n G"6J
@> 9
"
", 0 K( .#
+
5. " 66
H6< O 9 G366
"

A
J P 6J E %J >0, * Y
9 "0" :5 O& Gmorphogenetic aether " #
>1"
6< "0 ", "0 6
Q ", 3)
" "0
.""0 50 # @ , &
G5
# 6J G" @ , A
.I>, */ 5
L %*
", 0 " E %J >0,
9

5
)# "J .
? 3<6
0 0
3<6
&* #? P
9 E, 5&/
"
) G5)
E) E/ PT G B(, + 0 G1 " E . 9 ", "0 5&
G5
G1
% .%
:0
G9P
" A, / K
&
:0
)#
H6< 0 ./ - J
+ ) G/
@ 3 I6

S. J @ 0 G5>
5/ A G1 5
", /
P,
7
(&
O& 8
O& I6
Y
# A " "# 5) G
5

.+ , " 9L
A K
6 50 GE
5(
Gsocial fields "#? 5&
" @/ "0 */ P )/
H6< 5> ", K( Q
50(
G &
")*% *
3/, K/1 # K/ / A E, 6< / .1 =#
K/
* , =# M/ , A #? #
5&
A
J P
"0 ./ I1 w& * )
G
G=
G#
K/
5> ( +(, A +
*/ 6< .(
)#
G#?
>
90&
Gcultural fields >
5&
M> 50( #? 5&
* .)
G

.>

71 5
< .("
) "0 0
+&1 + A )
)
"
#
5&
5& K( "J
:0

(
:
" < ,
GP
5& P
)
50(1 @; ), A
J 3<6
5& 5> G)*
# / 0 # 7? " # 9 0
GP
p
" Y A
J #&
&

G9P
6 )
P 1 :5> L &* "/ 9 GK
6 " E? .+
9)
/
) L
&*
)
" <L .. .9P
6 )
-6 Gp*
9P
" % G9P
6 :
.I# , 7< A ) I, ? G0 &J % K ?

5&
" < 3 5% " @ @0( 98P U I 9/# " GK(
E G(
%
"0 G"6J
? *( , .@0V 9/#
A
J E? G Gp# G6 50
& 5& 5) I, G #

5& 5) G)
5&
@P )
*( , G0/
* , " * 50
& 5& 5) G0/ 5& 8P

#
5&
/ " ( / J < "0
6 ", GE, K( S .0 50
&
V(
%.

9 A 1 5&
= 5 I6
# / " A, Q/0 , Gt
9P
.# # , 0/ , 0 5&
Q, J Y
6< >0, =$/ /

-$ $ ) A
9

@$# I6
5*
G#
H# GLeeuwenhoek "K
" " ," #
9
T
9 )#
H6< "1 GE 5 & % !0)
", < &
"0
.I&
3<6
@ I6
">1"
.I(
0
# 9/ # 50( $* ">1"

# ! W> ) )
9 7(0 I, A +
7
"%$/ # (0 M:& " @ 0
%

;
( #J 58> ", "0 Q, M:& (0 ") %
! 0 G50 50( I&
3<6

H# GLeeuwenhoek "K
" " ," #
9
", 70 E/ 06
. / )
3( >0
GQ, & " "0
.I&
3<6
@ I6
">1" 9

@$# I6
5*
T G#

9
A
J # " &
P
@6 #
# 9/ G01 9
)
E%.*J 06U 9
^ 5* K <
.-$ $ $ 0
" O$& "& .)
M*
)

San Diego –

0 – ; "/ " Dr. Royal Rife 7 5 0
9% ebif / ebjf /
+ " E E 9/ . 66 M*
8
E @/ %

# * California
/ % " @ 0 0
" #
H6< .$ df,fff A& 0
" Rife 7 # Y*/ #/
M
" M*
Mortal Oscillatory Resonance MOR 5
366
"
@/ 5. . 0 +, "$&"
K
6 ) 2
/
9/#1 Y , 50 " "0 G8

=
.
3 , Y)(J
8

:0
5&
M* 3*

6 '&
"
A 5 &
8

* $# K
6 ( */
.

..
)(, & */ 66

-$ &
=/ 9
, O& )
6< A& &/ )
? %
" E
# $ df,fff E0 $"J
0J ) .*
+1 3% ", =*/ @8 , 8?J #

E0 9$ ", 0
#
=*/ 9
.E,
3# E# $ * H6< $"J. -.)
O&
(
L1 0 <, 6 $& 0 +, F
5&
>V % @
'/ @8 , 8?J
/
9/#2
)
7. E 7 # 3) 9
.)/
0
/ $/ % " "80
.9/#1 K A *8/
)(1 & 3 , 5. " >
:0

.)(1 & 3 , */ 8

/* ; – 0
5&
" >V & *

$ 1 $

#& $; 5$& ", 9>#
"0n @8 , 7(0
.@, </ &, =*/ 9
: >/ <P 7 7(0
.$ V 3/

" >#
! "v0 6< G$:
P $; ) K
6 0
/
@(
0(
E>& * & H# 9/ ? >0 a00) I)
0
– '% 3/ I6
30
!
"0 G5>
5/ A)
:
6
/
>#
) – $:
)
– :$
6 3/
>#
, 30
' ", (E , 5/./
E# < & :0 7(0 G<P
H6<
$* O&, ) .: ;
# 0 G(!8
%
" <L
:0 , living energy $&
%*
9

J ( ' ,
:0
H6< G3 50( #
A
J P
:0 @/ "0 # < GEF Q/ 9)
(0 9
& K .virtual-state forms ?
&

t
) ?
&
" / 3 5
& "0 O& Gvirtual-state organisms
#
0 < 6

", A
J 0
+

.(:
/
)

&
( 0
, G:

-, 0 5 & (?
&

&
") / ? 5
G?
&
" *& */ #

5) G? *&
6< B) ? )
:0
. > ) 9> #
5 A
J
*&

%
"0 ", $&
P 2
? G )
" * O&J 5#, " .#
*&
-, * ! .
=
5) */
& :0 ", O& G!/1 I < *(
6< "V
"$ .6

A >V

.K
6
H6< F "0 ? O& G=%

" 5 Q/ ( / < $&

", 7 0
5 P,
0 .
#6 50 8P 80 < /
H6< =# ", A
J .I)
#
*/ /

" M
0 < >
5$1 Q/
" I;
M
", O& ;
^ A
J Q/ "

!!Q/ ed K < ", 806 .I)
#
5. " H I6
I#
, 9
)

)
?
&
= & 5 5)

80 <
& "V - /? E6J *
"
7(0 7/ .)1 )
hyperspace %
+
Q/ 5) (
) , I, G(:#
) 0
+
M,
P
V/ /
"& GE)* .%
? /
H6< A >V
(
) 0
5)
"0 70 E&?
K
60 GP $& A # A
J G$& / # & 7 0
5 >, .)% L
.(=% =#) ? =:%
" /
=# A 5 & 0 *( 5% 90& 5 &

$0
6

"0 G5) G8>F & , &
:0
)
? /
H6<
%*
" P $& E, G/
0 G#
0
B&
, ./#
:0
580(

", (&
%*
)
? =%
"0 G:
&
50(1 H6< ", "$ .? =%
" /

3/ I6
:
50(
$/# ) 9> (E I, ) filter " " A/ 5. " $ 5
.H) F# "^ + A
J G7 0
Q
"$ 5%1 A 6< .!7

0
QW & T"

>, I,
"0 ", " $) : 9)
" $/# ", Q1 #
:0
/
9>#
"0 70
XK
6 A
J I$F I
:'
8 ", ) 8
J /

& $/# ? 0
GE/ 9/#
# "0

?
&

.K
6 5) " 0
$
7P

&
", ?J G
@
= I6
I0
-.)
# 9/#
%
0
, !
", 9L
./ :
"0 0
, !
/# J "0 O& # A
?

-$ ) 67) 1
A :< %

I6
I#
H# 9/ ) E :* < >#
/ P ", -$ ) >,
t
) ?
&
" / 3 5
& "0 G :0 # 7(0, G0

.

&
(:

!
I
Q/
0
Q/
" 5 # :0

"
0 .I#
=%
" Q/ ed "
F
"V
H# */ 7 0
7(0
0 .I)
#
5. " H I6
I#
9
)

" M
0 I;
M
^ A
J Q/
"n G

.(0
) :#
+
M, )
?
&
= M>
5

G;

.
I
Q/
; A
J IF 0
Q/
; I, 5 &
5)# 6< E <# Q1 /
, GI#
=%
" * & Q/ 9 #
3*
", ) 6<
.# " H/# J A /
(?
&
) 5)
+ 3/ K
6 .@ +
) > )

:) $ X7 )$ .>% &; $) 0# - " 2 $/ 0
/# $
?
&
A I& &

&
H6< G *&
/* ;0
%*
"
<
&
:0
=#
($$ # P ,) .=%
1 A :0
</# ", 3#
#6

!
/#

&
5
(0) 5:/ #n @< " >0, &
H6 9 ? #
3*

.0
,

.!
/# ) 0
/
&
' A& P G# ?
&
A G!
A +
)

.! I 50( !
/# G/ :
' ", )

( #
5&
) &
/* ;0

5 O&J , < !
A +
&
/

.@: H# =# 5&

.( #
5&
) )
I&
@
# 9 ", ) : 50( !
A(.

E$ & ) A
Wilhelm Reich
DF ! %
Orgone
9, 6 (
+? 9P
s
(
E$) <>0, G5#
>
)
5)
>0, &, " O& 7/
<0 J "0 ? " 58> @ , ?J G" & 3; E: @& 9 @ , 9L .Galileo "
L"
GM*
Y, I6
@:
" #
9
)
58> "0 N )
GM 5& @ V )
5% " H 9L .
/
& "% * !
G9$ 1 @ A G01 0
)U
&
M ", ,# E
"0 &
@ 0
.
* " % % K
6 n G"B 9" 9/? 06 $# .@
/ "% ( 5 G91 A
J
.

=
+% 5. " E: '$/ 3/

(
"/ u K
6 = G E 0) @
* 0 .ecbm 9 /
Wilhelm Reich "B 9"

% .(
!
9
G" ;/" 3.* , &, ' , G!
9)
#
p
P
! S 9./
E* ' , ", ) G@
# A Q, ( M8 % "0 6 3*
5# "0
Q, )# ( A 5 &
").

&, @ V 9
)
Q/ A E) "B 9" ' ,
"
" >.>
.E/
5
.//
1 I% !& !
9 5# * @ M % ./
-.)
!
9
M& 9 % .(
P&

>
:/
5
/

5

"B"
"^ ./ & && * / #
9
" $) "V ")
3(
M& G5&
= G# ,

9/ , " )
")*/ ") " (, A Q/ M* ? A)

=#
", & "B"
H6< "B" 0
):

51 " . )
/ #
9& G& 50 50(
The "(
#
/

&
" Character Analysis " (
5&" :" )
".& "0 P @& "

%. A "B" xPx& .=% L A& &
# 6, G1 ; K
6 ) .Mass Psychology of Fascism
G// ' 0 @ , 3*0 @ 3/ "0, +/ . >.>
7 A& G"" 9
H6/, = )* 5
.$ * & {, E& @/ 8M( S G> * "" " "B" 5
Eros and

&
/ #
;
5> G& = 0& "/ ( "V @, A "" P&
5)
K&
//1 -6
, G#
, GP
0
, A ")
"6< A
J TPT % GThanatos
K < "V
.)
H6<
Q1 5)
"
K < "0 6J E 0 "B" , G7*)

. $)
/
Q
H6
3#/ GK
6 L "0 % , G":0" %* "0 G8&
%*
" $) ?&
0 %* 7& ? , B0 ? 3/ %

>V
& & "0 ", "/ `
"0 5<
X@
", " E? .*)

)
50(
" ) Y , "P , A
J (
" Y , / 9%
"B" 9% G@, 01 A @ = /0
A !# I6
/
W
)

.
"3%
" = 6
!% .9) Q 0
9<>/ E &, 9 & 9/ 9
.H
I/#
9
)
9P
/
*
" H) #
P

H6< 6, % .@ )
L ?&
" O& G#
:0

.
< A
J E# /
; G!
9) "
=#
9)
/

A
J # .8&
3&
( " , 3% = >0
# J " "0 "
@ V "B 9" )( ebib 9
& @8
/
0 .(@8 P "0 6<) 9./
&
5P @ EL &
?

:

@) "B" 5& G0, H#
, @(( , 5*) , ; 5 & 6J O& G&

:0
%*
" 50(
I% : /# K < e
./ /# ((< "< A
J G&
":0
: ; 5 & A
J K
6 IF % G
@ W ", "0
" "0
GI
A )
/* ; , :0 !
< G@ " 6< %*
50( "J j
.%*
H6< 7>0
& /* ; :0 E?&
.) M* G9 50( / )*
"/& "0 G%*
H6< = 5)
* 3)/ 9 9 5& i
.H#
/
-.)
*
=#
@ ", 5% G$#
O&1 " / ) "B 9
" A, G0,
9/? M*, % .@& " A 7 //
@>&1
1 !/1 "B" = (K ) " ., u
" H
" /
GOrgone ""L1" / 9> " <
Y*/
%*
50( A (

.organic "I" 9

$( !
M* 7(0 % .
<<P & 5& G
H6< 5
^ / "B" ,
+ 9% % .*
G 0/
+0
G&
!
, E/ ( L 50( <& , "L1 %*
=#" 9/ #1 H6< A M* ""L1" %* " 0 , &( " =# A % V G,
.ORACS "K,"

J (, , orgone accumulators ""L1
"L1 =# 5 ,
"L1 =# ) ) < *(

&

A&
1 5)
A(. &
%*
K/# "&( M
H6< %
" +% < @) K 50

," +
E $ O& ("L1 %* =#) #
H# 0
>
"B" Q
' , Geble 9)

H# ""( ," 5) $ 5& & K < !
.#
6< HP I6
3;
>V
@, )/ ""( ^
I, > 9
, O& "B" 5#U "0 @ , 5% " K < G)/
W:
5<T6 @ V 5% " K < O& G#
6<
)
@%, +/ #
>V
" U
H6< " +( I, 06 9
"( s G5&1 =# "0
.@
Y*
+
6< 5& ) "B 9" 30 % .5%1 A
P
@%, !
G (
@06 ,
.The Einstein Affair ""( ^
V/" " ) 0 @/ <( > G
0
+& , =# ")
+.
" 0( V( , .7
F0 , 9
)0 +/ "B" 5, < G )1
"/ " , +*, 0 +.
K:
, " )
.">1" ""L1" %* Y 5& 01 5
1
9% &
?
.""L1" P * M*
5* A H& G"B"
A
1 A*
)
.""L1" -.)
Q, <P M* " <L ORACs "L1 %* =# #, # +*1 "
) 5> >0 5:? )/ P, .&

L , &
P 1 A +/ 3#
" .:< E "B" Q#,
A 5:? " O& % .
" Y , ) = 7% % "L1 %* " 80 0

":

high 0 # +
" L 3 , A Q#, .2
I#
7.;
"L1 %* #
:0 # >V ;
(() "V
& 5 &0 6( >^ 3 1 K P, O& vacuum tubes
.E/ E#
( #) 6$ F ! [7 $:S
The effect of Deadly Orgone Radiation
"L1" %*

" Y
6< A M* $ % A
J 5& ",
"0 %*
H6< "V B 0
7(0
.DOR T
Deadly Orgone "

I#
7.;
" M* ( J ."L1 %*

)*
L 50(1 &, < DOR

)*
@() I6
!F
O& 91 H6< ) "1 )% 0 /
=
H6< G2
.(%.1 L I

)
6< (
:0

"L1 9

(./?) :& #
* 50( 58 G0$& L 0 %* < DOR

'
M1 "
P +/
A )*
"L1 .$&
9/#1 5 I#
7.;
" 50 )*

"L1 %* .#/
/1 , /
5 E &, GP GDOR U
M*
GI
,
. 0/ < DOR
. , :
2 G# G G/ 0$& < )*

<V
M*
" O) I6

3
"J .@ , 0 O$
E) @)# DOR
+
#
0 "J
7/ 8>0
/
%*
H6
( $)

&
.DOR
5) 0
+#? 9 50( P
#
"L1 %* 5# A 0 50( )
(./?) :& #
* 5. " )
/
$)
"J .: A P& ( (
>1 = 5
5. ") & 9
( 0
>1)
.98&

G&
%*
?# 0 5. @ W % /
%*
H6
5

" DOR
3*/ 9 :

50(
"0 $) * DOR
+
#
$)
#(

, G 87 M1 .#(
" A1 9/
< /
%*
6 3 U 9/% 5$, G

.#(
& A1

9/
< G#(
% " 3
3L1 A "0
GE) $
" L1 !F .8(
(.
+&

" G5/1 A
J A1 " #(
.A(. 9> 9% "
A
J " L1 H6< !F A +&
5$& .8>V I6

./, "
A
J
$)

5$& G7>0 50( 80 DOR
"0
M*
.5
A
J -

.
'*/ A &/
"
*;
9> G; = 50( A /
,
H6
"0 .-
" #
5& 7>0 90 G5)
6

B # */ DOR

J 9 ", )
B 5, / 06 )# G<6 3# $) +#J K .&
E< E* 58> ", 0

)
50
!/1 < 01 1 50 # "L1 "n GB H#
E .Y
6

.#
:0
, .
Q/ A
J E? ..#
50( " ~+ # @6 ,
", P&? % .:&
06
/ */ 0
%*
H6< 9 @ V G/
* 5& 0
@>&, @
P,
5& %*
H6< "n G(armouring '

&
H6< ) 50( A E/# A#
G"<6

F

5% @ , I, Gpestilential ":
" 9/ 0 50( "'8
" (
/#

&
@/ 9% % .DOR A
J
GE.> /
1 , "*/
0 /#
1 ", < 9.0
. .P&
I, 8)
,
`
0 A
J )
%*
H6< 5) J < -.)
G %* A
J 9/#
&
"L1 %* 5$& 5) <
.'&

$ '>
0
1 " E +(
A A
/ "0 I6
"L1 %* =# " Y B 0
0
9/#

< $ 0
:& %*
$( 7) A
J )
3/ ",
* . "0 G " )
)*
$( A
J

$# ", ) 6< G( Q/ A P&
/

((
&
%*
)
< <0
:
5:/
Q&J .)*

P 5) */ 8)
,
A +
=*//
H6 ", O& G" ) " " " "
* " < @ # =# G3(
" M "
.*&
:
8
( 0
>1) "L1 " 0 0 =# "0 *

/ M

5 ("L1) 0
:& %*
7>0 GE & 8
M
6<
!#
38; ", " . G("L1 =#) 3*/ *
"0 GE# */ ,
.(

) I&
@
# *( A
.(DOR) 0
%*
A (I& "L,) 0$&
%*

)

=% 01 $) @ 0
G("/#
"/
) A
" >0
-. E.) B '#
=# K < ) 01 */

A 50
@%, %& GL 50( @ O& "#/
YV GO&

B 9
9/ A(. % G(@0 H0, " 0 50( / O& ")n / 9 @%, "V 80F /
.9/
)
W
" "#
")
$
% = )
< 0 G1 A
J (
06 "
XX
%* =# # @#

) )
+
)* L >^ M = ) "XX" 9/ (
#
,
/ 9P =*/ "L1 %* "0
&
%*
", A E& E.
"B" #
.ORAC "L1
9 &
" 5
58> , G.
( % 50(, P G$&
:0
( 50(V $/#

,
30
5, &, . ;
0
) @& "
H6< 0 .bions "
" 9/ M*V G&

@ / #J "0 5? I6
GCancer Biopathy " */
I)
5.?" " ) 30 <
K "B"
Cosmic " 0
30
" " ) "B //F"
( > K < E, .Q0
)
0

3<6 % K
6 ) .0
:#
"/
A >1/"L1 5
^ #
GSuperimposition
K
6 / % GMaine """ Rangely "; " " 3
V(
O& 0 A
J H @) E.% "B" 0

.Orgonon "" L," 9/ 0

"0 ."L1 %* G $ * 5$)U G>&) L Y*/ @ V "B" 0
S$ Geblm 9)

<( 9 ; > A
J G&
&
5% " / O.>
& 5& &
Y
6<

(1 >
K " / # GK6 ""L1 K&" " / "0 ", "0 = *) O&
#
6< =% A
J $,
F
!:/
" >0
( > "L1 K& % "J .;
</0
.X Files (
5//
" ;

H6< 7 "0 .50

B" ;#$"$

)/ @(
& *
P
0&
3&1 , G@# @>&, & " 6

H6<
+& , 0 +*1 A
J ""L1 7>0" #, " &( 5/J 7% //
9?& " "B"
.
O&1 ) +#J A
J 9< #
)
#1 H6< 9/ L "6
G&
?

9
"9;
" # ", "$ O& GE# 9/& E# 9 7(0 A
J "B" 5$
6 <
K 0
K ", , X5 , 9< 6< 5< !

#
:*
9/#1 36# "0 @ , 5 G* 8&
!*
980&
I# "0
0
H06 50 "0
G*
9) &, ? &
X0&
)
$/
=(
) :* 0 9/#1
/
K Q&J & % G#
6< @ 9/ "0 I6
=%
P 0 9/#1 K ", < "B"
6< <( *
" # & G&8/

B#

u 9$% " ) .@/ H6. " #
.(Q, "0, <P
H6< 06, 7/ //1 " 7 Y
6< ", ) .9 9V 1
//1 9? "0 8U 9:# ) "B 9" 9T ebgd 9)
.0( 5#
6< 0 5&1 =#
0& P & 7P 5P G

0&
!@? & - A
J "L1 7>0 #, 5 # <
5 7J 9 .

"#/
"
" + @ 90U& "B" J 9 G/ L

& M 0 ) ">0
# O& G " L G"B" HV( , I6
"" L,"
" #
!
"J .0&
" "B" 0
#, , 30 06 M M& 9 G"()
"

3# K < ", " 7(0 GA*/
)
B
90& 9, A
J )
G
51 K + "0

./ ( ", 5% / @ 8

)*

9
)
30
9
&
G9 0
G@0& + " % % 5% Gebgm 9)

> 50( ..."L1 <P @) ...% # "#/
GI&
">1" 7(0? I6
(

5$1 98)
3L 5P '0 / % orgonomy ""L1" 9 ""L1" %* ">&
=# "n G3#)

& , "L1 :
L "V "P&. 5#
6< "
)
K:
, " )
"n
&
% .H, I6

"0
t
" , Gzero point energy " *
%*" )
>&
)
(0? = E# # 50( 3/
.( _* "0
G%
A & # " O) "B" 0
/ O&, ,
.quantum vacuum
"" L," G"B 9" 7& 9/% S 9/ G"B" 0
3/& Gjffm 9)

% ."L1 %* 5& # E%^ '/
06
M:>
" )
9/
K
6 "/ GRangely #
5# P
0 "0/
H6< "V E.V .@ ) 9 "/
)
M:>
H6< +n "B" 0
,
E& K
6 "0/ .5* " 6 3L1 A > % A
HF, "0/ . * //& >01 (
" #
.M)
">1" 9
A
J E# E # GE#

ً
‫ﺍﳌﺮﺽ ﻳﻨﺘﻘﻞ ﻛﻬﺮﻭﻣﻐﻨﺎﻃﻴﺴﻴﺎ‬
$>:" -$$7) '
&? GK// *

? )
) < Vlail Kaznacheyev 7( 0 5. 0

& ) ? H6< ..
# " -, A / "( " >0, 6 I# .M/
/

#
3*
9 " E 7 O& I<# //, 50( -.)
K
60
5 0 3)/ 9
.:/

, @
"0 "
-6 " A/ , I

", G9# 50( (7?^ <) 7( 0 3# >,
Q&J .
,

& $/# /* ;0
#

/
.
GE/* ;0 @
/J
"0 .7( : #& 5 O& )
) 5 M.L 0& "+ = G%,
?
Q&J $ GE >
.
" # + 50 = .:
#&
# " ?J E "?) "+

.H^ A
J ... 5% #/ M Y)(J , G5% ! , GI Y)(J , G:0 $9/ , G0 Q)
"#

"0 6J @ V ? 5. " "$ .5)
H6< Q& $)
.
# A
J E& $, )
H6<
6J "0
.
5)
$)
.
#
.
; I, ,* 9
GI)
-#
" Y :
#&

P ", ) G/ ej 5. .E%.*J =% L E, 5 & 0
" Y :
#&
"0
.0
#& " N 3 #
A
Q1 .
# )
! P GQ)
$)
.

#& 5. " G* E: G

.
= 5 A
L .
6J @ V W / ^ K <
E: 5 )# L Q, . 5
L .
H6< ) 9> G/ jf , ec
0

5 & 9
@ V 9)
= ..
" >
>
#
H6< " P

, G0
#& 5. " *
.0
" #& 5. " G* E: 5
"0 .O.>
#
H6< " : 5 I,
)(J M* .

", P, I6
BL.t., 0
5) @ 7( 0 0
+6& 5. "
" O&
5. " 3# " 7( 0 M O& GQ, . A >V
0 ( ) mitogenetic radiation

#
#
&
.
", # .&

.
# " >
-#
" Y
#&
5. "
" #
H6< .#/
M
" % *,
"0
.8>V 9
)
#
.
K
6
G#/
M )(1 H6< 9% -#
"1 I)

G

.
! / Q1 .
A
J
" )(1 H6< 0 0
" E#& )
.E/* ;0 >&J
/J "0
,
-6 "V >, % 7( 0
7( 0 # ,
:," ) " $"$4 &) G
50(
G
.E/# & ,

E/* ;0 Q)
& , #
.
GE6J
; 5 & " < I, G5$1 9
I
Q/
A I# +#J # " < 9
& )* ", GE/ 06 0 G
)* 5 -6
"J .
)*
+1 :0 G:0 G:
0
+
M, )
?
&
= & M> 5 5)

80 <

A 5 & ; I, G

.)1 )
hyperspace %
+
Q/ 5) (
) , I, G(:#
)
.!
:
Q/
E.) $/# (?
&
I, ) "0
" Q/
6<
: ) % 3

# &) 2
c# J $( ) 6
A 8>F ?

& -6 5& "#/ M" /* ;0 M.*J 0
.
GE6J
/* ;0 5/n % )
/0
6 "0
.
3 Q1 .
&
?
&

3#
.X# # A 5 & / 5< X
.
A
J )
?
&
-6 5& "#/ M"
5$
9 E 9 : 6 @ , < & 061
\5;/ G@#
6< = ", 5% "0
! <
G & &
/
) 9
9 , 9L 1 " +(
0 >V
#/
M
", ) A
J
# E % )% ) % 5:/
H6< ", #
E0 "0 S#
6< GS# 5) 0 -.)
/
H6< "0
.1 0( F
", "P =#

.E,
" * ? !
9P) "J O& ... <06 3# * K < GY
6< x% /
5%
" "#
0
", < 3/
.&
/
H6< "0
.& A "/ " "?# < " #
0
" "9)
"
"/ 9 "
, G3L1 A "P 9< +)
.0
* "( /
" +)
" " "

? * "
& /
)
W
A ? P
") +)
.>0, " 9 , I, G"
" E.% .+(1 H6< @) ", "0 "% +(1 " 9 "
, .#
)
!/1 A

&
H6< G#
0
&
" 5#V +)
A ", "
"0 .! =
/
P

9$
.!+)
5 !
"
5 :< /
H6 G0
S /#
" # A >0 >, K < .
)
/
" ? "6
"
5 H&J 9 #
0

>
9# J 5 )

Q# L 9 0
01 /
x>0 9
" "
.5> 0, < "/, ! ... 3 A x/,
9)
" >0
%
>0 =# 06 G#/

M ($)(1)
*/ -.)
, .. A
J )
.=/ 50( <( 5% , )% $(

Q% 58 5% E.) # L
"0 O& ("/
$))
>0 Q%, < .
0 ", <
6 ($)(1) /* ;0

#. "/
&

-6 5& "0 9

A& G/* ;0

H6< "V - / A
J GK
6
./
0 "
/
A 0 >V
"n :( 0
A& G(7( 0 @
J 5 0 ?&)
The "=*
&
" " ) @? Q&J
#.)
H6< A
J E( !.L./ 9
0
5 .0

: (#
0
1 #
@ ) Cutting Edge
" ^ =: -. #

.
*
0
Q&J 7(, O&
5. H#J K 0 B<
"
@ J .."
0 "/
$) O& G1 % //F </, AMA 01 3*
* )%
#.)
"
G9
9$/ # & E " 0" "K0 <" "*
W
G9ebii 9)
.Q1 )#
#.)
%
...-.)
6< # E
A) .#/
M )(1 -. K
6 "/
9 GE6J .9

A *8/
)(1 H6 (
& -. 9 9ebjc 9)
@ , # GO&
"
5. ...
50( -.)
*
H6< 9/ 9 9
6
.E 9 : 6 #/
M +
*/
1 -.
"..X9
0 91 K :/
1 9P) ", G=/
X"N A& @ =/ 9

6
X!
"
" ()
6 G1 ! " ( % -. # $
.30
6< +% " + ? ) 3#
9
+
5% %
"
< % -.)
/
H6< ",
eblf " .)
0 # 0 W:
.#/
M $)(1 */
& eef -. 9 G9eblf 9)

.asthma
A& Gpolio 5*1 5( Gphlebitis
3
J ?& >0 ?& -. 9 Geblc
.9 A #/
M )(1 */ */
& 7
, lf -. 9 % "0 G )1 A&
.
"
" ()
) G#/ M /* ;0 # 8

Y +
X#.)

H6< 5
Y? + " ()
K <
-.)
"V 0
S$ .E #
% /
Q
& mb "V I..3.- 0
80, G9eblm 9)

"^ -. @ 1 / Q) 90&
E: @ ? "0 9
A #/
M )(1 */ */
"0/
/
H6< ", 806 ...*
/
K
60 GE, ! < ? G! < 1 .5$)
"
5 A
J 5 I0 I, "1
&
H6< E) I# ", I0
+
"0 ? K
6
..
5
.
!/
" !
5% =*/ #/
M Y)( "0
.E,
5 7/ !
5% 5#,
#/
M /* ;0
#
W
) 3* &
#/
M /* ;0
#

# , A I& Q, &
""!
/ 0 =
?

& -6 5& "#/ M" /* ;0 M.*J 0
.
", A
J
5/n % )
/0
6 :
+/ .
3 Q1 .
&
?
&
A 8>F
A 5 & / 5< X
.
A
J )
?
&
-6 5& "#/ M" /* ;0
A &
9 G: >/? W:
H6< ( " = @ 0
.7( 0 0
H0, 6< ! < 3#
.X# #
S./ A & % /
"0 0
7(0? 6 GE# ' < 3/
.! E, ")
5
H6< - ? ",
# */ M* " 0 ( # " H I, /# =*/ O& E# E# * #/
%
-6
M> ? 6< ", < 0(
.H/# 3*

(?
&
) -6 5& /* ;0
. #, A !
6 ,
O
= M "0
"0
G(K
6 " Q# ?

)"#

"$
Q
A& "0 ? O& 8) 5 5
, ?

-6
5#/ =*/ E# 8) 9P A
J E.) % M/
/
&? +)
", < .

G $#/ */ L, , 5#/ 0 G"$)

" M>
(?
&
)
G5#/
/0 A/
"0 G 5:/ #/ M 50( A "0
-6
H6< "
.(?
&
) -6
H6< @& I6

.
3 G) . A $
-6
H6< */
"
+( 3/
(? ?&
) -6
" 5#/ "0 G!0) 50( "0
G6 *

#
*/ $#
+(
& / "0

G@:(

@#6 @
50
G1
."
"
+(
-6
&

5
" O& # 9 5. "
9$ "0 .+
-.)
5# # P
' ,
GE6J
.)
#
G&
:0
" /* ;0

< 1 @* 50 .1 &

/#, @ & 9 S
I, , 0
1 " I1 #& ) 9
()
) :/
? -6
= 5 0
/#, A */
/* ;0
#
" # 5
. , Q I1 (%) & -6
/
:$$+ $"$4 &) G

"0 I6
-6
", ) 6< .)* holographic L
< < .
90&
? -6
",
" 9
" 0 5 &# G3/
6
.
.
K
6 G9/#
. 50

"0 G&
H6< 0 G^ "& A
J (
" ? (
-6
5&

)#. )( $) "&
G'& 50(
#
5) 9 G(
? -6
N "&
9/# % "&( "
#

.antibodies
9/#1 " )* 0 W , @ , A
J
/
: >/? @ 5. " $ >V
6< PJ " Antoine Prior H " , Y
"0
9P, 0 '# @ 0

G<P
H6
/ I, @
"0 9
3/
7) 9
@ V 9)
= .
"
" )/

= *
5 & 6< G5#V +)
"/ % "
"V H06 /, 06 ! / &
#
.H " ,

, % H A I
The Priore Machine and Phase Conjugation
( .<F , ( " "0

)
5# 5)
"H " " 9% G
"
" )/
/

%
3#
" :
:
5. " .E.) <6 W:
"0 G-.)
9/ /* ;0 ?^ +
% ;
G
G
1 " Y 0 +( " H ?^ 0 G & A G

50
-.)
A % H ?^ P, G?
" ". ) u
G/
0&
" 5 .+(
? " 7?N 5. " K

6 G(9
J) 0
A
J
*/
Y , =#
%eff
.9ebdf 9)
6 "$*
+)
A W:
% .
&
A %,

A
J (<
W:
H6< 9% " 5$, ./
9)
0, " "/
+)
, A ? =#
% .E# )/ "0 ? ?N H6< 5
^ ", .#

9/% G@0 "0 )
=#

@ , 3; " G?N H6< S# 3/ 9) 9*/ " (
)
(
6) "/
+)
" >0

5
^ 9
$/ "V Y

* % .?N K "/ 0 60< ."+/
M
" H6 @ ) 9
!
50 7) "0 H "0

.#)
+(
5. 5) 0 70 9 "0 9
E, Y
"0
G#
@
&, "0 6J 5& 9
A& 5# > 1 5? .# 50( 5) )# 0 A
J ?N H6< 70 0V
I, (9
+)
9P) A& ? ) & 9) &, "0 9
G*/ < 3/
.#)

N H6< 5) 70 9 , 9)
9
6< " E:( 9) 3;
&, "0 9
G&
.phase conjugation "I*
"%?" 9 " +(
6< A ) ") * /
"0
K .<6 W: M& H "0 "&
"
" /

.time-reversed waves "
/0)
#
9 A
J G9

7 ,A 0
B#$ )$ $:S
#
H / P, .!M:% 5. ( 5
@ 0 G # GI0 GI G@//, "0 I,
G9
5/
0
Q/ ", Y*/ . <
3/
# "(
/ / !0 =*/ V
sleeping 9
-. '# % .!5/0
0 Y? / )*1 (
5 / 5. A&
A ( >V
H
^ " >)
#
", .trypanosome /
" W

Gsickness
50 ", O& .50
9/#
Q/ A
J E)
Q/ " G$&
":0
90& I6
L

-6

.
-6
Y# " 78
F < I6

L

#6 E,

" 0,
H " ,
^
9/ " 0 6J G(H^ A

J..= , G5# G) 7*, + J ) ", =*/ &
+1 ", "$
!XE.) )*

H6< 5< .H
^ 5 * "0
)*
6
+(

", ?J G@0 < "/

+)
, M* " 9)
/
01 A
J 9$% % H 5 ", 9L
"#
/* ;0
" 9 5# A 0 "%
+)
+?F< "1 6< .
^ / =*/ 9
01
# " 0 #)
H
^ Gphase conjugation "I*
"%?" Gscalar electromagnetics
.electromagnetic device using phase conjugation G"I*
"%?" , M 5) "# /* ;0"
( 6& .. 6$" -

1

@ Y % ."0&
@F 9
H " A
J / 0&
; Q, G9ebml 9)

=, Y # A 1 @/
" "0 H ", < (%
! +0
) /
I6
.E,
E? (
0
"*/
?& W
) ", < "0 .& ) 9/#
50 A
J $)(, 5/J =*/ GM*

N K .(;
:0
9#& Q/ =/ 9
O& 9#&
; /
@?^ 0) * &
-. "
.<;L b,l & A @) 9> 7 em * "0 O& 9/% G
H 9/ G%.)

) A
J G$#
Y(
6< 5 9 +>1 51 5# " >0
5& GE& 5? H "0

H6< "0 E
L) " )
+)
5 A
J #
9<
H6< 5J
& "6
(+(
) "&
+)

9> " 9< V @/

A
J @
J 9> G#
6 / 7 5
()
*/
%
.E: 1 < 60< ... Q "
& ? "0
GH*
= )# &

?
"&1" +)
" # : 9% "
E& <06 3# &
& K <
" 9 A /
0&
H " / A
J "/ & E, "&1" "

" #
9)
I,
A ") (/
$*
=#
) 9L) M/1 &* 9> #1 H6< = 5
.
0 I6
)(
*;
5 )(
!#
"

" O& G@
:

) I6

5% " 5
9
3&/ 9
.")% L "; +?F< "0 90 "0
.=/
9. 5. " @ )#/
.) L 3/1 ...
A &/

#
=# .L 3/1 ... "

"
/,

@)*% GM* =1 6 H# K0 9 .@ 0 9 @6 < =*/ 9
/ `
EP E>J E0 H <)
.1 A
J #
@ 5) I6
,
Y 0 G>)

Gtime-reversed signal "

Y#/.
"
( - J 0J A "<
"J G5&1 =# "0
:
1 # G9/#
6 50 50 5 A
J 3$/ 0
/* ;
5#
= 30

!0 =*/ (J 60< ", & .E# 9<
9# 70 O& ", ) (
A 3# "0
G9
:/

"N # < G@) "6
+)
K
60 H 5, 5. " >, % 9/#
# I
& 50
5
< 1 50 G9
, " # H !
* A -.) ./
)
1
.?N H6< 5;( J * 9 7/ G/
0
K
60 3/

?
&
H6< :#
Q/
0
?
&
" 0& &
:0
", M/ " W / GE6J
. >F
/* ;0
#
A ? $;

1
5 9
//1 -6
G1 "
Q A ) GPasteur /
$ 1 $>#
$P
5 ?
K < 50
", I, .)
1 " $) -6 "
F/ $) 9># K < a"V 5 .9/#
0

.
@>#
) " O&

GE.> Bechamp 3( P K G
K
&
"0 9
/ P
.Pleomorphism
. " P
>#
"0

$/#
?& 50(1
50(V >#
P $P
% Q, $P A
J 5 S //1 >#
@P " A / ", 9L
P&
//1 @P !0 / 1 0( A ":
5
5# "0
GPleomorphism )
. ? < #
:*
'
A
A
J 50( " 5$&
A 0
% >, "6
+*1 " >0
O&
3*
P
+?F< . "0
:
*( 3/& K
6 G"*/
A& G^
/ A
J "$)
/ " G^
9 GP
+ %J " E? "0
./ P )% 9 9# 50( >, GE.> 7 0
5> G+*1
.&
(0 "6
+*1 + %J
"0
G) ) L @#. "*/
%
3/1 $", "80F ">&
5? O&
)
" %
6< A&
F & E: 9 0
G-.)
(0 3/
") 98 , "0F "6
"N ">&
" )
K < &

.%.)
1 0( $0&
$&
:
5% " &. =%
#
3*
//1 )
& ,
)
)
/
*
0
)#
0 G)
//F
,
? "6
+*1 Q/ -$ . G

G1 0( 5% " E
G(9
)
5& /

I0
+
) 9% " 7
+
L : 50( I, A "% 9)# >J , 8
, # " F
.(0(
@) I6

5:/
u
",
"$ G/
*
02
I &
, 5
)
W
9
980&
5. "
.Q1 #.)
u
" <L 0 )
O&
& " $# E <# a9 % -.)
$)*

3*
/ ) $&
< G9
)
$&

//F 9P) A */
0(
H6<
& & & , 98 1 GE%> E , >01 #.)
u$
E&, +*1 ) 9
O& $*
5
50
.9>&1

+
0( A 9

9<
-. 5:/ 0 ", 5)

5. " "0 G9
3*
9
90&
K

P
" >0
K <
"0
.<L G"*/
G*
, G/
G 5> G1 A
J +
1 5 :/ E# &#
@ 0 " >0, G#/ G// < 1 .1 # A M* 50( "*/
9
)
90& '
" !
6<
.!>0 >0, @ J ... / J G$*
&
+/ A ) G&/1 ) % 0, > ) E< E % #,
G$:
0(
H6<
/ 9< 0(
Q
.A
+( 9< $: 0( I, Q
# ? .&, &
"0/
" (

& &
+/ ( =$#( 7/
$:0

= # , M &
+/ A P&
=/
.
&
3/
58> E "
, #
)" Y %
F
<$ $ +#J *( "* :6;

1 0( A ":
=#
.E?
", " 9, )
#? H6< .eugenics @ /& 5/
& 7 )
/

) * ( 50 980& G3&
+#
" 0/

" &

$) 5:/ #J < <, Q&J
. )
0
1
6L1 5. " % 9/
H6< "8 !!3# >0

$ G&
" 9& +# <
$", 0 ( G9
)
+& , 9P) G1 0( &#

Q " $&
G5$) 9/& 50( G$*
9P
9% G@>

)
(
5. " .1 )

."<#
0
%)
" :& & 9# 9 G!
" $)
0
$&

-.)

."I(
9/#
) 5) 6 9) "0 9
91 )8*
" ", < //F /$0
#
1
.9) I6
H& O&
9)

< GE % GE GE// 7

5:
<6 5. " G3)(
" 0(
H6< ,
<#
&

1 9/" ", ."1 -. +( " &
//1 5F/
< I(
":0

#
" ",
.")*

#
:# K 58> &

E&& EP !0 < *
@P ", O& (@6 @6 () 6
+(
A
J E: 5$ "/ 9/# $"J

: "> G& L 9)* 5 5. " )*
*
)
H6< *> '0 A #, 0
.E<
.$
?& #
)
(1) $/ A ") G :6L ( /#,)
$ &( =$ 67)

)
W<
A
J "N A& * # 9

G
"
&
#
>
(0? )
.# P G# G# * / $&
A
J P
0n ' , G3)(
A
J
I6
)
W
@ !0) .5) 6 E# 9) G9P 5 5% " 0& )*
", < @ 80V
9 5$,
$% 3& B) V E, 9)
5# 7 G>&
(0? H6< ) .1 0( @/0
!#
50 M> ... #
2 G< ? GP
M* " K
6 9 ."N :/ < 0 !0)
!
!
I6
< G"0
#
I<#

6<
<<P
0(, 7
"0
GE: %* */ G06 * :#
0
#
9/
.!#
<

+ 9$ G%

! P G :0 " )*

$)
& $*
)
"/ !
G/ = G # A
J GK/
+06

8 # " 5 /
.E, :0
% 5 G*
G($0
) :#
, Q/
E: #
A
J P 6J .!/1 < ."0
<# < %)
.

H6<
@0V "0
K& 9 G )
#
5 ! .

H6< 5) .#
&
<
H6< ", Q

o0
o
=#
.M. ) "0 $/# ", "0 .6 " > : %* M* "
.90& "00 )*
$*
)#
$: $/
"/ *& .

< # "$ G@& I(
":0
/# 5 ?#
*
)
*(
& "
= /* ;0 %* " < .

H6< .(Q1 :0
=#)
. * G%> G*( <#
" 0 0 "$ O& G) I& 5& < G&
":0
*&
/* ;0
5#
6< ", "
Q& A 50 A
J @# & , @* E, 5& G
#
-6

. " 90&
)

7%
=
3/& * 7 G#6
P 9 G)% 3/& (
50(
A
J 5&
.p*

0

.
50( A & I& /* ; 5& # " "#

0V 70 ,

.@* I&
/* ;0
5&
6< & >
9 #

) A ? G" #

. + #

1 G I6

*&
:
= 9 9#/ ..50
"
& )*
H6< &
:0
=# .
>
& M +( 50
P , 5 I, K < # ? G3
3.
I, $/ 9

+6)
)*
.
.50
#/
<? +? " @ 0

0
*
)
$ < #
A
J M> (
" +) & ":0 50
5 */ $/ , % V 0/ 5. " >, :0
=# .@ $* </
G@: A P&

.5#
.E &, Y +06

" ? * P 9 % V $K( I, " >, E.> 9
.
5 *
.X1 # 90& I6
I*
5)
6< # ",
A .
% >, "6
"5( " "" (" 5> +)
" )
%,
: >/? ? )
"
", ) E* .
"
5 0J >, I6
7( 0 5. /
9
)
G 5

# M> < 5)
6< .#
:0
H6< K/ 5 //, 5 # " G0
" #& )
9 G/
.
*&
/* ;0
?#
* G/
.
" #/ M /* ;0
.5

+ +& ..9

.
", I, . *&
/* ;0

& ; 5. "
&

&
90&
"0 @ V ) "
.P K
60 &
<
& &
<
"

H6< &
? )

9/# j ...&
/* ;0

e
.()*
"0 ", 3# 70)
>

&
#6
? )
G)*

&
G5&

H6<
.E
/#

H6< ; I, 5 & $# "0

# 5>) 0

A :< %
# #, 9/ ) E :* < >#
/ P ", >,
t
) ?
&
" / 3 5
& "0 G :0 # 7(0, G(7 0

.

&
(:

"V
H# */ 7 0
7(0
0 .I#
=%
" Q/ ed "
F

M
0 I;
M
^ A
J Q/ "

#
5. " H I6
I#
9
)

"
= M>
5

G;
0 .I)

(0
) :#
+
M, )
?
&

A
J IF 0
Q/
; I, 5 & "n G

.
I
Q/
;
" * & Q/ 9 #

3*
", ) 6<
6< E <# Q1 /
, GI#
=%

+ 3/ K
6 .@ +
) > )
5)#
.# " H/# J A /
5)

9/#
%
0
, !
", 9L

&
", ?J G
@
= I6
I0
-.)
#
/# J "0 O& # A
?
./ :
"0 0
, !

:) $ X7 )$ .>% &; $) 0# - " 2 $/ 0
/# $ 2W3
?
&
A I& G *&
/* ;0
%*
"
<
&
:0
=# ", 06 DM
#n @< " >0, &
H6 9 ? #
3*
DZ .=%
1 A :0
</# ", 3#
#6

.0
, !
/#

&
5
5:/

.!
/# ) 0
/
&
' A& P G# ?
&
A G!
A +
) D`
.! I 50( !
/# / :
' ", ) DP

=# 5&

&
/* ;0

5 O&J , < !
A +
&
/
D\
.)
I&
@
# 9 ", ) : 50( !
A(. D] .@: H#

&
; 7/ G^ /* ;0 >V
9/#
)

=
I&
5#
) ", $# G%
! "0
, !
P
/
:
' .>V
3/& E#J , E/ J

& ;

>
?
/ >V G()*
? -6
A I& I6
) I&
/* ;0
5#
>V
0

:

5. "
&
H6< " )
"0 .0
P
3/ I, G/ -6 A
J 5$& @)#
)
", I, . *&
/* ;0

& ; 5. "
&

&
90&
"0 DM
H6< $) 6J G

DZ .P K
60 &
<
& &
<
"

H6< &
?

"

H6< &
? )
5 5 & 7/ / >V I, A
J /* ;0

(I
I/
A) I/# 5
& $/# ", " $ ? G

D` .P K
60 &
<
& &
<
. , 58*) G

$/

" , +( 50
/* ;0 %* < .

H6< ."/ *& .
< # >, 70 E/ 06
. * G%> G*( <# *(
& "
=
:
= 9 9#/ 50
"
& )*
H6< "/ M G
>
& M
:0
% 0
.@ *&

G@: A P&
<? +? " @ 0
0
*
)
E$ &
H6< "/

.@ $* </

M:& G@ 5 &

;
% "/ *&

F " 0 # #, 5:/ 7(0 )
. )
&
@
& <# %.
)

H6< $( ", " ."/&
"0 9
>0
+#J " <L G0

K 06
5)
Y 5&
)
? )
.@ *&
&
/* ;0

H6 50( +# H6< ", " G
:

< "0 : >/? /
H6< " >
M:&
9<,

&
$) *(
.
*&
/* ;0
5#

"0 G*(

"0 @ , 7(0
.50
> 50( /#

% $) *(

", :5 Q, 0 .&
#6
?
" 5 7)

.
*&
/* ;0
5#

"0 G < )

"0 "0

I, .=
A
?
&
*/ A
J IF 6< G&
#6
?
&
>V %
.) /# A
J IF )
<

",

=
)
0

&
< .

*(
6< 3/
//1 <#
3/1 Q&J
.

.$) )7 $ $ & 7 $ ( $
.$ $ & =7 9 '" 2/(1 $ A

G

& I, /# = O& &
#6
?
&
!0 " I (

.
& I, /# '/ O& &
#6
?
&
!0 " #) <

!0 A
J 5 (*) # ) A I& GI&
%*
5&
J (
G

H6< ", 06
5&
6< , G

H6< $( 7) , 5 5 & "0
.@. I6
(
#6
&

&

" @ 50) E0/ 9/#
+
.
)
1 8O A @%

7) GI&
/* ;0

./
,
0
$/#
' 9/#
7) G(<L 5:/ #/ , .
:<, >0 G&

5 , 7) 5 & A
J IF
3/1 ,
. (
*)
)

&
e
.9 50( /#
@
& @& " )#
)
I, G0

&
j
0 K 50( 1 H6< 5 "J .&
%*
"# 5 5 & A
J IF
G0
1 5 i
.9/#
)*

9P
.9/#
)8 :6L 5 , G
:6;
)

J :" W
6;
+/ l
50( =$# %
/
%*
9/#
5)# (..GQ GS#) 9)
, P
9 " W
O$
g
.&

>
?
&
A 38;
#

( Q/ 7
? < )
6< (
" Q)
1 5 & /:
3/

:6;
9P
A
J G>0, >0, @/ 9
#
3*
, ", 6 $/# ,
&
H6< .&

.3)(
A I6

$ $9 B%
% #
#, 0 9 G"/ `

&

&
/ %*
5& ( " <#
%.)
">&
" >0
7(0

& H# / +#J 6 "0 K
6 A + G&
Q/ & 9> " %*
( Q/ & =*/ >0
,
: >/? #1 H6< Q&J ."/ 9/# 50( A $/# ", 5% &
%*
7)
.9
)
5& E)/ E( (
( ) $ $

J$# 4$ &
# $% &

"

! "!
3 0# $3 2- "/ . 0 1"
* + , - .% " . '

' (!
.+4/ 5-! 6"!3 " 7
!/, ", " 9L

A .>0
)
O&1 " / - < &
%*
!
#J # "J
5. #)
" "V >, % E# %
3#
", ?J G(Y
I, 3/&) E 50 50( 9 L <P

.(

) / %*
5& 5) 5 G>F " <L , GI&
5
, /#
&
A
J ) ? !

O&, ) / )
5 ! 9
< GDr. George Egely #J -# 0
#
6< 9 Y "J
.%*
5 5& @ J .9)
;
0

%*

;J -# 0

/? ", .&

@
& >F (
"& %*
" Q/ "V E# 7) ' , ", )
"n GQ, & " .+
Q
$/# 7/ * E, "V ) % "
" *
&
%*
Q/

)
I/#
)
+1 " & / @ , ) 6< G= @
&
%*
Q/ "0 I6
(

/ "J .L$ $ $ % G " J$% c( K
'/
$) / / 0? Y
5$ .Q/

9
/ 7?N : ' , % .
K J 5& " 6& > < %*
" Q/ P
6J GE# */ 1 .9
&
%*
$( ) A ") &
9
& F
" )/ O& G9
)
5&
#
/
*;
G@
I6
+6;
) @ 3/ " O&
< @) K 50 G %*
5& "0
%*
5& ) G3/
6< 38 # < @) K 50 3/
) ) (3/, " <L ..G&
* "
.X&
$# * H6< !
, !E# Y?
, 8 K "

7/ )*
@$( Q/ A P& .8)
$&
3/ < G!/1 < I&
%*
5# "J
GI% I&
5&
"0 6n .M> I<# 50( I&
5&
5 K

# "1 .@ "0 G
?
&
' G7) I&
5&
"0 6J .=
A */ % )*
$&
?
&
"0
./

?
&
Y 3/& 1 /# A
J IF
)*

)! 7 9 #
*%,
)( " " $/ $$4 0

=# #
.1 0( G/

*
W
A ":
5% "
#.)
" >0
30
06

) 7(0? >& /* ;0 M.*J #, " <L G#/
M /* ;0
)(1 -.)
5>
H6< A +
&# % G/
0
? Q/
= 5) )# G(M/
/
&?
.(&( /,
*
) E>,
K ", " G50
#
:0

.
0
A +
" 0 G#/ M /* ;0 # M* 0
J #,

&
A 8>F
/* ;0
#
H6<
=*/ * 0
#1 ", '& 5< :< 5F/

X.
(E#J , E/) ?
/* ;0 # " E, < #

)
%*
!
,
X* / 5 ? 0 ( ? ()
A >F ", )
#
H6
"0 5< G5 ? =*/ ,
*
XE /
+(1
90&
"/ =*/ 5< .XA1 06
0
#1 5 ! 5) ", )
#
H6
"0 5<
.X0
*/ .
?
&

/ @ 0
"/ )* % J ...!>0 0, +0 ..!9) < 3#

. V(

)
<, >0 3/1 K
6 G/ 70
G

& I, /# = O& &
#6
?
&
!0 " I (

GE6J
K
6 .
& I, /# '/ O& &
#6
?
&
!0 " #) <

I6
(
#6
&

&
!0 A
J 5
(*
) #
)
A I& 1
@%

7) GI&
/* ;0
5&
6< , G

H6< $( 7) , 5 5 & $# .@.
,
0
$/#
' 9/#
7) GE0/ 9/#
+
.
)
1 8O A
./

" O&
& 9)
@# "0 ? E6J 6 GM.* A K
6 K( I, "0 ", " G&
H6< A
J 9)
5 ", )
"
=
5:/ " O&
" E? "/ /* ;0
)
5&
6< *( A / 5:/
? E/# :
9>#
5% ", & >, ", ) .X9/#
E//, $
0

9>#
5% 5.
= GK
6
& / ", $# 9>#
H6< /# A
J E: 5

)
? ?&
A +
0
." )
(
E: & / <
", 9)

:
A P&
< @) K 50 .<L , )(J ? 0 ? +*, A
J #& /
(
)*

#
&
A P&
) 580 7/ 5&
6< .E*( K I&
5&
+ 3/
:6;
9P

%
)
)
"I&
*
" 5>

# Q ")// G:
)*
-.)
K
60
? G<&
5) )*
Y . ) 5# " # 0
)*
# % " <L , GE.> 9/#

) 9) ", 3# G@0// I6
#
M*
A A
1 *
, 0
"0
.&, " @# I, , &, (
.
$1 1
. I1 ) 5& K/ $

?&
=# #
) $0 98) G
3 # $0 K/# 5) 70 98)
.. E# :*
)/ ?&
I, .* }E# & 7P "0
G(/
+*1 A
J #& K , '&
$, .$
1 )/ , p*
L A
J 5
#& , =*
< G:#
$

$/
O&0
98) K/ 7> ", 51 " G" .
" 1 A/ A& ,
1 , $
2
/

>0 0, "0 * $
E& +
K a"n 9)
A .I
?
9
" E)
&
#
) $0
IF K/# 9/ K " 7) 7/ "
" *
1 5 a"J .
)*
M*
) K8 ,
.K&
E * >0, +( A
J
IF G0 I& I **& A
J
.2
#& K , 5
0

*
6 KL 5/L A 5 % 9P
$3*
.+*2
#& /
,
*
* H6< A ":
3# A
J 51 M /? < K
6 5) " /:
9L $", < &

.#

% GK
& " )*
$/#
5)
G=#
M
a", KJ 5. " G6
7>
98)
5. " K/
.K/ )

5:/
\50 K$
+ ? 9/ 5

G % 91 )*
= 5) 70 9) ", < @) K 3# I6
&
+(

7)
3#
M:&
) K < .&/
<<P 5$V GK
& " )*
A >0, 7)
< !
5$, .K
.&
A
J 5 7/ /? G
!..= # 9 9 ." 9 #$# 9 #$ )..$:) B$

G %A

A

العلاجات المحظورة وامبراطورية الطب الحديدية - 39474

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

العلاجات المحظورة وامبراطورية الطب الحديدية - 39474

Uploaded by

Copyright:

Available Formats

‫ﺍﻟﻌﻼﺟﺎﺕ ﺍﶈﻈﻮﺭﺓ ﻭﺇﻣﱪﺍﻃﻮﺭﻳﺔ ﺍﻟﻄﺐ ﺍﳊﺪﻳﺪﻳﺔ‬

‫  ‪$ ! % $‬‬

‫ )(‪& ' $  $‬‬

‫‪, & ' $"+  *$‬‬

‫‪-%  ." & $/%‬‬

‫‪$ $ % 0 1  2$34‬‬

‫ ‪5 6‬‬

  &  &7 $(1 '

 ;  .

$ = : *$  #( <#

9$"( )$  $$ 9 ; ..$>:" $  $

$1 B$  .$ 

" 6$ , + C)

)( = % 1  $ "   .."$4 $ 

=$ ,"   2

% $ ) % ..:$!

DDD"+ DD% #D

$$   #

$/  -$ $   )  A

 DF ! % E$ &  )  A

$  $ G  $>:" -$$7) '

A " % "5<" 30/

@/ (   G   (1 

I, G".. > ,   T 

"/  S  @ V 9)  "0  . ) >  300

@/  9 . 1 @# A "/ J 50 &  * A

0, @P & , G" ()

0 .I ."#

 9) "

  ."+ >

."3L  3/& @# @)# +( 0 =#

 $ J

G" $ & G380 9  " _( "

ebeg . 0 )# Q&J  G9)

" "N "6)(

E)  G@    !/, A % H   , I6

!L K   H$/ /0

! <$ $&

!!Q $ $  -$ $" 9 $A

) A 7$ ) "N   .K

29   C)S 6 $ 0

9, $"V 9 + 9

E$  9  )  2"$ = +" ') 

W / 7/ G&/1  ) 9

)" $   =T $ ! 

$  + #J *(  "*  ( 0 : E  ) : 6;

/ 6 

9  .* + 

$ A 6 &7

>0, 6< 50 – + 

+ / . & " "6

&  $$   #$#

Q " $&

! ) 8  9 #$#

" !/, I, 

$ ! % $ 

+( 9< $:  0 ( I, Q

>0, 6< 50 – + 

9  .* + 

Q " $&

"   < "

 / O& G

 "* (  &

‫ ‪$ ! % $‬‬

‫ )(‪& ' $ $‬‬

‫‪, & ' $"+ *$‬‬

‫‪-% ." & $/%‬‬

‫‪$ $ % 0 1 2$34‬‬

‫ ‪5 6‬‬

& &7 $(1 '

; .

$ = : *$ #( <#

9$"( )$ $$ 9 ; ..$>:" $ $

$1 B$ .$

" 6$ ,+ C)

)( = % 1 $" .."$4 $

=$ ," 2

% $ ) % ..:$!

DDD"+ DD% #D

$$ #

$/ -$ $ ) A

DF ! % E$ & ) A

$ $ G $>:" -$$7) '

A "% "5<" 30/

@/( G (1

I, G"..> , T

"/ S @ V 9) "0 . ) > 300

@/ 9 .1 @# A "/ J 50 & * A

0, @P & , G"()

0 .I ."#

9) "

."+>

."3L 3/& @# @)# +( 0 =#

$ J

G"$& G380 9 " _( "

ebeg .0 )# Q&J G9)

" "N "6)(

E) G@ !/, A % H , I6

!L K H$/ /0

! <$ $&

!!Q $ $ -$ $" 9 $A

) A 7$) "N .K

29 C)S 6 $ 0

9, $"V 9+ 9

E$ 9 ) 2"$ = +" ')

W / 7/ G&/1 ) 9

)" $ =T $ !

$ +#J ( " (0 : E ) :6;

/ 6

9 .* +

$ A 6&7

>0, 6< 50 – +

+/ .& " "6

& $$ #$#

Q " $&

! ) 8 9 #$#

" !/, I,

$ ! % $

+( 9< $: 0( I, Q

>0, 6< 50 – +

9 .* +

Q " $&

" < "

/ O& G

"* ( &

5& @ 0n "0 .&

".> " <) - "$&

; 5 , " G3:

0( & @# < 0 G, W " "6

P //V ebef 9 9> .9)

, G)

9 6 , &

M) ) I, P '/ ? // ! (/1 )

@<J I)

K < "0 G(FDA) 6L1 1 J 3/& G@8 , = G

5) 6 9) "0 9

", P,

G@6 0 //F !: @ 0 0 " G@

A M 0

E :/ %

!L . .K 8%

M* " , 5

9, 5:, //V $9